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ABSTRACT 
1.1 Background 
This thesis is a narrative based on twelve papers published in international peer-
reviewed journals between 2000 and 2012 arising from the Victorian Adolescent 
Health Cohort Study (VAHCS) centred round the natural history and consequences 
of adolescent cannabis use. The VAHCS, conducted at the Centre of Adolescent 
Health (CAH), Murdoch Childrens Research Institute, is an ongoing population-
based cohort study that commenced in 1992, with 1943 participants and nine waves 
of data collection: six in adolescence between the ages of 14 and 17 years and three 
in young adulthood when the cohort had an average age of 20, 24 and 29 years.. 
I was VAHCS Project Manager from 1996 to 2004, overseeing data collection at 20 
and 24 years. During this time and subsequently I contributed to papers describing 
adolescent and young adult cannabis use. We initially focused on describing patterns 
of adolescent use, and later on continuity of use and adverse consequences in young 
adulthood. Initially I published as first author and, after retirement in 2004, as second 
author, with Professor George Patton (CAH) and colleagues from the National Drug 
and Alcohol Research Centre at the University of New South Wales as lead authors. 
When we commenced publication in 2000, debate was polarised between belief that 
adolescent cannabis use was benign and transient and another that it was potentially 
damaging, with risks for escalation to more damaging drug use. There was little good 
evidence to inform the debate. Most information on cannabis use arose from cross-
sectional and retrospective studies, with little distinction between occasional and 
regular use. It was already documented that adolescent cannabis use was associated 
with antisocial behaviour and other substance use. However, there was poor 
xviii 
 
understanding of the importance of these factors in the initiation and escalation of 
use. Likewise, whether cannabis was a drug of dependence was still debated in the 
1990s with little understanding of symptom patterns or natural history of use, despite 
the diagnosis being included as a diagnosis in the DSM manual. 
We addressed these gaps by examining prospective data from the VAHCS describing 
cannabis use from adolescence to young adulthood. Specifically, we explored risks 
for escalation of use to dependence and problematic use. We then assessed the risks 
cannabis posed for other licit and illicit substance use as well as mental health and 
psychosocial outcomes. We were also well placed to examine the interplay between 
cannabis use and substance use, mental health and psychosocial outcomes as young 
people progressed through adolescence to young adulthood. We measured licit 
substance use, cannabis and amphetamine use throughout the cohort study, with 
further assessment of cocaine and ecstasy use in the young adult phase. We also 
assessed anxiety and depression symptoms at each wave, transitions in education, 
relationships, childbearing, welfare dependence and other social outcomes. Important 
family, peer and background covariates were assessed and included in analyses as 
appropriate. Once we had progressed to analysing young adult outcomes, we used 
the innovative procedure of multiple imputation to adjust for potential bias arising 
from missing waves of observation. 
1.2 Chapter 1 
The introduction presents an overview of cannabis use in Australia and outlines some 
of the important unanswered questions about the natural history of use and the 
consequences of long term use. It provides an outline of the global spread of 
cannabis use in modern times and the development of drug control legislation in the 
xix 
 
United States and Australia, outlining the historical debate and current evidence on 
the longer term effects of regular use. Cannabis use in Australian adolescents is 
described and, more broadly, the natural history of cannabis use from adolescence to 
adulthood, to underscore the relevance of this to adolescent health and future well-
being. The biological mechanisms of intoxication and the mechanism underlying 
adolescent vulnerability to harmful consequences are presented, including brief 
discussion of the rimonabant trial and early research on genetic susceptibility. 
Finally, unanswered questions dating from the end of the 1990s are described, 
leading to the introduction of a population-based longitudinal study of adolescent 
health and development - the Victorian Adolescent Health Cohort Study, the study 
on which the papers described in this dissertation is based. 
1.3 Chapter 2 
This chapter presents a detailed account of the methodology of the VAHCS, and my 
contribution to its conduct, commencing with definitions of adolescence and young 
adulthood. An overview of the VAHCS methodology is given, followed by detailed 
descriptions of sampling, ethics approvals, consent processes, survey administration 
methods, tracing, follow-up and ascertainment by wave. All measures relevant to the 
papers to be presented are described with their corresponding data reduction. They 
are in the domains of background and time varying measures specific to the 
adolescent and the young adult phases of data collection. The derivation of summary 
adolescent measures is described, thus illustrating problems encountered due to 
missing data, a major challenge in all longitudinal studies. The various strategies we 
have used to deal with these are presented, including the application of multiple 
imputation. My history with the VAHCS is detailed including my contribution to its 
management as Project Manager over the ten years from 1995 to 2005, my ongoing 
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role in the VAHCS since my retirement and my involvement in the dissemination of 
its findings. An overview of the global context for the VAHCS is given, by 
comparing this study with other population-based cohort studies, along with the 
novel contributions that the VAHCS offers. Finally, cannabis use within the study is 
described briefly in order to provide the context for the following chapters. 
1.4 Chapter 3 
This chapter presents five related papers addressing the natural history of cannabis 
use from initiation in adolescence to continued use in young adulthood. I briefly 
describe the context, methodology and findings reported in each paper. The papers 
are presented in the order in which they were written in order to clarify the links 
between them. The first paper examines the factors associated with early initiation of 
cannabis use during adolescence, to age 17. This is followed by an paper examining 
adolescent precursors of cannabis dependence at age 20, noting the influence of early 
initiation and the possible protective influence of risky alcohol use. As a direct 
corollary to this last observation, the next paper examined in greater depth the 
diverging trajectories of cannabis use and risky alcohol use from adolescence to 
young adulthood, as far as 24 years. The focus of the following paper was the role of 
early onset adolescent cannabis use in predicting escalation to daily cannabis use and 
dependence at 24 years. It was apparent that regular cannabis use in adolescence did 
not inevitably lead to dependence, thus leading to the final paper in this series, 
examining the risk of escalating use and dependence in young people who moderated 
their cannabis use during adolescence. 
The following papers are synthesised in this chapter: 
xxi 
 
Paper 1. Initiation and progression of cannabis use in a population-based Australian 
adolescent longitudinal study. Coffey C., Lynskey M. Wolfe R. Patton GC. 
Addiction. 95(11):1679-90, 2000 Nov 
Paper 2. Adolescent precursors of cannabis dependence: findings from the Victorian 
Adolescent Health Cohort Study. Coffey C, Carlin JB, Lynskey ML, Li N, Patton 
GC. British Journal of Psychiatry 2003; 182: 330-336. 
Paper 3. Trajectories of adolescent alcohol and cannabis use into young adulthood. 
Patton G.C., Coffey C., Lynskey M.T., Reid S., Hemphill S., Carlin JB., Hall W. 
Addiction. 102(4):607-15, 2007  
Paper 4. Adolescent cannabis users at 24 years: trajectories to more than weekly use 
and dependence in young adulthood. Swift W., Coffey C., Carlin J.B., Degenhardt 
L., Patton G.C. Addiction. 103(8): 1361-70, 2008. 
Paper 5. Are adolescents who moderate their cannabis use at lower risk of later 
regular and dependent cannabis use? Swift W., Coffey C, Carlin J.B, Degenhardt L, 
Calabria B, Patton G.C. Addiction 104(5): 806-14, 2009 
1.5 Chapter 4 
This chapter presents a single paper addressing the question of the influence of 
adolescent cannabis use on early high school leaving. The background to that paper 
is discussed, followed by a short summary of the methods and findings. 
The paper discussed in this chapter is: 
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Paper 6. A longitudinal study of the effects of adolescent cannabis use on high 
school completion. Lynskey M,Coffey C, Carlin JB, Patton GC. Addiction. 98 (5): 
685-692, 2003. 
1.6 Chapter 5 
The tendency for cannabis users to progress to using other substances has long been 
a concern. We examined the parallel development of problematic cannabis use and 
alcohol use in adolescence (Patton, GC et al. 2007), concluding that young people 
often choose between these when their use escalated to abuse, possibly in response to 
availability. A brief summary of adverse outcomes of adolescent cannabis and 
alcohol use in that paper foreshadowed a more detailed examination of these in the 
papers included in this chapter, including psychosocial outcomes such as educational 
attainment, welfare dependence, anxiety and depression and personality disorder. 
The first paper examined the possibility that cannabis use by non-smokers increased 
the risk of subsequent cigarette smoking uptake and nicotine dependence measured at 
24 years. The focus of the next section is a discussion of our paper addressing 
outcomes for both occasional and regular adolescent cannabis users with respect to 
psychosocial, mental health and substance use outcomes at the same age. This paper 
forms a corollary to the final paper discussed in Chapter 3 which examined cannabis 
use outcomes in young adulthood associated with moderation of cannabis use in 
adolescence. A recently published paper is presented next, in which risks associated 
with cannabis use for both problematic licit and other illicit substance use in young 
adulthood at 29 years are assessed. The final paper in this series examines the 
predictors and consequences of adolescent amphetamine use. The dominant role of 
adolescent cannabis use in our assessment of the outcomes illustrates the importance 
of this in relation to other illicit substance use. 
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The following papers are synthesised in this chapter: 
Paper 7. Reverse Gateways? Frequent cannabis use as a predictor of tobacco 
initiation and nicotine dependence. Patton G.C., Coffey C. Carlin J.B., Sawyer S., 
Lynskey M. Addiction, 100; 1518-25, 2005 
Paper 8. Outcomes of occasional cannabis use in adolescence: 10 year follow-up 
study in Victoria, Australia. Degenhardt L, Coffey C, Carlin JB, Swift W, Moore E, 
Patton GC. British J Psychiatry 196, 290-295, 2010 
Paper 9. Cannabis and progression to other substance use in young adults: Findings 
from a 13-year prospective population-based study. W. Swift, C. Coffey, L. 
Degenhardt, J.B. Carlin, H. Romaniuk, G. C. Patton. J Epidemiol Community Health 
2012;66:e26 Published Online First: 19 July 2011 doi:10.1136/jech.2010.129056 
Paper 10. The predictors and consequences of adolescent amphetamine use: findings 
from the Victorian Adolescent Health Cohort Study. L Degenhardt, C Coffey, P 
Moran, J B. Carlin and G C. Patton. Addiction 102(7): 1076-84, 2007 
1.7 Chapter 6 
The VAHCS was designed to look at the common mental disorders which had, to 
date, received far less attention than the relatively rare mental health disorders of 
psychosis and schizophrenia. By the time of writing the first of the papers included in 
this chapter, it was reasonably well documented, though not universally accepted, 
that substance dependence and depression and anxiety co-occurred in both clinical 
and population samples, but these observations were cross-sectional and made 
primarily in adult populations. Uncertainty remained as to the direction of the 
association in adolescence, that is, whether cannabis use preceded these mental 
xxiv 
 
health problems, or young people used cannabis to self-medicate, or whether the 
association was an expression of other factors common to both conditions. This 
question has been addressed by two separate New Zealand cohorts originating in 
childhood. Although they confirm an association, their findings were inconclusive as 
to direction and causality, other than an observation that early cannabis users were 
vulnerable to later poor mental health and social outcomes. 
The VAHCS was able to address temporal questions regarding regular cannabis use 
and mental health, as it encompassed the developmental period when there is a high 
risk of cannabis use escalation and when common adult mental health problems often 
first manifest. There is a description of our paper examining the cross-sectional and 
longitudinal associations between cannabis use and depression/anxiety symptoms in 
Wave 7 at 20 years. This is followed by a recently published paper which discussed 
the association between adolescent cannabis use and the diagnostic outcomes of 
major depressive disorder and anxiety disorder at 29 years. The two papers are 
summarised, including a supplementary analysis of the Wave 7 data. 
The following papers are synthesised in this chapter: 
Paper 11. Cannabis and mental health in young people: cohort study. Patton G.P., 
Coffey C., Carlin J.B., Degenhardt L., Lynskey M.L., Hall W. BMJ 2002; 325 
(7374): 1199-212 
Paper 12. The persistence of the association between adolescent cannabis use and 
common mental disorders into young adulthood. L. Degenhardt, C. Coffey, H. 
Romaniuk, W. Swift, J. B. Carlin, W. D. Hall, G. C. Patton. Addiction DOI: 
10.1111/j.1360-0443.2012.04015.x 2012 
xxv 
 
1.8 Chapter 7 
Chapter 7 commences with a summary of the findings from the twelve papers 
included in this thesis relating to the natural history of cannabis use and those 
concerning the consequences in educational achievement, illicit substance use and 
mental health. A critical appraisal of the strengths and limitations of the VAHCS are 
presented to interpret the findings about the natural history and consequences of 
cannabis use. Possible biological mechanisms for the consequences of regular 
cannabis use and comorbidities are discussed. The translation of findings into 
practice in terms of public education, social policy and preventative intervention are 
presented. Implications for future research are discussed and several important 
questions are identified in general and with reference data arising from to the survey 
currently in progress when cohort participants are in their mid-30s. 
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CHAPTER 1 Introduction 
1.1 Chapter outline 
The introduction presents an overview of cannabis use in Australia and outlines some 
of the important unanswered questions about the natural history of use and the 
consequences of long term use. §1.2 provides an outline of the global spread of 
cannabis use in modern times and the development of drug control legislation in the 
USA and Australia. The epidemiology of cannabis use globally and in Australia is 
described in §1.3. In §1.4, the concepts of harm arising from prolonged cannabis use 
from adolescence to adulthood are discussed, to underscore the relevance of this to 
adolescent health and future well-being. Attempts to explain the natural history of 
cannabis use in adolescence and the association this holds with later adverse 
outcomes, such as compromised educational and other illicit substance use, are 
presented in §1.5. In §1.6, influential theories describing the initiation of cannabis 
use in adolescence and outcomes associated with adolescent use are discussed. The 
current understanding of the biological mechanisms of intoxication and those 
underlying adolescent vulnerability to harmful consequences are presented in §1.7, 
including brief discussion of the rimonabant trial and early research on genetic 
susceptibility. In §1.8 some unanswered questions at the close of the twentieth 
century are listed followed by the introduction of the Victorian Adolescent Health 
Cohort Study, a population-based longitudinal study of adolescent health and 
development, from which the papers described in this dissertation are derived. 
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1.2 Modern history of cannabis use 
1.2.1 Global spread of cannabis  
Cannabis sativa, the source of the psychoactive drug cannabis, grows wild in the 
Indian sub-continent and has been used over millennia for its fibre in the 
manufacture of hemp material, for medication and in religious ceremonies as an 
intoxicant. Cannabis is also known as marijuana, hash, hashish, ganja, Indian hemp 
and many other colloquial names, depending on the country of origin, the material 
form of the drug, the part of the plant from which it is derived and whether it is used 
for smoking or as an oil. Its use as a psychoactive drug has a relatively brief history 
in the Anglo-Saxon world, with no reference to cannabis intoxication in the 
European literature until the early nineteenth century (Mikuriya 1973a). By this time, 
cannabis use had become endemic in Mediterranean countries, presumably via the 
spice routes from the Indian subcontinent. Indian hemp made its way into Bohemian 
circles in Paris via the Napoleonic Egyptian campaigns (Carlson 1974) and into 
Britain via Indian colonisation. 
Widespread recreational cannabis use did not gather momentum in Western countries 
until the turn of the twentieth century. Cannabis entered the United States from Latin 
America, brought in by Mexican workers, thence into the Afro-American musical 
sub-cultures, taken up by white musicians and entertainers, by radical and non-
conformist groups and thus into the mainstream in the early 1960s (Musto 1972). 
The Mexican origins of cannabis in the United States is underscored by its local 
name of “marijuana”. 
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1.2.2 Drug control legislation 
International drug control, primarily directed towards containing recreational opiate 
use and controlling trade in medical use of listed substances, was ratified by the 
Geneva Convention in 1925. The Convention was auspiced by the League of Nations 
and was an extension of the pre-World War I Hague Convention. This was 
subsequently ratified by all Australian State jurisdictions in the 1920s. Indian hemp 
was specified in the list of restricted substances, despite there then being no 
conclusive evidence of harmful consequences of use, and its use virtually unknown, 
being first mentioned in the press in 1938 (Manderson 1993). At this time, and until 
the 1960s, Australia largely followed the British Department of Health model, 
whereby illicit substance use was regarded as a disease and was therefore considered 
to be a medical problem in the middle classes, if not in the “undesirable classes” of 
prostitutes, criminals and the ageing Chinese population. In contrast, the addict in the 
United States at that time was considered to be “irredeemably degenerate,” a view 
promulgated and promoted by Anslinger from the 1930s through to the 1960s, 
leading to the culture of strident prohibitionism, later intertwined with anti-
communism (Manderson 1993). 
Between the world wars, US legislation outlawing cannabis use occurred in an 
environment of experimentation, radicalism, criminality, fear, ignorance and 
superstition, and was based on speculation fuelled by emotion (Robson 1997). 
Recreational use of alcohol was banned in the United States in 1920, so it was argued 
that cannabis use should likewise be controlled. In the lead-up to national cannabis 
prohibition in 1937, a conflation of political expediency and alarm over widespread 
cannabis use in the Latino Diaspora held sway, despite the more reasoned and less 
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sensational views of the American Medical Association. Law enforcement agencies 
blamed cannabis for problems associated with Mexican labourers, who were 
sometimes there illegally, often criminal, and then progressively more unwanted as 
the country lurched towards economic depression in the 1930s (Musto 1972). 
As the United States gained worldwide influence and specifically, as Australia 
became aligned diplomatically with the US rather than Britain after World War II, so 
these opinions dominated the Australian drug debate, giving rise to the use of legal 
sanctions for possession, supply and importation. The influence of the US in the 
emergence and response to cannabis use in Australia is illustrated by the ubiquitous 
use of the Mexican word “marijuana” here. Australian laws prohibiting cannabis use 
as a notorius “sex drug” were passed in 1952, although it was not until 1957 that the 
first cannabis-related charges were laid. The first report of Indian hemp use was 
made by the New South Wales government in 1960. Thereafter, illegal hemp use 
accelerated: by 1967, 57 hemp addicts were reported (compared with 24 morphine, 2 
cocaine and 3 heroin addicts), and in 1968 one hundred cannabis-related charges 
were listed, predominantly in young adults. NSW saw the increases in substance use 
first, as it was then the initial point of contact for trade with the Pacific and Asia, but 
use soon permeated throughout Australia, helped along by US soldiers on leave from 
the Vietnam War (Manderson 1993; Pennington 1999). 
1.3 Epidemiology of cannabis use  
1.3.1 Prevalence 
By the late 1960s, cannabis had become, and remains, the most commonly used 
illicit substance in Australia (AIHW 2010) and worldwide (UNDOC 2010). Most 
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recent estimates (from 1999 to 2008, mostly 2004 onwards) of one-year prevalence 
of cannabis use in 15 to 64 year olds by country are shown in Figure 1.2.3, 
illustrating clearly that its use has permeated all countries with available statistics 
(UNDOC 2010). From these data, the annual prevalence of cannabis use was 
estimated to be between 2.9% and 4.3% of the global population of 15-64 year-olds. 
Ranking countries by prevalence shows that USA was 7th worldwide, with a 
prevalence of 12.5%, Australia was equal 11th with a prevalence of 10.6 % and the 
United Kingdom 26th with 7.9% prevalence (these estimates were dated 2008, 2007 
and 2009 respectively). The prevalence of recent use of cannabis in Australia in 
people aged 14 and over was estimated to be 13.1% in 1995, decreasing to 9.1% in 
2007, but possibly (taking into account sampling error) increasing again, with the 
most recent estimate at 10.3% in 2010 (AIHW 2010). This increase was apparent in 
both the 14-19 age groups (12.9 to 16.7%) and the 18+ (8.0 to 10.1%), but was 
statistically significant only in the latter group, presumably due to greater precision. 
All jurisdictions other than Tasmania showed apparent increases. 
 
Figure 2.3.1 The most recently available estimates of the annual prevalence of cannabis use 
as a percentage of the national population aged 16-64 
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Data source: UNODC, World Drug Report 2010 (United Nations, Publication, Sales 
No. E.10.XI.13). 
1.3.2 Adolescent cannabis use in Australia 
Cannabis use is recognised as being typically initiated during adolescence, with 
patterns of heaviest use usually occurring during late adolescence and young 
adulthood (Chen & Kandel 1995). The 2010 National Drug Strategy Household 
Survey (NDSHS) reported estimates of cannabis use in the past year: 8.8% of 12-17 
year-olds, 21.3% of 18-19 year-olds, 21.3% of 20-29 year-olds, 13.6% 0f 30-39 year-
olds, and 4.7% of those 40 years and over. In total, 10.3% of the Australian 
population were estimated to have used cannabis in the past year (AIHW 2010), a 
significant increase since the previous estimate of 9.1% in 2007. Clearly, cannabis 
use was initiated by many adolescents whilst still at school, with an appreciable 
increase by 20 years. 
Table 1.3.2 shows the frequency of use by past-year cannabis users by age group and 
sex, estimated in 2010 as reported by the NDSHS in 2011 (AIHW 2010). Thirteen 
percent of recent users aged 12-17 year-olds, 35% of 18-19 year-olds and 29% of 20-
29 year-olds reported using cannabis at least weekly. More recent cannabis using 
males than females were using at least weekly.. 
Higher rates of cannabis use was evident in some sub-groups. Although 
socioeconomic status (SES), education and remoteness had little influence, the 
unemployed, students, unmarried, Indigenous Australians and those who self-
identified as homo- or heterosexual were more likely to have used cannabis in the 
past year than the general population. We therefore must consider whether there are 
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specific environmental and social causes and consequences relating to uptake, 
continuation and escalation in use, as well as the possibility of toxicological 
consequences resulting from exposure to cannabis during adolescence. 
 
Table 1.3.2 Frequency (percent) of marijuana/cannabis use, in recent users (past 12 months) 
aged 12 years and older, by age and sex , Australia, 2010 
 
 
a. Large standard errors as a result of small sample size. 
 
Source: Australian Institute of Health and Welfare: 2010 National Drug Strategy Household 
Survey report, July 2011. AIHW cat. no. PHE 145. Canberra: AIHW (Drug Statistics Series 
No.25). 
1.4 Modes of delivery 
The dried leaves and buds of the female cannabis plant are rolled with tobacco into 
‘joints’ and smoked in pipes, water pipes or bongs. Hashish and hash oil are made 
from the fat-soluble resin extracted from the plant by threshing and can be cooked in 
cookie mixtures or added to milk. Hash oil is the most potent and expensive form of 
cannabis. Other illicit drugs are sometimes mixed with the resin or sprayed on to the 
dried herb. Plant potency may depend on the climate and method of cultivation, as 
well as which part of the plant is used (McLaren et al. 2008). The dose of psycho-
active ingredients absorbed by the smoker depends on two factors: the quantity 
contained in the plant, which can vary from traces to 18%, and on the method of 
smoking. Inhaling and holding the smoke greatly increase the absorption of these 
Persons
12–17 18-19 20-29 30-39 40+ Males Females
Every day 1.8a 10.1a 12.3 14.0 17.6 13.8 11.7 13.0
Once a week or more 10.9 24.8 16.8 23.2 27.0 23.3 17.0 20.9
About once a month 18.5 17.5 12.9 12.5 12.3 15.2 10.6 13.4
Every few months 21.7 20.2 20.2 15.4 15.1 17.7 18.4 18.0
Once or twice a year 47.1 27.4 37.8 34.8 28.1 30.0 42.3 34.6
Frequency of 
cannabis use
Percent of population
Age group (years) Sex
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substances (Korf, Benschop & Wouters 2007). Smoking from a bong or pipe is the 
most common method of delivery in Australia, with most people using heads (75%), 
followed by leaf (46%), resin (including hash) (11%) and oil (including hash oil) 
(5%) (AIHW 2010). The usual method of cultivation of Cannabis sativa was 
reported to be indoor hydroponic, yielding high potency cannabis with several 
harvests each year, lower chances of detection and higher prices, resulting in a more 
potent and expensive substance, compared with outdoor bush growing (AIHW 
2010). Plant potency is demonstrably variable and whether this has actually 
increased since the 1960s is hard to determine (McLaren et al. 2008) although recent 
estimates suggest that this is so (Cascini, Aiello & Di Tanna 2012). It is possible that 
users titrate their consumption to correspond with fluctuations in potency, thus 
ameliorating potency variations (Korf, Benschop & Wouters 2007; McLaren et al. 
2008). For this reason, variation in potency is possibly of little significance in terms 
of overall chronic toxicity. 
1.5 Concepts of harms arising from long term cannabis use 
1.5.1 Conflicting views on cannabis harms 
In the mid-nineteenth century there was no distinction between substance use and 
abuse and to identify a person as an addict was neither pejorative nor describing a 
disease state (Manderson 1993). Dr. W.B. O’Shaughnessy, Professor of Chemistry 
and Materia Medica at the Medical College of Calcutta, studied cannabis sativa and 
the drug cannabis extensively and in 1838 published this information with accounts 
of his experiments on animals and patients, thus raising medical awareness of the 
drug. Shortly afterwards, Dr Jacque Moreau de Tours, having been introduced to 
cannabis in Egypt, published a book including descriptions of self-experimentation in 
Chapter 1. Introduction 
9 
 
accordance with contemporary practice, and the promotion of cannabis as a treatment 
for mental illness. These publications were responsible for the advent of therapeutic 
cannabis use, for example with insomnia, melancholia and neurasthenia, though it 
was deemed useless in the treatment of chronic mania, stupidity or dementia. 
Medical use of cannabis in the West received attention spasmodically through the 
18th century, finally leading to concern about toxicity and possibly including 
insanity, which ultimately lead to the Indian Hemp Drugs Commission Report by the 
British Government. This was the first significant attempt to assess problems 
associated with cannabis (Carlson 1974). It was commissioned in 1893, published in 
1894, and was remarkably detailed and comprehensive (Mikuriya). This lengthy 
document provided anecdotal evidence from over a thousand informants in official 
and unofficial capacities. Participants were asked questions relating to, amongst 
other topics, the physical, mental and moral consequences of habitual moderate use, 
and excessive use, and the connections between use and crime. Very little harm was 
reported, possibly because few respondents actually had, or wanted to appear to have 
had, any experience with someone affected by the drug. Thus, the report concluded 
that the lack of evidence showed “most clearly how little injury society has hitherto 
sustained from hemp drugs.” Further research into the effects of cannabis use 
virtually ceased following prohibition by member countries following the Geneva 
Convention in 1925, until the surge in recreational use in the 1960s renewed medical 
interest (Mikuriya 1973b). 
Two opposing schools of thought became entrenched. One is that cannabis use is 
essentially benign and should be freely available with the same status in law as 
alcohol and further, that it can endow medicinal benefits (e.g. (Mikuriya 1973b), 
(Robson 1997)). The other view promulgated especially by Anslinger in the US is 
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that its use is degenerate and harmful (Manderson 1993), that it is always 
accompanied by criminal behaviour and its cultivation and possession should be 
controlled by legal sanction. To embrace the philosophy of unfettered use, it was 
necessary to ignore or discount any opposing inconvenient hypotheses (Hall, W 
1999). In the absence of evidence one way or the other, the view that cannabis use 
should be prohibited could be sustained only if it was assumed to be harmful, at least 
as harmful as alcohol and tobacco, and that legal sanctions could provide an effective 
solution to the perceived problem (Manderson 1993). In the last 20 years, this 
principle has been partially waived in some jurisdictions in Australia, as the 
willingness to pursue cannabis-related charges has reduced. Diversion of minor 
offenders to rehabilitation and education facilities has become accepted practice in 
Victoria, Queensland and Tasmania and low-level possession has been 
decriminalised in Western Australia, South Australia, the Australian Capital 
Territory and the Northern Territory. However, arguments in favour and in 
opposition to legalisation have been promoted regardless of the evidence, so the lack 
of evidence was effectively irrelevant (Hall, W 1999), with politicians and public 
alike devoid of concern for public health (Manderson 1993). Thus, there is an 
imperative to establish an evidence base to provide the opportunity to move beyond 
these entrenched positions, and to facilitate rational informed decisions about public 
health and education in relation to cannabis use. 
Another aspect of cannabis legislation involves zero tolerance of use by drivers in 
Australia. This arises from the belief that acute cannabis intoxication increases the 
risk of motor vehicle collision. Although debated in the past, a recent meta-analysis 
concluded that cannabis intoxication of the driver increases this risk, especially fatal 
collisions, although there was insufficient information for the authors to identify a 
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dose response (Asbridge, Hayden & Cartwright 2012). In this instance, the evidence 
base relating to this concern would appear to have informed legislation. 
1.5.2 Current evidence of harm 
The acute effects of cannabis are well known and the immediate consequences of 
intoxication have been easy to assess and describe. Conversely, there has been 
ongoing lack of consensus about whether prolonged cannabis use is harmful, 
specifically, whether: 
1. it is addictive;  
2. it has consequences for mental health:  
i. it precipitates psychosis and schizophrenia;  
ii. it leads to depression and anxiety;  
iii. an amotivational syndrome arises;  
3. it leads to other illicit substance use; 
4. it adversely affects transition to adult roles; 
5. it causes respiratory disease and cancers, similar to tobacco products. 
Cross-sectional, community-based studies and clinic-based case-control studies of 
young people can identify associations with cannabis use and have been used to 
generate hypotheses, but these can be evaluated using only long term community-
based cohort studies, randomised control studies being completely unacceptable. 
Inception into the cohort must occur before cannabis use commences and extend into 
adulthood, incorporating measurement of cannabis use frequency, including 
measurement of important possible behavioural and social confounders such as other 
substance use, family and peer measures, and outcomes of interest. A few such 
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studies have been conducted, often small and with only sparse measurement through 
adolescence, the period of rapid change often heralding outcomes in young 
adulthood. 
1.5.3 Cannabis dependence 
Whether prolonged cannabis is addictive was a point on which the two 
harmful/harmless extreme views originally differed, and still do, sometimes 
demonstrating inconsistency. For example, a prolific proponent of legalising medical 
use, wrote in 1973 that “in the light of such assets as minimal toxicity, no build-up of 
tolerance, no physical dependence and minimal autonomic disturbance immediate 
major clinical reinvestigation of cannabis preparations is indicated.....” (Mikuriya 
1973a), though references to differing acute effects of cannabis in novice users and 
“addicts” appear in reports in the reprinted papers in his book, implying directly or 
indirectly that tolerance was a feature of prolonged use. 
Early understanding of addiction was driven by observations of alcoholism, resulting 
in the idea that withdrawal was essential for a drug to be classified as addictive (Hall, 
Johnston, Donnelly 1999). Tolerance to prolonged cannabis use had long been 
documented, but withdrawal was seen as more equivocal. “Alcoholism” and “opium, 
morphia habit” were included in the 1900 edition of International List of Causes of 
Death. Drug addiction was subsequently omitted, but “alcoholism” continued to be 
included as a cause of death in each revision, and from 1928, a cause of both disease 
and death, as the conceptual underpinning of the classification widened. It was not 
until the development of the eighth edition of International Classification of Diseases 
(ICD-8) in 1965, by now under the aegis of the World Health Organisation. that the 
differing concepts of (psychological) habituation and (physical) addiction were 
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merged into the general diagnosis of “dependence”. This concept could then be 
applied to diverse categories of substances and allowed for variation in symptom 
profiles for different drugs. Within the umbrella term of dependence, psychological 
dependence referred to impaired control over substance use, incorporating 
“habituation” and physical dependence referred to tolerance and withdrawal 
symptoms, incorporating “addiction” (WHO). Similarly, cannabis dependence was 
included in DSM-II (1968), in which the diagnosis required evidence of habitual use 
or a clear sense of need for the drug, without the need for withdrawal symptoms. It 
was noted that “while always present when opium derivatives are withdrawn, they 
may be entirely absent when cocaine or marihuana are withdrawn” (AllPsych). The 
relaxation of the definition allowed cannabis to be classified as a drug of 
dependence, though it was only to receive cursory attention as such for another 35 
years. It is interesting to note that this conceptual shift coincided with the worldwide 
expansion in illicit substance use. It was, effectively, a pragmatic response to 
emerging drug related issues overlapping, but not identical with, the classic opioid 
dependence syndrome. 
From their observation of alcohol dependent patients, a broader concept of 
dependence was introduced, including, as well as tolerance and withdrawal, a 
narrowing of drinking repertoire, salience of drink-seeking behaviour, relief or 
avoidance of withdrawal symptoms by further drinking, compulsion to drink and, 
finally, reinstatement of compulsions to use after abstinence (Edwards & Gross 
1976). The application of these criteria were broadened to encompass other 
substances, subsequently published by WHO in 1981 (Edwards, Arif & Hodgson 
1981) and incorporated into ICD-10 in 1990. Similar to the ICD-10 classifications, 
though not identical, substance dependence was specified in the Diagnostic and 
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Statistical Manual of Mental Disorders (DSM-IV) by the presence of: “(1) substance 
abuse; (2) continuation of use despite related problems; (3) increase in tolerance 
(more of the drug is needed to achieve the same effect); and (4) withdrawal 
symptoms” (AllPsych). It was noteworthy that the nosological work on substance 
dependence and abuse had rested exclusively on alcoholism and opiate addiction, 
and by the early 1990s there was no specific understanding of the features of 
cannabis dependence. Since then the development of tolerance and the experience of 
withdrawal have been demonstrated in the animal model, suggesting that it is due to 
direct association between the CB1 and opioid receptors in the central nervous 
system (Maldonado et al. 2011). The identification of a biological mechanism by 
which tolerance and withdrawal can be explained has aided the acceptance of 
cannabis as a drug of dependence (Copeland & Swift 2009), and a cannabis 
withdrawal syndrome, its symptomatology and duration has now been described 
(Budney & Hughes 2006; Budney et al. 2003). It has been suggested that the 
relatively slow metabolism of cannabis may mask withdrawal symptoms (Murray et 
al. 2007). 
1.5.4 Mental health  
There has long been a perception that cannabis use was associated with poor mental 
health. For example, question 25(f) in the Indian Hemp Drugs Commission Report 
reads: “25. (f) Does it deaden the intellect or produce insanity?”. The question led to 
detailed enquiry about the permanence of insanity (if reported), re-emergence of 
symptoms after “liberation from restraint”, typical symptomatology (if any), ganja 
use by “insanes”, dose effect and so on (Mikuriya). It is clear from these questions 
that around the turn of the nineteenth century, people were concerned, and wanted 
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certainty about the impact of cannabis on mental health, concerns that still have not 
been entirely resolved today. Questions of interest now largely relate to the possible 
association between cannabis use and psychotic illness and the common mental 
disorders, anxiety and depression. 
1.5.4.1 Amotivational syndrome. 
In the 1960s and ‘70s, the idea of an “amotivational syndrome” as a danger 
associated with cannabis had currency. This was invoked to explain anecdotal reports 
of impaired motivation and achievement by regular cannabis users (e.g.,(McGlothlin 
& West 1968). This syndrome was defined as “an impaired desire to engage in 
normal social activities and situations due to external factors such as relationships, 
substance or events.” It included reduced energy and attentiveness, apathy, reduced 
motivation, passivity, and reduced concentration and desire to work. Hall and 
colleagues, in their review of the evidence for the cannabis-induced amotivational 
syndrome, concluded that the existence of this syndrome in heavy, prolonged 
cannabis users was rare (Hall, Johnston, Donnelly 1999). Criticisms of the studies 
supporting the hypothesis included uncontrolled observations, where cannabis use 
was most common in poor communities with high unemployment, so that 
impairment could not be detected, and also that poor mental health could not be 
ignored as the underlying cause. Conflicting evidence was cited in others, for 
example, where lack of employment was not universal amongst heavy users, and, 
indeed, heavy users who were employed consumed cannabis in larger quantities than 
those not employed. Recent advances in understanding the mechanism of adverse 
effects of regular cannabis use on the developing neural structure in the adolescent 
brain suggest that some aspects of this syndrome may be attributable to diminution in 
executive cognitive functioning observed in long-term heavy users seeking 
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treatment, particularly if heavy cannabis use was initiated in early adolescence 
(Crean, Crane & Mason 2011). 
1.5.4.2 Psychosis and schizophrenia. 
Recent reviewers have now established that cannabis use has a cross-sectional 
association with psychosis-proneness (having psychotic experiences in the absence 
of a clinical diagnosis of psychosis), and further, that in non-clinical cohort studies, 
cannabis use independently increases the likelihood of emerging psychosis, at least 
in young people who are at genetic risk of psychosis or are psychosis-prone (Barkus 
& Murray 2010; Semple, McIntosh & Lawrie 2005). A recent case-control study 
comparing first-episodic psychosis patients with a healthy control group recruited 
from the general population confirmed the interaction effect of a putative genetic 
modifier on the link between cannabis use and psychosis (Di Forti et al. 2012). 
Increased risk of later hospital admission for schizophrenia in cannabis users (used 
>10 times) measured at conscription (18-20 years) has been reported, the authors 
suggesting cannabis as a precipitating cause in a vulnerable group, but if this were 
so, it accounted only for a relatively small number of the total cases identified 
(Andreasson et al. 1987). They subsequently extended linkage with the hospital 
discharge register until 1996 in order to re-examine the putative association. They 
identified an elevated risk in cannabis users at baseline consistent with a dose 
response, after accounting for other substance use and the possibility of prodromal 
cases at study inception (Zammit et al. 2002). However, there is contention at the 
population level. In a study comparing cannabis use and psychosis prevalence data 
since 1940, Degenhardt and associates found no evidence that the increasing 
prevalence of cannabis use was associated with an increased prevalence of 
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schizophrenia (Degenhardt, Hall & Lynskey 2003b). The low lifetime prevalence of 
schizophrenia, estimated as 0.4% (Saha et al. 2005), possibly combined with 
diagnostic and reporting variation over time, may have made identification of change 
difficult. Conversely, other investigators have observed an increase in incident 
schizophrenia in parallel with increasing prevalence of cannabis use in the U.K. since 
1965, with a marked increase in the proportion of cases using cannabis prior to 
diagnosis (Murray et al. 2007). This can be clarified using longitudinal population 
studies but the relative rarity of schizophrenia necessitates numerically large samples 
in order to have sufficient power to examine temporal questions relating to cause and 
effect of cannabis use on this disease, necessary for a definitive conclusion. This is 
beyond the capacity of the cohort study, on which this thesis is based, to address. 
1.5.4.3 Depression and anxiety. 
The relationship between prolonged cannabis use and depression and anxiety is 
likewise still to be properly understood. In a review of the literature pertaining to 
adolescent addictive and depressive disorders, Rao reported that commonly-observed 
clinical symptoms in people undergoing treatment for withdrawal from psychoactive 
drugs include dysphoric or depressive mood, suggesting a link between addictive 
disorders and depression (Rao 2006). In clinical settings, treatment for depression 
often alleviates substance abuse, perhaps a reflection of the use of substances to ease 
feelings of depression. In other words, amelioration of depression reduces the need 
for “self-medication” illustrating the motivational-reward processes present in both 
depression and substance addiction. A link between anxiety and panic attacks and 
cannabis use in clinical populations is well documented, but the mechanism for this 
association is not understood (Crippa et al. 2009). 
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In their 2003 review, Degenhardt and colleagues reported the consensus view that 
rates of depression are elevated in frequent cannabis users at the population level 
when measured cross-sectionally. There may be a risk of later depression in some 
heavy users, or in early onset users, but these associations may possibly be mediated 
by other factors consequent to early cannabis use, such as poor educational 
attainment, unemployment and crime, and possibly other illegal substance use 
(Degenhardt, Hall & Lynskey 2003a). A neuro-biological explanation of the links 
between depression, psycho-social stress and substance use has been suggested (Rao 
2006). 
1.5.5 Respiratory disease. 
The possibility that cannabis smoke may cause Chronic Obstructive Pulmonary 
Disease (COPD) and lung cancer comparable with cigarette smoke has long been a 
concern. There are plausible biological pathways by which this may occur: apart 
from the psycho-active components nicotine and the cannabinoids, the gas and 
particulate constituents of cigarette and cannabis smoke are remarkably similar. It is, 
of course, difficult to distinguish specific effects of cannabis smoke, as it is often 
mixed with tobacco, but most studies assessing the link adjust for confounding by 
cigarette smoking. A review of the recent literature concluded that there was no clear 
evidence that cannabis smoking independently causes either COPD or lung cancer 
(Tashkin 2010). However, the lack of supportive evidence to date does not preclude 
the possibility that a causal association exists. Harm arising from contamination by 
pesticides and other additives remains a possibility in this largely unregulated 
industry (McLaren et al. 2008). 
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1.5.6 Hospitalisation 
Unexpected adverse events associated with cannabis overdose have been reported, 
though rarely. A recent French report examining 200 medical histories of inpatients 
with cannabis-related admissions, that is, where cannabis use was documented and 
identified as possibly related to the diagnosed outcomes, estimated adverse events to 
be about 1.2/1000 regular users. Most frequent adverse events recorded were related 
to psychiatric, neurological and cardiovascular disorders’s with one fatality (Jouanjus 
et al. 2011). 
1.6 Cannabis use in adolescence 
Although the recognition of harm arising from prolonged and regular cannabis use 
was emerging as the twentieth century progressed, little attention was focused 
specifically on adolescent use, despite understanding that most users commenced at 
this time. As the post-war explosion of cannabis use by main-stream youth in 
westernised countries proceeded, observers attempted to find mechanisms by which 
initiation occurred, most notably the Gateway Theory of Kandel (Kandel 1975) and 
the idea of “transition proneness” suggested by Jessor (Jessor 1976). Other illicit 
substance use emerged alongside cannabis, which again called for an explanation and 
was incorporated in the Gateway Theory. The common perception then and now was 
that initiation into cannabis use was generally complete by 20 years and declined 
rapidly by the mid-20s along with alcohol use, but not cigarette smoking (Kandel & 
Logan 1984). The Gateway Theory still has considerable currency in the emerging 
literature reporting on transitions in licit and illicit substance use, but the theory that 
cannabis use declined by the mid-nineteen twenties, although originally a reasonable 
observation, is possibly far less valid now, as illustrated by the 2010 report that 
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13.6% of 30-39 year olds surveyed in Australia had used cannabis in the past month 
(AIHW 2010). 
1.6.1  “Transition proneness” to initiation of cannabis use 
An early series of longitudinal studies concerned with monitoring alcohol abuse and 
other problematic behaviours in adolescence was reported progressively by Richard 
Jessor and associates in the 1970s onwards (Jessor, 1976). Their research was 
thorough and robust, with replicated findings in the USA and the People’s Republic 
of China. The functional theory that was developed was based on the premise that 
“all behaviour is the result of person-environment interaction” and so did not allow 
for the innate genetic or physiological influences. This was a reasonable hypothesis 
at the time but has since has come under scrutiny. This theory led ultimately to the 
current, much applied, risk and protective factor framework, e.g.,(Hawkins, Catalano 
& Miller 1992). Influences were divided into three domains: personal and social 
behaviour and the perceived environment. Problem behaviour was defined as norm-
violating and included such activities as alcohol abuse, cannabis and other illicit 
substance use, general delinquency, risky driving, precocious sexual intercourse and 
overt disregard of conventional norms, such as school achievement and parental 
control. Involvement in any one of these increased the likelihood of involvement in 
others. Conversely, pro-social behaviour included socially-approved conventional 
behaviour, such as engagement with education, sport and religion. As regulatory 
norms were age- related, that is, less or more mature, the identification of age-related 
status on these behaviours allowed the development of the concept of “transition 
proneness”, allowing the theory to predict future transitions based on current 
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behaviour. Specifically, in the context of cannabis, it implied that other problem 
behaviours will both predict uptake, and be currently associated with cannabis use. 
1.6.2 Cannabis use as a “gateway” to other illegal substance use. 
The association between cannabis use and use of other illicit substances, such as 
heroin, cocaine and, more recently, amphetamines and ecstasy, has strong historical 
foundation and is well documented by many cross-sectional studies. Furthermore, the 
proportion of those using other substances demonstrably increased with increasing 
levels of cannabis use (Kandel 1984). Focusing on adolescent substance use, Kandel 
and colleagues developed the theory that cannabis use acted as a stepping stone on 
the pathway to escalating drug use, in essence a specific application of Jessor’s 
(1976) transition proneness concept (Kandel 1975) (Kandel et al. 1986). Using 
retrospective data from two New York cohort studies, she proposed the “gateway 
theory”, that adolescents move from no substance use to (1) beer/wine, to (2) hard 
liquor/cigarettes, to (3) cannabis and then to (4) other illicit drug use, with 
consequences in psycho-social functioning, such as educational attainment and 
continuity and participation in adulthood roles. She was careful to clarify that this 
sequence of events is not inevitable, and that many young people did not proceed 
from one stage to the next, but she asserted that few skip a stage. Appealing though 
this hypothesis is, it requires confirmation using prospective cohort data and cross-
cultural testing. It also invites the multi-faceted question as to why some young 
people are vulnerable to these transitions whilst others are not. For example, how 
important are background factors such as parental conflict, parental substance use, 
parental education, rural environment, peer substance use, overseas birth as well as 
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deviant behaviours other than cannabis use, personality factors and emotional 
distress? 
1.6.3 Transition to adult roles 
Concerns that chronic, regular use of cannabis by young people may adversely affect 
the transition to adult roles, such as educational achievement and regular 
employment, were consistent with the attempt to identify and explain these sequelae 
by the amotivational syndrome. Research has focused only on this question in recent 
years, as relevant adolescent cohorts mature into adulthood (Fergusson, Horwood & 
Beautrais 2003; Lynskey & Hall 2000). Although evidence pointing to adverse 
educational outcomes associated with adolescent cannabis is clear, the direction of 
the associations is not apparent. For example, do young people drop out of school 
and then commence regular use, or does the reverse mechanism apply: do users drop 
out of school? Or are both outcomes unconnected and mediated by some other 
factor? Whether there is a dose effect or a threshold was uncertain. These questions 
are similar to the uncertainty surrounding the association between cannabis and 
common mental disorders. 
1.7 Possible biological mechanisms  
1.7.1 Biological mechanisms of intoxication. 
The euphoric and relaxing effects of acute cannabis intoxication and its dysphoric 
effects including anxiety, panic and depression have been thoroughly described, both 
autobiographically in the style of de Quincey in “Confessions of an English Opium 
Eater” (De Quincey 1856) and through observation (for several examples see 
(Mikuriya 1973b). In 1933, Bromberg described “the typical disturbances in time 
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relation, in consciousness, in memory, in attention, in sensory perception were all 
found in marijuana smokers as well as those who took it in the form of a purified 
drug” (Bromberg 1933). The search for the psycho-active ingredient in cannabis 
smoke, accompanied by a series of unfortunate accidents, was finally identified as 
Δ9- tetrahydrocannabinol (THC) in 1942 (Ames 1958). This compound is the major 
psycho-active compound in cannabis smoke but it is only one of a large number of 
possible biologically-active substances including cannabadiol (CBD) (McLaren et al. 
2008), which may act as an antagonist to THC. Two series of cannabinoid receptors, 
along with naturally-occurring endocannabinoids, have been identified in animal 
models and in humans (Castle & Murray 2004). CB1 receptors are found only in the 
brain and CB2 receptors in the both the brain at a lower level in the central nervous 
system than the CB1 receptors and also in the peripheral nervous system. The CB1 
receptors are located presynaptically on glutamatergic terminals (Murray et al. 2007) 
and are probably involved in the regulation of a range of neurotransmitters, including 
dopamine and serotonin. They are found in the cerebral cortex, primarily in the 
frontal regions, and in other regions of the brain, though not in the brainstem. THC 
acts as an agonist on the CB1 brain receptors and also to some extent on the CB2 
receptors, markedly disrupting neuronal signalling and circuit dynamics (Murray et 
al. 2007). The absence of receptors from the brainstem possibly accounts for the 
rarity of lethal toxicity THC. Genetic modification of cannabis sativa has resulted in 
lower levels of CBD relative to THC (Morgan & Curran 2008), which may have 
toxicological consequences. This has been suggested as a possible factor in 
determining the potential for psychotic-like symptoms in cannabis users (Morgan & 
Curran 2008). The processes involved in cannabis intoxication are starting to be 
clarified as the roles of these receptors are explained (McLaren et al. 2008). 
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1.7.2 Biological mechanism underlying vulnerability to early 
adolescent cannabis use. 
In this dissertation, I will describe papers we wrote before the biological mechanisms 
underlying the consequences of adolescent cannabis use had gathered much 
currency. However, it is interesting to present these briefly, in order to provide a 
contextual framework to extend the interpretation of our findings beyond those we 
were in a reasonable position to propose at the time of publication. 
Generally, poor consequences of cannabis use have been shown to be greater when 
use was initiated in adolescence compared with young adulthood (e.g., (Fergusson, 
Horwood & Swain-Campbell 2002). In her review of the adverse effects of cannabis 
use, in which she cites a number of our papers, Schneider (Schneider 2008), agrees 
that these depend not only on the amount consumed, but also on the age of initiation, 
with the adolescent developmental period representing the period of highest risk. She 
refers particularly to puberty as the period when sexual maturity develops, along with 
associated gonadal and hormonal changes and many neurodevelopmental 
maturational processes, with the pubertal period occurring earlier in girls than boys 
and lasting a shorter time. Increasing density of CB1 receptors in the brain during 
puberty has been observed in the rat model and there have been some supporting 
observations in human brains, indicating involvement of the endocannibinoid system 
in the  re-organisation that occurs in puberty. Thus, Schneider suggested, there is 
likely to be marked vulnerability to exogenous cannabinoids during this period of 
development, reporting some supporting evidence. Due to difficulties in estimating 
cannabis dosage (as discussed earlier), evidence from animal model studies can be 
more informative. These studies confirmed human studies proposing that exposure to 
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cannabis during puberty probably leads to residual effects on cognitive processing. 
Furthermore, it seemed the risk of mental health sequelae, such as depression and 
anxiety, psychotic episodes and later schizophrenia, increased if cannabis use 
commenced prior to 15 years, suggesting a genetic liability expressed if exposure 
occurred during adolescence. Similarly, dependence, although only relatively 
recently recognised, has been observed as more likely to occur with pubertal onset 
compared with post-pubertal onset. The increased tendency to use other illicit 
substances following initiation to cannabis may be another manifestation of the same 
liability, or may be environmental, due the individual’s exposure to social mores 
where drug use is accepted or encouraged and substances are easily available. 
Understanding the importance of early initiation is essential to determine the most 
likely effective education and prevention interventions (Solowij & Grenyer 2002), as 
well as treatment strategies for those who initiated heavy use early in adolescence 
(Crean, Crane & Mason 2011). 
1.7.3 Biological mechanisms underlying concurrent substance abuse 
and depression/anxiety 
As described earlier, current understanding of the biological mechanism underlying 
vulnerability to concurrent substance abuse and depressive disorders in adolescence 
was reviewed by Rao (Rao 2006). The link between psycho-social stress (such as 
that which may be implicated in the initiation and maintenance of substance use 
disorders), depression/anxiety and substance abuse may be mediated by the limbic-
hypothalamic-pituitary-adrenal (LHPA) system. Rao postulated that the immaturity 
of the neuro-biological systems in adolescence may lead to greater vulnerability to 
co-occurrence of these disorders. She advocated longitudinal study of adolescents 
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during the high risk period for development of depressive and addictive disorders, to 
determine whether neuro-biological changes precede or result from exposure to one 
or the other or both. 
1.7.4 Rimonabant 
The story of the drug rimonabant provides and interesting aside. This drug is an 
endocannabinoid-1 blocker and can trigger a severe cannabis withdrawal response 
(Murray et al. 2007). It has been used in the reduction of obesity and, indirectly, to 
improve metabolic disorders. A review of randomised control trials examining its 
effectiveness found that it was successful in weight reduction, but discontinuation of 
treatment due to depressive mood disorders and anxiety occurred more frequently in 
treatment groups than in those given placebo (Christensen et al. 2007). After this 
report, a multi-centre trial to assess whether rimonabant improved major vascular 
event-free survival was abruptly discontinued by the safety monitoring board, due to 
concerns about an excess of suicide attempts and completed suicide in the treatment 
group, despite excluding those with depression or mental illness from the trial. In 
addition to suicide, anxiety, depression and depressed mood were all more common 
in the treatment group (total psychiatric disorders, treatment versus control: 30% 
versus 17%) (Topol et al. 2010). Although not addressed by the authors, these 
findings pose intriguing questions about the role of the cannabinoid system in the 
maintenance of sound mental health, and, by inference, for the effect of prolonged 
cannabis use on mental health within the context of its interference in the natural 
physiological balance of endocannabinoid system. 
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1.7.5 Heritability of cannabis use and abuse 
Identification of at least some of the acute and chronic biological processes involved 
in cannabis toxicity makes it likely that genetic influences are implicated in these 
responses. In recent years there has been considerable activity examining whether, to 
what extent and by what mechanism there is a heritable component to cannabis use 
initiation and escalation to dependence. Understanding the gene/environment 
interactions by which genetic liability is expressed only in response to specific 
environmental stressors adds further complexity (van Os, Rutten & Poulton 2008). 
Population genetics was initially used to address these questions, using a sample of 
twins in the US, the Mid Atlantic Twin Registry, which allowed examination of the 
relative importance of environmental factors and inherited characteristics. From this 
study, it has been established that genetic influences are active in heavy, long term 
cannabis use. For example, in a study of female mono- and di-zygotic twins, genetic 
factors accounted for 60% to 80% of the variance in liability (Kendler & Prescott 
1998). Interestingly, evidence to date suggests that social factors, such as availability 
and drug-accepting peers, may be the more active drivers of cannabis use initiation, 
with genetic influences becoming apparent only when drug use is well established 
(Kendler et al. 2008). 
It is beyond the scope of this dissertation to provide a detailed account of the 
complex advances in the various fields of microbiology involved in the investigation 
of the molecular basis of cannabis addiction. Briefly, gene association studies in 
animal models focusing on the CB1 and other subsidiary receptors implicated in the 
brain reward system indicate promising lines of enquiry in humans, with the 
intriguing addition of the possible involvement of CB2 receptors in the central 
Chapter 1. Introduction 
28 
 
nervous system (Maldonado et al. 2011). Genome-wide techniques now available are 
more likely to identify candidate genes or combinations of genes that endow 
vulnerability, but, given the likelihood that effects due to individual variants will be 
small, such studies will require very large samples to reach informative conclusions. 
Proteomics is an exciting new field, which is making progress towards identifying 
CNS proteins involved in addiction. Recent advances in the field of epigenetics 
(including whole epigenome scans) open new possibilities for studying relationships 
between cannabis use and gene regulation. These include the role of early cannabis 
use in programming gene expression through DNA methylation and histone 
modification, and the longer-term health consequences of such gene programming 
for cannabis users. For example, the role of early cannabis use in creating 
vulnerability to schizophrenia via epigenetic mechanisms in vulnerable individuals is 
a promising field of research (Maric & Svrakic 2012). Furthermore, given the 
potential reversibility of epigenetic markers, knowledge of these processes may 
ultimately inform the development of effective pharmacotherapy tailored to 
individual need. However, addressing potentially modifiable environmental triggers 
implicated in the expression of genetic liability is currently the only strategy that will 
promote prevention and assist treatment, which presently remains in the 
psychotherapeutic domain (Copeland & Swift 2009). This takes us back full circle to 
the unavoidable necessity of understanding the aetiology of problematic cannabis 
use, its trajectories and its consequences. 
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1.8 The Victorian Adolescent Health Cohort Study (VAHCS) 
1.8.1 Uunanswered questions in the late 1990s 
Historically, the link between the use of cannabis and adverse outcomes was a source 
of concern, with the antecedents of drug use better understood than the long term 
consequences (Kandel et al. 1986). In the late 1990s there was still controversy about 
the extent of the harmful social and health consequences, with debate polarised 
between those who argued that adolescent cannabis use was essentially a benign, 
transient practice with few social and health consequences for the great majority of 
young people (Robins 1995) (Shedler & Block 1990) and those who viewed cannabis 
as having the potential to lead to escalating drug use and attendant problems (Kandel 
et al. 1986) (Fergusson, Lynskey & Horwood 1996). A few cohort studies had shown 
that adolescent cannabis users were vulnerable to poor psycho-social outcomes, such 
as crime, mental distress, incomplete education, unemployment and other illicit 
substance use (Fergusson & Horwood 1997; Fergusson, Horwood & Swain-
Campbell 2002; Kandel et al. 1986; McGee et al. 2000), with those who initiated use 
while at school at particular risk. Poor educational outcomes had been explained by a 
propensity for socially deviant behaviour, the rejection of parental influences, the 
association with drug-using peers and early parenthood (Lynskey & Hall 2000). 
However, assessment of the specific role of adolescent cannabis use had been 
hampered by infrequent and imprecise measurement, with no attention paid to the 
specific timing of this use in relation to the school career. 
Cross-sectional association between cannabis use and use of other illicit substances 
by young people was well documented. Likewise, prospective associations between 
regular adolescent cannabis use and initiation of other illicit substance use had been 
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reported by many investigators (e.g.,(Fergusson, Horwood & Swain-Campbell 
2002)), with the likelihood of this transition increases with increasing levels of 
cannabis use (Kandel 1984). More specifically, Kandel maintained in her Gateway 
Theory that cannabis use acted as a stepping stone on the pathway to escalating drug 
use (Kandel, D 1975; Kandel et al. 1986). Little or no attention had been given to the 
possibility that licit substances could follow cannabis use, or the risks associated with 
occasional or fluctuating cannabis use in adolescence. Again, the specific timing of 
uptake and the risks accorded to the duration of use during the teens had not been 
assessed. 
That mental health problems could follow or be causally associated with problematic 
cannabis use were reasonable propositions but still unclear (Kandel & Chen 2000). 
As opposed to association with psychosis and schizophrenia, the association with the 
common mental disorders, depression and anxiety, had received scant attention 
(Crippa et al. 2009) and, although there was reasonable evidence of cross-sectional 
associations between mental distress and cannabis use in adolescence, the temporal 
direction of this association was unclear, (Fergusson & Horwood 1997; Fergusson, 
Horwood & Swain-Campbell 2002). It was suggested that the association 
commenced with mental distress in adolescence, that is self-medication, but that it 
subsequently reversed in young adulthood (McGee et al. 2000) or that both factors 
could be attributed to the some other cause (Jessor, Chase & Donovan 1980). 
1.8.2 The VAHCS 
To understand the natural history of cannabis use it is necessary to identify factors 
predicting uptake and, furthermore, to identify those that incline a young person to 
continue or escalate their use. These are questions that can be informed by studying 
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the same group of young people over time, most usefully before the initiation of 
cannabis use, using consistent measurement of cannabis use and putative risks for 
initiation, continuation, escalation and other adverse outcomes, as well as possible 
confounders and mediators. By the end of the twentieth century it was clearly 
necessary to provide an evidence base examining predictors and consequences of 
adolescent cannabis use and we were in a unique position to do this with data 
obtained from the VAHCS. 
The VAHCS is (currently) a nine-wave, 15-year representative longitudinal cohort 
study conducted in the state of Victoria, Australia. There were six waves of data 
collection in adolescence at six-monthly intervals, commencing at 14 years, and a 
further three in young adulthood to 29 years. The short intervals between the 
adolescent waves of data collection allowed a fine grained analysis of transitions 
during this period of rapid change as well as allowing the summary of the duration 
and extent of various behaviours and mental health measures during this period. The 
young adult waves enabled a periodic understanding of changes in behaviour and 
mental health and transitions to adult roles. The methodology of VAHCS is 
presented in detail in the following chapter, in so far as it is relevant to important 
questions relating to the natural history and consequences of adolescent cannabis use. 
In the following chapters, twelve papers are presented examining the natural history 
and consequences of adolescent cannabis use which form the basis of this PhD 
dissertation. Each paper is inserted into the document at the end of the section in 
which it is discussed, following its header page. 
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CHAPTER 2 Victorian Adolescent Health Cohort Study: 
methodology  
2.1 Introduction 
This chapter presents a detailed account of the methodology of the VAHCS, and my 
contribution to its conduct. In §2.2, adolescence and young adulthood are defined as 
they apply to this study. §2.3 gives an overview of the VAHCS, followed by detailed 
descriptions of sampling, ethics approvals, consent processes, survey administration 
methods, tracing, follow-up and ascertainment by wave. §2.4 describes in detail all 
relevant measures and their corresponding data reduction, restricted to those 
variables that were used in the cannabis-related papers included in this thesis. They 
are in the domains of background and time varying measures specific to the 
adolescent and the young adult phases of data collection. §2.5 presents the derivation 
of summary adolescent measures, thus illustrating problems encountered due to 
missing data, a major challenge in all longitudinal studies. The various strategies we 
have used to deal with these are described, including the use of multiple imputation. 
§2.6 describes my history with the VAHCS including my contribution to its 
management as Project Manager over the ten years from 1995 to 2005, my ongoing 
role in the VAHCS since my retirement and my involvement in the dissemination of 
its findings. In §2.7, the context for the VAHCS is presented by comparing this study 
with other population-based cohort studies, including a description of the novel 
contribution that the VAHCS offers. 
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2.2 Definition of adolescence and young adulthood 
An informal but common practice has evolved of referring to early adolescence 
extending from 10 to14 years, late adolescence from 15 to 19 years and young 
adulthood from 20 to 24 years in order to observe changes in health and social status 
occurring during and between these periods of rapid change (Sawyer et al. 2012). 
Throughout the description of the VAHCS methodology, results and their 
interpretation, for ease of writing, we refer to late-adolescence as “adolescence”, and 
“young adulthood” to encompass not only 20-24 years, but also including 29 year 
olds in the final survey in the cohort study presented here. We generically refer to 
participants in the age group encompassed so far by VAHCS as “young people”. 
Adolescence (from the Latin “adolescere”, to grow up), that is, the period of gradual 
behavioural and social maturation between childhood and adulthood, overlaps, but is 
not synonymous with, puberty (from the Latin, pubertas, sexual maturity), which 
refers exactly to the time period during which sexual maturity occurs (Schneider 
2008). 
2.3 Conduct of the VAHCS 
2.3.1 Overview  
The VAHCS is a population-based longitudinal study of young people from 14 years, 
through their adolescence and into young adulthood. When the VAHCS was first 
proposed, despite the accepted understanding that many adult problems such as 
depression, licit and illicit substance abuse and obesity first surfaced in adolescence, 
there was a dearth of information on the developmental perspective of these and 
other mental health problems and health risk behaviours measured prospectively as 
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they emerged. Population-based cohort studies of sufficient sample size and retention 
are necessary to assess temporal dimensions in initiation of behaviours and mental 
health issues. 
Investigation into causation, continuity and consequences of cannabis use and other 
adolescent health risk behaviours and mental health issues beyond adolescence was 
considered to have important public health benefits and justified the continuation of 
the VAHCS into young adulthood. Specifically, relevant to this thesis, it is important 
to understand factors involved in the initiation, continuation and escalation of 
cannabis use, and the consequences of use on the developmental transitions to 
economic and social independence that occur in young adulthood. Integral to this is a 
need to understand health-compromising sequelae consequent to cannabis use by 
young people. 
The cannabis-related aims addressed in the published papers synthesised in this 
thesis were to determine: 
x which factors predicted uptake and escalation of cannabis use in adolescence 
x the degree to which adolescent cannabis use continued into young adulthood 
x which factors predicted, or were associated with, progression to regular 
cannabis use and cannabis dependence 
x which were the substance use, social, interpersonal, educational and 
employment consequences in young adulthood of adolescent cannabis use. 
2.3.2 Sample 
Between August 1992 and January 2008, the Centre for Adolescent Health, 
Melbourne, conducted a nine-wave cohort study of health in adolescents and young 
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adults resident in the state of Victoria, Australia. The cohort was designed as a 
representative sample of the Victorian population of mid-secondary-school students 
in 1992, defined in a two-stage cluster sample. Initially, one class was selected at 
random from a state-wide sample of 45 schools, selected at random from within a 
state-wide stratified frame of Government, Catholic and Independent private schools, 
with probability of selection proportional to the number of students. The study 
originated as a cross-sectional survey of Victorian school children in Years 7 (about 
12 years), 9 (about 14 years) and 11 (about 16 years).  During the conduct of this 
survey, further funding was obtained which allowed the Year 9 arm to constitute the 
first year of follow-up for an ongoing cohort study. In order to double the size of the 
study, thereby increasing its capacity to detect associations both cross-sectionally and 
longitudinally, the sample size was doubled by including a second class from each 
participating school early in Year 10, that is, 6 months after the inaugural survey. 
Thus, one class entered the study in the latter part of the ninth school year (Wave 1) 
and a randomly selected second class six months later (Wave 2). The school 
retention rate to Year 9 in the year of sampling was 98%. One small rural school 
(n=13) from the initial cross-sectional survey (Wave 1) was unavailable for 
continuation into the cohort study leaving a total sample of 44 schools, including 24 
Government, 11 Catholic and nine Independent private schools. Participants were 
subsequently reviewed a further four times at six-month intervals during the teens 
(Waves 3 to 6) with three follow-up waves in young adulthood aged 20 years 
(Wave7), 24 years (Wave 8) and 29 years (Wave 9). Sampling and ascertainment are 
summarised in Figure 2.3.2. With the exception of height and weight during the 
school years and the assessment of personality disorder in Wave 8, all measures were 
by self-report. 
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Figure 2.3.2 Sampling and ascertainment in the Victorian Adolescent Health Cohort, 1992 
to 2008. 
 
2.3.3 Ethics approval  
Data collection protocols for each wave were approved by the Ethics in Human 
Research Committee of The Royal Children’s Hospital, Melbourne. 
2.3.4 Informed consent. 
Informed parental consent was obtained for each participant prior to entry into the 
cohort in either Wave 1 or Wave 2, depending on the student’s intake point. 
Participant consent was implicit in their agreement to complete the survey at each 
wave. In the young adult phase, cohort participants were initially informed by mail of 
each new round of data collection, then just prior to their survey they were again 
contacted by mail to introduce their interviewer and finally verbal consent was 
obtained from each participant prior to commencement of the telephone interview. 
2.3.5 Survey administration method 
Adolescent phase: Twenty-eight lap top computers were used for self-administration 
of the questionnaire within each class. This methodology enabled the use of branched 
questions so that participants did not have to answer unnecessary or inappropriate 
questions. Survey staff oversaw computer administration in the classroom, with 
teachers absent to augment a sense of confidentiality. Telephone interviews were 
phase
survey wave 1 wave 2 wave 3 wave 4 wave 5 wave 6 wave 7 wave 8 wave 9
year 1992 1993 1993 1994 1994 1995 1998 2001/03 2006/08
mean age 14.9 yr 15.5 yr 15.9 yr 16.4 yr 16.8 yr 17.4 yr 20.7 yr 24.1 yr 29.1 yr
sample n 898 1727 1697 1628 1575 1530 1601 1520 1501
design
      Total intended sample = 1037( w1) + 995 (w2) = 2032
ascertainment       96% (1943) of sample participated at least once in waves 1-6
2 entry points 
Young adultAdolescent
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used where participants were absent from school on the day of survey or otherwise 
unavailable for follow-up. 
Young adult phase: For each of Waves 7 to 9, and in contrast to Waves 1 to 6, a 
team of interviewers surveyed young adults using a computerised assisted telephone 
survey (CATI). For Waves 1 to 6 surveys, the follow-up survey was designed to be 
administered by computer, thereby allowing branched questions. Most of the 
interviews were completed by telephone with a small number of people completing 
via email (Wave 7), self-completing on a computer within the Centre for Adolescent 
Health (Waves 7 and 8) or by completing a reduced hardcopy subset of questions 
(Wave 9) for those who were keen to participate, but had limited time. 
2.3.6 Tracing 
Substantial tracing efforts occurred with each young adult survey. Dead letters 
obtained from each information mail-out signalled the need for tracing of participants 
who had moved from their previous address. Voting registers were scanned as a 
source of information, along with contact information provided by parents and 
school contemporaries when considered appropriate by the interviewer. When traced 
in this way, participants would then be contacted by mail in the prescribed fashion. 
The National Death Index was searched prior to each young adult survey. After the 
completion of Wave 7, participants were contacted on a regular basis at least twice a 
year (e.g., Christmas cards, the distribution of general reports) to identify losses to 
follow-up and act as a prompt for tracing to commence. 
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2.3.7 Ascertainment 
Of the intended sample of 2032, 1943 (96%) completed at least one survey between 
Wave 1 and Wave 6. Adolescents whose parents had consented to their children’s 
participation were invited to complete the survey in either Waves 1 or 2 but were not 
always available on the day of survey. If this happened they continued to be invited 
until Wave 5. Of the 1943 ever participants in the adolescent phase, 898 (46%) 
entered the study in Wave 1, 953 (49%) entered in Wave 2, 86 (4%) entered in Wave 
3, 5 (0.3%) entered in Wave 4 and 1 entered in Wave 5. Of the 1943 ‘ever’ 
adolescent participants (that is, participated in at least one wave), and taking into 
account the staggered entry between Waves 1 and 2, 1248 (62%) completed all 
possible adolescent Waves: 605 of the 899 Wave 1 entrants and 643 of the 1044 
Wave 2 entrants. All three young adult phase surveys were completed by 1282 (66%) 
but 182 (9%) of the adolescent participants were lost to follow-up, at least currently. 
Overall, again taking into account late entry in Wave 2, 954 (49%) completed all 
possible waves and 288 (15%), 159 (8%), 132 (7%), 106 (5%), 63 (3%), 50 (3%) and 
44 (2%) completed 7, 6, 5, 4, 3, 2 and 1 Wave respectively. 
2.4 Measures 
All questionnaires dealt with a broad range of adolescent health risk behaviours and 
symptoms of mental disorder, with important measures consistent between waves. 
Background factors relating to the individual and parents were assessed at study 
inception and as the cohort aged, with increasing detail about school leaving and 
employment. Other measures (e.g., self-harm, eating disorder, childhood sexual 
abuse) were introduced during the course of the study as they became 
developmentally appropriate. With the exception of height and weight, all measures 
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were by self-report. I have defined important measures used in many of the cannabis-
related publications below, all of which were asked consistently from Waves 1 to 6, 
and in more detail from Wave 7-9. 
2.4.1 Fixed background measures 
Table 2.4.1 shows the details of data collection culminating in the derivation of fixed 
covariates used in many of the analyses described in this thesis to adjust for possible 
confounding. 
Table 2.4.1 Fixed background measures, their categories and their waves of origin. 
 
1 Measure augmented by data from the case-control study conducted between Waves 3 and 6. 
Measures included: 
x Sex 
x Rural/metropolitan location of school at study inception. This was known at 
the time of randomisation. 
x Non-Australian birth. 
x Early school leaving was assessed in Waves 5, 6, 7 and 8 as the latter two 
waves became available. Those who left school before completing Year 11, 
and before completing Year 12 were identified. 
1 2 3 4 5 6 7 8 9
P a rt ic ipa nt  m e a s ure s
Sex male ; female NA
Scho o l a t inceptio n in Melb metro 0 'no ' 1 'yes ' NA
No n-Aus tra lian birth no ; yes x x x x x
Childbirth no ; yes  x x x
Las t year s eco ndary educucatio n <yr11; yr11; yr12 x x x x
P a re nta l m e a s ure s
Divo rce /s epara tio n1 no ; yes x x x x x x x x x
Educatio n (maximum fo r e ither parent)
inco mple te  s cho o ling, co mple te  s cho o l o r vo ca tio na l qua l, 
univers ity degree
x x x x x x
Cigare tte  s mo king (a t leas t o ne  parent)1  no n-s mo ker; any s mo king x x x x
M EA S UR E C A TEGOR IES
WA VE OF  D A TA  C OLLEC TION
A do le s c e nt
Yo ung  
a dult
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x Childbirth was assessed in Waves 7, 8 and 9 and was identified cumulatively, 
i.e., any reported childbirth was carried forward. 
x Highest level of education of both parents. This was assessed at Waves 2, 3, 4 
and 6 and again at Waves 7 and 8. Preference was given to the most recent 
report as adolescents are known to be unreliable reporters of their parent’s 
qualifications. 
x Parental divorce/separation or never having lived together was identified if 
this occurred at some point by Wave 6 or equivalent age, i.e., during the 
adolescent phase. It was assessed up to Wave 8. Information at Waves 7 and 
8 included the participant’s age when this occurred, allowing the application 
of the Wave 6 or equivalent age cut-point retrospectively. 
x Parental cigarette smoking. If any responses throughout the cohort indicated 
at least one parent smoked cigarettes (“any smoking”), then the participant 
was classified as having at least one parent who smokes cigarettes. 
 
2.4.2 Time varying measures  
Apart from substantive considerations relating to the aims of the study, two 
important considerations were involved in the choice of measures at each survey: 
developmental appropriateness and the optimisation of reducing respondent burden. 
This latter consideration sometimes resulted in measures being dropped in the course 
of the study. For example, in Wave 8, we dropped the detailed measure of depression 
and anxiety used since Wave 1, in favour of a shorter instrument for this purpose, 
thus allowing inclusion of other measures. Table 2.4.2 lists the time-varying 
measures used in the cannabis-focused analyses and the waves in which they 
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occurred. Many variables used in different analyses were reduced to accommodate 
specific questions, but the table illustrates where these originated and in what form. 
The measures are described separately by phase. 
Table 2.4.2 Time-varying measures, their response sets and the waves in which they were 
applied. The type of measure is indicated in footnotes. 
 
 
 
1 Type of measure: self-report 
2 Type of measure: standardised and validated tool 
3 Type of measure: cut-points suggested in the literature. 
1 2 3 4 5 6 7 8 9
Educ a t io n
1
Study s ta tus
never s tudied; full-time; part-time; finis hed; 
deferred; dro pped o ut; o ther
x
1 At univers ity no ; yes x
1 Highes t qua lifica tio n do ne  o r do ing no ne; vo ca tio na l; degree x x
Em plo ym e nt
1
Current wo rk s ta tus
pa id wo rk; unemp/jo bs earch; unemp/no  jo bs earch; 
vo ulta ry wk; payment in kind; o ther
x
1 Rece iving go vernment welfa re  s uppo rt no ; yes x x x
R e la t io ns hips 1 Rela tio ns hip s ta tus no  re la tio ns hip; bo y/girlfriend; married/defac to x x x
1 Exclus ive  re la tio ns hip in pas t 3 years no ; yes x
1 Ho w o ften fee l a lo ne never; s o metimes ; o ften; a lways x
Ho us ing
1
Living a rrangements
with mo /fa ; friends ; o ther family; o ther peo ple ; 
a lo ne ; partner; o ther
x x x
S UB S TA N C E US E
C a nna bis  us e 1 Frequency o f us e  (6m) mo s t da ily; 3,4 d/wk; 1/2 d/wk; 1/3 d/mo ; <1/mo x x x x x x
1
Max frequency o f cannabis  us e  (12m)
no ne; <5/yr; <1/mo ; 1/3 d/mo ; 1/2 d/wk; 3,4 d/wk; 
a lmo s t da ily
x x x
1 Data  reduc tio n: frquency cannabis  us e 0 'no  thc  las t 6 mo ' 1 'o ccas io na l' 2 'weekly' 3 'da ily' x x x x x x x x x
C a nna bis  d ia g no s is 2 DSM4 cannabis  dependence  (CIDI-auto ) no ; yes x x x
2 DSM4 cannabis  dependence  & abus e  
(CIDI-auto )
no  digno s is , abus e , dependence x x x
Othe r illic it s 1 Amphetamines  o r die t pills  (6mo ) no ; yes x x x x x x
1 Amphetamines  (12m) no ; yes x x x
1 Barbitura tes  (12m) no ; yes x x x
1 Benzo diazepam (no n-pres criptio n) (12m) no ; yes x x x
1 Co caine  (12m) no ; yes x x x
1 Ecs tacy (12m) no ; yes x x x
1 Hero in (12m) no ; yes x x x
1 Inha lents  (12m) no ; yes x x x
1 Acid (12m) no ; yes x x x
1 Haluc ina to ry mus hro o ms  (12m) no ; yes x x x
P e e r drug  us e 1 Mo s t friends  us e  illic it drugs no ; yes  x x x x x x x x x
C ig a re t te s 1 Cigare tte  s mo king no n-s mo ker; o cas s io na l; 6/7 days x x x x x x x x x
N ic o t ine  de pe nde nc e 2 Fagers tro m ques tio nna ire s co re :1-3; >=4 x x x
A lc o ho l 1 >12 drinks  las t 12mo no n-drinker; drinker; drinker: binged 2wk x x x x x x x x x
D rinking  dia ry 1 3+ days  drinking in previo us  week no ; yes x x x x x x x x x
1 To ta l units  (10g) drunk in previo us  week numeric x x x x x x x x x
1 Average  units (10g)/drinking day numeric x x x x x x x x x
1 Maximum no . units  (10g) in 1 day numeric x x x x x x x x x
3 NHMRC (2001)  lo ng te rm ris k lo w; ris ky; hi ris k x x x x x x x x x
3 NHMRC (2001) s ho rt te rm ris k lo w; ris ky; hi ris k x x x x x x x x x
3 NHMRC (2007) ris k : 15+ s td drinks  in pas t 
week
no ; yes x x x x x x x x x
A lc o ho l d ia g no s is 2 Alco ho l dependence  (CIDI-auto ) no ; yes x x
2 DSM4 a lc  abus e  o r dependence  (CIDI-
auto )
no ; any diagno s is x x x
M EN TA L HEA LTH, P ER S ON A LITY A N D  B EHA VIOUR
A nxie ty/ de pre s s io n 2 CIS-R (to ta l o f 14 s ub-s ca les ) s co re  0-11; >11 x x x x x x x
2 Genera l Hea lth Ques  (12 item) s co re  0-2; >=3 x x
2 Majo r depres s ive  dis o rder (CIDI-Auto ) diagno s is : no ; yes x
2 Anxie ty dis o rder (CIDI - Sho rt Fo rm) diagno s is : no ; yes x
A ntis o c ia l be ha v io ur 3 Two  o r mo re  multiple  ASB a t each wave  no ; yes x x x x x x
P e rs o na lity d is o rde r 2 Clus te r A P D (SAP ) no ; yes x
2 Clus te r B P D (SAP ) no ; yes x
2 Clus te r C P D (SAP ) no ; yes x
S OC IA L EN VIR ON M EN T
WA VE OF  D A TA  C OLLEC TION
A do ls c e nt
Yo ung  
a dult
D OM A IN R ES P ON S E S ETM EA S UR E
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2.4.3 Adolescent phase. 
Cannabis use. Assessment of cannabis use was based on self-reported frequency. At 
each wave, participants were asked how often they used marijuana, with the response 
set: (1) never used, (2) not used in the past six months, (3) a few times, (4) monthly, 
(5) weekly, (6) daily. This was reduced to four levels describing use in the past six 
months: “none”, “occasional”, “weekly” and “daily” with the top two levels often 
reduced to “weekly or more frequent” or “weekly+”. This also allowed derivation of 
binary variables identifying “any use”,” weekly+ use” and “daily”. As discussed in 
the Introduction, it is not possible to estimate the actual dose in the way that alcohol 
intake can be assessed from retrospective diaries, as the origin and part of the plant 
used, the preparation of the drug, its method of delivery and the way in which it is 
smoked all contribute unmeasurable variation to the dose. Although self-report data 
cannot be externally validated, it is accepted as an appropriate data collection tool for 
large studies of this (Darke 1998; Fendrich et al. 2005). 
Amphetamine use. Participants were asked how often they used 
speed/amphetamine/diet pills with the response set: (1) never used, (2) not used in 
the past six months, (3) a few times, (4) monthly, (5) weekly, (6) daily. As the 
frequency of amphetamine use was low, this was reduced to a binary variable 
defining “any use” in the past six months. 
Cigarette smoking. Initially participants were asked: “At the present time are you: 
(1) A non-smoker? (2) An ex-smoker ? (3) An occasional smoker ? (4) A light 
smoker ? (5) A medium smoker ? (6) A heavy smoker?” Self-classified ex-smokers 
were asked when they stopped smoking and those who stopped within the past month 
were re-classified as current occasional smokers. Current smokers who had smoked a 
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cigarette within the past week were asked to complete a one week retrospective diary 
specifying the days on which they smoked, and the number of cigarettes they smoked 
on each day. This information was reduced to a single variable identifying “non-
smokers”, “ex-smokers” (not in the past month), “occasional smokers” (not in the 
past week), “daily smokers” (6 or 7 days in the past week). Further detail from the 
diary allowed the categories: “daily smoking <10 cigarettes” (6 or 7 days in the past 
week, average <10 cigarettes/day), “daily smoking ≥10 cigarettes” (6 or 7 days in the 
past week, average ≥10 cigarettes/day). This measure was generally reduced to three 
categories “none” (including ex-smokers), “occasional” (in the past month, <daily) 
and “daily” (6 or 7 days in the past week). Binary variables identifying “any” or 
“daily” cigarette smoking were sometimes used. 
Symptoms of depression and anxiety were assessed using the revised Clinical 
Interview Schedule – Revised (CIS-R) (Lewis et al. 1988). The CIS-R is a branched 
questionnaire, designed for assessing symptoms of depression and anxiety in non-
clinical populations. Fourteen subscales delineate the frequency, severity, persistence 
and intrusiveness of symptoms commonly found in depression and anxiety. These 
scores were added and the total scores dichotomised so that scores ≥12 delineated a 
mixed depression-anxiety state at a lower threshold than syndromes of major 
depression and anxiety disorder, but where clinical intervention would be appropriate 
(Lewis et al. 1992). 
Alcohol use. Participants were initially asked the question: “Alcohol is commonly 
used in our society. We would like to know how much alcohol you drink. At the 
present time are you : (1) A non-drinker? (2) A light drinker? (3) A moderate 
drinker? (4) A heavy drinker?” Participants who reported that they drank alcohol 
were asked if they had drunk in the previous week, and if so, which days they had 
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drunk. They then completed a beverage and quantity-specific one week retrospective 
diary which allowed estimation of the total consumption of alcohol in the previous 
week. As no definitions are currently available for alcohol-related risk in 
adolescence, we used one of two adult thresholds applied to the retrospective diary 
defined according to National Health and Medical Research Council (NHMRC) 
Australian guidelines: (1) high risk of long term health problems (Australian alcohol 
guidelines for low-risk drinking: draft for public consultation  2007), defined as 
drinking an average of more than two standard drinks/day (one standard drink = 10 
gm alcohol); (2) risky drinking for short term harm according to the 2001 guidelines 
(Australian alcohol guidelines: health risks and benefits  2001) defined as ≥20 
standard drinks (one standard drink=10gm alcohol) for males and as ≥11 standard 
drinks for females on any day. We used the latter thresholds in papers written before 
2007 and currently we are reverting to it following the report by Livingston and 
colleagues (Livingston, Laslett & Dietze 2008). Other measures used prior to the use 
of the 2001 NHMRC guidelines derived from the diary during the adolescent phase 
included a binary measures of “more than 3 drinking days in the past week” and 
another that identified “ average >5 units (>50g)/ drinking day” 
Antisocial behaviour was assessed using ten items from the Moffitt and Silva Early 
Delinquency Scale (Moffitt & Silva 1988). Participants were asked the question: “In 
the last 6 months have you done any of the following? 
 Run away from home 
 Got into physical fights with other people 
 Carried a weapon 
 Damaged something in a public place 
 Purposely damage something of your parents 
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 Damaged a parked car, scratched a panel, broken an aerial 
 Stolen something 
 Driven a car without permission 
 Been suspended or expelled from a school 
 Done “graffiti” 
The response set for each behaviour was as follows: (1) Not at all, (2) Once, (3) 
More than once. (Note that the minimum age for being granted a driving licence in 
Victoria is 18 years. A learner’s licence with this cohort was available at 17 years but 
they had to be accompanied by a licensed driver.) These responses were reduced to a 
binary measure which identified global antisocial behaviour, characterised by a 
response of “more than once” to two or more behaviours. 
Peer cannabis use was assessed from the question: “How many of your friends take 
drugs?” with the response set: (1) None, (2) Some, (3) Most of them. This was 
reduced to a binary variable which identified that “most or all friends used drugs”. 
As cannabis was by far the most frequently used illicit substance in the adolescent 
age range, this question was assumed to refer to cannabis, and was used with this 
definition in publications. 
2.4.4 Young adulthood phase 
Cannabis use. At the start of the cannabis use module the following questions were 
asked: 
1. Have you ever smoked or used marijuana or cannabis products? These 
include grass, dope, pot, weed, mull, hash and skunk. [yes/no] 
2. Have you used marijuana more than 5 times in the last year? [yes/no] 
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3. Thinking about the past 12 months, when you were using marijuana most 
frequently, about how often did you use it? [Almost every day/3 or 4 days a 
week/1 or 2 days a week/1 to 3 days a month/less than once a month] 
4. When did you last use marijuana at all? [Within last 2 weeks/4 weeks to less 
than 1 month ago/3 months to less than 6 months ago/ 8 months to less than 
one year ago/In the last 12 months, Don’t know when/More than 1 year ago] 
The variable describing maximum frequency of cannabis use in the past year was 
reduced to the same four categories applied in Waves 1-6: “none”, “occasional”, 
“weekly (<daily)”, “(almost) daily”. These were also further reduced to binary 
variables describing each level. 
Cannabis abuse and dependence. We administered the 12 month version of the 
computerised Composite International Diagnostic Interview (CIDI) incorporated into 
the interview schedule in participants reporting at least weekly cannabis use in the 
past 12 months (Composite International Diagnostic Interview (CIDI) Core Version 
2.1, 12 month version 1997; Lewis et al. 1992). We applied this filter to minimise 
responder fatigue as we considered that a diagnosis of cannabis dependence was only 
consistent with regular cannabis use, given the DSM-IV description of substance 
dependence as occurring with a “pattern of repeated (substance) self-administration”. 
The DSMIV definition of abuse required at least one positive response to: 
1. recurrent substance use resulting in failure to fulfil major role obligations at 
work, school, or home; 
2. recurrent substance use in situations in which it is physically hazardous; 
3. recurrent substance-related legal problems; 
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4. continued substance use despite having persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of the substance. 
The DSMIV definition of dependence required at least three positive responses to: 
A maladaptive pattern of substance use leading to clinically significant impairment 
or distress, as manifested by three or more of the following, occurring at any time in 
the same 12-month period: 
1. tolerance as defined by either of the following: (a) a need for markedly 
increased amounts of the substance to achieve intoxication or desired effect, 
(b) markedly diminished effect with continued use of the same amount of the 
substance; 
2. withdrawal as manifested by either of the following: (a) the characteristic 
withdrawal syndrome for the substance; (b) the same (or a closely related 
substance) is taken to relieve or avoid withdrawal symptoms; 
3. the substance is often taken in larger amounts or over a longer period than 
was intended; 
4. there is a persistent desire or unsuccessful efforts to cut down or control 
substance use; 
5. a great deal of time is spent in activities necessary to obtain the substance, 
use the substance, or recover from its effects;  
6. important social, occupational, or recreational activities are given up or 
reduced because of substance use; 
7. the substance use is continued despite knowledge of having a persistent or 
recurrent physical or psychological problem that is likely to have been 
caused or exacerbated by the substance. 
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We adapted the list of withdrawal symptoms, which, in the original CIDI interview, 
were predicated on alcohol and opioid withdrawal symptoms and were not 
necessarily relevant either to cannabis withdrawal as it was reported in the clinical 
literature or to the target age group. We asked “In the last year, did stopping or 
cutting down on marijuana cause you any problems such as irritability, sleep 
problems, anxiety, tremor, sweating or muscle aches?” We omitted: nausea or 
vomiting, hallucinations or illusions, psychomotor agitation and grand mal seizures. 
We considered that applying the CIDI-AUTO interview for both alcohol and 
cannabis dependence/abuse separately from the main interview would have been 
cumbersome for the interviewer and an unnecessarily load on respondent burden and 
so decided to incorporate it into the interview schedule. I obtained the CIDI cannabis 
dependence/abuse module from the questionnaire schedule used by the 1998 
Australian National Mental Health Survey (NMHS) and transferred it into the CATI 
instrument used in Wave 7. I also translated into Stata the corresponding SPSS 
algorithm that had been developed at the WHO Collaborating Centre for Mental 
Health and Substance Abuse, NSW. A problem with the coding and branching of 
tolerance in Wave 7 was identified after publication of these data had commenced. 
As can be seen from the definition above, tolerance was defined as a need for 
markedly increased amounts of cannabis OR a markedly diminished effect. The CIDI 
questionnaire as used in the NMHS and the corresponding SPSS algorithm required 
both criteria. This was further compounded by my using the branching in the 
cannabis module parallel with the alcohol dependence algorithm, rather than the 
(incorrect) cannabis NHMS branching. Correction of this error resulted in Wave 7 in 
an increase in prevalence of tolerance with a corresponding though trivial increase in 
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that of dependence of 0.5% above what was initially reported, well within the 
confidence interval. 
Other illicit substance use was assessed either from a binary question asking about 
use in the past 12 months (Waves 7 and 8) or from maximum self-reported frequency 
of use over the past twelve months (Wave 9) of amphetamines; opiates; sedatives; 
cocaine; ecstasy and currently available “designer” drugs. We listed the street name 
for each substance in the questions. Generally we reduced these variables to “any use 
in the past year”. We also sometimes employed a variable describing “any other 
(than cannabis) illicit substance use” obtained by identifying a positive response to 
any substance. 
Cigarette smoking and nicotine dependence. Those who had smoked cigarettes 
within the past month were identified in the same way as for the adolescent phase 
(Waves 1-6). Nicotine dependence was measured using the Fagerstrom Test for 
Nicotine Dependence (FTND) and was defined as a score of 4+ on the FTND, 
corresponding to a cut-point of 7 or more on the Fagerstrom Tolerance Questionnaire 
(Heatherton et al. 1991). 
Alcohol consumption and DSM diagnosis was assessed at each wave. Firstly, those 
participants who reported any alcohol use in the past week completed a 4-day 
beverage and quantity specific retrospective diary, with the days reported being 
Friday, Saturday, Sunday and the nearest weekday to the interview. The weekday 
quantity of alcohol was then extrapolated to any other weekday on which alcohol 
was consumed and the total alcohol consumption for the week was calculated. This 
allowed the identification of high risk drinking in the week prior to interview 
according to either the 2001 or the 2007 NHMRC definition of high risk drinking. 
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Both DSM4 diagnoses (Composite International Diagnostic Interview (CIDI) Core 
Version 2.1, 12 month version 1997) of alcohol abuse and dependence were available 
for Wave 7 and 8 but in Wave 7 the dependence module was applied only to 
participants who reported drinking on three or more days, resulting in a systematic 
downward bias, albeit it small but quantifiable, which was identifiable through 
examination of results from the 1998 Health and Wellbeing Survey in the same age 
group. In Wave 8, both DSM4 abuse and dependence were assessed separately. In 
Wave 9, due to a programming error, only the summary DSM4 diagnosis of abuse 
&/or dependence was available. Because of these limitations, we used either 
dependence just in Wave 8 or the portmanteau “alcohol diagnosis” for all three 
young adult waves. 
Common mental disorders were assed in different ways as the cohort aged. In Wave 
7, symptoms of depression and anxiety were assessed using the Clinical Interview 
Schedule – Revised (Lewis et al. 1992) as described in the adolescent phase (Waves 
1-6). In Waves 8 and 9, symptoms of depression and anxiety were assessed with the 
GHQ-12 (Goldberg 1988) and were dichotomised at a score ≥3, a threshold believed 
to delineate a mixed depression-anxiety state at a lower level than syndromes of 
major depression and anxiety disorder but where clinical intervention would be 
appropriate (Lewis et al. 1988). In Wave 9, Major Depressive Disorder was defined 
according to ICD-10 and was measured using the CIDI-Auto (Composite 
International Diagnostic Interview (CIDI) Core Version 2.1, 12 month version 
1997). Anxiety disorder was defined according to ICD-10 and was measured using 
the CIDI-Short Form (Kessler et al. 2006). Participants were classified with anxiety 
disorder if they were diagnosed with any of the following: generalised anxiety 
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disorder; social phobia disorder; agoraphobia; panic disorder. Specific phobia 
disorder was not measured. 
Personality disorder was assessed using the Standardised Assessment of Personality 
(SAP) (Pilgrim et al. 1993). This is a semi-structured interview conducted with an 
informant, either face-to-face or by telephone. It has good inter-rater, inter-temporal 
and inter-informant reliability (Pilgrim et al. 1993). All Wave 8 participants were 
asked to nominate a friend, with whom a telephone interview could be conducted, in 
order to assess the participant for the presence of personality disorder. 
Social outcomes. Specifically designed questions were included at each wave to 
describe: 
x educational outcomes: years of higher education. Completion (or not) of 
university studies was assessed; 
x employment in the previous twelve months for those not in full time higher 
education; 
x presence and duration of a stable relationship; 
x childbirth. 
2.5 Summary adolescent measures and missing data 
Initial analyses were concerned with questions relating to the detailed transitions 
identifiable in the adolescent phase. When we wished to examine associations 
between adolescent exposures and young adult outcomes, it was often strategic to 
summarise adolescent measures into what were effectively cross-sectional measures. 
This was done in three ways: (1) maximum level recorded for measures with more 
than two categories (e.g., frequency of cannabis use, reduced to none, less than 
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weekly, weekly or more often); (2) the number of waves a binary level was positive 
(e.g., the number of waves any cannabis use was recorded, reduced to none, one, 
more than one wave); and (3) any occurrence (e.g., any cannabis use in Waves 1 to 6 
or, alternatively, 2 to 6). Logically, early initiation was embedded in the 
identification of two or more waves of any exposure in adolescence. This was 
considered a reasonable approach in a substantive sense, as Waves 1-6 were 
conducted over a two and a half-year period and Waves 2-6 over a two-year period. 
Similarly, we could identify early onset (e.g., before Wave 4).  
However, when using complete-case data, an important bias may arise due to 
missing observations, so that participants with incomplete data were likely to be 
under-specified, especially when Wave 1 was included in the observation period. The 
solution was either to compare estimates with those from a sensitivity analysis using 
a dataset restricted to participants with all waves observed or to impute missing data. 
The first solution was possibly subject to a different bias, as compliant participants 
with complete observations might be systematically different from those who had 
missed waves. Thus, the challenge to identify suitable multiple imputation strategies 
became an imperative, as this was judged to offer the least biased solution. 
2.5.1 Multiple imputation 
A complication of the study design is that about half the cohort was not recruited 
until the second wave, resulting in an unavoidable later entry point for these 
participants. In addition, as with all studies of this kind, there were problems with 
sample attrition and missing data due to missing waves, although missing data within 
waves was generally minimal. Of the total intended cohort of 2032 students, 1209 
responded at every time period in which they were included in the study in the first 
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six waves and 1943 responded at least once, with this latter group becoming the de 
facto cohort. Despite the generally high rate of follow-up, there is some potential for 
response bias. We were likely to lose contact with participants involved in extreme 
health-related risk-taking behaviours increasingly as the cohort aged. This resulted in 
a risk of under-estimation of the frequency of these behaviours due to differential 
under-ascertainment. We pursued a number of strategies to minimise the effect of 
differential loss, with increasing sophistication as the cohort aged and new 
techniques became available. 
As we collected at least some data on 96% of the intended sample from the earlier 
years of the cohort study, we are able to identify factors independently predicting 
poor study compliance (e.g., male sex, divorced parents, born overseas, smoking at 
entry into the cohort). Initially, in analyses examining data collected in Waves 1 to 6, 
we adjusted prevalence estimates by weighting according to these identified factors 
and possible chance variation in geographic sampling, obtained by comparing the 
achieved sample with actual school populations within each stratum (Carlin, J. B. et 
al. 1999). This assumed that those lost to follow-up resembled those who were still in 
the study, within categories defined by baseline characteristics. We reported 
longitudinal incidence-type analyses without weighting, under the assumption that, at 
the subject-specific level, weighting was unnecessary, as these relationships were 
represented by those individuals retained in the study and were similar in those who 
were absent. 
Subsequently, when examining outcomes measured in Waves 7 and 8, we used 
multiple imputation to address potential bias and loss of information arising from 
missing waves of data collection. This required the assumption that missing data 
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were missing at random (MAR), that is, the behaviour of two participants who share 
observed values have the same statistical behaviour on the other observations, 
whether observed or not. Each round of imputation was performed by a statistician 
under the supervision of a VAHCS principal investigator, Professor John Carlin, 
Director of the Clinical Epidemiology and Biostatistics Unit in the Murdoch 
Childrens Research Institute (MCRI). Initially, sets of five complete datasets were 
imputed separately for males and females containing sufficient variables to enable a 
number of papers to be written from the one round of imputation. Each imputation 
was performed under a multivariate normal model (Schafer 1997) using Schafer’s 
standalone NORM software, incorporating all the exposure and outcome variables of 
interest measured at all waves, along with the fixed covariates of sex, age, 
rural/urban residence and parental education (available on all participants). Right-
skewed continuous and ordinal variables were imputed after log transformations and 
dichotomous measures were imputed as binary variables. After imputation, 
transformed variables were converted back to their original scale and all were 
categorised for analysis, with adaptive rounding used for binary measures 
(Bernaards, Belin & Schafer 2007). We could then derive estimates of parameters of 
interest (prevalence, (log) odds ratio) by averaging across the imputed datasets, with 
Wald-type confidence intervals obtained under multiple imputation using Rubin’s 
(Rubin 1987) combination rules. For example, this allowed the estimation of 
exposure to time-varying adolescent behaviours over the six waves of adolescent 
data collection for all participants who were available for interview in Wave 7 as 20-
year-olds or in Wave 8 as 24-year-olds. This method allowed us to make the least 
biased estimation of missing data, but deviations from the MAR assumptions may 
have left residual bias. The inclusion of auxiliary variables in the imputation models 
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should mitigate against this, at least to some extent. In papers employing this method 
of multiple imputation we used Stata software (Carlin, J.B., Galati & Royston 2008) 
to analyse multiply-imputed datasets. 
More recently, when we aimed to examine outcomes measured in Wave 9, 
statistician and co-author Dr Helena Romaniuk imputed twenty complete datasets 
specifically defined by the proposed analysis, with the addition of extra auxiliary 
variables, deemed to be informative. Imputation was performed again separately for 
males and females, under a multivariate normal model in Stata 11 or 12 (StataCorp  
2011) incorporating all analysis and auxiliary variables and using the same pre- and 
post-imputation transformations described earlier. At this point, we decided to reduce 
the sample used for imputation by removing those participants with very little data as 
these provided insufficient information on variables and cases to be recovered by 
modelling. Firstly, we omitted Wave 1 as it contained observations from only 46% of 
the cohort and secondly, we omitted 182 participants with no adult phase 
observations, as they contained too little information. Thus, participants were 
included in the imputation-based analysis if they had been seen once in adolescence 
(i.e., Waves 2-6) and once in adulthood (Waves 7-9). Forty-one participants had 
responded to one or more of the adult waves but had only a single adolescent 
observation in Wave 1. Within the context of using summarised adolescent measures, 
we considered it was a reasonable strategy to include these individuals by bringing 
forward their Wave 1 observations to Wave 2 (that is, they were measured six 
months earlier than the rest of Wave 2). Thus, these imputation datasets were defined 
by young adult phase participation, with the exclusion of participants who had died 
by Wave 9. 
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2.6 My contribution to the conduct of the VAHCS 
In 1994 I commenced with the Centre for Adolescent Health, now auspiced by 
MCRI, as an epidemiologist employed to analyse data already collected in Waves 1 
to 6 of VAHCS. My initial task involved cleaning and collating these data. I worked 
in collaboration with Professor George Patton, the Project Director, in these activities 
and also in paper preparation. My role expanded to Project Manager (1995-2005), 
ultimately as a Senior Research Fellow and then as an Honorary Research Fellow 
post- retirement (2005-present). I have been involved in all aspects of the academic 
development and dissemination of the study from 1994. 
2.6.1 Contributions to the VAHCS as Project Manager (1995-2004)  
(a) Involvement in writing and administration of each grant listed in Appendix 1, 
according to my responsibilities described in the proposal, with the exception 
of Grant 7, for reasons described below. 
(b) The design, computerisation, resource, personnel and process management of 
the 1998 (Wave 7) and 2001/03 (Wave 8) surveys.  
(c) Preparation, negotiation and maintenance of ethics approvals from the Royal 
Children’s Hospital Ethics Committee and the National Death Index Ethic 
Committee. 
(d) Cohort database maintenance. This involved, and still involves, a continuous 
process of data maintenance including documentation, data extraction and 
correction responding to differing needs of new and experienced researchers. 
(e) Paper and report writing, both as first author and assisting other researchers 
and post-graduate students in the Centre of Adolescent Health.  
Chapter 2 VAHCS methodology 
 
57 
 
(f) Since 1997, the development of collaborations leading to co-authorship with 
researchers in the CAH and from other institutions including the National 
Drug and Alcohol Research Centre in the University of New South Wales 
(1999 onwards), the Institute of Psychiatry in London (2004 onwards); and, 
finally, commencing in 2009, participation in the Cannabis Cohort Research 
Consortium, a collaborative effort involving researchers from Australian and 
New Zealand cohorts, that seeks to integrate large scale data sets from 
multiple research. 
2.6.2 Ongoing contributions to the VAHCS post-retirement (2005-
present) 
In December 2004, after obtaining NHMRC funding for the Wave 9 survey, in which 
I was one of the chief investigators, I retired from the CAH and my managerial role 
with VAHCS, due to a family tragedy. My role with the cohort changed substantially 
as I was no longer project manager, but I continued to be actively involved with most 
aspects of the study. With my detailed knowledge of the conduct of VACHS and all 
the data accumulated over the 20 years of the study, as well as a practical knowledge 
and understanding of the various statistical techniques we have used in answering 
substantively different questions over the years and an abiding interest in the diverse 
aspects of the study, I was, and continue to be, in a uniquely useful position to 
continue my involvement  
Contribution to Wave 9: In 2006, due to a change in personnel, I was required to 
apply my experience with the cohort to collate and clean the data collected during the 
conduct of Wave 9. I therefore prepared and documented the Wave 9 datasets for 
analysis, consistent with the way in which I had prepared Waves 7 and 8. 
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Contribution to the current Wave 10 data collection: I am currently acting as a 
consultant to the Project Manager responsible for the NHMRC-funded Wave 10 
survey, which commenced in the second half of 2012. I have continued to consult 
with other researchers preparing papers based on VAHCS data, including the CCRC. 
VAHCS Manual: Before retiring I had written and collated a study handbook which 
requires continuous update and I am still actively involved in this process. My aim in 
preparing and maintaining this document was to provide a complete reference for 
researchers wanting to operationalise their questions, access the relevant data and 
perform their analysis. 
Database management: I have also rigorously maintained the datasets and cohort 
dataset structure, available on the CAH intranet, along with all relevant Stata analysis 
files (dofiles), instruments and documents of historical interest, again documented in 
the manual. Inevitably, in a study of this size and duration, there are idiosyncrasies 
and inconsistencies in the data, which are essential to understand and I have 
attempted to document all of these and render them logically accessible. 
Primary and co-authorship: I was developing first author publications until my 
retirement but after that time I worked in collaboration with other researchers with 
substantive backgrounds in the subject of focus, largely because I was no longer was 
in a position to promulgate the findings. I have continued collaborations with 
Professor George Patton, Professor John Carlin and other MCRI researchers and also 
researchers Dr Wendy Swift and Professor Louisa Degenhardt at the National Drug 
and Alcohol Research Centre and Dr Paul Moran at the London Institute of 
Psychiatry in the preparation of papers based on VAHCS data. In the papers in which 
I was second author, I always had a lead role in the methods and analysis and a 
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contributory role in the design, introduction and discussion. In other multiple-
authored papers, I contributed in varying degrees to the development of the paper. 
A complete list of peer-reviewed papers based on cohort data to which I have 
contributed is listed in Appendix 1, amounting to 43 papers to date. A primary focus 
of my published research has been the aetiology, continuity and consequences of 
adolescent cannabis use, which forms the basis of this thesis. Other areas of enquiry 
include cigarette smoking, alcohol use, mental health, personality disorder, eating 
disorder, obesity, childhood sexual abuse and self harm, necessarily including 
considerable overlap. The papers included in this dissertation are indicated by an 
asterisk. They include the domains of the natural history of cannabis use and risks 
associated with exposure to cannabis use in adolescence. 
2.7 The VAHCS in context  
2.7.1 Comparable population-based cohort studies 
Cannabis-focused publications have arisen from a number of population-based 
cohort studies covering a similar age range to the VAHCS. These were identified 
through review papers and cannabis-focused publications and are listed in Table 
2.7.1. 
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Table 2.7.1 Comparable population-based cohort studies 
 
2.7.2 Novel contributions of the VAHCS 
Although recruitment in the VAHCS did not include early childhood as in some of 
the cohort studies listed above, it differs further in specific methodology and 
measurement, which endow advantage. The ways in which the VAHCS makes an 
original contribution in domains where exposures and outcomes have been 
consistently measured include:  
x The bi-annual adolescent surveys. As a result of repeated surveys at 6-
monthly intervals our study is in the unique position of being able to tease 
out, for example, initiation, remission and other transitions in cannabis use 
during the period of rapid change during this period. This allows examination 
of the aetiology of common mental health problems and teenage health risk 
Study Location Start Sample Size Follow-up (yr) Retention Cannabis measures
National  Survey of 
Health and 
Development 1970 Birth 
Cohort Study
UK 1970 Birth cohort 15571 5, 10, 16, 26, 30, 34, 38, 
42
90% 16 years : ever
30 years : used in past 12mo
RAND Adolescent Panel  
Study
USA 1985 7th grade 5800 one fol low-up at 5 
years
nearly 70% 
(4390)
# time used in past year and past month
National  Longitudinal  
Surveys  NLSY97
USA 1997 12-16 years  
old on 
31/12/96
~9000 Annual  to 2005 (7 
fol low-ups)
# days  used in past month
Seattle Socia l  
Development Project
USA 1985 5th grade 
(10 years )
808 annual  to 1991, 1993 
(age 18 years )
94% in 1993 Ever used (?)
The Dunedin 
Multidiscipl inary Health 
and Development Study 
NZ 1972 3 year-olds 1037 Every 2 years  to 18, 
then 21,26,32,38
96% at last 
survey
From 13yrs : once or twice, 3+ times
From 18yrs : Frequency of use and dependence
The Chris tchurch Health 
and Development Study 
NZ 1977 birth 1265 Annual ly to 18 yrs , 
25,30 yrs
80-85% 14 yrs : ever
From 15 yrs : #times  used in the past year (0-50)
The Mater-Univers i ty of 
Queens land Study of 
Pregnancy and 
O t
Austra l ia 1981/3 6 months 7223 5, 14/15, 21 years 52% at lat 
survey
21 years : Current use in past mo: never,  da i ly, every 
few days , once, and not in the past month)
Recal led age of ini tiation
The Austra l ian 
Temperament Study
Austra l ia 1983/4 4-8mo 
babies
2443 Annual , then biannal  
from school  
commencement to 19 
years , then three 
yearly.
Effective 
sample s ize 
reduced due 
to sub-
sampl ing
13/14: l i fetime use (never/1-2/3+) 
15/16: l i fetime use, #days  in past 30 days ;  
#joints/day
17/18 onwards : harms 12 mo 
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behaviours and the ability to quantify associations. The short reference period 
at each adolescent wave enhances measurement reliability. 
x Sample size. Our sample size approaching 2000 endows an advantage over 
smaller cohorts when examining relatively infrequent exposures and 
outcomes. 
x Retention. It is noteworthy that 96% of the intended sample had at least one 
observation in the adolescent phase, and ascertainment in the young adult 
phase remains at a acceptably high level. 
x Multiple imputation. We pioneered the use of multiple imputation in the 
context of cannabis research to deal with missing data. This was innovative 
and original at the time, and we have continued to use these techniques as 
they were developed and incorporated into Stata. This enabled us to obtain 
least biased estimations of the duration and exposure of individuals to 
measures of interest during adolescence. 
x Measurement of cannabis use frequency. Unlike most other studies here and 
overseas, we enquired about the participants’ frequency of cannabis use, 
rather than the more usual questions in other cohort studies about the number 
of times it has been used “ever”, “in the past year”, “in the past month”. 
These questions are sometimes adapted to correspond to a frequency measure 
(e.g., “used 4 times in the past month” is often classified as “weekly”), but 
that is probably less reliable than asking the question in the first place. 
x Measurement of licit substance use. The one-week retrospective diary for 
alcohol use and cigarette smoking used throughout the cohort enhances our 
capacity to measure these time-varying behaviours and estimate exposure in 
adolescence and young adulthood, with the awareness that it is susceptible to 
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both over- and under- estimation due to the short recall period. In that 
context, the diary provides a useful estimate of behaviour at the time of 
survey. 
x Measurement of other illicit substance use. Unlike other studies, we 
measured amphetamine use throughout the cohort, allowing us to specifically 
examine amphetamine use from adolescence to young adulthood.  
2.7.3 Cannabis use in the VAHCS 
In the following chapters (3 to 6) I discuss a selection of papers that were written 
specifically to contribute to the evidence base concerned with the natural history and 
consequences of cannabis use in adolescence and young adulthood. Papers are 
generally presented in this dissertation in chronological order so, as the cohort ages, 
the data included in each analysis progresses from the adolescent phase initially, 
then, progressively, through the young adult phase. The questions we address are 
either in response to deficits in the literature, or sometimes, prompted by previous 
findings. 
The context for the following chapter is illustrated in Table 2.7.3, showing the 
prevalence of cannabis use throughout the cohort as it matured. Cannabis use 
increased from Waves 1 to 4 when it appeared to stabilise in the remaining 
adolescent waves. It then increased substantially in the young adult phase, although 
weekly/daily use remained relatively stable throughout this period. Peak use occurred 
in Wave 7, largely due to a spike in the prevalence of occasional users, which 
subsequently reduced substantially. Overall, 60% (CI 58-63%) of the cohort reported 
cannabis use at least once. Of these, half (52%, CI 49-55%) had initiated use by 
Wave 6 and the vast majority (91%, CI 89-93%) had done so by Wave 7, at 20/21 
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years. Cannabis dependence was identified in 7% (95%, CI 6-9%), 6% (CI 5-7%) 
and 3% (CI 2-4%) of participants in Waves 7, 8 and 9 respectively, and over the 
young adult phase, 11% (CI 9-13) were identified at least once with dependence. 
 
Table 2.7.3. Frequency of cannabis use by wave.
 
 
n (% ) n (% ) n (% ) n (% )
Adolescent phase (current use)
1 14.9 762 696 (91) (88.8 -93.8) 59 (8) (5.4 -10.1) 8 (1) (0.1 -1.9) -
2 15.5 1673 1438 (86) (82.9 -89.0) 195 (12) (8.9 -14.5) 33 (2) (0.8 -3.2) 7 (0.4) (0 -0.9)
3 15.9 1659 1426 (86) (82.9 -89.0) 174 (10) (7.8 -13.2) 56 (3) (1.8 -4.9) 3 (0.2) (0 -0.6)
4 16.4 1597 1328 (83) (79.9 -86.4) 180 (11) (8.5 -14.1) 73 (5) (2.7 -6.4) 16 (1) (0.1 -1.9)
5 16.8 1539 1259 (82) (78.4 -85.2) 226 (15) (11.6 -17.7) 43 (3) (1.3 -4.2) 12 (1) (0.0 -1.6)
6 17.4 1506 1253 (83) (79.9 -86.4) 191 (13) (9.8 -15.6) 54 (4) (1.9 -5.2) 9 (1) (0 -1.3)
Young adult phase  (maximum use in the past 12 months)
7 20.7 1590 658 (41) (39.0 -43.8) 717 (45) (42.6 -47.5) 105 (7) (5.4 -7.8) 110 (7) (5.7 -8.2)
8 24.1 1516 979 (67) (64.6 -69.3) 282 (21) (18.6 -22.7) 76 (6) (5.0 -7.4) 76 (6) (5.0 -7.4)
9 29.1 1480 1091 (74) (71.5 -76.0) 222 (15) (13.2 -16.8) 54 (4) (2.7 -4.6) 113 (8) (6.3 -9.0)
Wave 
Average 
age
(years)
N
Cannabis use 
(95%  CI) (95%  CI) (95%  CI) (95%  CI)
Almost daily/dailyWeeklyLess than weeklyNone
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CHAPTER 3 Natural history of cannabis use 
3.1 Chapter outline 
This chapter presents five related papers describing the natural history of cannabis 
use from initiation in adolescence to continued use in young adulthood. I briefly 
describe the context, methodology and findings reported in each paper. The papers 
are presented in the order in which they were written, in order to clarify the links 
between them. §3.2 presents the first paper on the factors associated with early 
initiation of cannabis use during adolescence, to 17 years (Wave 6). §3.3 discusses 
an paper examining adolescent precursors of cannabis dependence at 20 years (Wave 
7), noting the influence of early initiation and the possible protective influence of 
risky alcohol use. As a direct corollary to this observation, the paper presented in 
§3.4 examines in greater depth the diverging trajectories of cannabis use and risky 
alcohol use from adolescence to young adulthood, as far as 24 years (Wave 8). The 
focus of §3.5 is the role of early onset adolescent cannabis use in predicting 
escalation to daily cannabis use and dependence at 24 years (Wave 8). It was 
apparent that regular cannabis use in adolescence did not inevitably lead to 
dependence, thus leading to the final paper in this series presented in §3.6, examining 
the risk of escalating use and dependence in young people who moderate their 
cannabis use during adolescence. Finally, in §3.7, the five papers are summarised. 
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3.2 Initiation and progression of cannabis use in adolescence 
Paper 1. Initiation and progression of cannabis use in a population-based Australian 
adolescent longitudinal study. Coffey C., Lynskey M. Wolfe R. Patton GC. 
Addiction. 95(11):1679-90, 2000 Nov 
Journal impact factor 4.3 (source: Journal Citation Reports, 4/03/2013) 
102 citations, as at 4/03/2013 (source: Google Scholar). 
This early paper was the first in series of publications examining the natural history 
of cannabis use. At the time it was written, there was controversy within both the lay 
and scientific communities about whether prolonged and frequent use of cannabis 
might be associated with harms (Robson 1997; Strang, Witton & Hall 2000). The 
ubiquitous nature of cannabis use amongst young people in the developed world was 
well known. However, our understanding of the paths by which usage commenced 
was restricted to either cross-sectional studies, relying on recall, or cohort studies 
with infrequent measurement points during the period of rapid lifestyle change in 
adolescence (e.g. (Fergusson, Lynskey & Horwood 1996; Kandel 1975; Yamaguchi 
& Kandel 1984). A further limitation in the literature was the failure to examine 
anything other than “any” use, ignoring the potential importance of high frequency 
and persistent use. Some putative risk factors involved in cannabis uptake had been 
documented and included drug availability and association with peers with positive 
attitudes to drug use. 
Jessor (1976) developed a theory of “transition proneness” in which involvement in 
one problem behaviour increased the probability of involvement in others. Problem 
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behaviours included alcohol abuse and cannabis and other substance use, antisocial 
behaviours such as vandalism and risky driving, and disregard for conventional 
norms such as school achievement and parental control (Jessor 1976). Thus, 
adolescents who were involved in other problem behaviours were vulnerable to drug 
use initiation. A more specific theory, the so-called “Gateway Theory” of substance 
use transition developed by Kandel and associates (Kandel 1975) specified that 
cigarette smoking and alcohol use (rather than abuse) by adolescents preceded 
cannabis use, which then increased the risk of moving to other illicit substance use. 
Both these theories, originating in the 1970s when cannabis use was accelerating 
rapidly and causing particular concern in the U.S.A., were well-grounded as far as 
they went, but their relevance to cannabis use by young people 25 years later 
required assessment. Detailed examination of the correlates of cannabis use and the 
predictors of initiation and (in those who had commenced use) escalation to regular 
and daily use could inform their current general applicability. This last question had 
not been previously addressed and was particularly important, as adolescents who 
use cannabis daily undoubtedly constitute a group at high risk of later harm. With the 
close measurement points of the frequency of cannabis use during the period of rapid 
change in adolescence, the VAHCS was well-placed to examine these theories in 
more detail than had been published to date using either life history measures or, at 
best, annual surveys with less precise measurement of the frequency of cannabis use. 
3.2.1 My contribution 
I was first author, responsible for conceptualisation and development of the question 
in collaboration with the other authors, operationalisation, analysis with assistance 
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from Associate Professor Wolfe (statistician) and report writing. The declaration of 
my contribution, estimated as 50%, is in Appendix 2. 
 
3.2.2 Analysis and results 
The analysis used data covering the two and a half-year period from Waves 2 to 6, 
commencing once the cohort sampling was completed in Wave 2. In order to identify 
initiation, continuity and escalation of use, we divided this period into two phases: 
mid-school, consisting of Waves 2 and 3 (both waves in Year 10) and late-school 
consisting of Waves 4, 5 and 6 (two waves in Year 11 and one in Year 12). Measures 
were summarised within each of these phases and so the analysis was restricted to 
participants with at least one observation in each. We were able then to examine 
correlates of mid-school use, predictors of incident cannabis use in late-school, 
predictors of continuity in use from mid- to late-school and initiation of daily use in 
the late-school period. Reflecting Jessor’s (1976) and Kandel’s (1975) problem 
behaviours and social mores as putative risk factors, we assessed cigarette smoking, 
alcohol use and antisocial behaviour, as well as two measures of social context, 
namely, peer illicit substance use and a measure of exposure to environmental 
cannabis use at the school attended by the participant at study entry. This last factor 
enabled an additional indicator of drug availability and social mores and was derived 
from the probability of regular (≥weekly) cannabis use within each participant’s 
school in Wave 2, which had not, to our knowledge, been employed previously. In 
addition, we included symptoms of anxiety and depression as a putative risk factor, 
as we had previously shown that this predicted cigarette smoking initiation in the 
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cohort (Patton, GC et al. 1998b). Unlike any other study to date, we also tested 
whether risks were consistent for transitions to occasional use, compared with 
regular and daily cannabis use. 
A novel and important finding was the persistence of cannabis use during the 
secondary school years once it had commenced: later quitting occurred in only about 
one fifth of mid-school users. Moreover, over a quarter of occasional users, two-
thirds of weekly users and three-quarters of daily users in the mid-school period were 
using regularly (≥weekly) in the late-school period. 
There were cross-sectional associations between mid-school licit substance use and 
antisocial behaviour measures, after adjustment for background factors including 
school environmental use. The same factors predicted late-school uptake in mid-
school non-users, direct associations not previously specified to our knowledge. On 
testing for interactions between explanatory variables and the transition points in 
cannabis use frequency, we found that the effects appeared consistent with increasing 
frequency of cannabis use; thus these factors endowed a general risk. 
The risk profile predicting continuation of cannabis use from mid- to late-school 
cannabis use was less consistent: male sex, ≥weekly cannabis use (with reference to 
occasional use), peer cannabis use and cigarette smoking were clearly predictive, 
while the influence of alcohol abuse and antisocial behaviours were confounded by 
these measures. Predictably, although school environment was influential in cannabis 
initiation, it did not influence continuation in those already using. Significantly, apart 
from the importance of greater frequency of cannabis use, the risk profile for boys 
and girls escalating their cannabis use from occasional or weekly in mid-school to 
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potentially harmful daily use in late-school differed markedly. The co-occurrence of 
alcohol abuse and antisocial behaviour predicted this transition in girls, perhaps 
indicating extreme norm-violating behaviour, whilst for boys, perceived peer use 
predicted this transition, signifying that the social phenomenon of companionship 
and availability mediated the effects of licit substance use. Symptoms of anxiety and 
depression were a modest predictor of incident cannabis use and were not implicated 
in the continuation or escalation of cannabis use in adolescence, indicating that self-
medication did not appear to be an important mechanism. 
3.2.3 Implications 
Our findings supported the theory of a cluster of deviant behaviours preceding 
cannabis initiation (Jessor 1976), and specifically, that these factors included both 
alcohol abuse and cigarette smoking, in accordance with the Gateway Theory 
(Kandel 1975), the two theories actually having considerable common ground. The 
extent of agreement of VAHCS data with the Gateway Theory is examined in precise 
detail later in this dissertation in the discussion in Chapter 7, as this level of enquiry 
was not included in the current paper. The independent effect of environmental 
exposure on cannabis uptake and continuation measured at both the peer and 
classroom levels was consistent with the “risk and protective” framework outlined in 
an important review (Hawkins, Catalano & Miller 1992), in which they asserted that 
drug availability influenced substance use initiation over and above the risk posed by 
individual characteristics. The risk profile describing continuation of cannabis use 
from mid- to late-school in which cigarette smoking, but not alcohol abuse or 
antisocial behaviours, was influential, perhaps emerged as a consequence of purely 
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social influences, where teenagers smoked cigarettes and cannabis together as a 
communal activity, perhaps in an environment where cannabis was easier to obtain 
than alcohol, or possibly preferred because of its illegality, or its specific intoxicating 
effect. 
These findings laid the foundation for us to examine the continuities and 
consequences of adolescent cannabis use as the cohort matured into young 
adulthood. We observed fluctuating frequencies of use, with some young people 
appearing to quit whilst others increased their frequency of use to weekly or daily, 
delineating a group at likely risk of harm and perhaps indicating a vulnerability to 
cannabis dependence. This led us to the following series of papers in which we 
examined factors that predisposed teenagers to later regular use and cannabis 
dependence and the relative importance of the fluctuations in use, alongside their 
alcohol and cigarette use, in the natural history of cannabis use into young adulthood. 
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3.2.4 Paper 1: Initiation and progression of cannabis use in a 
population-based Australian adolescent longitudinal study. 
Coffey C., Lynskey M. Wolfe R. Patton GC. Addiction. 95(11):1679-90, 2000 Nov 
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Initiation and progression of cannabis use in a
population-based Australian adolescent
longitudinal study
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1Centre for Adolescent Health, Department of Paediatrics, University of Melbourne, 2National
Drug and Alcohol Research Centre, University of New South Wales, Sydney & 3Clinical
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University of Melbourne, Australia
Abstract
Aims. To examine predictors of cannabis use initiation, continuity and progression to daily use in
adolescents. Design. Population-based cohort study over 3 years with 6 waves of data collection. Partici-
pants. 2032 students, initially aged 14–15 years, from 44 secondary schools in the state of Victoria,
Australia. Measurements. Self-report cannabis use was categorized on four levels (none, any, weekly,
daily) and summarized as mid-school (waves 2/3) and late-school (waves 4/5/6) use. Background, school
environment, mid-school peer use and individual characteristics were assessed. Findings. Peer cannabis use,
daily smoking, alcohol use, antisocial behaviour and high rates of school-level cannabis use were associated
with mid-school cannabis use and independently predicted late-school uptake. Cannabis use persisted into
late-school use in 80% of all mid-school users. Persisting cannabis use from mid- to late-school was more likely
in regular users (odds ratio (OR) 3.4), cigarette smokers (OR any smoking: 2.0, daily smoking: 3.3) and
those reporting peer use (OR 2.1). Mid-school peer use independently predicted incident late-school daily use
in males (OR 6.5) while high-dose alcohol use (OR 6.1) and antisocial behaviour (OR 6.6) predicted
incident late-school daily use in females. Conclusions. Most cannabis use remained occasional during
adolescence but escalation to potentially harmful daily use in the late-school period occurred in 12% of early
users. Transition was more likely in males, for whom availability and peer use were determinants. In contrast,
females with multiple extreme behaviours were more likely to become daily users. Cigarette smoking was an
important predictor of both initiation and persisting cannabis use.
Introduction
There is concern about cannabis use by young
people in most developed countries (Adlaf &
Smart, 1991; Fergusson, Lynskey & Horwood,
1993; Johnston, OMalley & Bachman 1998;
Hall, Johnston & Donnelly, 1999; Lynskey &
Hall, 1999). Cannabis use is typically initiated
during adolescence with patterns of heaviest use
usually occurring during late adolescence and
young adulthood (Chen & Kandel, 1995).
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1st sample
N1 =1037
Wave 1
n1 =898
(87%)
late 1992
2nd sample
N2 =995
Wave 2
n2 =1728
(85%)
early 1993
Wave 3
n3 =1699
(84%)
late 1993
Wave 4
n4 =1629
(80%)
early 1994
Wave 5
n5 =1576
(78%)
late 1994
Wave 6
n6 =1530
(75%)
early 1995
Total intended sample = N1 + N2 = 2032
Total achieved sample = 1947 (96%)
1680 C. Coffey et al.
Figure 1. Participation rates of 2032 secondary school students in the adolescent health cohort study in Victoria, Australia.
Controversy remains about the extent of the
harmful social and health consequences of
occasional use of this drug. Debate has been
polarized between those who argue that ado-
lescent cannabis use is essentially a benign, tran-
sient practice with few social and health
consequences for the great majority of young
people (Shedler & Block, 1990; Robins, 1995)
and those who view cannabis as having the
potential to lead to escalating drug use and its
attendant problems (Kandel et al., 1986; New-
comb & Bentler, 1988; Fergusson, Lynskey &
Horwood, 1996; Hall, 1997). Its peak use also
coincides with the time of greatest risk for
adverse effects of substance use such as acciden-
tal injury, educational and legal difculties (Hall,
1995).
Most information on the risk factors for can-
nabis use derive from cross-sectional and retro-
spective studies. These studies have generated
useful hypotheses but the processes involved can
only be explored longitudinally, that is, with
prospective measurement at multiple time-points
of drug use and putative risk factors (Kandel,
1980; Farrington, 1991; Cicchetti & Rogosch,
1999). Longitudinal studies beginning early in
life have identied childhood and early ado-
lescent risk factors for cannabis use, but
infrequent observations during the adolescent
years have limited the ability of these studies to
clarify risk processes around mid- to late teens, a
period of rapid change in drug use behaviour.
Well documented risk factors for licit and illicit
substance use include ready substance avail-
ability together with afliation with drug-using
peers (Dembo et al., 1979; Kandel & Andrews,
1987; Maddahian, Newcomb & Bentler, 1988),
but predictors of more regular use have been less
explored than those for initial uptake. Further,
few investigators have distinguished between
occasional/experimental use and more regular
use, thereby being insensitive to the possibility
that risk factors for the two levels may differ.
The aims of this report are to use data from a
3-year prospective study of a representative sam-
ple of Australian adolescents to quantify the
correlates of early cannabis use and to quantify
risk factors for incident use, continuation and
progression in use.
Method
Procedure and sample
Data were collected from subjects in a 6-wave
cohort study of adolescent health performed
throughout the state of Victoria, Australia
between August 1992 and July 1995. The cohort
was dened using a two-stage sampling pro-
cedure. At stage 1, 45 schools were selected from
a stratied frame of government, catholic and
independent schools (total number of students
60 905). One school from the initial cross-sec-
tional survey was unavailable for the cohort
study leaving a total of 44 schools. At the second
stage, a single intact class was randomly selected
from each school and these students were mea-
sured in wave 1. At the second wave of data
collection, 6 months later, when the cohort had
moved into year 10, a second intact class from
the same grade at each participating school was
selected at random (Fig. 1). Thus half the partic-
ipants had been interviewed once before wave 2.
The entire sample was followed-up from wave 2
to completion of the study.
The study was presented as dealing with
important adolescent health issues and covered
both adolescent mental health and life-style.
Written parental permission was sought at entry
into the study. Subjects completed the question-
naire at intervals of 6 months between year levels
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9 and 12 (6 waves). The mean age at wave 1 was
14.5 (SD 0.5) years and at wave 6, 17.4 years
(SD 0.4). The survey was administered at school
using 28 laptop computers which allowed the
collection of detailed self-report data through the
use of branched questionnaires (Paperny et al.,
1990). Subjects who were unavailable for follow-
up at school were interviewed by telephone. The
proportion of interviews conducted by telephone
increased from 2% in wave 2 to 14% in wave 6.
Measures
Cannabis use
Assessment of cannabis use was based on self-re-
ported frequency. Participants described their
cannabis use during the past 6 months using the
following rating scale: (1) never used, (2) not
used in the past 6 months, (3) a few times, (4)
monthly, (5) weekly and (6) daily. Cannabis use
was summarized over two periods of the study:
the highest reported level of cannabis use in
waves 2 and 3, and similarly in waves 4, 5 and 6.
These intervals correspond to the third last year
at school, and the last 2 years of school. For
convenience, these intervals are referred to as
“mid-school” and “late-school”, respectively, al-
though the second interval contained data from
219 (11%) participants who had left school be-
fore their nal year.
Background and putative risk factors
A wide range of social, demographic, peer and
individual factors were examined as possible pre-
dictors of cannabis use. These were selected on
the basis of prior review of the literature which
identied factors most likely to be related to
cannabis use and subject to availability within
our data. The factors included were:
Demographic variables
These were assessed at study entry and included
gender, place of birth, metropolitan or rural lo-
cation of school and parental separation or div-
orce. However, rural school location was not
associated with any cannabis use variable and so
was dropped from all outcome analyses.
Peer cannabis use
At each wave, participants reported whether (1)
none, (2) some or (3) most of their friends used
cannabis. This variable was summarized over the
mid-school period so that those reporting in at
least one wave that most of their friends used
cannabis were characterized accordingly.
School level of cannabis use
In order to examine early exposure to regular
cannabis use at school, the proportion of stu-
dents within each school using cannabis at least
weekly was calculated at wave 2. The schools
were then divided into tertiles on the basis of
these proportions. In all analyses of late-school
cannabis use with the three-level variable de-
scribing school-level exposure, only the highest
category held a univariate association (if at all)
with the outcome variable. Therefore the binary
variable, top tertile vs. middle or bottom tertile,
was used in each analysis.
Cigarette smoking
Participants reporting that they had smoked on 6
or 7 days in the previous week were categorized
as daily smokers. If daily smoking was recorded
in either waves 2 or 3 then the individual was
characterized as a daily smoker during the mid-
school period (291 of the 1890 participants). For
more detailed analysis of the effects of smoking,
occasional smoking was dened as reporting
smoking in the last month, but less than 6 days
in the past week. Non-smoking was dened as
not having smoked in the past month.
Alcohol consumption
Subjects reporting that they had drunk alcohol in
the week before the survey were asked to com-
plete a 1-week retrospective alcohol diary (bever-
age- and quantity-specic). Two measures of
alcohol consumption were derived from the diary
in waves 2 and 3:
(1) Those who reported drinking on three or
more days in the previous week in either
wave 2 or 3 were classied as frequent
drinkers in the mid-school period (123 of
1890 participants).
(2) Subjects were characterized by their average
consumption of ethanol per drinking day
(one unit equivalent to one standard drink,
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9 g ethanol). Those with an average of ve
units or greater were classied as high dose
drinkers (312 of 1890 participants).
Antisocial behaviour
Antisocial behaviours were evaluated with 10
items from the Moftt & Silva (1988) self-
report early delinquency scale. Items included
antisocial behaviour relating to property damage
(vandalism, car damage, making grafti), inter-
personal conict (ghting, carrying weapons,
running away from home, expulsion from
school) and theft (stealing property from par-
ents, or other, stealing cars). Items concerning
alcohol or other substance use were not
included. The reference period was 6 months.
Antisocial behaviours were categorized accord-
ing to whether more than one behaviour was
endorsed “more than once” in order to dis-
tinguish participants with more global antisocial
behaviours. If this occurred in either wave 2 or
wave 3, individuals were characterized as dis-
playing antisocial behaviour in the mid-school
period (240 of 1890 participants).
Mental health
A computerized form of the Clinical Interview
Schedule (CIS-R) was used to rate psychiatric
morbidity (Lewis & Williams, 1989; Lewis et
al., 1992). This is a structured psychiatric inter-
view designed for assessing symptoms of general
psychiatric morbidity in non-clinical populations
and includes indicators of depression and anxi-
ety. The instrument generates 14 subscales
which can then be added to form a scale indi-
cating the degree of psychiatric morbidity.
Mean scores for waves 2 and 3 were calculated
and then dichotomized at the 11/12 cut-point,
corresponding to the level at which a general
practitioner might be concerned about a sub-
ject’s mental health (Lewis & Williams, 1989;
Lewis et al., 1992). Thirty-two per cent of
females and 15% of males scored above this
threshold.
Data analysis
Data analysis was undertaken using Stata (Stat-
aCorp, 1999). Initially, cannabis use was
assessed using a three-category ordinal scale:
(1) not used in previous 6 months, (2) used in
the last 6 months but less often than weekly
and (3) weekly or more regular use. We con-
sidered two alternative ways of analysing this
data. The rst alternative was to dichotomize
cannabis use as: (1) versus (2)–(3); or (1)–(2)
versus (3), and then to examine separate logistic
regression models tted to these dichotomous
outcomes. This approach would have resulted
in two different odds ratio (OR) estimates of
the association of a factor with cannabis use. A
marked difference between these OR would
indicate that the association was different at dif-
ferent parts of the ordinal scale. If the underly-
ing association with cannabis use that we were
trying to estimate was, in fact, the same across
the ordinal scale (i.e. the underlying OR were
equal) then this analysis method would be
inefcient and would ignore some of the infor-
mation from the three-category scale. To
optimize efciency we used the alternative
strategy of tting ordinal logistic regression
models. Within these models, it was possible to
perform likelihood-ratio (LR) tests (Peterson &
Harrell, 1990) of the assumption of a factor’s
association with cannabis use being constant
across the ordinal scale (the proportional odds
(PO) assumption (McCullagh, 1980)). All vari-
ables in the multivariable ordinal models
included in this report complied with the pro-
portional odds assumption at the 0.05 level of
signicance.
Exploratory univariate analyses were per-
formed followed by multivariable ordinal logis-
tic regression modelling. First-order interactions
with gender were tested in all models using the
LR test comparing the more complex model
with the simpler model. All reported condence
intervals (CI) are based on a 95% condence
level.
Other analyses performed were on the binary
outcomes: poor survey completion, late-school
daily use and persistence from early to late-
school use. These analyses used multivariate
logistic regression. In the case of the predictive
model for daily cannabis use, backwards step-
wise selection was used to examine interaction
terms with gender, keeping all main terms in
the model. Items were dropped if p. 0.2 and
reincluded if p , 0.1. A similar process was
then used in the selected model in order to
examine the main terms, dropping terms if
p. 0.1, and reincluding if p, 0.05.
Analysis Mid-school
level of use
Late-school
level of use
(1) Mid-school cannabis use (cross-sectional)
outcome
no use
< weekly
weekly
daily
no use
< weekly
weekly
daily
(2) Cannabis use initiation
no use
< weekly
weekly
daily
outcome
no use
< weekly
weekly
daily
(3) Continuity of cannabis use 
no use
< weekly
weekly
daily
outcome
no use
< weekly
weekly
daily
(4) Daily use initiation
no use
< weekly
weekly
daily
outcome
no use
< weekly
weekly
daily
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Results
Sample characteristics
From the total sample of 2032 students on class
registers, 1947 (95.8%) completed the question-
naire at least once in the course of the study.
Based on the intended sample, response rates
across waves were as follows: wave 1, 87%; wave
2, 85%; wave 3, 84%; wave 4, 80%; wave 5,
78%; and wave 6, 75%. The gender ratio of the
cohort (males 47.0%) was similar to that in
Victorian schools at the time of sampling (Aus-
tralian Bureau of Statistics, 1993). A total of
1890 (93%) young people participated in waves
2–6. The mean age at wave 2 was 15.4 (SD 0.5)
years and at completion of the follow-up was
17.4 years (SD 0.4).
Two hundred and three subjects (11%) com-
pleted only one or two waves between waves 2
and 6. Characteristics of these low completers
were examined in a logistic regression model.
Males were over-represented (OR 1.8, 95% CI
1.3–2.5), as were non-Australian-born subjects
(OR 2.0, CI 1.3–3.1), those who had experi-
enced parental divorce or separation (OR 2.6, CI
1.8–3.7) and those who reported using cannabis
at least weekly at study inception (OR 1.9, CI
1.0–3.5).
Four major outcome analyses were performed
and are shown in Fig. 2. This gure illustrates
one cross-sectional analysis and three prospec-
tive analyses that are the subject of this report.
Table 1 shows the frequency of mid-school can-
nabis users by late-school users, and denes the
observations included in the prospective analyses
(2) to (4) illustrated in Fig. 2.
(1) Mid-school cannabis use
Twenty-one per cent of the 1864 participants in
waves 2 and 3 (24% of males and 18% of
females) reported using cannabis in the mid-
school period of follow-up (Fig. 2). As daily use
was infrequent we combined this category with
weekly use to generate a three-level variable de-
scribing cannabis use: (1) none, (2) less often
than weekly (,weekly), (3) weekly or more
often (weekly 1 ). Male gender held a modest
univariate association with mid-school cannabis
use, but this association was not sustained after
adjustment for covariates (Table 2). Reported
peer use held the strongest independent associ-
ation with cannabis use with a greater than 10-
fold increase in odds. Antisocial behaviours,
daily smoking and high-dose alcohol use were
markedly associated with cannabis use, showing
between three- and ve-fold increases in odds,
while alcohol use on three or more days was only
modestly associated. Having divorced or sepa-
rated parents showed a slightly elevated univari-
ate risk, which was still evident after adjustment
for possible confounders. There was no evidence
of an association with either psychiatric morbid-
ity or Australian birth after adjustment for con-
founders.
Figure 2. Description of analyses. Shaded areas indicate
data included in analysis, borders indicate boundaries
between categories, gaps between categories indicate levels of
outcome, and arrows indicate path of transition.
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Table 1.Frequency of mid-school cannabis use by late-school cannabis use. Figures in brackets
are row percentages
Late-school cannabis use
Mid-school
cannabis use None ,Weekly Weekly Daily Total
None 1153 163 26 5 1347
(85.6) (12.1) ( 1.9) ( 0.4) (100)
,Weekly 63 123 61 10 257
(24.5) (47.9) (23.7) ( 3.9) (100)
Weekly 3 22 28 22 75
( 4.0) (29.3) (37.3) (29.3) (100)
Daily 3 2 8 7 20
(10.0) (40.0) (35.0) (100) (15.0)
Total 1222 310 123 44 1699
(71.9) (18.3) ( 7.2) ( 2.6) (100)
There were 123 non-users, 25 ,weekly, 10weekly and seven daily cannabis users from
the mid-school period who had no late-school observations.
Table 2. Associations with mid-school cannabis use measured on three levels*: OR from
ordinal logistic regression models (n5 1864)
Univariate Multivariate
Explanatory variable OR 95% CI OR 95% CI
Gender (male vs. female) 1.4 1.2–1.8 1.2 0.86–1.5
Australian birth 1.7 1.2–2.4 1.3 0.85–2.1
Divorced/separated parents 2.3 1.8–3.0 1.5 1.1–2.1
Peer cannabis use 26 19–35 12 8.6–17
Daily smoking 11 8.3–14 4.7 3.5–6.4
Alcohol . 2 days per week 6.0 4.2–8.7 1.6 1.0–2.5
High dose drinker 8.7 6.7–11 3.2 2.3–4.3
Antisocial behaviours 8.6 6.5–11 3.9 2.8–5.5
Psychiatric morbidity 2.1 1.7–2.7 1.0 0.76–1.4
* Levels of cannabis use: none (79%), less than weekly (15%), weekly or more often
(6%). 1. Proportional odds (PO) assumed for all variables and interaction terms. 2.
Overall likelihood-ratio test of PO assumption for multivariable model: v2 (8)5 7.8;
p5 0.45.
(2) Prediction of rst cannabis use
Four hundred and forty-four of 1725 late-school
participants (34% of males, 24% of females)
reported cannabis use in the late-school period.
Eighteen per cent reported using less than
weekly, 7% weekly and 2.6% daily. Incident
late-school cannabis use was examined in 1347
individuals who had not reported using cannabis
in the mid-school period and had observations
available in the late-school period (Fig. 2). In the
multivariate ordinal model, peer use, daily smok-
ing, frequent and high-dose alcohol use and anti-
social behaviours all predicted cannabis uptake
in the late-school period with between a two-
and three-fold increase in odds (Table 3). Early
exposure to a high level of school cannabis use
was also predictive of subsequent cannabis
initiation. Gender was not associated with late
school initiation. There were no rst order inter-
actions with gender.
(3) Continuity between mid- and late-school any
cannabis use
We dened participants who reported any level
of use in both mid- and late-school as continuing
users. Continuing users (N 5 283, 57% male)
were compared with those reporting mid-school
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Table 3. Prediction of late-school cannabis use measured on three levels* for adolescents with no earlier
reports of cannabis use (n5 1347): OR from ordinal logistic regression models.
Univariate Multivariate
Explanatory variable OR 95% CI OR 95% CI
Gender (male) 1.4 0.52–1.0 1.3 0.94–1.8
Australian birth 1.9 1.1–3.3 1.6 0.91–2.7
Divorced/separated parents 1.6 1.1–2.5 1.4 0.88–2.1
High level of weekly cannabis use in 1.8 1.3–2.4 1.7 1.2–2.4
school at study inception
Mid-school: most peers used cannabis 2.5 1.2–4.8 2.0 1.0–4.2
Mid-school: daily smoker 2.9 1.8–4.8 2.3 1.3–3.9
Mid-school: alcohol .2 days/week 4.1 2.3–7.3 2.1 1.1–3.9
Mid-school: high dose drinker 3.9 2.6–5.8 2.6 1.7–4.1
Mid-school: antisocial behaviours 3.4 2.1–5.5 2.3 1.4–3.8
Mid-school: psychiatric morbidity 1.6 1.1–2.2 1.5 1.0–2.1
* Levels of cannabis use: no use (83%), less than weekly (13%), weekly or more often (4%). 1.
Proportional odds (PO) assumed for all variables. 2. Overall likelihood-ratio test of PO
assumption for nal multivariable model: v2 (10)5 11.7; p5 0.31
cannabis use but who reported no subsequent
use (N5 69, 46% male) (Fig. 2). Seventy-ve
per cent of the 257 , weekly mid-school users
and 94% of 95 weekly 1 mid-school users con-
tinued (Table 4). In the initial analysis it was
clear that daily smoking was an important pre-
dictor of continued use. In order to examine this
effect further we included mid-school smoking in
the model on three levels: non-smoker (60/83
continued), smoked in the last month (104/129
continued) and daily smoking (161/182 contin-
ued). Compared with non-smokers, occasional
smokers were at double the risk of continuation
and daily smokers were at over three times elev-
ated risk, with evidence of a dose effect with
increasing frequency of smoking. More frequent
mid-school cannabis use and peer use were asso-
ciated with a three-fold and two-fold elevation in
risk, respectively. Although there was evidence of
an interaction between parental divorce and gen-
der (likelihood ratio v2 (1)5 5.9, p5 0.015), the
effect of divorce within each gender was not
substantial. The residual gender effect showed
that males were at increased risk of continuing
after allowing for this interaction (males to
females adjusted OR 2.6, 1.3–5.6). Interaction
between gender and mid-school level of cannabis
use could not be tested due to the small number
of weekly 1 users who discontinued. There were
no other signicant rst order interactions with
gender.
(4) Daily cannabis use
Young people reporting daily cannabis use were
considered to be at high risk of harmful and
dependent patterns of use so we were particu-
larly interested in patterns of continuity and pro-
gression to daily use. Forty-four young people
(3.7% of males and 1.7% of females) of the 1699
with observations in both periods reported using
cannabis daily in late-school (another two had
late-school but no mid-school observations)
(Table 1). Only ve of these had not reported
some mid-school use. Twelve per cent of all
mid-school users (25/192 males and 14/146
females) reported late-school daily use, consti-
tuting 4% of , weekly mid-school users and
31% of weekly 1 mid-school users. There was
strong evidence of a dose–response relationship
between late-school daily use and level of mid-
school use after adjustment for confounders
(adjusted OR: less than weekly use mid-school
4.4, 1.3–15; weekly use mid-school 27, 7.0–1.5;
daily use mid-school 25, 4.3–142).
Prediction of initiation into late-school
daily cannabis use
The onset of daily cannabis use was examined in
those participants not previously reporting daily
cannabis use in the mid-school period (Fig. 2).
There were 37 reports (24 males) of incident
late-school daily cannabis use (male versus.
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Table 4. Prediction of continuation of cannabis use frommid-school into late-school (n5 283) for those
adolescents reporting earlier cannabis use (n5352): OR from logistic regression models
Univariate Multivariate
Explanatory variable OR 95% CI OR 95% CI
Australian birth 1.6 0.66–3.7 2.4 0.92–6.1
Parental divorce
females 2.1 0.87–5.3 2.1 0.82–5.6
males 0.63 0.26–1.6 0.47 0.14–1.6
High level of weekly cannabis use 1.1 0.66–1.9 0.87 0.49–1.6
in school at study inception
Mid-school: cannabis use weekly1 4.8 2.0–12 3.4 1.3–9.0
Mid-school: most peers used cannabis 2.5 1.4–4.4 2.1 1.1–4.0
Mid-school:
Non-smoker 1 1
Smoked in the last month 1.7 0.86–3.2 2.0 1.0–4.2
Daily smoker 2.9 1.5–5.7 3.3 1.6–7.2
Mid-school: alcohol .2 days/week 1.1 0.55–2.3 0.61 0.27–1.4
Mid-school: high dose drinker 1.3 0.75–2.2 0.62 0.33–1.2
Mid-school: antisocial behaviours 2.0 1.1–3.7 1.5 0.74–3.0
Mid-school: psychiatric morbidity 1.2 0.68–2.1 1.0 0.55–2.0
female OR 2.2, 1.1–4.3). All main effects and
interactions between gender and the explanatory
variables were examined using backwards step-
wise regression. As all incident cases of daily
cannabis use were participants born in Australia,
this variable was not included in the analysis.
There was evidence of important interactions
between gender and three mid-school predictors
(Table 5). Males who reported that most of their
peers used cannabis were at six-fold increased
risk, in contrast to females for whom this effect
was negligible. Conversely, females, unlike
males, were at around six-fold elevated risk if
they reported earlier high dose drinking or anti-
social behaviours. There was a trend for school-
level exposure to cannabis use to predict incident
daily cannabis use in late-school, independent of
gender. The residual effect for gender was not
signicantly predictive of daily use at p5 0.05
(OR 3.8, 0.82–18). Parental divorce or separ-
ation (univariate OR: 3.2, 1.6–6.3), mid-school
daily smoking (univariate OR: 5.5, 2.4–13), mid-
school frequent alcohol use (univariate OR: 3.8,
1.6–8.9) and mid-school psychiatric morbidity
(univariate OR: 2.0, 1.0–3.9) were removed
from the model during the selection process as
they were not predictive of initiation into daily
cannabis use in the multivariate model.
Discussion
One in ve Australian adolescents used cannabis
during the mid-teens. For the great majority the
frequency of cannabis use remained at low levels
with around two-thirds of all users in both mid-
and late-school periods reporting less than
weekly use. By examining progression to daily
use we were able to delineate a group who were
at unequivocal risk of harmful use. The mid- to
late teens was an important period for pro-
gression in use with 13% of male and 9% of
female mid-school users going on to daily can-
nabis use.
This study differs from earlier work in that it is
based on the repeated measurement of cannabis
use at multiple points. It is therefore able to
address questions of both initiation of use and
progression to higher levels of use. As school
retention rates were 98% in this state in the year
of initial sampling, the sample frame provided an
almost representative adolescent study popu-
lation (Australian Bureau of Statistics, 1993).
The age range is around the previously reported
peak age for initiation of cannabis use (Chen &
Kandel, 1995). One issue of importance is that
of the validity of self-report of cannabis use.
Self-report of cannabis use has been demon-
strated to have good construct validity, to have
reasonable stability and to be no worse in this
regard than other self-report measures
(O’Malley, Bachman & Johnstone, 1983). Sta-
bility has been shown to be related to the recall
period so we can expect that the daily and
weekly response categories were reasonably
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Table 5.Prediction of initiation into late-school daily cannabis use (n537) by adolescents who reported
none or less than daily mid-school cannabis use (n5 1679): OR from logistic regression models
Univariate Multivariate
Explanatory variable OR 95% CI OR 95% CI
High level of weekly cannabis use in 3.6 1.9–7.1 2.0 0.97–4.3
school at study inception
Mid-school: cannabis use (weekly or 29 11–74 8.7 2.8–26.8
less often)
Mid-school: most peers used cannabis
Females 11 3.5–32 1.3 0.35–4.6
Males 23 9.3–58 6.5 2.3–18.3
Mid-school: high dose drinker
Females 29 7.8–107 6.1 1.4–25.4
Males 4.0 1.7–9.0 1.0 0.41–2.6
Mid-school: antisocial behaviours
Females 22 6.9–69 6.6 1.9–23.3
Males 3.9 1.7–9.0 0.91 0.36–2.4
reliable. Although the occasional category used a
6-month reference period, enhanced ability to
remember unusual events could have countered
a tendency to under-report (O’Malley et al.,
1983). Another source of bias could have been
the lower participation rates noted to be associ-
ated with weekly cannabis use at study entry.
There was possibly the potential for mis-
specication of cannabis use in individuals
absent from waves within each study period. We
have assumed that patterns of associations
observed in the data were similar for individuals
for whom data was missing. This could have
resulted in slightly biased OR estimates.
Different mechanisms have been suggested to
explain the uptake of illicit drugs in young peo-
ple. The stage theory implies that use of one
drug further down a sequence, for example
alcohol and/or nicotine, in some way facilitates
the use of drugs at higher levels, for example
cannabis (Adler & Kandel, 1981; Yamaguchi &
Kandel, 1984; Welte & Barnes, 1985; Fleming et
al., 1989; Graham et al., 1991; Ellickson, Hays
& Bell, 1992; Kandel, Yamaguchi & Chen,
1992). Evidence from these studies is also con-
sistent with the hypothesis that drug use is deter-
mined by a single underlying dimension of
vulnerability to drug use or “transition prone-
ness” (Jessor & Jessor, 1977) and that the use of
different drugs at different times is an oppor-
tunistic response to changing environmental
conditions such as availability. The concept of
vulnerability has been extended further to sug-
gest that drug use was one of a constellation of
deviant behaviours described collectively as a
syndrome of problem behaviours (Donovan &
Jessor, 1985). The veracity of these theories can
be informed by examining risk processes
involved in the natural history of cannabis use.
In this study, prior use of cannabis was found
to be strongly and independently predictive of
subsequent use. Overall, four-fths of those who
reported earlier cannabis use continued at some
level. Only ve of the 44 using cannabis daily in
the later period had not reported earlier use, with
strong evidence that more frequent early use
substantially increased the propensity to later,
possibly harmful, daily use. Specically, both
weekly and daily use carried around a six-fold
elevated risk of later daily use relative to
occasional use. However, it must be remembered
that escalation was far from being an inevitable
consequence of early occasional use in that only
4% of mid-school occasional users made this
transition.
Quitting and persistence in cannabis use in
adolescence has not been studied previously in
non-clinical settings. Eighty-two per cent of
those reporting cannabis in the mid-school
period continued use in the late school period.
Continued use was more common among males,
young people reporting more regular cannabis
use, smokers and those with cannabis using
friends.
The co-occurrence of tobacco use and can-
nabis use is well documented (Hall, 1995). We
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found that although both alcohol use and smok-
ing were associated with cannabis uptake, only
smoking was independently predictive of persist-
ent use by early users. This nding indicates
that it is the co-occurrence of smoking rather
than alcohol use that distinguishes between tran-
sient experimentation and entrenched behav-
iour, with the degree of entrenchment
apparently related to smoking frequency. It is
interesting to speculate whether the mechanism
is purely social, reecting the companionable
experience in common with smoking cigarettes
and smoking cannabis, or whether there may in
part be an underlying physiological or psycho-
logical vulnerability to both nicotine and can-
nabis dependency in these young people. This
vulnerability may simply be that initiation of
cannabis is unlikely in the absence of some prior
history of smoking as a method of drug inges-
tion. That peer use was also an independent
predictor of persistent use tends to support the
possibility of a social determinant component.
The lack of independent association with other
norm-violating behaviours or with symptoms of
depression and anxiety would seem to discount
problem behaviour or psychological vulnerability
as the mechanism.
A number of previous studies have reported
that tendencies in childhood to disruptive or
norm-violating behaviours are important predic-
tors of the development of cannabis use (Shedler
& Block, 1990; Lynskey & Fergusson, 1995). In
an extension of these ndings and in contrast to
persisting use, we found that antisocial behav-
iour in the mid-school period was predictive of
cannabis uptake. As is already well-documented,
we found that reported peer cannabis use held
clear and robust associations with cannabis use
and was strongly predictive of uptake. Further,
to the best of our knowledge, this is the rst
study to specically examine the inuence of the
level of cannabis use within the individual’s
school environment measured at the school
level. Elevated risk of cannabis initiation associ-
ated with environmental cannabis use is consist-
ent with earlier reports that family, peer and
community levels of drug use are important
determinants of substance use behaviours
(Hawkins, Catalano & Miller, 1992).
The analysis method we used to examine risk
factors for cannabis initiation allowed us to infer
that the inuence of each risk factor was similar
for incident occasional use and incident regular
use. This nding must be interpreted cautiously
as the test of “proportional odds” had low
power, but it may indicate that identied factors
endowed a general blanket of risk, irrespective of
the level of uptake.
Initiation of daily cannabis use in the late-
school period differed between males and
females. Males were more than twice as likely to
make the transition to daily use but earlier
norm-violating behaviour, indicated by anti-
social behaviour and high-dose drinking, was
found to predict of daily use only in females.
This observation lends credence to the existence
of a syndrome of problem behaviours described
by Donovan & Jessor (1985), but only for young
women. Males, on the other hand, appeared to
be responding more to social expectations and
opportunities indicated by their greater respon-
siveness to peer inuences. This nding has
important implications for the prevention of
harmful substance use and suggests that differ-
ent strategies may be needed to address risks of
heavy cannabis use in young males and females.
Prevention of early cannabis use is likely to
affect rates of daily cannabis use in both sexes.
For boys preventive and early treatment inter-
ventions might sensibly address the peer social
context. In contrast, girls who become daily
users appear to lead more chaotic lives and it is
likely that intervention responses would sensibly
extend beyond a focus on cannabis alone.
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3.3 Adolescent precursors of cannabis dependence 
Paper 2: Adolescent precursors of cannabis dependence: findings from the Victorian 
Adolescent Health Cohort Study. Coffey C, Carlin JB, Lynskey ML, Li N, Patton 
GC. British Journal of Psychiatry 2003; 182: 330-336. 
Journal impact factor 6.6 (source: Journal Citation Reports, 4/03/2013) 
87 citations, as at 4/03/2013 (Source: Google Scholar) 
The decriminalisation of cannabis use debate was continuing in Victoria at the time 
of planning this paper. It was spearheaded by Professor David Pennington, in his role 
as Chair of the Victorian Drug Policy Expert Committee, who was urging policy 
reform in order to place illicit substance use squarely into the health arena and 
remove it from the predominantly punitive culture involved in prohibition (Lenton 
2004) . The debate centred on an understanding of the harmful effects of illicit drugs, 
or lack thereof, with regard to cannabis, response options and the consequences of 
policy reform. Solid evidence with a sound epidemiological base was needed to 
inform the general public and the medical profession about consequences of 
sustained cannabis use, to contribute to treatment strategies and to inform the reform 
debate (Robson 1997). Specifically, if cannabis was to be regarded as addictive, 
dependence would inevitably prolong regular use at a level that increased the 
potential for harm. Agreement that cannabis was a drug of dependence and 
understanding the aetiological pathway to dependence was a pressing public health 
need. 
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3.3.1 My contribution 
I was first author, responsible for conceptualisation and development of the question, 
in collaboration with the other authors, operationalisation, analysis with assistance 
from Professor Carlin (statistician) and report writing. The declaration of my 
contribution, estimated as 50%, is in Appendix 2. 
3.3.2 Analysis and results 
Wave 7, when the cohort participants were mostly in their 20s and at the age of peak 
use, was the first occasion that we assessed cannabis dependence, using the DSMIV 
definition and the interview schedule from the CIDI, as described in Chapter 3. This 
paper was innovative in a number of respects. Firstly, we used multiple imputation to 
deal with possible bias due to missing observations during the adolescent phase, the 
first time to our knowledge that imputation had been used in this context. The Stata 
algorithms used for use with imputed datasets were developed and published by co-
author Professor John Carlin as described in Chapter 2 (Carlin, J.B., Galati & 
Royston 2008). Secondly, ours was one of the first longitudinal studies to measure 
cannabis dependence. Thirdly, because we had frequent, close waves of 
measurement during the adolescent period when there were rapid changes in 
behaviour, we were in a position to derive measures of adolescent exposure during 
this period, defined by the number of waves when observations were positive and 
also the maximum reported level, facilitated by the use of imputation to estimate 
values in missing waves. Thus, putative adolescent risk factors were assessed both in 
terms of duration of exposure (number of waves) and also the maximum level 
reported in the first six waves. We used these measures to assess the risk represented 
Chapter 3 Natural history of cannabis use 
 
 
74 
 
by adolescent cannabis use, cigarette smoking, high dose and frequent alcohol use, 
psychiatric morbidity (symptoms of anxiety and depression) and antisocial behaviour 
on dependence at 20 years. 
Approximately 20% of all adolescent cannabis users and a third of all adolescent 
regular (weekly or more often) users were classified as dependent at 20 years. Those 
identified as early users, as indicated by four or more waves of cannabis use in 
adolescence, necessarily the same group of continuing mid-school users identified in 
the first paper, were at notably increased risk of progression to dependence. Not 
surprisingly, all putative risk factors held unadjusted associations with cannabis 
dependence at 20 years, consistent with the characteristics of early users identified in 
the first paper. However, in contrast to the predictors of incident use in the late-
adolescent phase, only male sex, cannabis use, cigarette smoking and antisocial 
behaviour independently predicted the transition to dependence at 20 years, 
excluding alcohol abuse, which actually appeared protective in the adjusted model. 
Peer use was not assessed in this analysis as it was in the first paper, so the models 
are not completely comparable. The univariable association with adolescent 
symptoms of anxiety and depression was not sustained in the adjusted model, 
suggesting that self-medication was unlikely to be a mechanism in the escalation to 
dependence at this age. 
3.3.3 Implications  
Our observation that a third of regular cannabis users in adolescence were later 
identified with cannabis dependence at 20 years has taken on more significance since 
these papers were written, with the recent advances in the understanding of the 
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plasticity of the adolescent brain and its vulnerability to cannabis exposure 
(Schneider 2008). The phenomenon of liability of early use to progress to 
dependence is explored in more depth in the paper discussed in §4 which examines 
predictors of cannabis dependence at 24 years, and links neatly with the current 
paper under discussion.  
The apparently counter-intuitive protective role of risky alcohol use actually led us to 
the next paper in this series. Referring to the analysis in the first paper in this chapter, 
we observed that high-dose drinking and frequent alcohol use were cross-sectionally 
associated with mid-school cannabis use, predicted initiation of late-school use but 
neither predicted continuation nor, in males, escalation to daily use. Thus, it appeared 
that alcohol abuse had a potent effect on the initiation of cannabis use but not 
subsequent to that, possibly indicating a drop-off at the expense of cannabis use. 
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3.3.4 Paper 2: Adolescent precursors of cannabis dependence: 
findings from the Victorian Adolescent Health Cohort Study. 
Coffey C, Carlin JB, Lynskey ML, Li N, Patton GC. British Journal of Psychiatry 
2003; 182: 330-336. 
  
Background Dependence increases
the likelihood of adverse consequences of
cannabis use, but its aetiologyis poorly
understood.
Aims To examine adolescent
precursors of young-adultcannabis
dependence.
Method Putative risk factorswere
measured in a representative sample
(n¼2032) of secondary students in the
State of Victoria,Australia, six times
between1992 and1995.Cannabis
dependencewas assessed in1998, at age
20^21years.
Results Of1601youngadults,115 met
criteria for cannabis dependence.Male
gender (OR¼2.6, P50.01), regular
cannabis use (weekly:OR¼4.9; daily:
OR¼4.6, P¼0.02), persistent antisocial
behaviour (linear effect P¼0.03) and
persistentcigarette smoking (linear effect
P¼0.02) independentlypredicted
cannabis dependence.Neither smoking
severity (P¼0.83) norpersistent
psychiatricmorbidity (linear effect
P¼0.26) independentlypredicted
dependence.Regular cannabis use
increasedriskonly inthe absence of
persistentproblematic alcoholuse.
Conclusions Weeklycannabis use
marks a threshold for increasedriskof
laterdependence, with selection of
cannabis inpreference to alcoholpossibly
indicatingan early addictionprocess.
Declaration of interest None.
Half to two-thirds of young adults in the
UK, the USA, New Zealand and Australia
have used cannabis recreationally (Webb
et al, 1996; Fergusson & Horwood, 2000;
Coffey et al, 2002; Johnston et al, 2002).
Most have used it infrequently without
health consequences, but a minority progress
to harmful heavy use (Fergusson &
Horwood, 1997). Adverse consequences
include accidental injury, educational and
legal difficulties, mental health problems
and respiratory effects beyond those attrib-
utable to tobacco use alone (Ameri, 1999;
Hall & Babor, 2000; Taylor et al, 2000;
Johns, 2001; Ashton, 2002). Cannabis de-
pendence is increasingly recognised as a
further consequence of heavy use, with a
lifetime risk in ever-users of about 10%
(Anthony et al, 1994). The development
of dependence probably prolongs use and
increases the potential for harm (Ashton,
2002). Increasing use of more effective
methods of drug delivery and increasing
drug potency may underlie the development
of dependence, but other contributing fac-
tors remain little explored (Hall & Babor,
2000). An understanding of the adolescent
antecedents of dependence can inform the
extent to which substance exposures
increase risks for dependence as opposed
to other factors such as intercurrent emo-
tional or behavioural disorders (Fergusson
& Horwood, 2000).
METHOD
Procedure and sample
Between August 1992 and December 1998
we conducted a seven-wave cohort study
of adolescent health in Victoria, Australia.
The cohort was defined using a two-stage
sampling procedure in which we selected
two classes at random from each of 44 gov-
ernment, Catholic and independent schools
(total number of students 60 905). School
retention rates to year nine in the year of
sampling were 98%. One class from each
school entered the cohort in the latter part
of the ninth school year (wave 1) and the
second class 6 months later, early in the
tenth year (wave 2). Participants were
subsequently reviewed at a further four
6-month intervals during their teens (waves
3 to 6) with a final follow-up at the age of
20–21 years (wave 7), 3 years after the final
school year (Fig. 1).
Adolescent phase: waves 1 to 6
Altogether, 1947 adolescents (96% of the
intended sample) participated at least once
during waves 1 to 6, with a gender ratio
(males 48.6%) similar to that in Victorian
schools at the time of sampling (Australian
Bureau of Statistics, 1993). Surveys were
self-administered at school using laptop
computers, thereby allowing the use of
branched questions. Participants unavail-
able for follow-up at school completed the
questionnaire by telephone.
Young-adult survey (wave 7, 1998)
The young-adult survey was carried out by
telephone using computer-assisted inter-
views consistent with the adolescent phase.
A total of 1601 young adults (82% of
cohort participants; mean age 20.7
(s.d.¼0.5) years, 46.0% male) were inter-
viewed between April and December
1998. All analyses are based on this subset.
Reasons for non-participation at wave 7
were: refusal (n¼152); person traced but
non-contactable (n¼59); person not traced
(lost) (n¼133); and death (n¼2). Of the
1601 participants interviewed, 71%, 27%
and 3% respectively lived at home, with
others or alone; 82% had completed the
final school year; 85% had commenced
post-school study, with 68% still studying
at the time of the interview; 82% were in
paid employment; 8% were neither studying
nor employed.
Characteristics of non-completers at
wave 7 were examined in a multivariate
logistic regression model. Males were over-
represented (odds ratio (OR)¼1.9, 95% CI
1.5–2.4), as were those who had experi-
enced parental divorce or separation
(OR¼1.8, 95% CI 1.4–2.5) and those re-
porting daily smoking at study inception
(OR¼2.1, 95% CI 1.5–2.9).
Outcome measure: DSM^IV
cannabis dependence
A DSM–IV diagnosis of dependence re-
quired evidence that, within the previous
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PRECURSORS OF CANNABIS DEPENDENCE
12 months, an individual continued canna-
bis use despite significant substance-related
problems (American Psychiatric Associa-
tion, 1994), supported by endorsement of
three of the following seven criteria: toler-
ance to the effects of cannabis; withdrawal
symptoms on ceasing or reducing use;
cannabis used in larger amounts or for a
longer period than intended; a persistent
desire or unsuccessful efforts to reduce or
cease use; a disproportionate amount of
time spent obtaining, using and recovering
from use; social, recreational or occupa-
tional activities reduced or given up owing
to cannabis use; and use continued despite
knowledge of physical or psychological
problems induced by cannabis (American
Psychiatric Association, 1994).
To generate the DSM–IV criteria for a
diagnosis of cannabis dependence, the
Composite International Diagnostic Inter-
view 2.1, 12-month version (CIDI; Hall
et al, 1999), was administered. We assessed
cannabis dependence only in participants
reporting weekly cannabis use in the pre-
ceding 12 months, to minimise responder
fatigue. We considered that a diagnosis
of cannabis dependence was consistent
only with regular cannabis use, given the
DSM–IV description of substance depen-
dence as occurring with a ‘pattern of
repeated [substance] self-administration’
(American Psychiatric Association, 1994).
Population prevalence estimates for
cannabis dependence and dependence
symptoms in the cohort at wave 7 have been
reported earlier (Coffey et al, 2002). We es-
timated that 7% of the cohort, equivalent to
13% of ever-users, met criteria for DSM–IV
cannabis dependence within the preceding
12 months. The most prevalent symptoms
were persistent desire or unsuccessful absti-
nence attempts (10%) and unintentional use
(8%). Tolerance (2%) and social conse-
quences of use (1%) were the least prevalent
symptoms. Eleven wave 7 participants did
not report on their cannabis use and were
classified as non-users for all analyses.
Measures: waves 1 to 6
Demographic variables
Gender and country of birth were recorded
at study entry. Parental partnership status
was assessed throughout the study.
Cannabis use
Cannabis use during the previous 6 months
was assessed using the following rating
scale: never used; not used in the past 6
months; a few times; monthly; weekly; daily.
Those reporting the use of cannabis at least
a few times in the past 6 months were
classified as ‘any users’.
Cigarette smoking
Participants reporting that they had smoked
on 6 or 7 days in the previous week were
categorised as daily smokers. Occasional
smoking was defined as reporting smoking
in the past month, but on fewer than 6 days
in the past week.
Alcohol consumption
Participants reporting that they had drunk
alcohol in the week before the survey com-
pleted a 1-week retrospective alcohol diary
(specifying beverage and quantity), allow-
ing derivation of two measures of prob-
lematic alcohol consumption: ‘frequent
drinking’ on 3 or more days in the previous
week, and ‘high-dose drinking’ with an
average consumption of 5 units or more
of ethanol per drinking day (1 unit is
equivalent to one standard drink containing
9 g ethanol).
Antisocial behaviour
Ten items from the Moffitt & Silva (1988)
self-report Early Delinquency Scale assessed
antisocial behaviour relating to property
damage, interpersonal conflict and theft in
the previous 6 months. Antisocial behav-
iours were categorised according to
whether more than one behaviour was
endorsed ‘more than once’, in order to
distinguish participants with more-global
antisocial behaviours.
Psychiatric morbidity
A computerised form of the Clinical Inter-
view Schedule (CIS) was used to quantify
the severity of psychiatric morbidity (Lewis
et al, 1992). Scores greater than 11 were
taken to indicate psychiatric morbidity,
reflecting the level at which clinical
intervention is appropriate.
Explanatory variables: waves 1 to 6
Responses on adolescent risk factors (waves
1 to 6) were summarised as follows:
(a) The number of waves in which a condi-
tion was reported. It was necessary to
collapse small categories, so we reclassi-
fied into four levels: none, one wave
(indicating experimentation), two or
three waves (indicating moderate expo-
sure), and four to six waves (indicating
persisting exposure and implying early
onset, that is, the behaviour was
necessarily reported at least by wave 3).
This categorisation was applied to any
cannabis use, any cigarette smoking,
frequent alcohol use, high-dose alcohol
use, antisocial behaviour and psychiatric
morbidity.
(b) The maximum level reported during the
six waves of follow-up for cannabis use
(none, occasional, weekly, daily) and
cigarette smoking (none, less than daily,
daily).
Missing waves of data collection:
waves 1 to 6
Seventy-five per cent of the cohort completed
five of the first six waves of data collection,
but owing to the staged recruitment, 54%
of observations were missing from the first
wave (Fig. 1). Missing observations for waves
2, 3, 4, 5 and 6 were 11%, 13%, 16%, 19%
and 21% respectively. Overall, 59% of parti-
cipants missed at least one wave. Multiple
imputation was used to handle this fact,
enabling summary measures to be defined
for each participant in each of five ‘com-
pleted’ data-sets. Imputation was performed
using the multivariate mixed effects model
of Schafer & Yucel (2002).
Data analysis
Logistic regression analyses were performed
on the binary outcome of cannabis depen-
dence. In multivariable models, exposure
3 31
Fig.1 Participation rates of 2032 secondary school students in theVictorianAdolescentHealth Cohort Study.
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effects were estimated as linear trends in the
log odds ratio across ordered categories of
exposure on explanatory variables. Two-
tailed P values are reported based on Wald
tests.
All analyses were performed using Stata
7.0 for Windows (Stata, 2001). We used
the method of Rubin (1987) for creating
valid inferences with the multiple imputa-
tion model, by combining over standard
analyses performed on each of the imputed
data-sets. Software for facilitating these
analyses was written in Stata (details
available from the authors upon request).
Ethical approval
Ethical approval for the study was obtained
from the Royal Children’s Hospital Ethics
in Human Research Committee. Written par-
ental consent was obtained at study inception
and individuals gave informed verbal consent
before commencing the wave 7 interview.
RESULTS
Young-adult cannabis dependence
Of 1601 young-adult participants, 936
(66% of males; 52% of females) inter-
viewed in wave 7 reported ever using
cannabis and 115 (7% of wave 7 partici-
pants) met criteria for DSM–IV cannabis
dependence within the past 12 months. Par-
ticipants with cannabis dependence were
less likely to be female (10.3% of males
and 4.5% of females; OR¼0.41, 95% CI
0.27–0.61). Individuals of Australian birth
(OR¼2.5, 95% CI 1.1–5.4), with parental
divorce or separation (OR¼1.7, 95% CI
1.1–2.6) and neither studying nor employed
(OR¼2.9, 95% CI 1.7–4.9) were at
increased risk of dependence.
Overall, 32% (95% CI 30–35) of the
1601 wave 7 participants reported cannabis
use in the adolescent waves 1–6. Eighteen
per cent (95% CI 14–21) of wave 1–6 users
and 32% (95% CI 25–39) of those report-
ing at least weekly use later met criteria
for cannabis dependence. Conversely, of
the 115 with cannabis dependence at wave
7: 17% (95% CI 10–25) reported
occasional use in waves 1–6; 22% (95%
CI 10–34) weekly use; 38% (95% CI 27–
49) daily use; and 22% (95% CI 14–30)
initiated cannabis use after wave 6.
Univariate associations between
young-adult cannabis dependence
(wave 7) and adolescent exposures
(waves 1^6)
The frequencies of a range of adolescent
factors were estimated and crude associations
between these and cannabis dependence
were assessed (Table 1).
Maximum frequency of cannabis use
and cigarette smoking
Maximum frequency of cannabis use in
waves 1–6 showed strong association with
3 3 2
Table1 Estimated frequency of time-varying adolescentmeasures and their associationwith cannabis
dependence at age 20 years (n¼1601): odds ratios (OR) from univariate logistic regression models
Adolescentmeasure: Estimated frequency Cannabis dependence at age 20 years
waves 1 to 6
Category n 95% CI OR 95% CI P
Maximum frequency
Cannabis use None 1083 1046^1120 1 50.011
Less thanweekly 332 299^364 4.7 2.7^8.2
Weekly 127 106^149 20 11^35
Daily 59 43^75 23 11^47
Cigarette smoking None 831 790^871 1 50.011
Less than daily 401 366^435 4.3 1.9^9.6
Daily 370 336^403 13 6.8^23
Persistence
Any cannabis use None 1083 1046^1120 1 50.011
1wave 140 114^166 3.9 1.8^8.2
2 or 3 waves 151 126^177 6.2 3.2^12
4 to 6 waves 227 198^255 17 9.9^27
Linear effect2 2.5 2.1^2.9
Any cigarette None 831 790^871 1 50.011
smoking 1wave 171 145^197 2.2 0.70^7.0
2 or 3 waves 186 158^214 4.5 2.0^10
4 to 6 waves 413 378^448 13 6.8^24
Linear effect2 2.3 2.0^2.8 50.01
High-dose alcohol None 890 850^931 1 50.011
use 1wave 308 275^342 3.5 1.7^7.1
2 or 3 waves 276 246^306 5.6 2.8^11
4 to 6 waves 126 105^148 10 5.2^20
Linear effect2 2.1 1.7^2.6 50.01
Frequent alcohol use None 1358 1328^1387 1 50.011
1wave 162 135^188 2.5 1.3^4.5
2 or 3 waves 71 54^88 2.7 1.1^6.8
4 to 6 waves 11 4^17 4.0 0.80^20
Linear effect2 1.8 1.3^2.3 50.01
Psychiatric morbidity None 857 808^905 1
(CIS score411) 1wave 245 202^288 1.6 0.84^3.1 0.031
2 or 3 waves 272 241^302 1.8 0.84^3.7
4 to 6 waves 228 199^257 2.1 1.1^3.8
Linear effect2 1.3 1.1^1.5 50.01
Two ormore None 1300 1269^1331 1 50.011
antisocial 1wave 153 130^177 3.7 2.1^6.6
behaviours 2 or 3 waves 104 83^124 5.8 3.2^11
4 to 6 waves 44 29^59 11 5.2^25
Linear effect2 2.3 1.9^2.8 50.01
CIS,Clinical Interview Schedule.
1.Wald test of null hypothesis of no difference in the frequency of cannabis dependence across categories.
2. Across the four categories of ‘never’,‘1wave’,‘2 or 3 waves’ and ‘4 to 6 waves’.
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cannabis dependence in wave 7, with both
weekly and daily maximum use carrying
about a 20-fold increase in odds, indicating
evidence of a threshold at weekly use.
There was a strong increase in frequency
of dependence with increase in maximum
frequency of cigarette smoking from
occasional to daily.
Persistence of adolescent behaviours
Strong associations, with evidence of linear
relationships, were observed for the number
of waves in which cannabis use, cigarette
smoking, high-dose drinking and antisocial
behaviour were reported, with a two-fold
or greater average odds increase with each
increase in level of reporting frequency.
For all four measures the most persistent
levels carried elevated odds of ten-fold or
greater. A weaker association, but still with
some evidence of a linear relationship, was
observed with the number of waves in
which psychiatric morbidity was identified,
with an average increase in odds of 1.3 with
increasing level of reporting frequency.
With frequent drinking the clearest differ-
ence was between ‘none’ and ‘some’, with
weak evidence for a dose-related effect.
Independent associations between
young-adult cannabis dependence
(wave 7) and adolescent exposures
(waves 1^6)
We used multiple logistic regression to
quantify the independent predictive associ-
ations and to adjust for possible confound-
ing. To aid parsimony, measures of
persistence (all of which showed univariate
linear relationships) were entered in the
multivariate model as linear effects. After
adjustment, the only adolescent measures
(apart from gender) demonstrating an
independent relationship with cannabis
dependence were: maximum frequency of
cannabis use; and the number of waves in
which each of cigarette smoking and anti-
social behaviour were reported (Table 2).
There was no evidence of first-order inter-
action effects between gender and any
explanatory variable.
The relationship between cannabis de-
pendence and persistent frequent drinking
in adolescence changed direction, from a
risk association in the univariate model to
a protective association in the adjusted
model. We therefore examined the inter-
action between this factor and maximum
cannabis use, adjusting only for factors in-
fluential in the multivariate model reported
in Table 2. We selected individuals report-
ing frequent drinking in two or more
waves, and identified evidence of an inter-
action between this characteristic and
maximum weekly or daily cannabis use
(Wald w2 P¼0.01). Elevated risk for later
dependence associated with maximum
weekly or daily cannabis use was evident
only in participants not reporting frequent
drinking in two or more waves (OR¼7.4,
95% CI 3.9–14; P50.01). There was no
evidence that those reporting both weekly
or daily cannabis use and multiple waves
of frequent drinking were at risk of later
cannabis dependence (OR¼1.2, 95% CI
0.28–5.0; P¼0.81).
Confounding by cigarette smoking
and antisocial behaviour on the
effect of early-onset cannabis use
The reason for a lack of independent asso-
ciation between cannabis dependence and
early cannabis use was explored in three
further models. We characterised indivi-
duals who reported using cannabis in the
first three waves of follow-up, i.e. in year
9 or year 10 (average 359 of a total of
517 users in waves 1 to 6). We compared
the association of early use v. later onset
only in young adult participants reporting
any adolescent use, progressively adjusting
for the persistence of smoking and anti-
social behaviour (Table 3). Both cigarette
smoking and antisocial behaviour con-
founded the effect of early cannabis use.
Persistent cigarette smoking showed the
greater confounding effect, particularly
when reported in four or more waves, that
is, with early onset. After adjusting for
these factors there was no evidence of an
independent association between early
cannabis use and later dependence.
DISCUSSION
Almost 60% of a representative sample of
young adults aged 20–21 years in Victoria,
Australia, reported ever having used canna-
bis and 7% met DSM–IV criteria for canna-
bis dependence in the 12 months prior to
survey. Progression to dependence was
common, in that one in five adolescent
users were later classified as dependent in
young adulthood. Weekly cannabis use
was an even stronger predictor, with one in
three meeting the criteria for dependence.
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Table 2 Independent predictive associations between background and adolescent time-varying factors and
cannabis dependence at age 20 years: odds ratios (OR) frommultiple logistic regression
Adolescentmeasure: waves 1 to 6 Category Cannabis dependence at age 20 years
OR 95% CI P
Background factors
Female gender 0.38 0.22^0.66 50.01
Australian birth 2.0 0.82^4.8 0.13
Parental divorce/separation 1.0 0.63^1.72 0.87
Maximum frequency of use
Cannabis use None 1 0.021
Less than weekly 1.7 0.59^4.7
Weekly 4.9 1.3^19
Daily 4.6 1.0^21
Cigarette smoking None 1 0.831
Less than daily 0.73 0.18^3.0
Daily 0.71 0.13^3.8
Persistence
Any cannabis use Linear effect2 1.1 0.70^1.7 0.71
Any cigarette smoking Linear effect2 1.9 1.1^3.2 0.02
Frequent alcohol use Linear effect2 0.69 0.46^1.0 0.07
High-dose alcohol use Linear effect2 1.1 0.81^1.5 0.55
Psychiatric morbidity Linear effect2 1.1 0.91^1.4 0.26
Two ormore antisocial behaviours Linear effect2 1.3 1.0^1.7 0.03
1.Wald test of null hypothesis of no differences in the frequency of cannabis dependence across categories.
2. Across the four categories of ‘never’,‘1wave’,‘2 or 3 waves’ and ‘4 to 6 waves’.
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Additional predictors were male gender,
early and persistent cigarette smoking, and
early and persistent antisocial behaviour.
In contrast, regular drinking in the teenage
years appeared protective against cannabis
dependence.
Cannabis dependence was assessed at
an age of peak cannabis use in a close-to-
representative sample with high participa-
tion into young adulthood. To circumvent
bias from non-response during the adoles-
cent waves, multiple imputation of missing
covariate values was performed using a
model based on background measures
(available for 96% of the sampling frame).
This allowed us to define exposure mea-
sures of time-varying adolescent behaviours
based on all six waves of data collected in
the adolescent phase for all 1601 partici-
pants who were interviewed in wave 7
aged 20–21 years.
A potential study limitation was the
underspecification of cannabis dependence.
First, although the response rate in wave 7
was high, differential under-ascertainment
of illicit substance users – a notoriously
difficult group to reach – might have oc-
curred. Second, as a third of young adult
cannabis users had commenced using only
in the preceding 3 years (that is, since wave
6), it is likely that some currently non-
dependent participants would develop
cannabis dependence in the next few years
(Rosenberg & Anthony, 2001). We have
assumed that the risk profile for cannabis
dependence in our sample would be the
same for all members of the cohort, but
these possible sources of error could result
in attenuation of the observed associations.
In defining adolescent measures of
smoking we elected not to distinguish
between persistent occasional smoking
and daily smoking. This decision was taken
to aid parsimony and was supported by the
similarity in risk association of occasional
and daily smoking in the adjusted model
describing cannabis dependence. We
assessed persistence only in problematic
alcohol use, as ‘any’ alcohol use was too
common to be informative.
Predictors
Gender
Males were marginally more likely than
females to use cannabis overall, but the
transition to dependence was considerably
more likely in males. We found no evidence
of effect modification by gender, indicating
that some underlying unmeasured factors
were responsible. The suggestion that gen-
der differences might be due to differing
opportunity rather than differing transition
rates is not supported by our findings (Van
Etten & Anthony, 2001).
Adolescent cannabis use, antisocial behaviour
and cigarette smoking
Early initiation of cannabis use, often pre-
ceded by antisocial behaviour and cigarette
smoking, is generally accepted as an
important predictor of escalation in drug
use (Fergusson & Horwood, 1997, 1999).
Although we found that early cannabis
uptake predicted later dependence in the
crude analysis, cigarette smoking and anti-
social behaviour largely accounted for this
effect in the adjusted model. Furthermore,
as no dose effect was evident with fre-
quency of cigarette smoking, our findings
are consistent with the suggestion of Bierut
et al (1998) that daily smoking is not a
specific marker for an underlying vulner-
ability to cannabis dependence. This non-
specific association with cigarette smoking
probably reflects the social environment in
which both activities occur, rather than
individual biological susceptibility.
Why does early deviant behaviour pre-
dict cannabis dependence? It is possible
that the prolonged cannabis exposure that
often accompanies early deviant behaviour
might bring forward the transitions from
occasional use to regular use and thence
to dependent use evident in our young adult
sample. If this is so, the effect could
moderate as the cohort ages, because older
initiators might make the transition to
dependence later.
The threshold of risk that we observed
with weekly cannabis use indicates that it
is the transition to regular use that provides
sufficient drug exposure in the development
of early dependent use. The slow metabo-
lism of cannabis results in the persistence
of measurable physical and psychological
changes well beyond the duration of the
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Table 3 Secondary analysis of the association between early cannabis uptake and cannabis dependence in adolescent cannabis users (n¼517), showing the effect of
adjusting for the number of waves of cigarette smoking and antisocial behaviour: odds ratios (OR) from univariate andmultivariate logistic regression models
Adolescentmeasure (waves 1 to 6) Association with cannabis dependence at age 20 years
Unadjusted Adjusted for smoking
Adjusted for antisocial
behaviour
Adjusted for smoking and
antisocial behaviour
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Any cannabis use in waves 1 to 3 (n¼359) 2.1 1.1^4.0 1.7 0.85^3.3 1.8 0.95^3.6 1.4 0.70^2.9
Cigarette smoking
None 1 1
1wave 1.3 0.35^4.8 1.2 0.31^4.4
2 or 3 waves 1.8 0.63^5.3 1.8 0.61^5.1
4 to 6 waves 2.9 1.1^7.2 2.7 1.1^7.0
Antisocial behaviour
None 1 1
1wave 1.8 1.0^3.5 1.9 1.0^3.6
2 or 3 waves 2.2 1.1^4.4 2.2 1.1^4.5
4 to 6 waves 4.0 1.7^9.2 3.8 1.7^8.7
n, mean n.
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subjective effects (Ameri, 1999). The main-
tenance of a low but stable frequency of
intake might be sufficient to produce long-
lasting neuro-adaptive changes thought to
be associated with the ‘drug-wanting,
seeking and taking’ process which occurs
with the initiation of addictive behaviour
(Hyman & Malenka, 2001). Interestingly,
out-of-control use early in the cannabis-
using career has been reported to distin-
guish individuals who make the transition
to dependence from non-dependent users,
supporting the notion of an early biological
response (Rosenberg & Anthony, 2001).
Adolescent alcohol use
An apparently counterintuitive finding was
that persistent frequent alcohol use as a
teenager negated the risk of developing
cannabis dependence in regular cannabis
users. It is well established that problematic
adolescent alcohol use is one of the constel-
lation of behaviours associated with canna-
bis initiation (e.g. Donovan & Jessor,
1985), but our findings indicate that a
different picture emerges, with escalation
of use in the transition between adolescence
and adulthood. This reflects the divergence
in criminality in the transition to young
adulthood observed in early drug users
compared with adolescent alcohol users
identified by Newcomb & Bentler (1988:
pp. 102–119). Our findings may therefore
illustrate a social process whereby indi-
viduals select into either a predominantly
alcohol-using or a cannabis-using lifestyle.
From the physiological perspective, prefer-
ential cannabis use as an early indication
of dependence is consistent with a sub-
stance-specific biological susceptibility to
addiction (Hyman & Malenka, 2001).
Selective regular cannabis use during ado-
lescence may mark a neurophysiological
and psychological precursor of dependence.
Adolescent psychiatric morbidity
Although cannabis use has been linked with
increased rates of depression and anxiety
cross-sectionally (Johns, 2001), we did not
find that adolescent psychiatric morbidity
independently predicted cannabis depen-
dence. This observation argues against
self-medication as a mechanism for conti-
nuing problematic cannabis use beyond
the teenage years and is consistent with
earlier findings (McGee et al, 2000). Con-
versely, we have reported separately that
regular cannabis use in adolescence predicts
later psychiatric morbidity in young women
(Patton et al, 2002).
Implications
Hall & Babor (2000) pointed out that we
have not yet adequately explored the patho-
physiological consequences of cannabis
use – a process that took many years
with tobacco and eventually led to broad-
ranging policies aimed at reducing con-
sumption. The recent reclassification of
cannabis from a class B drug to a class C
drug by the Home Office in the UK in part
reflects a view that cannabis use poses a les-
ser public health problem than use of other
illicit substances. The lethality and with-
drawal severity of cannabis may indeed
differ from other drugs, but its use is far
more common (Hall et al, 1999; Johnston
et al, 2002). As well as the increasing
prevalence of cannabis use in young people,
the transition rate to dependence would
appear to be increasing, with concomitant
personal, social and physical harms
resulting from prolonged heavy use and
addictive behaviour (Hall & Babor, 2000;
Ashton, 2002). In 1990–1992 it was
estimated that 9% of ever-users were at
life-time risk of dependence (Anthony et al,
1994) but more recent estimates report that
between 13% and 16% of users are at risk
by their early 20s (Poulton et al, 1997;
Fergusson & Horwood, 2000; Coffey et al,
2002). The case for a more concerted
public health response seems strong.
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3.4 Trajectories of adolescent alcohol and cannabis use. 
Paper 3. Trajectories of adolescent alcohol and cannabis use into young adulthood. 
Patton G.C., Coffey C., Lynskey M.T., Reid S., Hemphill S., Carlin JB., Hall W. 
Addiction. 102(4):607-15, 2007  
Journal impact factor 4.3 (source: Journal Citation Reports, 4/03/2013) 
79 citations, as at 4/03/2013 (Source: Google Scholar) 
In the previous paper, we were alerted to the possibility of discrepant pathways in 
problematic alcohol use and cannabis use as the VAHCS participants matured, 
illustrated by our observation that risky alcohol abuse in adolescence appeared to 
protect against later cannabis dependence. From this observation we hypothesised 
that, as they mature, young people who are following a trajectory of excessive 
substance use, may adopt alcohol or cannabis as their substance of choice. Thus, we 
were interested in teasing out the trajectories of alcohol and cannabis abuse from 
adolescence into young adulthood in the VAHCS. As a corollary, if we confirmed 
this hypothesis, we were then interested in comparing the prognosis for social and 
substance use outcomes at 24 years for the two groups defined by their favoured 
substance. 
3.4.1 My contribution 
Prior to preparing the paper, I spoke informally to clinicians working in the area as 
well as a few young people and received anecdotal confirmation that this hypothesis 
was worth pursuing. I played a major role in the conceptualisation of the question 
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and with the analysis, assisted with the paper preparation and finally with the 
response to the reviewers’ comments. Professor George Patton was the lead author. 
The declaration of my contribution, estimated as 45%, is in Appendix 2. 
3.4.2 Analysis and results 
By the time the cohort had completed Wave 8 at 24 years, we had 10 years of follow-
up with consistent measurement of alcohol and cannabis use throughout. In the same 
manner as the previous paper, we could take advantage of the frequent measurement 
points in the adolescent phase to derive summary measures of exposure to both 
problematic cannabis use and alcohol use, augmented by multiple imputation to 
allow for missing waves of observation. One of the issues we faced was to determine 
a realistic indicator of harmful drinking in adolescence as this had never been 
objectively defined. We decided to identify this using the adult-defined measure of 
(at least) “moderate risk” (derived from the average and quantity specific one week 
retrospective diary administered at each wave) and then we determined that the 
young adult outcome of interest measured at 24 years (Wave 8) was “high risk” use. 
Similarly, for cannabis we used “≥weekly use” as the potentially harmful adolescent 
exposure and “daily use” as the young adult outcome of interest in Wave 8. If 
participants reported using either substance for two or more waves during Waves 1 to 
6 at the risky level, they were identified as having persisting problematic substance 
use in the adolescence. 
We illustrated that, indeed, there seemed to be predominantly separate trajectories of 
harmful use of alcohol and cannabis identifiable as the cohort matured. That is, 
although both substances were used together at the start of their substance-using 
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career, as illustrated in the first paper in this chapter, adolescents who escalated their 
use generally appeared to progress towards either heavy cannabis or heavy alcohol 
use, rarely both. At each wave, problematic cannabis and alcohol were associated, 
but the strength of this association reduced as the cohort matured, reflecting the 
reducing dual substance group. We therefore were able to identify a persistent 
problem alcohol group (“alcohol”), a persistent problem cannabis group (“cannabis”) 
and a smaller group where both substances persisted at the problematic level through 
adolescence (“cannabis&alcohol”). Having defined three groups according to these 
criteria, we were then able to assess their progression to high risk cannabis and 
alcohol use measured at 24 years. In addition, we were interested in association with 
other outcomes including educational, employment, relationship and childbirth 
outcomes and daily cigarette smoking and other illicit substance use in the past year. 
Firstly, we examined prospective relationships between the defined groups and high 
risk cannabis and alcohol use at Wave 8, similarly classified into high risk cannabis 
only, alcohol only and a relatively small “cannabis&alcohol” group of cannabis & 
alcohol together. The adolescent cannabis group was strongly associated with the 
high risk cannabis group, and showed less association with the alcohol only group. 
The alcohol only group was similarly associated with both exclusive groups, but 
somewhat more with high risk alcohol only. The adolescent cannabis and 
cannabis&alcohol groups were predominantly associated, with the high risk cannabis 
group showing a tendency to move towards cannabis with time. These findings 
illustrated the emerging dichotomy in general although it clearly was not entirely 
exclusive. 
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Secondly, we assessed the cross-sectional associations between high risk alcohol, 
cannabis and cannabis&alcohol groups defined at 24 years with the educational, 
social and substance use outcomes at the same age. The high risk cannabis and 
cannabis&alcohol groups were similar: they were less likely to be tertiary educated, 
or in a relationship, but more likely to be smoking cigarettes daily and to have other 
illicit substance in the past year than those with no high risk use. Just the cannabis 
only group was more likely to have experienced parenthood. The alcohol group was 
also less likely to be in a relationship, to be smoking daily and using other illicit 
substance than those with no persistent risky substance use. In general the estimates 
for the alcohol group were less marked than those for the cannabis and 
cannabis&alcohol groups, indicating that their associated risks were somewhat less at 
this age at least. 
Finally, we assessed prospective relationships between the moderate risks groups 
defined in adolescence and the same outcomes. Apart from females who were more 
likely to have experienced parenthood, the alcohol group was not elevated on the 
social outcomes, but was more likely to smoke cigarettes daily, and to have used 
ecstasy or cocaine in the past year than non-risky substance users. The cannabis 
group had a greater likelihood of poor educational outcome, no current relationship, 
daily cigarette smoking and other illicit substance use compared with the non-risky 
reference group. Apart from clear associations with smoking and other illicit 
substance use, the cannabis&alcohol group appeared unremarkable, though precision 
was reduced due to the relatively small group number. 
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3.4.3 Implications  
There are a number of possible explanations for these observation, which may 
involve substance availability, peer group norms, and individual drug responses and 
susceptibility in varying degrees. Illustrating the separate trajectories informed our 
understanding of the natural progression of cannabis use and also added a further 
dimension to the possible interplay between alcohol and cannabis abuse prevention 
efforts: it is possible that by seeking to reduce alcohol use, cannabis use may be 
actually enhanced (DiNardo & Lemieux 2001). Furthermore, the practice of 
fashioning interventions for problematic cannabis use on those for alcohol (Copeland 
& Swift 2009), apart from considerations of differing drug withdrawal, may be out of 
context with the natural history of the drug use itself. 
With respect to cannabis, these analyses serve as an introduction to the collection of 
papers examining cannabis use outcomes in young adulthood to be discussed later in 
the thesis. The question now to be addressed in this chapter is to examine in more 
detail the prognosis and trajectories of adolescent cannabis users as the cohort 
matured. 
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3.4.4 Paper 3: Trajectories of adolescent alcohol and cannabis use into 
young adulthood. 
Patton G.C., Coffey C., Lynskey M.T., Reid S., Hemphill S., Carlin JB., Hall W. 
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Trajectories of adolescent alcohol and cannabis use
into young adulthood
George C. Patton1, Carolyn Coffey1, Michael T. Lynskey2, Sophie Reid1, Sheryl Hemphill1,
John B. Carlin3 & Wayne Hall4
Centre for Adolescent Health, Murdoch Children’s Research Institute, Royal Children’s Hospital, University of Melbourne. Victoria, Australia,1 Department of
Psychiatry, Washington University School of Medicine, St Louis, MO, USA,2 Clinical Epidemiology and Biostatistics Unit, Murdoch Children’s Research Institute and
Department of Paediatrics, University of Melbourne, Victoria, Australia3 and Ofﬁce of Public Policy and Ethics, Institute for Molecular Bioscience, University of
Queensland, St Lucia QLD, Australia4
ABSTRACT
Background Both alcohol and cannabis use carry health risks. Both are commonly initiated in adolescence. To date
little research has described trajectories of adolescent cannabis or alcohol use or compared their respective conse-
quences in young adulthood. Methods The design was a 10-year eight-wave cohort study of a state-wide community
sample of 1943 Victorians initially aged 14–15 years. Moderate- and high-risk alcohol use was deﬁned according to
total weekly alcohol consumption. Moderate- and high-risk cannabis use were deﬁned as weekly and daily use,
respectively. Results Around 90% of young adults used either alcohol or cannabis. Although an association existed
between alcohol and cannabis use, there was a tendency for heavy users to use one substance predominantly at any
one time. Weekly or more frequent cannabis use in the absence of moderate-risk alcohol use in teenagers predicted a
sevenfold higher rate of daily cannabis use in young adults but only a twofold increase in high-risk alcohol use.
Conversely, moderate-risk adolescent alcohol use in the absence of weekly cannabis predicted an approximately three-
fold increased rate of both high-risk drinking and daily cannabis use in young adulthood. Selective heavy cannabis use
in both adolescence and young adulthood was associated with greater illicit substance use and poorer social outcomes
in young adulthood than selective alcohol use. Conclusions Heavier teenage cannabis users tend to continue selec-
tively with cannabis use. Considering their poor young adult outcomes, regular adolescent cannabis users appear to be
on a problematic trajectory.
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INTRODUCTION
Alcohol and cannabis use both begin commonly in ado-
lescence. Alcohol use is more prevalent but cannabis use
has become widespread among adolescents and young
adults in many countries over the past three decades
[1–3]. A majority of young people in the developed
world experiment with cannabis and in some commu-
nity studies the proportion of daily users has
approached one in 10 [4–6]. A range of adverse
sequelae in young adulthood have been documented for
both heavier adolescent alcohol and cannabis use [7–9],
with the available studies indicating dose–response rela-
tionships between teenage use and the risk of abuse in
early adulthood [10,11]. However, existing studies have
focused generally upon the progression and conse-
quences of alcohol and cannabis use individually, with
the other drug considered only as a potential con-
founder [12,13]. For that reason, little is known about
the comparative consequences in adulthood of regular
alcohol or cannabis use in adolescence. This question is
of more than theoretical interest, given the evidence
that policies affecting the use of alcohol (such as age of
legal use and price) may affect the use of cannabis and
vice versa [14].
In this report we used data from a cohort of almost
2000 adolescents followed from adolescence to young
adulthood to examine the following questions:
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1 To what extent do individuals report potentially
harmful use of alcohol and/or cannabis during adoles-
cence and young adulthood?
2 To what extent does heavier adolescent use of alcohol
and/or cannabis predict substance use in young
adulthood?
3 To what extent does heavier adolescent use of alcohol
and/or cannabis predict different social circumstances
in young adulthood?
METHOD
Sample
Between August 1992 and March 2003 we conducted an
eight-wave cohort study of health in adolescents and
young adults resident in the state of Victoria, Australia.
Data collection protocols were approved by The Royal
Children’s Hospital’s Ethics in Human Research Commit-
tee. Sampling details are provided in earlier reports [15].
Brieﬂy, the cohort was designed as a representative
sample of the Victorian population of mid-secondary-
school adolescents in 1992, deﬁned in a two-stage cluster
sample with two classes selected at random from a state-
wide sample of 44 schools, with one class entering the
study in the latter part of the ninth school year (wave 1)
and the second class 6 months later (wave 2). Partici-
pants were reviewed subsequently at a further four
6-month intervals during the teenage years (waves 3–6)
with two follow-up waves in young adulthood, aged
20–21 years (wave 7) and 24–25 years (wave 8). In
waves 1–6, participants self-administered the question-
naire on laptop computers with telephone follow-up of
those absent from school [16]. The seventh and eighth
waves of data collection were undertaken using
computer-assisted telephone interviews.
From a total sample of 2032 students, 1943 (95.6%)
participated at least once during the ﬁrst six (adolescent)
waves (Fig. 1). In wave 8, 1520 (75% of the initial
sample, 78% of teenage participants) were interviewed
between April 2001 and April 2003. Reasons for non-
completion at wave 8 were refusal (n = 269), loss of
contact (n = 147) and death (n = 7).
The sample of 1943 participants consisted of 943
males, 1443 from metropolitan schools, 617 had no
parent complete secondary school, 630 had one parent
complete secondary school or had a vocational diploma
or certiﬁcate and 596 had a tertiary qualiﬁcation, 717
had at least one parent who smoked regularly and 439
had parents who were divorced or separated by wave 6.
Measures
Alcohol use was assessed at each wave using self-reported
frequency of use and a retrospective 1-week alcohol diary
(beverage- and quantity-speciﬁc) for those reporting
alcohol use in the previous week. For each wave, the total
weekly alcohol consumption was calculated. Moderate-
and high-risk drinking were deﬁned according to the Aus-
tralian National Health and Medical Research Council
guidelines, which are based on risk for longer-term health
problems in adults [17]. At least moderate-risk drinking
was deﬁned as exceeding 28 standard drinks (one stan-
dard drink = 10 g alcohol) for the previous week in males
and 14 standard drinks in females. High-risk drinking
was deﬁned as exceeding 43 standard drinks in males and
28 standard drinks in females. As no deﬁnitions are avail-
able for alcohol-related risk in adolescence, the same
thresholds were used throughout the cohort study in
order to provide consistency of measurement.
Cannabis use was assessed using self-reported fre-
quency of use in the previous 6 months (waves 1–6) and
12 months (waves 7 and 8). Risk associated with can-
nabis use was deﬁned on the basis of previous studies
examining risks of dependence or mental health prob-
lems in cannabis users [9,18]. At least moderate-risk can-
nabis use in both males and females was deﬁned as at
least weekly use and high-risk as daily or almost daily.
Analysis
We used the method of multiple imputation to address
potential bias arising from respondents missing waves of
data collection [19]. We imputed ﬁve complete data sets
under a multivariate normal model incorporating all the
outcome variables of interest measured at all waves of
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Figure 1 Sampling and ascertainment in the Victorian Adolescent Health cohort, 1992–2003
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data collection, along with the ﬁxed covariates of sex,
age, rural/urban residence and parental education (avail-
able on all participants) [20]. Data analysis was under-
taken using STATA 8 [21], with all estimates of
prevalences (frequencies) and odds ratios obtained by
averaging across the ﬁve imputed data sets. Multinomial
logistic regression analysis was used to model longitudi-
nal associations between persisting moderate-risk sub-
stance use during adolescence and substance use in wave
8 by category of high-risk substance use. Logistic regres-
sion analysis was used to model associations between
social and behavioural outcomes and high-risk substance
use in wave 8 and, similarly, persisting substance use in
waves 1–6. Effect modiﬁcation by gender was assessed
in each model using the Wald test at the 0.01 level of
signiﬁcance.
RESULTS
Throughout cohort follow-up the prevalence of alcohol
use was consistently higher than that of cannabis (waves
1–8 alcohol: 40%, 52%, 58%, 62%, 68%, 71%, 86%,
86%; cannabis: 8%, 17%, 18%, 20%, 21%, 21%, 59%,
35%). The overall prevalence of either alcohol or can-
nabis use at each of the three levels is shown in Fig. 2.
‘Any’ alcohol or cannabis use increased from 42% at wave
1 to 73% at wave 6 and stabilized at just under 90% for
waves 7 and 8. At least moderate-risk use was infrequent
at the study outset (1.3%), but rose to 10–12% between
waves 4–6 and increased further to around 26% at waves
7 and 8. High-risk use of either alcohol or cannabis
increased to 3–4% for waves 4–6 and then to around 13%
at waves 7 and 8.
Table 1 shows associations between alcohol and can-
nabis use at the three levels of use (any, moderate- or
greater and high-risk) at each study wave. Cannabis and
alcohol use were associated at all levels of risk, but the
strength of association declined as the cohort aged,
reﬂecting the increasing prevalence of cannabis and
alcohol use at each level.
Figure 3 displays the proportion of selective users of
alcohol and cannabis at each of the three levels of use, in
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Figure 2 Prevalence of alcohol and/or
cannabis use by wave and severity of use:
any use, at least moderate-risk and high-
risk.The x-axis scale represents the rela-
tive timing of each survey
Table 1 Cross-sectional associations between alcohol use and cannabis use by wave in 1943 cohort participants across three levels of
risk.
Phase
Age1 (years)
Any alcohol and/or
cannabis
At least moderate
risk alcohol and/or
cannabis
High risk alcohol and/or
cannabis
Mean (SD) OR (95% CI) OR (95% CI) OR (95% CI)
Adolescent (wave 1–6)
1 15.0 (0.50) 8.1 (4.5–15) 33 (8.9–122) 18 (2.3–142)
2 15.5 (0.50) 13 (8.3–21) 16 (8.2–30) 23 (4.1–136)
3 15.9 (0.50) 12 (7.4–19) 8.7 (5.1–15) 13 (3.0–58)
4 16.4 (0.49) 9.5 (6.0–15) 7.5 (4.4–13) 8.7 (3.0–26)
5 16.9 (0.49) 11 (5.9–19) 7.7 (4.9–12) 13 (5.7–30)
6 17.4 (0.50) 9.3 (5.8–15) 6.2 (3.7–11) 5.3 (1.5–19)
Young adult (wave 8)
7 20.7 (0.51) 5.4 (4.0–7.3) 2.2 (1.6–3.0) 2.2 (1.3–3.7)
8 24.1 (0.61) 3.4 (2.2–5.1) 2.9 (2.1–3.9) 2.9 (1.7–4.9)
1Ages obtained by averaging across the ﬁve imputed data sets.
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each wave of data collection. Just under a third of those
reporting any substance use during the teenage years
were concurrent users of cannabis and alcohol. This frac-
tion rose to 63% at wave 7 but fell to 36% at wave 8.
Cannabis use alone was uncommon (< 4% at any wave)
but alcohol use alone was common in adolescence
(70–80%), but fell to 33% at wave 7 before increasing
again to 61% at wave 8.
For those reporting at least moderate-risk use, concur-
rent use of alcohol and cannabis remained at around
15–17% throughout follow-up. The proportion using
cannabis only at this level varied between 34% and 42%
from waves 1–7 and then fell to 24% at wave 8. The
proportion using alcohol alone was 41–51% for waves
1–7 and increased to 59% at wave 8.
For those using at a high-risk level, concurrent
alcohol and cannabis use was consistently low through-
out the study at 5–11%. The proportion of cannabis-only
users varied between 22% and 33% for all waves except
wave 7, when it peaked at 41%. The proportion of
alcohol-only users varied between 51% and 67%
throughout follow-up, with the lowest relative proportion
at wave 7 and the highest at wave 5.
Table 2 examines continuities in cannabis and
alcohol use from adolescence to young adulthood.
Young adult high-risk use was classiﬁed into four cat-
egories: no high-risk use, high-risk cannabis only, high-
risk alcohol only and both high-risk substances.
Multinomial logistic regression was used to compare
each of the three high-risk categories with those report-
ing no high-risk use. We assessed the associations
between (at least) moderate-risk adolescent use and
high-risk use in young adulthood, aiming thereby to
investigate the progression towards high-risk use in
young adults. Adolescent moderate-risk categories were
not mutually exclusive. However, 90% of persistent
(2 + waves) moderate-risk adolescent alcohol users and
80% of persistent moderate-risk cannabis users did not
use the other drug persistently at a moderate-risk level
concurrently or at other times.
Twenty-three per cent of persistent moderate-risk
teenage cannabis users were daily users at wave 8 and
14% were high-risk drinkers. After adjustment for back-
ground factors, adolescent moderate-risk cannabis use
predicted a sevenfold higher rate of high-risk cannabis
use in young adulthood but only a twofold elevation
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in later high-risk alcohol use. In contrast, 10% of
moderate-risk teenage drinkers were daily cannabis
users at wave 8 and 20% were high-risk drinkers. Ado-
lescent moderate-risk alcohol use independently pre-
dicted a threefold higher rate of later high-risk alcohol
use, a similar level of association to that with later high-
risk cannabis use. There was no evidence of effect modi-
ﬁcation by gender.
Cross-sectional associations between high-risk can-
nabis and alcohol use and social context and other sub-
stance use in young adulthood are shown in Table 3.
High-risk cannabis use was associated with failure in
education and training, not being in a relationship and
higher rates of parenthood. It was also associated with a
ﬁvefold higher risk of daily smoking and over sevenfold
higher risks of amphetamine and cocaine usage, and
higher rates of consultation with drug and alcohol
counselling services, particularly in females. With the
exception of parenthood, those concurrently using
alcohol at a high-risk level had similar associations to
those in the selective high-risk cannabis group. High-
risk alcohol users were more likely to use other sub-
stances, but with the exception of relationship status,
their social circumstances and help-seeking did not
differ from those without a history of high-risk sub-
stance use.
Associations between adolescent persistent moderate-
risk cannabis and alcohol use and young adult social
measures and other substance use are shown in Table 4.
Moderate-risk adolescent cannabis use (weekly + on at
least two occasions) predicted poor education and train-
ing outcomes in young adulthood, with less likelihood of
being in a relationship and clearly elevated rates of later
illicit substance use and drug and alcohol service consul-
tation. Adolescent moderate-risk alcohol users were at
elevated risk for later daily cigarette smoking, ecstasy and
cocaine use, but with the exception of higher rates of
parenthood in females, this group appeared similar in
their later social context to non-risk substance-using
adolescents.
Table 2 Associations between high-risk substance use in young adulthood and persistent (two or more waves) at least moderate
substance use in adolescence.
Adolescent persistent
alcohol and cannabis
use (waves 1–6)1 n2 (%male)
Young adult high risk cannabis and alcohol use (wave 8)
Selective high risk
cannabis use
[n2 = 89 (59%male)]
Selective high risk
alcohol use
[n2 = 177 (66% male)]
Concurrent high risk
cannabis and alcohol use
[n2 = 27 (92% male)]
OR3 (95% CI) OR3 (95% CI) OR3 (95% CI)
Univariate
Selective moderate
cannabis use
106 (66) 9.9 (4.5–22) 2.4 (1.2–4.8) 14 (4.7–43)
Selective moderate
alcohol use
112 (53) 2.9 (1.4–5.9) 3.1 (1.5–6.3) 3.7 (0.68–20)
Concurrent moderate
alcohol and cannabis
41 (46) 7.6 (2.3–26) 1.1 (0.11–10.2) 15 (3.9–55)
Adjusted for all persistent substance use measures
Selective moderate
cannabis use
106 (66) 8.7 (3.9–20) 2.5 (1.2–5.2) 11 (3.2–40)
Selective moderate
alcohol use
112 (53) 3.0 (1.4–6.3) 3.2 (1.6–6.3) 3.9 (0.90–17)
Concurrent moderate
alcohol and cannabis
41 (46) 3.1 (0.81–12) 0.67 (0.07–6.7) 5.2 (0.94–29)
Adjusted for all persistent substance use measures and background measures4
Selective moderate
cannabis use
106 (66) 7.4 (3.3–17) 2.2 (1.1–4.5) 9.1 (2.5–34)
Selective moderate
alcohol use
112 (53) 2.6 (1.2–5.7) 3.0 (1.5–6.0) 3.6 (0.83–16)
Concurrent moderate
alcohol and cannabis
41 (46) 3.2 (0.80–13) 0.69 (0.07–7.1) 7.3 (0.75–70)
1Categories of (at least) persistent moderate substance use were not mutually exclusive. 2Frequencies obtained by averaging across the ﬁve imputed data
sets. 3Odds ratios (OR) from univariate and multivariate multinomial logistics regression models with reference category for all outcome variables: neither
hazardous alcohol use nor daily cannabis use in wave 8 (average n = 1650). 4Estimates adjusted for all persistent substance using measures, gender,
non-metropolitan school of origin, parental education and parental divorce/separation and smoking during particpant’s adolescence.
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DISCUSSION
Alcohol and/or cannabis were used by close to 90% of
young adults in our sample. Moreover, close to one in ﬁve
young adults used either alcohol or cannabis at a high-
risk level. We found some association between alcohol
and cannabis at each level of use but there was a ten-
dency for high-level users to use one substance predomi-
nantly. Close to one in four moderate risk (weekly +)
teenage cannabis users were later high-risk (daily) users
as young adults. Weekly or more frequent teenage can-
nabis use predicted a later sevenfold higher rate of daily
cannabis use compared with a doubling of the odds for
high-risk drinking. In contrast, moderate-risk adolescent
alcohol use in the absence of weekly cannabis predicted
an approximately threefold increased rate of both later
high-risk drinking and cannabis use. These ﬁndings seem
consistent with an early selection into heavier cannabis
use for a substantial minority.
What might explain an early selective progression to
heavier cannabis use? One possibility is that it reﬂects a
substance-speciﬁc heritable tendency to respond to can-
nabis and alcohol in different ways [22]. However, the
evidence to date from twin studies suggests both that can-
nabis and alcohol misuse in adulthood are inﬂuenced by
genetic factors, but these factors overlap substantially
and are generally non-speciﬁc [23,24]. An alternative
explanation is that substance selection in vulnerable
young people is determined by psychosocial context
[13,23]. This context might, in turn, explain the associa-
tion between heavier cannabis use and both less settled
social roles and high substance use in young adulthood.
It is also possible that cannabis use may lead directly or
indirectly to poorer young adult outcomes. Different peer
group values and drug preferences as well as exposure to
other drugs may explain the higher rates of other sub-
stance use. A further possibility is that academic failure
and absence of a stable relationship lead to social margin-
alization and greater use of cannabis. There is, ﬁnally, a
possibility that for a minority of young people the selec-
tive use of cannabis reﬂects a preference for the drug, a
possibility that may be linked to the development of a
dependence syndrome [25].
Ultimately this study is unable to delineate whether
the selective use of cannabis reﬂects an individual’s
response to the drug or may arise from unmeasured back-
ground confounders. However, the associations between
frequent cannabis use in adolescence and later illicit drug
use are similar to that reported recently by Fergusson
et al. [26], who had greater scope for control of potential
early childhood confounders. An absence of relevant
measures of alcohol-speciﬁc harms such as antisocial
behaviour or accidental injury could explain the current
study’s failure to ﬁnd an association between adolescent
alcohol consumption and later adverse social outcomes.
Even taking this limitation into account, the course of
risky adolescent drinking appears very different from that
of risky cannabis use.
Despite limitations, the policy relevance of the ﬁnd-
ings remains. The poor outcomes of regular adolescent
cannabis users provide a strong rationale for prevention
and early intervention. The tendency to specialize in can-
nabis use also raises a question about policies to reduce
youth alcohol use. Such policies have been shown to
increase youth cannabis use which in the light of this
study’s ﬁndings might increase inadvertently levels of
risky cannabis use and the harms associated with the
latter [27]. On the other hand, there is a risk that, because
high-risk alcohol use appears to be associated with fewer
social difﬁculties, it may escape policy attention and the
intervention that it deserves, given its longer-term
adverse health consequences [28].
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3.5 Regular and dependent cannabis use at 24 years 
Paper 4. Adolescent cannabis users at 24 years: trajectories to more than weekly use 
and dependence in young adulthood. Swift W., Coffey C., Carlin J.B., Degenhardt 
L., Patton G.C. Addiction. 103(8): 1361-70, 2008. 
Journal impact factor 4.3 (source: Journal Citation Reports, 4/03/2013) 
44 citations as at 4/03/2013 (source: Google Scholar). 
This paper extends our understanding of the progression from adolescent cannabis 
use to problematic use in young adulthood, by examining predictors of dependence 
and daily use at 24 years an age beyond the peak period of experimentation (Wave 
8),, when we can consider that at least some of those who have continued using will 
be more entrenched in their use and show clearer aetiology. At the time this paper 
was published, the view that prolonged cannabis use was harmful was gaining 
currency in the medical and mental health professions, though still not universally 
accepted (Roxburgh et al. 2010). Despite this and the contemporary evidence that 
cannabis use appeared to be declining (although this trend has apparently 
subsequently reversed (AIHW 2010) ), hospital separations for problems due to 
cannabis use were increasing, though largely due to mental health issues rather than 
for treatment of dependence (Roxburgh et al. 2010). Again, the VACHS was well-
situated to make an important contribution to the evidence with the detailed 
measurement of cannabis use frequency throughout the study, the ability to identify 
early uptake and drug exposure and the innovative use of multiple imputation. 
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3.5.1 My contribution 
The lead author of this paper was Dr. Wendy Swift from the National Drug and 
Alcohol Centre at the University of New South Wales. I was intrinsically involved in 
conceptualising the question and in operationalising and performing the analysis. I 
wrote the methods, contributed substantially to the results, assisted with the 
introduction and discussion and with the response to the reviewers’ comments. The 
declaration of my contribution, estimated as 40%, is in Appendix 2. 
3.5.2 Analysis and results 
In this paper we concentrated particularly on describing adolescent exposure to 
various putative risk factors and examining their association with two outcomes: 
daily cannabis use (that is, maximum use in past year reported as daily) and 
dependence at 24 years. The use of imputation to deal with missing waves of data 
collection in the adolescent phase allowed us to reasonably classify duration of 
adolescent exposures into one or two waves and three to six waves, the latter 
categorisation indicating persistent exposure and logically incorporating 
commencement at the latest by Wave 4. Early cannabis use was defined as use in the 
first three waves and we also identified maximum frequency of use in Waves 1 to 6. 
Not surprisingly, initiation after adolescence was highly protective of later 
problematic use and the risk of these outcomes was clearly highest with the most 
severe levels of adolescent exposure on each cannabis measure. Persistent adolescent 
cigarette smoking was independently predictive of the young adult cannabis 
outcomes, especially dependence, possibly as a result of a mix of genetic 
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vulnerabilities and societal pressures. As we would expect from the previous paper, 
risky alcohol use in adolescence was unrelated to these outcomes. Thus, we showed 
clearly that early and frequent cannabis use in adolescence carries with it a high risk 
of later problematic use and dependence in young adulthood. 
3.5.3 Implications 
The elevated risk associated with early regular cannabis use in the follow-up was 
particularly noticeable with dependence and implied an underlying mechanism 
related to the intensity and duration of drug exposure, possibly indicating an early 
leaning towards dependence. This finding is consistent with the vulnerability of the 
developing endocannabinoid system in the brain to exogenous cannabis exposure 
around puberty which has been replicated in a number of animal models (Schneider 
2008). 
The paper added to the accumulating literature supporting the concept of dependence 
and underlined the importance of intervening with adolescents who have commenced 
cannabis use to prevent escalation and continued use as they mature. While we 
observed strong continuity from early and frequent adolescent cannabis use to 
problematic use at 24 years, this was not irrevocable, as there was a notable 
proportion of early heavy users abstaining by 24 years (Wave 8), in line with 
findings from other studies. The observation that use fluctuated led us to the final 
paper in this series, in which it was important for us to determine the importance of 
perturbations in adolescent use in terms of escalation to later problematic cannabis. 
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3.5.4 Paper 4: Adolescent cannabis users at 24 years: trajectories to 
more than weekly use and dependence in young adulthood. 
Swift W., Coffey C., Carlin J.B., Degenhardt L., Patton G.C. Addiction. 103(8): 
1361-70, 2008. 
 
  
Adolescent cannabis users at 24 years: trajectories to
regular weekly use and dependence in
young adulthood
Wendy Swift1, Carolyn Coffey2, John B. Carlin3, Louisa Degenhardt1 & George C. Patton2
National Drug and Alcohol Research Centre, University of New South Wales, Australia,1 Centre for Adolescent Health, Murdoch Children’s Research Institute,
Australia2 and Clinical Epidemiology and Biostatistics Unit, Murdoch Children’s Research Institute and University of Melbourne Department of Paediatrics,
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ABSTRACT
Aims To examine the association between cannabis use by 18 years and problematic cannabis use at 24 years,
considering possible mediating and confounding factors. Design Ten-year representative prospective study with data
from six time-points in adolescence (mean age 14.9–17.4 years) and two in young adulthood (mean age 20.7 and 24.1
years) Setting Victoria, Australia. Participants Inception cohort of 1943 secondary school students (95.6%
response rate), with 1520 (78% of adolescent participants) interviewed in the ﬁnal wave. Measurements Participants
reported frequency of cannabis use for the past 6 months at each time-point in adolescence (age 14–17 years).
Cannabis exposure was deﬁned as: maximum frequency of use (occasional, weekly, daily), number of waves of use (1
or 2; 3–6) and ﬁrst wave of use (early use: ﬁrst waves 1–3). Young adult (24 years) outcomes were: weekly+ cannabis
use and DSM-IV cannabis dependence, referred to collectively as problematic use. Findings Of those interviewed at
age 24 (wave 8), 34% had reported cannabis use in adolescence (waves 1–6), 12% at a level of weekly or more frequent
use; 37% of these adolescent cannabis users were using at least weekly at wave 8, with 20% exhibiting dependence.
Persistent adolescent cannabis and tobacco use as well as persistent mental health problems were associated strongly
with problematic cannabis use at 24 years, after adjustment for potential confounding factors. Conclusions Heavy,
persistent and early-onset cannabis use were all strongly predictive of later cannabis problems. Even so, occasional use
was not free of later problems. Where there was co-occurring tobacco use or persistent mental health problems, risks
for later problem cannabis use was higher.
Keywords Cannabis, dependence, longitudinal studies, outcomes, trajectories, young adults.
Correspondence to: Wendy Swift, National Drug and Alcohol Research Centre, University of NSW, NSW 2052, Australia. E-mail: w.swift@unsw.edu.au
Submitted 6 September 2007; initial review completed 7 December 2007; ﬁnal version accepted 1 April 2008
INTRODUCTION
Cannabis use is initiated typically during adolescence, but
rates of use peak in young adulthood. In Australia, 18%
of 14–19-year-olds and 26% of 20–29-year-olds report
cannabis use in the previous year [1]. Even though the
prevalence of past-year use has declined since the late
1990s, the proportion of adolescent and young adult
users reporting regular (at least weekly) consumption
has remained steady (approximately one in three) [1,2].
While for many young people cannabis use is sporadic,
of limited duration and without major consequence [3],
entrenched users are at high risk of cannabis dependence
and other related adverse outcomes. Early initiation and
regular adolescent (at least weekly) use have been identi-
ﬁed as risk factors for later problematic cannabis use
[4–9]. We have found previously that weekly adolescent
cannabis use marked a threshold for increased risk of
daily and dependent use at 20 years [10], particularly in
the absence of problematic alcohol use [11]. There is
clearly scope for extending our understanding of the rela-
tionship between adolescent use patterns and heavy use
further into adulthood at a point beyond the peak period
for experimentation, and which has been found in older
cohorts to herald the decline of cannabis use among
many users [12–14]. The identiﬁcation of consumption
RESEARCH REPORT doi:10.1111/j.1360-0443.2008.02246.x
© 2008 The Authors. Journal compilation © 2008 Society for the Study of Addiction Addiction, 103, 1361–1370
patterns that place cannabis users at long-term risk of
continued and/or problematic use has clear relevance for
health education as well as early intervention strategies.
This paper examines the associations between pat-
terns of adolescent cannabis use and subsequent prob-
lematic use in a cohort of 1943 adolescents followed from
14 to 24 years. Speciﬁcally, it addresses the questions:
1 What is the relationship between the pattern of ado-
lescent cannabis use and the frequency of problematic
cannabis use at 24 years?
2 To what extent are other background and adolescent
factors associated with problematic cannabis use at 24
years?
METHODS
Sample
Between August 1992 and March 2003 we conducted an
eight-wave cohort study of health in adolescents and
young adults resident in the state of Victoria, Australia.
Data collection protocols were approved by The Royal
Children’s Hospital’s Ethics in Human Research Commit-
tee. The cohort was designed as a representative sample of
the Victorian population of mid-secondary school adoles-
cents in 1992, deﬁned in a two-stage cluster sample. Two
classes were selected at random from a state-wide sample
of 44 schools selected at random from within a state-wide
stratiﬁed frame of government, Catholic and independent
private schools, with probability of selection proportional
to the number of students. One class entered the study in
the latter part of the ninth school year (wave 1) and the
second class 6 months later (wave 2). School retention
rates to year 9 in the year of sampling were 98%. Partici-
pants were reviewed subsequently at a further four
6-month intervals during the teens (waves 3–6), with
two follow-up waves in young adulthood aged 20–21
years (wave 7) and 24–25 years (wave 8). In waves 1–6,
participants self-administered the questionnaire on
laptop computers with telephone follow-up of those
absent from school. The seventh and eighth waves were
undertaken using computer-assisted telephone inter-
views [15]. This report concerns observations from waves
1–6 and wave 8.
From a total sample of 2032 students, 1943 (95.6%)
participated at least once during the ﬁrst six (adolescent)
waves (Fig. 1). In wave 8, 1520 (78% of adolescent par-
ticipants) were interviewed between April 2001 and April
2003. Reasons for non-completion at wave 8 were refusal
(n = 269), loss of contact (n = 150) and death (n = 4).
Four failed to answer the cannabis questions and nine
claimed to have never used cannabis despite reporting
weekly+ use in an earlier wave, so these responses were
also treated as missing.
Measures
Background factors included sex, school location at sam-
pling, parental divorce or separation by wave 6, at least
one regularly smoking parent and the highest level of
education achieved by either parent.
Adolescent measures (waves 1–6)
Cannabis use was assessed using self-reported frequency
of use in the previous 6 months, categorized as: never,
less than weekly (occasional), weekly and daily. We cat-
egorized individuals according to the maximum fre-
quency reported during the adolescent phase. We deﬁned
early initiation of cannabis use as ﬁrst recorded use in
waves 1, 2 or 3; that is, occurring before school year 11
when the mean age was over 16 years [10].
We assessed adolescent exposure for cannabis use and
the following measures by counting the number of waves
in which a participant met each deﬁned criterion. We
classiﬁed exposure as ‘1 or 2 waves’ and ‘3–6 waves’, with
the latter category deﬁned as persistent exposure.
Symptoms of depression and anxiety were assessed at
each wave using the revised Clinical Interview Schedule
(CIS-R) [16], a valid [17], moderately branched psychiat-
ric interview designed to assess symptoms of depression
and anxiety in non-clinical populations. The total scores
phase
survey wave 1 wave 2 wave 3 wave 4 wave 5 wave 6 wave 7 wave 8
year 1992
mean age 14.9 yr
sample n 898
1993
15.5 yr
1727
1993
15.9 yr
1697
1994
16.4 yr
1628
1994
16.8 yr
1575
1995
17.4 yr
1530
1998
20.7 yr
1601
2001/03
24.1 yr
1520
design
      Total intended sample = 1037( w1) + 995 (w2) = 2032
ascertainment       95.6% (1943) of sample participated at least once in waves 1-6
2 entry points 
Young adultAdolescent
Figure 1 Sampling and ascertainment in the Victorian Adolescent Health Cohort, 1992–2003
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on the CIS-R were dichotomized with scores greater than
11 taken to deﬁne a mixed depression–anxiety state at a
lower threshold than syndromes of major depression and
anxiety disorder but where clinical intervention would be
appropriate [18].
Alcohol consumption in each wave was calculated
from a retrospective alcohol diary (beverage and quantity
speciﬁc) in which participants reported alcohol use in the
previous week. As no deﬁnitions are available for alcohol-
related risk in adolescence, we used the adult threshold of
moderate risk of long-term health problems, deﬁned
according to Australian guidelines [19]. At least moder-
ate risk (‘risky’) drinking was deﬁned as exceeding 28
standard drinks (one standard drink = 10 g alcohol) for
the previous week in males and 14 standard drinks in
females.
Cigarette smoking in each wave was assessed using
self-report of frequency of smoking over the past 6
months. Those who reported having had a cigarette in
the past month also completed a 7-day retrospective
diary of tobacco use that was then used to classify fre-
quency of smoking. Any smoking was deﬁned as report-
ing having smoked at least one cigarette in the last
month.
Antisocial behaviour in each wave was assessed using
10 items from the Self-Report of Early Delinquency Scale
[20] relating to property damage, interpersonal conﬂict
and theft in the previous 6 months. Antisocial behaviour
was categorized according to whether more than one
behaviour was endorsed ‘more than once’.
Young adult (wave 8) cannabis use at 24 years
To assess cannabis use frequency at wave 8 participants
were asked to report their maximum cannabis use in the
past year. In order to delineate frequent cannabis users,
we identiﬁed those participants who were using cannabis
weekly or more often (‘weekly+’).
We administered the computerized Composite Inter-
national Diagnostic Interview (CIDI 2.1, 12-month
version), a fully structured diagnostic interview based
upon operationalized diagnostic criteria, to generate the
DSM-IV criteria for a diagnosis of cannabis dependence in
participants reporting at least weekly cannabis use in the
past 12 months. We applied this ﬁlter to minimize
responder fatigue, as we considered that a diagnosis of
cannabis dependence was consistent only with regular
cannabis use, given the DSM-IV description of substance
dependence as occurring with a ‘pattern of repeated
(substance) self-administration’ [21]. The CIDI has been
found to provide reasonably reliable and valid assess-
ments of substance use disorders [22].
Dependent cannabis use and weekly+ cannabis use
are referred to collectively as problematic use.
Analysis
Data collection was undertaken at a developmental point
when young people are difﬁcult to trace because of high
mobility. There were very few missing data on individual
measures, but 36% of respondents missed at least one
wave of data collection in the adolescent phase (waves
1–6), leading to potential bias in summary measures cal-
culated from these data. To address this, we used the
method of multiple imputation [23]. We imputed ﬁve
complete data sets under a multivariate normal model
incorporating all the outcome variables of interest mea-
sured at all waves, along with the ﬁxed covariates sex,
age, rural/urban residence and parental education (avail-
able on all participants) [24], using adaptive rounding for
binary measures [25]. All frequencies and estimates of
association were obtained by averaging results across the
ﬁve imputed data sets, with inferences under multiple
imputation obtained using Rubin’s rules [23].
Unadjusted associations between adolescent cannabis
use indicators and background factors were assessed
using odds ratios (with 95% conﬁdence intervals). Multi-
variable logistic regression was used to estimate odds
ratios (ORs) for associations between wave 8 cannabis
use outcomes and adolescent cannabis use indicators,
adjusted for background factors. The outcome analysis
data set comprised all wave 8 participants (n = 1520),
with cannabis data multiply imputed for the 13 missing
observations. Wald tests and related conﬁdence intervals
under multiple imputation were used to assess statistical
signiﬁcance and precision. Effect modiﬁcation by sex and
adolescent maximum cannabis use was assessed using a
signiﬁcance level of 0.1. When examining possible inter-
actions with maximum adolescent cannabis use, we col-
lapsed the categories of weekly and daily use because of
the small numbers in the daily category. Data analysis
was undertaken in the STATA package [26], with impu-
tations performed using the stand-alone program NORM
(http://www.stat.psu.edu/~jls/misoftwa.html#mi)[27].
RESULTS
One-third (34%) of the 1520 24-year-old cohort partici-
pants had reported in adolescent interviews that they had
used cannabis: 22% had a maximum level of occasional
(<weekly) use, 12% weekly/daily use. More than half
(55%) of the 521 adolescent users reported persistent use
(3+ waves) and two-thirds (67%) had commenced use by
wave 3 [mean age 15.9 (standard deviation 0.5) years].
Both early uptake and persistent use were common in
adolescents reporting maximum weekly and daily use:
56% of occasional users, 81% of weekly and 95% of daily
cannabis users had commenced by wave 3; 36% of occa-
sional users, 87% of weekly users and 92% of daily users
reported persistent use.
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We examined the association between background
factors and adolescent cannabis use in participants who
had completed the wave 8 survey. Cannabis use was more
common among males, participants with divorced or
separated parents and those with a parent who smoked
cigarettes (Table 1).
Five hundred and nine (33%) of 1520 24-year-old
participants reported using cannabis in the past year,
of whom 190 (37%) were classiﬁed as weekly+ users
and 103 (20%) with dependence. Fifty-six (54%) of the
weekly+ users were also classiﬁed as dependent. Almost
one in three (29%) of those who used weekly+ in adoles-
cence (waves 1–6) were dependent subsequently at wave
8 and 43% were using at least weekly.
We examined associations between adolescent can-
nabis use and wave 8 cannabis outcomes (24 years)
(Table 2) with adjustment for background factors linked
to adolescent cannabis use (Table 1). The risk of both
frequent and dependent cannabis use at 24 years
increased with increasing levels of adolescent maximum
use frequency. Those who commenced use in waves 1–3
and those who used for more than two waves were at
between two- and threefold elevated odds of frequent and
dependent use outcomes at 24 years relative to later start-
ers and those who used for one or two waves, respectively.
Non-use of cannabis in adolescence was clearly protec-
tive for both wave 8 outcomes, compared even with the
lowest levels of cannabis use measures.
In order to focus upon risk trajectories for those who
used cannabis in adolescence, we examined associations
between summary adolescent exposures and weekly+
cannabis use and dependence at 24 years (wave 8)
among the subset of the 515 participants who had used
cannabis during adolescence (Table 3). We adjusted each
association ﬁrst for background factors and then for ado-
lescent cannabis use to assess effects independent of
this exposure. Due to the strong correlation between the
three adolescent cannabis exposure measures we selected
maximum use as the cannabis covariate of interest, as we
have found it previously to be clearly predictive of young
adult use [9]. Cannabis-using adolescents with persistent
symptoms of depression and anxiety were more likely to
be problematic cannabis users at 24 years, an effect that
was accounted for only partially by high frequency of use
in adolescence. This possible confounding was more
apparent with the cannabis dependence outcome.
Adolescent cigarette smoking was associated with a
two- to fourfold elevation in odds for subsequent weekly+
cannabis use and four- to almost eightfold elevation in
odds for cannabis dependence, accounted for only par-
tially by the level of adolescent cannabis use. The asso-
ciations between each of persistent alcohol use and
antisocial behaviour and both cannabis use outcomes
were reduced substantially after adjustment for the
frequency of adolescent cannabis use. There was no evi-
dence of any ﬁrst-order interactions by sex or by weekly/
daily adolescent cannabis use.
Finally, we examined independent associations with
problematic cannabis use outcomes at 24 years in the
subset of adolescent cannabis users by including esti-
mated background factors, maximum adolescent can-
nabis use and adolescent summary exposures in a
combined model for each outcome (Table 4). Male sex
remained associated independently with both later can-
nabis use outcomes. Daily adolescent cannabis users were
at elevated risk of later weekly+ cannabis use and can-
nabis dependence compared with occasional users, with
adolescent weekly users at intermediate risk for both
outcomes.
Cigarette smoking in adolescent cannabis users was
associated with later weekly+ cannabis use and cannabis
dependence, with the association clearest between persis-
tent smoking and later cannabis dependence. The asso-
ciations between persisting symptoms of depression and
anxiety and cannabis use outcomes in adolescent can-
nabis users were reduced substantially by inclusion of the
other measure in the models (compared with Table 3).
Similarly, the association between persisting antisocial
behaviour was accounted for largely in the fully adjusted
models. Persisting risky alcohol consumption was not
associated with either cannabis use outcomes in adoles-
cent cannabis users.
DISCUSSION
This paper has identiﬁed both strong continuities and dis-
continuities between regular adolescent cannabis use
and problematic use at age 24 years in a representative
sample of young people recruited in Victoria, Australia. A
signiﬁcant minority of 24-year-old cannabis users had
problematic use levels, with 37% using cannabis at least
weekly and 20% meeting DSM-IV cannabis dependence
criteria. Adolescent weekly+ cannabis users had up to a
threefold elevated risk of these problematic use outcomes
compared to occasional users, while non-use was
strongly protective.
Continuities and discontinuities in cannabis use
Persistent, heavy and early-onset cannabis users have
high rates of subsequent problematic use [4,9]. Nearly
one-half (43%) of those reporting weekly+ adolescent
use reported weekly+ use at age 24 years, and 29% were
dependent. We found a relationship between increasing
levels of adolescent cannabis use and problematic use in
young adulthood even after adjusting for other back-
ground and adolescent factors, with daily adolescent use
associated with the greatest odds of problematic cannabis
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use. This association was particularly pronounced with
dependence. We have speculated previously [10] that the
transition to weekly use may act as a critical threshold by
providing sufﬁcient drug exposure to initiate the early
stages of cannabis dependence. This notion is supported
by our ﬁndings that show a marked difference in odds
between occasional and weekly cannabis use in adoles-
cence for problematic use at 24 years. They also suggest
that the increased exposure afforded by daily use may
further sensitize adolescents to the effects of cannabis,
although the precise interplay between neuroadaptive
(e.g. effects of tetrahydrocannabinol on the brain), social,
psychological and environmental (e.g. entrenchment in a
drug using milieu, expectancies for use) mechanisms
related to this process are not well understood.
Although we selected a maximum of weekly+ use fre-
quency as our main measure of adolescent cannabis
involvement it was, not surprisingly, associated highly
with early onset of use and persistent use. These
measures are also linked to adverse cannabis-related
outcomes [5–8]. The identiﬁcation of any of these behav-
iours among adolescent users should warrant further
assessment and intervention, although they seem likely
to co-occur.
Nevertheless, there was variation in cannabis use over
time. Wave 8 dependent users comprised approximately
equal proportions of occasional, weekly and daily adoles-
cent users (Table 2), while persistence of heavy use was
not inevitable, with 57% of weekly or more often
adolescent users reporting none or less than weekly use
at age 24. This paradoxical ﬁnding of ‘substantial discon-
tinuity and substantial continuity’ [28] in use and depen-
dence is consistent with other research on the natural
history of cannabis and alcohol use [14,28]. It contrasts
somewhat with the ﬁndings on tobacco smoking from
this cohort, whereby ‘hard core’ users at wave 8 were
predominantly those already entrenched smokers as ado-
lescents [29]. This suggests that cannabis use patterns
may not become established as early and that high-dose
exposure to cannabis during adolescence, while strongly
predictive, may not be the overriding factor in the later
development of problematic cannabis use.
Adolescent males are not only more likely than
females to have tried cannabis [1], but are also more likely
to become long-term entrenched users. Male adolescent
cannabis users were approximately twice as likely as
females to be problematic users at 24 years, even after
allowing for their more frequent adolescent use, suggest-
ing that this ﬁnding is not due simply to greater opportu-
nity to use. Does this simply reﬂect a greater propensity
for long-term risk-taking among males? Societal norms
may play a reinforcing role, given the stigma associated
with illicit drug use by females [30]. Gender differences in
subjective responses to cannabis and the physiological
processes involved in establishing dependent behaviours
are areas worthy of further exploration, particularly
given some ﬁndings of converging rates of cannabis use
between young males and females [14].
Table 2 Association of adolescent cannabis use (waves 1–6) with weekly or more frequent cannabis use (weekly+) and cannabis
dependence in 1520 cohort participants at 24 years (wave 8), adjusted for background factors.
Adolescent cannabis use
(waves 1–6) N*
Cannabis use at 24 years (wave 8)
Weekly+ (n* = 190) Dependent (n* = 103)
n* (%†) OR‡ (95% CI) n* (%†) OR‡ (95% CI)
Maximal frequency of use
None 999 44 (4) 0.21 (0.13–0.33) 15 (1) 0.16 (0.08–0.32)
Occasional 331 65 (20) 1 33 (10) 1
Weekly 124 43 (35) 2.2 (1.4–3.6) 28 (22) 2.8 (1.5–5.1)
Daily 66 38 (58) 4.9 (2.6–9.3) 27 (41) 5.8 (2.7–12.3)
Number of waves of use
None 999 44 (4) 0.27 (0.14–0.51) 15 (1) 0.16 (0.07–0.36)
1 or 2 waves 234 39 (17) 1 24 (10) 1
3–6 waves 287 107 (37) 2.7 (1.5–4.6) 64 (22) 2.3 (1.2–4.5)
First wave of reported use
None 999 44 (4) 0.27 (0.15–0.47) 15 (1) 0.16 (0.08–0.33)
Late (waves 4–6) 171 28 (16) 1 17 (10) 1
Early (waves 1–3) 350 119 (34) 3.2 (1.9–5.3) 71 (20) 2.7 (1.5–4.8)
*Frequencies obtained by averaging across the imputed data sets. †Percentage of those in the exposure category with the outcome. ‡Odds ratio (OR) from
multivariable logistic regression models, adjusted for sex, parental divorce/separation and parental smoking. For each analysis the reference exposure
category was deﬁned to be the lowest level of adolescent cannabis use. CI: conﬁdence interval.
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Persistent adolescent cigarette smoking and persistent
anxiety/depression
There was an independent association between persistent
adolescent cigarette smoking and problematic cannabis
use, particularly dependence, at age 24 years. This does
not seem to be an effect of adolescent polysubstance use
per se, because persistent adolescent drinking was unre-
lated to subsequent cannabis use. These data are consis-
tent with evidence of a common vulnerability to both
cannabis and nicotine dependence, inﬂuenced by shared
genetic risk factors and environmental inﬂuences, such
as the common route of administration and milieu asso-
ciated with cannabis and nicotine use [31,32]. It is also
possible that the pharmacological effects of concurrent
cannabis and nicotine use on the developing adolescent
brain may establish brain pathways that mutually rein-
force continued use and dependence upon these drugs
[33].
We found that, despite some confounding of the rela-
tionship, escalation in cannabis use from adolescence to
young adulthood was more evident in those with persis-
tent depression/anxiety. While many mechanisms for
this relationship have been proposed [34], our ﬁndings
are unable to specify the underlying nature of this
association.
Strengths and limitations
The main strengths of this study include the population-
based sample, the high participation rates and the fre-
quent measures of drug use and psychosocial outcomes
over a 10-year period. It is possible that non-participation
at wave 8 was associated with different outcome patterns
than those seen in the participants. By deﬁnition we can
only speculate on such effects, but given the relatively
high cohort retention (78% of adolescent participants)
we believe that they are unlikely to have caused major
biases in our results. All data were based on self-report
which was not validated externally, but this has been
accepted as an appropriate way in which to gain informa-
tion about population behaviours [35–37]. There were
also no negative (or other) consequences for admitting to
drug use [36].
A potential limitation is that wave 8 cannabis depen-
dence may have been under-estimated, as it was assessed
only in those reporting weekly or more frequent cannabis
use in the previous year. However, it was ascertained pre-
Table 4 Associations of background factors and adolescent measures (waves 1–6) with weekly or more frequent cannabis use
(weekly+) and cannabis dependence at 24 years (wave 8) in 515 wave 8 participants who had used cannabis during adolescence,
adjusted for all covariates shown.
Background and adolescent measures (waves 1–6)
Cannabis use at 24 years (wave 8)
Weekly+ (n* = 145) Dependence (n* = 87)
OR* (95% CI) OR* (95% CI)
Background measures
Male sex 2.5 (1.5–4.3) 2.7 (1.4–5.0)
Parental divorce/separation 1.9 (1.2–3.2) 1.9 (1.1–3.4)
One parent a regular smoker 0.9 (0.60–1.5) 0.83 (0.48–1.4)
Maximum frequency of
cannabis use
Occasional 1 1
Weekly 1.7 (1.0–2.9) 2.0 (1.0–3.9)
Daily 3.3 (1.5–7.4) 3.8 (1.6–9.3)
Other adolescent measures
Depression and anxiety
symptoms (CIS-R > 11)
None 1 1
1/2 waves 1.2 (0.66–2.2) 0.83 (0.37–1.9)
3/6 waves 2.0 (1.0–3.8) 1.4 (0.71–2.9)
Any cigarette smoking None 1 1
1/2 waves 1.9 (0.77–4.9) 4.0 (1.2–14)
3/6 waves 3.0 (1.4–6.3) 5.5 (1.6–19)
Alcohol use: moderate
long-term risk
None 1 1
1/2 waves 1.1 (0.65–1.9) 0.97 (0.49–1.9)
3/6 waves 1.0 (0.36–2.9) 0.80 (0.23–2.8)
Antisocial behaviour None 1 1
1/2 waves 1.4 (0.72–2.8) 1.6 (0.71–3.5)
3/6 waves 1.4 (0.71–2.6) 1.8 (0.86–3.6)
*Odds ratio (OR) from multivariable logistic regression models. CI: conﬁdence interval.
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viously through comparison with a national survey of
mental health disorders that this diagnosis, reliant upon
repeated and recurrent behaviours and problems, is likely
to be infrequent in occasional users [38].
We also cannot specify the exact chronological rela-
tionship between adolescent cannabis use measures and
other measures such as mental health and cigarette and
alcohol consumption. However, by measuring the persis-
tence of these behaviours we are conﬁdent that there was
substantial overlap between their occurrence and adoles-
cent cannabis use, particularly given the association
between the different measures of cannabis exposure.
Implications
The vast majority of problematic young adult cannabis
users had smoked cannabis during adolescence. These
data indicate clearly that adolescents who engage regu-
larly in cannabis use are particularly at risk for cannabis-
related problems up to 10 years later. Being male,
persistent cigarette smoking and, to a lesser extent, per-
sistent anxiety/depression, are important co-factors that
seem to serve as markers for this risk, with male tobacco
smokers who were either persistent or weekly+ cannabis
users in adolescence most likely to progress to dependent
cannabis use in young adulthood. In addition to primary
prevention efforts to delay or prevent the uptake of
cannabis use, intervention efforts need to incorporate
appropriate messages about the risks of cannabis use,
particularly those posed by the increased exposure to
cannabis-related harms accompanying persistent and
escalating use. Such efforts should also consider the
potential impact of persistent cigarette smoking, particu-
larly in male cannabis users, and ongoing symptoms of
anxiety or depression. As motivation to address sub-
stance use can be a real issue for young people, motiva-
tional enhancement techniques [39] and the use of
opportunistic assessment and intervention may be par-
ticularly appropriate approaches.
Can these ﬁndings be used to recommend a ‘safe’ level
of adolescent cannabis use with regard to later problem-
atic use? Although regular adolescent cannabis users
appear to have an elevated long-term risk of problematic
cannabis use compared to their less regularly using peers,
occasional adolescent use per se clearly does not preclude
these outcomes at age 24. In this context, it would be
irresponsible to promote such use as ‘safe’.
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3.6  Moderation of cannabis use in adolescence and later 
harmful use 
Paper 5. Are adolescents who moderate their cannabis use at lower risk of later 
regular and dependent cannabis use? Swift W., Coffey C, Carlin J.B, Degenhardt L, 
Calabria B, Patton G.C. Addiction 104(5): 806-14, 2009 
Journal impact factor 4.3 (source: Journal Citation Reports, 4/03/2013) 
5 citations as at 4/03/2013 (source: Google Scholar). 
By the time we commenced work on the next paper, it was well established by 
ourselves and others (e.g., (DeWit et al. 2000; Ellickson, Martino & Collins 2004; 
Fergusson & Horwood 1997) that young people who initiated their cannabis use in 
adolescence were at greatly elevated risk of problematic use in young adulthood 
compared with those who started using at an older age. However, from the findings 
in the papers already discussed, it is clear that cannabis use in adolescence did not 
necessarily follow a rigid trajectory to problematic use in young adulthood. In our 
cohort, there was notable group of teenagers who started using, but then reduced or 
abstained permanently or temporarily and another group who never progressed 
beyond occasional use. In order to enlarge our understanding of the natural history of 
cannabis use in VAHCS, we wanted to examine whether the risk of later dependence 
in young adulthood was elevated in these groups, compared with adolescent non-
users, about half of whom initiated cannabis use later. We expected that reduction in 
use would endow some protection from later problematic use, but it was also 
possible that the effect of early regular use was pervasive. 
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Previous reports indicated that reduction in risk for later problematic use and other 
outcomes may follow moderation when use commenced later than in adolescence, 
but possibly not if initiation occurred early (Ellickson, Martino & Collins 2004). This 
is an important question as it informs the aims and approaches of preventative 
intervention and treatment. 
3.6.1 My contribution 
The lead author was Dr. Wendy Swift from the National Drug and Alcohol Centre at 
the University of New South Wales. I was involved in conceptualising the question 
and in operationalising and performing the analysis. I wrote the methods, contributed 
substantially to the results section and assisted with the introduction and discussion, 
and, finally, with the response to the reviewers’ comments. The declaration of my 
contribution, estimated as 40%, is in Appendix 2. 
3.6.2 Analysis and results 
We classified moderation of adolescent cannabis use in the course of the first six 
waves by identifying each participant’s first wave of maximum use in Waves 1 to 5 
as their index wave, and recording whether they reduced frequency of use 
subsequently or maintained the same level. Again, we used multiple imputation to 
enable least biased estimates to be made of this variable. The outcomes of interest 
were weekly or more frequent use (i.e., regular use) and dependence at 20 years and 
again at 24 years. Having identified the common dynamic patterns of adolescent use 
we found that almost all adolescent cannabis users reported at least some use in 
young adulthood. 
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We observed a continuation of risk for regular adolescent users with both outcomes 
at both ages, despite moderation of use in adolescence, although a period of 
abstinence appeared to reduce risk to some extent. Adolescent occasional users were 
at intermediate risk of poor outcomes, with abstinence possibly beneficial. 
3.6.3 Implications 
These findings are useful to inform strategies for adolescents seeking treatment and 
also for public health initiatives by illustrating that aiming for abstinence may be a 
more effective strategy than settling for occasional use as a treatment outcome. This 
is an important point and places health promotion for cannabis in the same arena as 
smoking, where abstinence is the only desirable outcome. 
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3.6.4 Paper 5: Are adolescents who moderate their cannabis use at 
lower risk of later regular and dependent cannabis use? 
Swift W., Coffey C, Carlin J.B, Degenhardt L, Calabria B, Patton G.C. 
Addiction 104(5): 806-14, 2009 
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ABSTRACT
Aims To examine whether moderation of cannabis use among adolescent cannabis users is associated with reduc-
tions in cannabis use frequency and risk of dependence in young adulthood. Design Ten-year representative cohort
study with six surveys in adolescence (mean age 14.9–17.4 years) and two in young adulthood (mean age 20.7 and
24.1 years). Participants Inception cohort of 1943 Victorian secondary school students (96% response rate), with
1520 (78% of adolescent participants) interviewed in the ﬁnal wave. Measurements Participants were classiﬁed into
six groups according to the maximum level of adolescent use and the extent of subsequent moderation in such use:
non-users, occasional to abstinence, occasional persisting, weekly to abstinence, weekly to occasional and weekly
persisting. Outcome measures were weekly+ cannabis use and DSM-IV cannabis dependence at 20 and 24 years.
Findings Thirty-one per cent reported cannabis use during adolescence. Most adolescent users had moderated their
use: from occasional to abstinence (71% of occasional users), weekly to abstinence or weekly to occasional (28% and
48% of weekly+ users, respectively). By age 24, both occasional use groups were at similar, elevated risk of regular and
dependent cannabis use compared to non-users. Weekly+ adolescent users were at greatest risk of these outcomes,
although the weekly to abstinence group exhibited lower risk than those in the weekly persisting and weekly to
occasional groups, who were at similar risk. Conclusions While many young people have dynamic cannabis use
patterns, a pattern of moderating adolescent cannabis use was associated with less risk of later problematic use than
among those persisting, but risks were still elevated substantially compared with never-users.
Keywords Cannabis, dependence, longitudinal studies, moderation, young adults.
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INTRODUCTION
Cannabis use is initiated typically during adolescence,
a period encompassing enormous maturational
changes, including neurobiological reorganization and
development associated with puberty [1,2]. While for
most young people cannabis use is transient with few
consequences [3], some will experience negative long-
term outcomes associated with their use in a variety of
life domains. Despite variation in individual use trajec-
tories, early onset and regular use of cannabis during
adolescence are strongly predictive of problematic can-
nabis use in young adulthood [4–9], with weekly or
more frequent adolescent use increasing the risk of
regular and dependent cannabis use up to 10 years later
[10].
This ﬁnding merits a closer examination of adolescent
use patterns, as it raises the question of whether the risks
imposed by regular use can be mitigated to some extent
by periods of abstinence or reduced use during adoles-
cence. Evidence for such effects would provide an impetus
for ongoing investment in age-appropriate interventions
for adolescent cannabis users. However, there is a dearth
of research on the long-term impacts of adolescent can-
nabis use interventions [11].
Studies examining adolescent cannabis use trajecto-
ries have identiﬁed their dynamic nature and their con-
siderable heterogeneity with regard to structural risk
RESEARCH REPORT doi:10.1111/j.1360-0443.2009.02534.x
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factors associated with use, age of initiation, rates of
change in use and association with a variety of young
adulthood outcomes, such as substance use, behaviour
and wellbeing [12–16]. Typically, those that have catego-
rized adolescent use patterns in a way that enables some
insight into the longitudinal impact of use escalation and
moderation have found variants of stable/experimental
light use, increasing and decreasing adolescent use pat-
terns more common than chronic heavy use [13–16].
Those whose use was categorized as more heavy/chronic
or increasing throughout adolescence appeared to be at
greatest risk of later problematic cannabis use, and less
likely to attain at least some young adult milestones suc-
cessfully [13,15,16]. Those whose use decreased during
this period were at somewhat less risk of later problematic
cannabis use [13,16], but not necessarily if use com-
menced early [15]. Such ﬁndings provide some limited
support for a notion that moderating use during adoles-
cence may attenuate later risk for some users.
In this paper we extend our previous work [10] on
adolescent cannabis use in a long-term Australian ado-
lescent cohort by addressing this issue speciﬁcally, asking
the following questions.
1 Among adolescents whose ﬁrst reported level of ado-
lescent use is occasional (<weekly), what is the impact
of subsequent abstention during adolescence on the
risk for regular (weekly+) and dependent cannabis use
at ages 20 and 24?
2 Among adolescents whose ﬁrst reported level of ado-
lescent use is at least weekly, what is the impact of
subsequent abstention or reduction in use (to <weekly)
on the risk for regular (weekly+) and dependent can-
nabis use at ages 20 and 24?
METHODS
Sample
Between August 1992 and March 2003 we conducted an
eight-wave cohort study of health in adolescents and
young adults resident in the state of Victoria, Australia.
Data collection protocols were approved by The Royal
Children’s Hospital’s Ethics in Human Research Commit-
tee. The cohort was designed as a representative sample of
the Victorian population of mid-secondary-school ado-
lescents in 1992, deﬁned in a two-stage cluster sample.
Two classes were selected at random from a state-wide
sample of 44 schools selected at random from within a
state-wide stratiﬁed frame of government, Catholic and
independent private schools, with probability of selection
proportional to the number of students. One class entered
the study in the latter part of the ninth school year (wave
1) and the second class joined the cohort at the following
survey conducted 6 months later (wave 2). School reten-
tion rates to year 9 in the year of sampling were 98%.
Participants were reviewed subsequently at a further four
6-month intervals during the teens (waves 3–6), with
two follow-up waves in young adulthood aged 20–21
years (wave 7) and 24–25 years (wave 8). In waves 1–6,
participants self-administered the questionnaire on
laptop computers with telephone follow-up of those
absent from school. The seventh and eighth waves were
undertaken using computer-assisted telephone inter-
views [17]. All consenting cohort participants continued
to be invited to participate at every adolescent wave and
at every subsequent wave after entry unless they with-
drew or were lost to follow-up.
From a total sample of 2032 students, 898 entered
the cohort in wave 1, 1045 in wave 2, 86 in wave 3, ﬁve
in wave 4 and one in wave 5, resulting in 1943 (95.6%)
who participated at least once during the ﬁrst six (adoles-
cent) waves (Fig. 1). In wave 8, 1520 (78% of adolescent
participants) were interviewed between April 2001 and
April 2003. Reasons for non-completion at wave 8 were
refusal (n = 269), loss of contact (n = 150) and death
(n = 4). Four failed to answer the cannabis questions and
nine claimed to have never used cannabis despite report-
ing weekly+ use in an earlier wave so were set to missing.
There was only weak evidence that using cannabis in
adolescence was associated with missing the wave 8
design
      Total intended sample = 1037 ( w1) + 995 (w2) = 2032
ascertainment       96% (1943) of sample participated at least once in waves 1-6
phase
survey wave 8
2001/03
24.1 yr
1520
year
mean age
sample n
exposure & outcome  outcome 2outcome 1   assessment of maximum cannabis use
measures
assessment of  reduction in use
2 entry points
Young adultAdolescent
wave 1
1992
14.9 yr
898
wave 2
1993
15.5 yr
1727
wave 3
1993
15.9 yr
1697
wave 4
1994
16.4 yr
1628
wave 5
1994
16.8 yr
1575
wave 6
1995
17.4 yr
1530
wave 7
1998
20.7 yr
1601
Figure 1 Sampling, ascertainment and exposure and outcome measures in the Victorian Adolescent Health Cohort, 1992–2003
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interview [OR (odds ratio) relative to no adolescent can-
nabis use: maximum occasional use 0.92, 95% conﬁ-
dence interval (CI) 0.67–1.3; maximum weekly+ 1.3
(95% CI 0.95–1.9].
Cannabis use measures
Adolescent cannabis use (14–17 years, waves 1–6)
Cannabis use was assessed using self-reported frequency
of use in the previous 6 months, categorized initially as:
never, less than weekly (occasional) and weekly or more
frequent (weekly+). The ﬁrst reported wave of use and the
ﬁrst reported wave of weekly+ use were identiﬁed in
waves 1–5 of data collection, thus giving all users the
opportunity to abstain from, reduce or sustain their use
subsequently within the adolescent phase; that is, until
wave 6. Use moderation (reduction or abstinence) was
classiﬁed according to the minimum frequency of use
reported in all adolescent waves after the index report.
Adolescent use moderation categories were then created,
incorporating data on the maximum level of adolescent
cannabis use reported between waves 1 and 5, and sub-
sequent use moderation in later adolescent waves (see
below). It was not possible to incorporate complex pat-
terns of variation in cannabis use uptake and moderation
in these categories due to the potential loss of statistical
precision, but they do incorporate information on age of
onset, use escalation (to maximum use frequency) and
use moderation (reduction or abstinence). All periods of
use moderation were of at least 6 months duration,
which was the time-period assessed in each adolescent
wave of data collection. It should be noted that the term
‘moderation’ is not meant to imply intentionality in
behaviour, as we did not collect information on reasons
for changes in use patterns and cannot say whether
reduction or abstinence was planned or unplanned
behaviour.
We classiﬁed participants in a hierarchical fashion
according to their cannabis use between waves 1 and 6,
as follows: (i) non-users: no use in waves 1–5; (ii) occa-
sional to abstinence: maximum occasional use in waves
1–5 with abstinence in at least one subsequent
adolescent wave; (iii) occasional persisting: maximum
occasional use in waves 1–5 with no moderation in
subsequent adolescent waves; (iv) weekly to abstinence:
maximum weekly+ use in waves 1–5 with abstinence in
at least one subsequent adolescent wave; (v) weekly to
occasional: maximum weekly+ use in waves 1–5 with
reduction to occasional use in at least one subsequent
adolescent wave; and (vi) weekly persisting: maximum
weekly+ use in waves 1–5 with no moderation in subse-
quent adolescent waves. Participants who commenced
use in wave 6 were necessarily included in the reference
category (i.e. non-users in waves 1–5).
There was a strong association between wave of
uptake and maximum adolescent cannabis use (associa-
tion between early uptake for maximum weekly versus
occasional use: average OR per wave 1.8 (95% CI: 1.5–
2.2). Figure 2 displays the distribution of age of onset of
cannabis use within each category of adolescent can-
nabis use moderation. Regardless of their subsequent
use moderation status, the vast majority of adolescent
weekly+ users had commenced use in waves 1–2 (before
16 years). In comparison, age of cannabis use onset
among occasional users was spread more evenly across
adolescence, with about half initiating by 16 years; those
in the occasional to abstinence group appeared to initiate
use slightly earlier than those in the occasional persisting
group.
Young adult cannabis use (20 years, wave 7; and
24 years, wave 8)
Cannabis use frequency. Participants reported their
maximum frequency of cannabis use in the past year.
Regular use was deﬁned as weekly or more often
(weekly+).
Young adult cannabis dependence. Young adult cannabis
dependence was assessed with the computerized Com-
posite International Diagnostic Interview (CIDI 2.1,
Occasional
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Abstinence
0
20
40
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%
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100
Occasional
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Weekly to
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Weekly to
Occasional
Weekly
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Figure 2 Distribution of age at cannabis
uptake within each category of maximum
adolescent cannabis use, classiﬁed by sub-
sequent reduction in use in the adolescent
phase
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12-month version), a fully structured diagnostic inter-
view based on operationalized diagnostic criteria, devised
for administration by non-medical professionals [18].
Only those participants who reported that their most fre-
quent use of cannabis in the past 12 months was at least
weekly were assessed for symptoms of DSM-IV cannabis
dependence. We applied this ﬁlter to minimize responder
fatigue, as we considered that a diagnosis of cannabis
dependence was consistent only with regular cannabis
use, given the DSM-IV description of substance depen-
dence as occurring with a ‘pattern of repeated (sub-
stance) self-administration’ [18].
Other measures
Background factors included sex, school location at sam-
pling, parental divorce or separation by wave 6, and the
highest level of education achieved by either parent. Ado-
lescent tobacco smoking was deﬁned as any cigarette
smoking within the month of survey in any adolescent
wave. Adolescent long-term high alcohol risk was calcu-
lated from self-reported alcohol consumption, measured
using a retrospective beverage and quantity speciﬁc
1-week alcohol diary. Australian alcohol consumption
guidelines [19] were used to classify males who reported
drinking more than 420 g and females more than 280 g
in the previous week in any adolescent wave as adoles-
cent high-risk drinkers. To examine treatment seeking
behaviour at age 24 years, participants who reported
seeking health advice from any listed health professional
in the past year were then asked whether any visit was for
‘problems with drugs or alcohol’.
Analyses
Multivariable logistic regression was used to estimate ORs
for associations between wave 7 and wave 8 cannabis use
outcomes and adolescent cannabis use patterns, adjusted
for background and adolescent factors, using the data set
deﬁned by survey participation in wave 8 (n = 1520). We
used multiple imputation to address potential bias and
loss of information arising from respondents’ missing
waves of data collection [20]. We imputed ﬁve complete
data sets under a multivariate normal model incorporat-
ing all the outcome variables of interest measured at all
waves, along with the ﬁxed covariates of sex, age, rural/
urban residence and parental education (available on all
participants) [21], using adaptive rounding for binary
measures [22].
All estimates of prevalence and (log) ORs were
obtained by averaging across the ﬁve imputed data sets
with Wald-type conﬁdence intervals obtained under mul-
tiple imputation using Rubin’s combination rules [20].
Data analysis was undertaken in the Stata package
[23] with imputations performed using the stand-
alone program NORM (http://www.stat.psu.edu/~jls/
misoftwa.html#mi) [24].
RESULTS
Adolescent use patterns
Almost one-third (31%) of the 24-year-old cohort partici-
pants (696 males and 824 females) reported using can-
nabis in the ﬁrst ﬁve adolescent waves of data collection;
that is, by approximately 17 years of age. A larger pro-
portion of males reported using cannabis in this period
than females (36% males versus 27% females). Of the
306 (20%) participants with maximum adolescent use
classiﬁed as occasional (155 males and 151 females),
71% were classiﬁed as occasional to abstinence and 29%
as occasional persisting. Of the 169 (11%) participants
(95 males and 74 females) identiﬁed as reporting weekly+
cannabis use at least once between waves 1 and 5, 28%
were classiﬁed as weekly to abstinence, 48% as weekly to
occasional and 24% as weekly persisting.
Young adult use patterns
Cannabis was used in at least one of the young adult
waves by 50% of adolescent non-users, 99% of occa-
sional persisting users, 92% of occasional to abstinence
users, 100% of both weekly persisting and weekly to
occasional users and 97% of weekly to abstinence users.
At age 20 years (wave 7), 910 (60%) participants
reported using cannabis in the past year, of whom 208
(23%) were classiﬁed as using at the weekly+ level and
112 (12%) as dependent. At 24 years, 509 (33%) partici-
pants reported using cannabis in the past year, of whom
190 (37%) were classiﬁed as weekly+ users and 103
(20%) with dependence. About half (54%) the weekly+
users were also classiﬁed as dependent at both ages 20
and 24.
Impact of adolescent use moderation
In the following tables we present measures of associa-
tion between the hierarchical categorization of adoles-
cent use moderation with later weekly+ cannabis use
(Table 1) and cannabis dependence (Table 2) at 20 and
24 years. In each table we ﬁrst present estimates adjusted
for several background factors, and then additionally
adjusted for adolescent cigarette smoking and alcohol
use. While adjustment for adolescent licit drug use modi-
ﬁed the strength of the associations presented, this did
not change the pattern of results. It should be noted that,
due to small numbers in the maximum weekly+ user
groups, some estimates were imprecise.
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Table 1 The association between maximum adolescent cannabis use, classiﬁed by subsequent reduction in use, and weekly or more
frequent cannabis use at 20 years and 24 years in 1520 cohort participants who completed the interview at 24 years, adjusted for
background factors.
Maximum adolescent cannabis use
(waves 1–5), classiﬁed by subsequent
reduction in adolescent use
Weekly or more frequent cannabis use in young adulthood
20 years (wave 7) 24 years (wave 8)
na = 208 n = 190
n (%b)
Adjusted for
background
factors
+Adolescent
smoking and
alcohol use
n (%b)
Adjusted for
background
factors
+Adolescent
smoking and
alcohol use
n ORc (95% CI) ORd (95% CI) ORc (95% CI) ORd (95% CI)
Non-user 1044 56 (5) 1 1 52 (5) 1 1
Occasional (<weekly)
Occasional–abstinence 217 35 (16) 3.1 (1.9–5.2) 2.0 (1.1–3.7) 41 (19) 4.1 (2.6–6.4) 2.7 (1.6–4.4)
Occasional persisting 89 29 (33) 7.8 (4.5–13) 5.1 (2.8–9.1) 24 (26) 5.9 (3.1–11) 3.7 (1.9–7.3)
Maximum weekly/daily (weekly+)
Weekly–abstinence 47 13 (28) 5.7 (2.3–14) 3.6 (1.3–9.9) 14 (30) 6.8 (2.8–17) 4.0 (1.5–11)
Weekly–occasional 81 43 (53) 20 (11–36) 12 (5.8–24) 37 (45) 14 (8.1–24) 7.8 (4.2–15)
Weekly persisting 42 31 (75) 53 (23–121) 32 (13–77) 22 (52) 18 (8.9–38) 10 (4.7–23)
aFrequencies and percentages were obtained by averaging across the imputed data sets. bPercentages are of exposure category in outcome. cOdds ratios
(OR) from multivariable logistic regression models adjusted for sex, rural school at study inception, parental education. dORs from multivariable logistic
regression models adjusted for sex, rural school at study inception, parental education and during adolescence: any cigarette smoking and any high
long-term risk alcohol use (National Health and Medical Research Council deﬁned). CI: conﬁdence interval.
Table 2 The association between maximum adolescent cannabis use, classiﬁed by subsequent reduction in use, and dependent
cannabis use at 20 years and 24 years in 1520 cohort participants who completed the interview at 24 years, adjusted for background
factors.
Maximum adolescent cannabis use
(waves 1–5), classiﬁed by subsequent
reduction in adolescent use
Dependent cannabis use in young adulthood
20 years (wave 7) 24 years (wave 8)
na = 208 n = 190
n (%b)
Adjusted for
background
factors
+Adolescent
smoking and
alcohol use
n (%b)
Adjusted for
background
factors
+Adolescent
smoking and
alcohol use
n ORc (95%CI) ORd (95%CI) ORc (95% CI) ORd (95% CI)
Non-user 1044 27 (3) 1 1 19 (2) 1 1
Occasional (<weekly)
Occasional–abstinence 217 13 (6) 2.2 (1.1–4.4) 1.4 (0.68–2.9) 24 (11) 6.2 (3.2–12) 3.5 (1.7–7.2)
Occasional persisting 89 14 (15) 5.9 (2.6–13) 3.7 (1.5–9.5) 9 (10) 5.1 (2.0–13) 2.8 (1.0–7.8)
Maximum weekly/daily (weekly+)
Weekly–abstinence 47 7 (16) 6.0 (1.8–20) 3.9 (0.93–16) 10 (21) 12.3 (4.3–35) 6.7 (2.2–20)
Weekly–occasional 81 29 (36) 21 (11–39) 12 (5.6–26) 26 (32) 23 (11.2–47) 11 (5.0–25)
Weekly persisting 42 22 (52) 39 (18–82) 24 (11–53) 15 (35) 26 (10.8–61) 13 (4.9–33)
aFrequencies and percentages were obtained by averaging across the imputed data sets. bPercentages are of exposure category in outcome. cOdds ratios
(ORs) from multivariable logistic regression models adjusted for sex, rural school at study inception, parental education. dORs from multivariable logistic
regression models adjusted for sex, rural school at study inception, parental education and during adolescence: any cigarette smoking and any high
long-term risk alcohol use (National Health and Medical Research Council deﬁned). CI: conﬁdence interval.
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At 20 years, the occasional to abstinence and occa-
sional persisting users both had elevated odds of weekly+
use compared to non-users, with occasional persisting
users at highest risk. The weekly to occasional and weekly
persisting users had markedly elevated odds of this
outcome compared to non-users, with the weekly to
abstinence group similar to the occasional persisting
group. By 24 years the two groups of occasional users
and the weekly to abstinence group had similar, three- to
fourfold elevated odds of weekly+ use, with the weekly to
occasional and weekly persisting groups at highest risk
compared to non-users. The pattern of results for can-
nabis dependence (Table 2) was very similar to that for
weekly+ use.
Forty-eight participants (10% of adolescent cannabis
users) reported seeking treatment for alcohol- and drug-
related problems (not necessarily cannabis use problems)
at 24 years (Table 3). With the exception of the occa-
sional to abstinence users, all other adolescent cannabis
user groups had elevated odds of having sought help.
Help-seeking was most common among the weekly+ user
groups, although there was little differentiation in risk
according to their reduction status.
DISCUSSION
These data show clearly the dynamic nature of adoles-
cent cannabis use patterns, regardless of the initial level
of adolescent cannabis use, with most moderating their
use during adolescence. They also illustrate its pervasive
nature, with half of adolescent non-users and virtually
all adolescent users reporting some use in young adult-
hood. However, consistent with evidence for increased
risk of problematic cannabis use outcomes with regular
adolescent use [4–10], weekly+ adolescent cannabis use
was associated with the greatest odds of regular use and
dependence in young adulthood, regardless of modera-
tion status.
Our ﬁndings on the links between regular adolescent
cannabis use and later regular/dependent use support
the notion that the transition to adolescent weekly use
may act as a critical threshold by providing sufﬁcient
drug exposure to initiate the early stages of cannabis
dependence [10]. Although the precise interplay between
neuroadaptive, social, psychological and environmental
mechanisms related to this process are not well under-
stood, it has been suggested that during puberty the
developing brain may be less sensitive to the aversive
effects of cannabinoids [2]. The fact that half of adoles-
cent non-users reported use in young adulthood is also
consistent with recent data showing an apparent prolon-
gation of risk of initiation to cannabis use beyond adoles-
cence in younger cohorts of users [25].
Nevertheless, there was some gradation of risk among
regular adolescent users. The weekly to abstinence group
had lower odds of regular/dependent cannabis use at
ages 20 and 24 compared to the weekly persisting and
weekly to occasional groups, suggesting that among
regular adolescent users, periods of abstinence rather
than use reduction may be of greater beneﬁt to future use
patterns. Adolescent occasional users had odds of
regular/dependent use in young adulthood intermediate
between adolescent non-users and all categories of
weekly user, with abstinence having little impact on use
outcomes. These data are not directly comparable to the
previously mentioned longitudinal studies of adolescent
cannabis use trajectories that incorporated measures of
use variation [13–16], although we also identiﬁed occa-
Table 3 The association between maximum adolescent cannabis use, classiﬁed by subsequent reduction in use, and service use for
drug and alcohol problems at 24 years in 1520 cohort participants who completed the interview at 24 years, adjusted for background
factors.
Maximum adolescent cannabis use (waves 1–5),
classiﬁed by subsequent reduction in adolescent use.
Service use at 24 years
na = 50
na n (%b) ORc (95% CI)
Non-user 1044 16 (1) 1
Occasional (<weekly)
Abstinence 217 11 (5) 2.4 (0.93–6.2)
Persisting 89 3 (4) 3.3 (1.1–10)
Maximum weekly/daily (weekly+)
Abstinence 47 5 (10) 8.2 (2.9–24)
Occasional 81 10 (12) 8.5 (3.1–23)
Persisting 42 5 (12) 6.7 (1.7–26)
aFrequencies and percentages were obtained by averaging across the imputed data sets. bPercentages are of exposure category in outcome. cOdds ratios
(ORs) from multivariable logistic regression models adjusted for sex, rural school at study inception, parental education. CI: conﬁdence interval.
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sional (light) use as the most common use pattern. Our
ﬁndings of the relative likelihood of cannabis dependence
at 24 years are similar to those of Windle & Weisner [16],
who found those who commenced and persisted with
regular use at greatest risk of this outcome in young
adulthood, and those who commenced at this level but
decreased their use across adolescent waves at an inter-
mediate risk between the most chronic group and experi-
mental users.
Our ﬁndings indicate that efforts focusing upon delay-
ing the uptake of cannabis use may have more impact on
the future use patterns of occasional adolescent cannabis
users than attempts to encourage use reduction. While
regular adolescent users comprise a smaller group, the
well-documented risks posed by this use pattern and the
apparent impact of abstinence in attenuating this risk
suggest that, in addition to preventing or delaying uptake,
further investment in interventions to prevent escalation
in cannabis use and promote abstinence among regular
users are warranted. However, the factors associated with
the uptake and persistence of cannabis (and other sub-
stance) use are complex. Young people who persist in
regular use differ from those that have different use tra-
jectories on a number of socio-demographic and attitudi-
nal factors, some of which are determined early in life
[13–16,26]. While these data provide important infor-
mation on the role of adolescent cannabis use patterns,
they need to be considered in the context of the broader
determinants of substance use, and the variety of ways in
which these need to be addressed.
This is clearly an area worthy of further exploration.
As we deﬁned moderation as the minimum use reported
in adolescent waves of data collection subsequent to the
index level of use, we cannot ascertain the impact of the
reasons for moderation (e.g. formal, intentional versus
unplanned, circumstantial), the duration or number of
adolescent reduction or abstinence periods on later risk
of regular/dependent use. However, reported periods of
moderation were of at least 6 months duration, which is
not inconsequential. While we were unable to account for
complex variations in adolescent cannabis use patterns
due to potential loss of statistical precision, the frequency
of data collection across the adolescent waves ensured
that we had good coverage of cannabis use in this impor-
tant period. The strong relationship of age of initiation
with adolescent use frequency re-afﬁrms the importance
of delaying uptake of cannabis use.
In this population-based sample, treatment seeking
was not examined until age 24 years, at which time only
one in 10 cannabis users had sought assistance for sub-
stance use problems. However, this is consistent with
international data indicating that few cannabis (or other
substance) users seek professional assistance [27,28].
While treatment seeking was associated generally with
maximum adolescent use frequency, probably because of
its association with problematic use in young adulthood
[10], there was little indication that adolescent use mod-
eration had an impact on this behaviour. Other, more
proximal, factors unmeasured in this paper are likely to
be more relevant in the decision to seek help at this later
stage. On a related theme, we also know little about the
relationship between adolescent cannabis use treatment
and long-term outcome and whether the factors that
facilitate or hinder use moderation, or the impact of
reduction and abstinence, in the therapeutic setting,
differ from each other and from that achieved without
professional assistance [29,30]. This remains a subject
for further study. Further, while we focused upon the
central young adult outcomes of regular and dependent
cannabis use, the trajectories literature indicates that per-
sistence, reduction and abstinence may be associated dif-
ferentially with other outcomes such as problematic use
of alcohol and other drugs and psychosocial functioning
[13–16].
Strengths and limitations
The main strengths of this study include the population-
based sample, the high participation rates and the fre-
quent measures of drug use and other indices over a
10-year period. It is possible that non-participation at
waves 7 and 8 was associated with different outcome
patterns than those seen in the participants. By deﬁni-
tion, we can only speculate on such effects, but given the
relatively high cohort retention (78% of adolescent par-
ticipants) we believe that they are unlikely to have
caused major biases in our results. All data were based
on self-report which was not validated externally, but
this has been accepted as an appropriate way in which
to gain information about population behaviours
[31–33].
A potential limitation is that waves 7 and 8 cannabis
dependence may have been under-estimated, as it was
assessed only in participants reporting weekly or more
frequent cannabis use in the previous year. However, it
was ascertained previously through comparison with a
national survey of mental health disorders that this diag-
nosis, reliant upon repeated and recurrent behaviours
and problems, is likely to be infrequent in occasional
users [34].
Implications
These ﬁndings indicate that while many young people
moderate their cannabis use patterns during adoles-
cence, the impact of moderation on later regular/
dependent use may be limited, particularly among
adolescents initially reporting regular cannabis use. This
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suggests that delaying initial uptake and attempts to con-
strain early consumption remain prime strategies for
reducing the risk of this outcome, while abstinence
should be encouraged among more frequent adolescent
cannabis users. Young people need to be given accurate
and appropriate information on the risks associated with
early heavy use, including being made aware that the
risks posed by such use can persist into the mid-20s, even
following attempts at moderation.
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3.7  Transition to dependence 
The proportion in adolescent users of later dependence in young adulthood was not 
reported in any of our papers, but is interesting to consider. In the cohort sub-sample 
with at least one measure in Waves 7 to 9 (N=1748), dependence was identified in 
27% of adolescent users (and the same percent of all users to 29 years, as initiation 
usually occurred in adolescence), 44% of weekly adolescent users and 52% of daily 
adolescent users. The frequency of dependence in all users was considerably higher 
than estimates from other countries, for example, 16% in users aged 15-24 in the 
U.S.A., 14% users in New Zealand, a previous report of 17% in Australia, and 4-5% 
in Germany (Anthony 2006). In the VAHCS, the equivalent rates of later dependence 
in adolescent cigarette smokers were 25% and 38% of any and daily smokers 
respectively. Thus, in VAHCS participants, it seemed that overall risk of later 
dependence for those who initiated cannabis use was similar to that for cigarette 
smoking, but a considerably higher risk was evident for weekly and daily cannabis 
users than for daily cigarette smokers. Again, this , is at odds with published findings 
that the risk of later dependence is lower for cannabis than cigarette smoking in the 
U.S.A (Hall 2010). The high estimates for rates of cannabis dependence observed in 
the VAHCS may be due to augmented case identification using repeated measures of 
dependence, and difficulties comparing prospective data collection with cross-
sectional household surveys necessarily relying on retrospective data collection, such 
as The National Comorbidity Survey in the U.S.A (Degenhardt & Hall 2012). In the 
VAHCS, the relatively high rates of cannabis dependence subsequently diagnosed in 
adolescent users and all that this may imply in terms of disrupted and disruptive 
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lifestyle, illustrate the common trajectory that may follow early experimentation and 
regular use. 
3.8  Summary  
Together, these papers have promoted a detailed understanding of the natural history 
of problematic cannabis use from 14 years through late-adolescence, to the age of 
peak use in the early 20s and finally to the mid-20s. It is noteworthy that escalation 
in use was not inevitable and that we observed an important minority of adolescent 
heavy users, who were no longer on this trajectory by the time they reached 24 years. 
However, although at less at risk of problematic use, occasional adolescent users and 
those who moderated their use were still vulnerable to problematic use in young 
adulthood, with escalation occurring after school age. 
Males were overall more susceptible to cannabis use in adolescence and to escalation 
of use into young adulthood. Clearly, social mores and drug availability played an 
important role in the initiation of cannabis use during adolescence, as we illustrated 
in the first paper in this series, though boys appeared to be more vulnerable to this 
influence. The identification of choice of drug early in the drug using career clarifies 
the general relationship between alcohol and cannabis use, where alcohol appeared to 
potentiate cannabis use, but subsequently became either unimportant or protective in 
the subsequent development of problematic cannabis users. This observation 
corresponds to the findings from the Mid Atlantic Twin Registry, reported by 
Kendler and associates (Kendler et al. 2008), suggesting that drug selection was an 
environmental rather than a genetic phenomenon, whilst continuation may have a 
genetic component. This reinforces the possibility that public education initiatives 
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aimed at reducing alcohol use by young people in isolation may inadvertently 
increase cannabis uptake. It is therefore important that interventions promoting 
responsible alcohol drinking should do this alongside those that promote cannabis 
abstinence, or at least, moderation. 
Escalation of cannabis use from adolescence to young adulthood, resulting in regular 
use as a prelude to dependence, is the fundamentally important finding of the papers 
described in this chapter. There was probably a socially-mediated stimulus to this 
evolution, whereby young people responded to the social mores and drug availability 
of the community in which they matured. However, it could also include a 
toxicological component. Recent research elucidating the central mechanism of 
cannabis intoxication (McLaren et al. 2008), combined with increased understanding 
of neural development in early-adolescence (Wang, Yuan & Li 2011) is starting to 
clarify the impact of chronic cannabis exposure on the developing cannabinoid 
system in the brain of susceptible individuals (Schneider 2008). 
We illustrated the adverse outcomes of continuing problematic and harmful use of 
cannabis in the paper identifying the largely separate trajectories of cannabis and 
alcohol abuse. Daily cannabis use at 24 years was associated with poor educational 
achievement, less likelihood of a stable relationship, early childbirth, cigarette 
smoking and other illicit drug use. Education and substance use sequelae will be 
examined in more detail in subsequent chapters, but it is important to draw attention 
to the overall pattern of reduced life chances that these young people face, in large 
part predicted by their ongoing problematic drug use. It is essential to promote a 
general understanding of the consequences of adolescent cannabis use to inform 
Chapter 3 Natural history of cannabis use 
 
 
94 
 
professional and public debate regarding public health and targeted interventions. 
Cannabis dependence is a debilitating disorder by nature of its definition and is 
worthy of treatment (Hall 2010). It is therefore desirable to have a system in place to 
identify young people at risk, or to enable them to recognise that indeed they are at 
risk, before they reach this stage in their drug-using careers. To date, there is little 
evidence of treatment effectiveness, despite increasing demands for strategies to treat 
cannabis use disorder here and overseas (Copeland & Swift 2009; Hall 2010). 
Providing information on possible outcomes of regular cannabis use, facilitating 
treatment seeking and making viable and evaluated treatment options available 
would seem still to be imperatives. 
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CHAPTER 4 Consequences of adolescent cannabis use: high 
school completion 
4.1 Chapter outline 
This chapter presents a single paper in §4.2 addressing the question of whether 
adolescent cannabis use influences early high school leaving. The background to the 
paper is discussed, followed by a short summary of the methods and findings, 
including a discussion of a meta-analysis on the same topic published by the 
Cannabis Cohort Research Consortium including VAHCS data. Finally, I describe 
where the field stands at the moment. 
4.2 High school completion 
Paper 6. A longitudinal study of the effects of adolescent cannabis use on high school 
completion. Lynskey M,Coffey C, Carlin JB, Patton GC. Addiction. 98 (5): 685-692, 
2003. 
Journal impact factor 4.3 (source: Journal Citation Reports, 4/03/2013) 
96 citations as at 4/03/2013 (source: Google Scholar). 
The paper was written against a background of mounting evidence that early 
cannabis use in school-aged teenagers was associated with poor school performance 
and absenteeism, and, conversely, that those not at school had higher rates of 
cannabis and other substance use, independent of background factors (Lynskey & 
Hall 2000). Much of the evidence was based on cross-sectional observations or 
retrospective recall (eg (Kandel et al. 1986), sufficient to hypothesise that there may 
be a connection, but not enough to determine temporal direction or the extent of 
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confounding by other personal, family or social factors. Cannabis use could be a 
prelude to leaving school, or dropping out of school could lead to cannabis use, or a 
combination of the two, or the association could actually be due to other underlying 
influences. A number of longitudinal studies had already illustrated that cannabis use 
appeared to increase the risk for early school leaving (Lynskey & Hall 2000), 
independent of other factors (Fergusson, Lynskey & Horwood 1996), but the 
mechanism was unknown, that is, whether the intensity of cannabis use was related 
to the likelihood of school dropout. Cannabis use was measured at such a low 
threshold, for example, “use in the past year” (Fergusson, Lynskey & Horwood 
1996), that any association with drug exposure would have been attenuated, with a 
possibility that the effects of higher dose use would be masked, if any existed. We 
were interested to know whether frequent cannabis use in the mid-school period was 
associated with early school leaving, after accounting for possible confounding 
factors and whether the risk changed as the cohort matured through school. 
4.2.1 My contribution 
The lead author of this paper was Professor Michael Lynskey, then at the National 
Drug and Alcohol Centre at the University of New South Wales. I was intrinsically 
involved in conceptualising the question and in operationalising and performing the 
analysis. I was responsible for writing the methods and constructing the tables, 
assisted with writing up the results, contributed to the introduction and discussion 
and with the response to the reviewers’ comments. The declaration of my 
contribution, estimated as 35%, is in Appendix 2. 
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4.2.2 Analysis and results 
We were in a unique position to be able to examine the influence of early regular 
cannabis use on school completion, taking advantage of the substantial numbers with 
higher-level cannabis use. This was measured prospectively during periods of school 
attendance or non-attendance. The study also assessed important potential 
confounders, such as parental education and divorce, rural school location, and other 
behaviour measures. As well as concurrent questions about school attendance as the 
cohort matured, school leaving prior to completing the final assessment in Year 12 
was assessed retrospectively from detailed information obtained when participants 
were 20 years old (Wave 7). We established that, in the VAHCS, regular (weekly or 
more frequent) cannabis use in Year 10 was strongly and independently associated 
with early school leaving, with the influence of regular cannabis use decreasing as 
the cohort aged, until at Year 12 it apparently was not influential. 
4.2.3 Implications 
We suggested that one mechanism for the observed association in the youngest group 
of adolescents may have been the anti-conventional lifestyle adopted by these users 
in defiance of accepted social norms that applied when students were in mid-high 
school. By the end of high school, cannabis use was more common and therefore 
more acceptable and other factors were likely to have become influential in a 
decision to leave school. The influence of parental and societal factors and drug 
availability in drug initiation, rather than genetic liability as reported by Kendler and 
associates (Kendler et al. 2008), supports the mechanism we proposed as these young 
people left school necessarily early in their drug using career. 
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Recent insights into the biological mechanisms of cannabis exposure and adolescent 
brain development may lead to speculation that we were observing, at least partially, 
adverse consequences on developing brain structure (Schneider 2008) and IQ (Meier 
et al. 2012). It is not possible in a population study of this size to untangle drug 
effects from those due to the influence of deviant lifestyle, but it is sensible to be 
alert to the possibility of a biological mechanism early in the drug using history, as a 
mechanism separate from the genetic liability expressed by this exposure. 
In a 2007 systematic review of the relationship between substance use and school 
dropout, the authors identified ten longitudinal studies, other than the VAHCS and 
the Christchurch Study, examining whether cannabis use predicted school dropout 
(Townsend, Flisher & King 2007). These were all conducted in the Unites States, 
with white, Latino and Black African groups identified. Nine of these studies 
reported a predictive association between cannabis use and subsequent dropout, some 
having adjusted for educational and family factors. In only one report (other than 
ours) was an attempt made to classify regular cannabis use by identifying those who 
had used cannabis more than 20 times. Other than these papers, three studies reported 
a “reverse causal pattern”, whereby cannabis use increased (but was not initiated) 
after school dropout, though the evidence was equivocal. Adolescents not attending 
school were reported as having higher rates of cannabis use than school attendees. 
Thus, it appears that the association between cannabis use by adolescents and school 
dropout is well-established at least in both Australasia and the United States. Our 
contribution was to show that this effect weakened as the cohort proceeded through 
high school, as this level of detail was not available to other researchers. 
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The Cannabis Cohort Research Consortium (CCRC), a virtual research group set up 
to pool data from several Australasian cohorts and coordinated through at the 
National Drug and Alcohol Research Centre (University of New South Wales), 
addressed the question of adolescent cannabis use and educational achievement in its 
inaugural publication (Horwood et al. 2010). The consortium was formed primarily 
so that similar data collected with comparable methodology could be combined to 
address questions involving relatively small subgroups, thus resolving the power 
limitations in the individual studies. Data were pooled from three Australasian cohort 
studies, including The Christchurch Health and Development Study, The Mater-
University of Queensland Study of Pregnancy and Outcomes and the VAHCS. Meta-
analytical techniques were used with the resulting data set of 6000 observations. The 
outcomes used in the paper described above were expanded to include university 
enrolment and degree attainment. The exposure was the age at which cannabis use 
commenced, so did not examine regular use in adolescence. In a general sense, it 
confirmed that early cannabis use decreased the risk for school completion after 
adjustment for available confounders, with the underlying assumption that the 
cannabis use culture and the risk processes were similar enough between the regions 
to allow overall generalisation. Only information common to each study could be 
pooled, so we were limited to the assessment of the association between cannabis use 
frequency at 20 years and university degree attainment, finding that they were 
negatively associated. This was hardly surprising, as the effect would at least partly 
be mediated by incomplete schooling in those who started using cannabis early. This 
meta-analysis confirmed our VAHCS findings in the broader Australasian context. 
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4.2.4 Paper 6: A longitudinal study of the effects of adolescent 
cannabis use on high school completion. 
Lynskey M,Coffey C, Carlin JB, Patton GC. Addiction. 98 (5): 685-692, 20 
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ABSTRACT
Objective To examine the extent to which weekly cannabis use during mid-
adolescence may increase the risk of  early school-leaving.
Setting A prospective study of  a general population sample of  adolescents stud-
ied from ages 15–21 years in Melbourne, Australia.
Method Computer-assisted self-completion questionnaires and telephone
interviews conducted in six waves at ages 15–18 and again at age 21 in a sam-
ple of  1601 male and female school students.
Results Weekly cannabis use, assessed prospectively, was associated with sig-
niﬁcantly increased risk of  early school-leaving. This effect remained after
adjustment for a range of  prospectively assessed covariates including demo-
graphic characteristics, other substance use, psychiatric morbidity and antiso-
cial behavior. There was suggestive evidence of  an interaction between weekly
cannabis use and age with the effects of  weekly cannabis use on early school-
leaving being strongest at the youngest ages and diminishing progressively with
age.
Conclusions Early regular cannabis use (weekly use at age 15) is associated
with increased risk of  early school-leaving. These effects of  regular cannabis use
may diminish with increasing age and are likely to operate through the social
context within which cannabis is used and obtained.
KEYWORDS Adolescence, cannabis, education
INTRODUCTION
Cannabis is the most widely used illicit drug among youth
in most western societies (Hall, Johnston & Donnelly
1999; Lynskey et al. 1999; Johnston, O’Malley &
Bachman 2000) and the majority of  youth in many
countries report at least some use of  this drug (Smart &
Ogborne 2000). Although less is known about the health
effects of  cannabis than tobacco and alcohol (Hall, Room
& Bondy 1999) there is growing public concern and
research into the effects of  adolescent cannabis use.
One focus of  this concern has centered on the extent to
which adolescent cannabis use may disrupt or impair
educational performance and attainment (Lynskey & Hall
2000). Increasing levels of  cannabis use have been asso-
ciated with a lower grade point average (Resnick et al.
1997), less satisfaction with school (Brook et al. 1998),
negative attitudes to school (Jones & Heaven 1998) and
poor school performance (Novins & Mitchell 1998).
Other research has shown that rates of  cannabis and
other illicit drug use are higher among young people who
no longer attend school (Swaim et al. 1997) or who are
absent from school on any given day (Fergusson, Lynskey
& Horwood 1995; Lynskey et al. 1999).
While these cross-sectional studies show that can-
nabis use is associated with increased risks of  poor edu-
cational performance, they do not elucidate the causal
mechanisms underlying this association. Several pro-
spective studies have examined the association between
cannabis use and educational attainment and concluded
that adolescent cannabis use may increase risk of  early
school-leaving (Fergusson & Horwood 1997; Fergusson,
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Lynskey & Horwood 1997; Brook, Balka & Whiteman
1999; Ellickson, Collins & Bell 1999). Similarly, longitu-
dinal studies examining the effects of  substance use in
general (including cannabis use) have concluded that
early substance use predicts early school-leaving, failure
to graduate from high school and decreased college par-
ticipation (Ellickson et al. 1999; Newcomb & Bentler
1988; Krohn, Lizotte & Perez 1997; Tanner, Davies &
O’Grady 1999).
Thus, the available evidence suggests that early can-
nabis use places adolescents at increased risk for poor
educational attainment and, in particular, early school-
leaving. However, several issues remain. First, only a rel-
atively small number of  longitudinal studies have been
conducted on this issue.
Secondly, considerable imprecision has existed in the
timing of  the measurement of  cannabis use and educa-
tional outcomes. In particular, the studies of  Fergusson
and colleagues involved intervals between data collec-
tions of  1 (Fergusson et al. 1996) and 2 (Fergusson et al.
1997) years, while the study by Brook et al. (1999)
involved an interval of  5 years. This issue is not solely of
methodological importance, as there are sound reasons
for hypothesizing that the effects of  cannabis use vary
with the age at which cannabis use is initiated. Speciﬁ-
cally, previous research has indicated that earlier initia-
tion of  cannabis and other drug use is associated with
greater risk of  later development of  heavy or dependent
use (Fergusson & Horwood 1997; Grant & Dawson 1997,
1998; Brook et al. 1999); increases the likelihood of  other
illicit drug use (Brook et al. 1999; Kandel, Yamaguchi &
Chen 1992); engaging in risky sexual behaviour
(Newcomb & Bentler 1988; Brook et al. 1999); and
becoming involved in criminal activity (Brook et al.
1999). These associations have persisted after controlling
for a number of  confounding factors, including socio-eco-
nomic background, parental alcohol use and misuse and
early childhood behaviour (Fergusson, Lynskey & Hor-
wood 1994; Pederson & Skrondal 1998).
Thirdly, the way in which cannabis use has been
quantiﬁed varies from life-time use (Fergusson et al.
1996), heavy use (deﬁned as 10 or more occasions in the
past year) (Fergusson & Horwood 1997) and monthly use
(Brook et al. 1999). Notably, in all studies the level of  can-
nabis use associated with early school-leaving is so low
that observed effects are unlikely to be due either to can-
nabis’ contribution to cognitive impairments or motiva-
tional effects, two hypotheses that have dominated the
literature on the potential effects of  cannabis use, albeit
with only limited empirical support (Hall, Degenhardt &
Lynskey 2001). Given such low levels of  cannabis use, the
effects observed in these studies may well be due either to
pre-existing characteristics of  those who use cannabis, or
to the social context within which cannabis is used
(Fergusson & Horwood 1997). In evaluating the effects of
cannabis use on educational attainment, a more perti-
nent issue concerns whether prolonged or regular, heavy
cannabis use inﬂuences risks of  early school-leaving. Spe-
ciﬁcally, given the known acute effects of  cannabis use
which include impaired reaction time, impaired short-
term memory and loosening of  associations (Hall et al.
2001), it is reasonable to hypothesize that regular, heavy
cannabis use may impair educational attainment.
Against this background, the aims of  this study were
to use prospective data collected at 6-monthly intervals to
examine the extent to which regular cannabis use during
adolescence may be associated with increased risks of
early school-leaving after a range of  potentially con-
founding covariates have been taken into account. This
work builds on and extends the existing literature by:
1 Assessing both cannabis use and school participation
at yearly intervals.
2 Assessing people during the period (15–18 years) of
maximum risk for both heavy cannabis use and early
school-leaving.
3 Focusing on the effects of  weekly cannabis use rather
than life-time or less regular levels of  cannabis use.
4 Examining potential age differences in the inﬂuence of
regular cannabis use on educational participation.
METHOD
Data were collected during a seven-wave cohort study of
adolescent health in Victoria, Australia. There were six
adolescent waves of  data collection between August
1992 and July 1995 and a further collection in late
1998, when the cohort was 3 years older than the usual
school-leaving age. The cohort was deﬁned using a two-
stage sampling procedure. At stage 1, 45 schools were
selected from a stratiﬁed frame of  government, catholic
and independent schools (total number of  students
60 905). One school from the initial cross-sectional sur-
vey was unavailable for the cohort study, leaving a total of
44 schools. At the second stage, a single intact class was
randomly selected from each school and these students
were measured in wave 1 (mean age 14.9 years (SD
0.46), 48% male). At the second wave of  data collection,
6 months later, when the cohort had moved into year 10
(mean age 15.4 years (SD 0.44)), a second intact class
from the same grade at each participating school was
selected at random (Fig. 1). The entire sample was
followed-up to completion of  the study, when their mean
age was 20.7 years (SD 0.47).
Subjects  completed  a  questionnaire  at  intervals  of
6 months between school year levels 9 and 12 (six
waves). These surveys were computer-based and self-
administered at school, and allowed the collection of
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detailed self-report data through branched question-
naires. Subjects who were unavailable for follow-up at
school were interviewed by telephone. The young adult
survey was administered by telephone using computer-
assisted interviews between April and December 1998.
This report includes data collected in the adolescent
waves 2, 4 and 6 and the 1998 young adult survey.
Sample description and loss to follow-up
A total of  1601 young adults (79% of  the total sample,
82% of  all participants) were interviewed in wave 7.
Three hundred and forty-six earlier participants (18%)
were not interviewed at wave 7. Reasons for non-
participation at this wave were refusal (n = 152); located
but not contacted (n = 59); lost to follow-up (n = 133);
and death from natural causes (n = 2). Only 1535 of  the
possible 1601 interviewed in wave 7 were included in the
analysis, as 66 who were surveyed at wave 7 did not have
observations in waves 2, 4 or 6.
We used multiple logistic regression to characterize
participants lost to follow-up. These individuals were
more likely: (a) to be male [OR 1.8, 95% conﬁdence inter-
val (CI) 1.3–2.4]; (b) to have experienced parental divorce
or separation (OR 1.5, CI 1.1–2.2); and (c) to have par-
ents who did not complete secondary education (versus
complete secondary schooling/technical qualiﬁcation OR
1.4, CI 1.1–1.9). Attending a rural school, any cigarette
smoking and using cannabis at least occasionally at
study inception were not associated independently with
exclusion from analysis.
Measures
Weekly cannabis use
At all waves, participants reported their cannabis use
during the past 6 months using the following rating
scale: (1) never used, (2) not used in the past 6 months,
(3) a few times, (4) monthly, (5) weekly or (6) daily. For
the purposes of  these analyses, individuals reporting
weekly or daily cannabis use were classiﬁed as at least
weekly cannabis users.
Early school-leaving
Secondary school in Victoria commences in year 7 when
students are aged 11–12 years. The ﬁnal year of  school is
year 12 and the Victorian Certiﬁcate of  Education,
awarded on successful completion of  year 12, is the only
school-based qualiﬁcation available. It is the policy of  the
Victorian government that all students complete year 12
but it is only compulsory for young people to attend
school until age 15 years, with the expectation that all
students complete year 10.
In the 7th wave of  the study all participants were
asked to name the last year of  secondary school in which
they had participated (with year 12 being the ﬁnal and
therefore highest year of  secondary schooling). Individu-
als nominating years 10 and 11 and no further educa-
tion afterwards were deemed to have left school during or
at the end of  that year.
In the ﬁnal year of  schooling (year 12) all students
who complete successfully at least four subjects are
awarded a Victorian Certiﬁcate of  Education (VCE). Each
student also receives a Tertiary Education Rank (TER), an
aggregated score giving each student’s percentile rank in
that year’s State-wide VCE class. Participants were asked
to report their TER score and any progression to
postschool study (technical, vocational or tertiary). Indi-
viduals who did not provide a TER score and who did not
continue with their education in any capacity were
deemed to have not completed year 12. Of  the 1601 wave
7 cohort participants, 49 reported year 10 as their last
year, 57 reported year 11 and 68 were deemed to have
incomplete year 12 (Fig. 1).
Figure 1 Participation rates of 2032 secondary school students followed into young adulthood in the adolescent health cohort study in
Victoria, Australia, showing the subpopulation included in the analysis of early school-leaving
Intended 1st sample 2nd sample Total intended sample = 2032 Measures:
sample 1037 995 Total achieved sample (interviewed at least once) = 1947 (96%) incomplete education
Total sample included in the current analysis = 1565 social transition
Cohort Wave 1 Wave 2 Wave 3 Wave 4 Wave 5 Wave 6 Wave 7
Follow-up 1992 1993 1993 1994 1994 1995 1998
Late Early Late Early Late Early  3 yrs
Year 9 Year 10 Year 10 Year 11 Year 11 Year 12 Post-school
n1= 898 n2 = 1728 n3 = 1699 4 = 1629 n5 = 1576 n n6 = 1530 7 = 1601
Current Stayed = 1340 Stayed = 1336 Complete year 12 = 1251
analysis Left during 1993 = 43 Left during 1994 = 47 Incomplete year 12 = 60
n
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Covariates
Demographic variables
These included: (a) place of  birth; (b) location of  school
(metropolitan or rural); (c) parental separation or
divorce; and (d) parental education, classiﬁed on four lev-
els: incomplete secondary (reference category); complete
secondary and/or technical qualiﬁcation; tertiary quali-
ﬁcation; not known by participant.
Cigarette smoking
At each wave, participants who reported having smoked
any cigarettes in the past week were asked to complete a
1-week retrospective diary recording the days and quan-
tity smoked. Those reporting that they had smoked on at
least 6 days in the previous week were categorized as daily
smokers.
Alcohol consumption
At each wave participants reporting that they had drunk
alcohol in the week before the survey were asked to com-
plete a 1-week retrospective alcohol diary. Two indicators
of  alcohol consumption were derived from the diary:
1 Frequent drinking. Those who reported drinking on
three or more days in the previous week were classiﬁed
as frequent drinkers.
2 Heavy drinking. The average number of  units of  alcohol
consumed per drinking day was calculated (one unit
equivalent to one standard drink, 9 g ethanol). Sub-
jects with an average consumption of  5 units or greater
were classiﬁed as high-dose drinkers.
Antisocial behavior
Antisocial behaviors in the previous 6 months were
assessed using 10 items from the Mofﬁtt & Silva (Mofﬁtt &
Silva 1988) self-report early delinquency scale. Items
included property damage (vandalism, car damage, mak-
ing grafﬁti), interpersonal conﬂict (ﬁghting, carrying
weapons, running away from home, expulsion from
school) and theft (stealing property from parents, or other,
stealing cars). Items concerning alcohol or other sub-
stance use were not included. Antisocial behaviors were
categorized according to whether more than one behavior
was endorsed ‘more than once’ in order to distinguish par-
ticipants with more global antisocial behaviors.
Psychiatric morbidity
Psychiatric morbidity was assessed using a computerized
form of  the Clinical Interview Schedule (CIS-R; Lewis &
Williams 1989; Lewis et al. 1992), a structured psychiat-
ric interview designed for assessing symptoms of  general
psychiatric morbidity in non-clinical populations. It
includes indicators of  depression and anxiety and gener-
ates 14 subscales that can be added to form a scale indi-
cating the degree of  psychiatric morbidity. High
psychiatric morbidity was deﬁned as scoring above 11.
This has been shown previously to correspond to a level
at which a general practitioner might be concerned about
a subject’s mental health (Lewis & Williams 1989; Lewis
et al. 1992).
Data analysis
Data analysis was carried out using Stata (Stata 1999).
Data were arranged into a long form allowing multiple
lines of  data for each individual, one for each year of
observation in which they were ‘at risk’ of  school-leaving
and had a complete set of  covariates. In order to choose
the most proximal observations to predict school drop-
out, we combined wave 7 data specifying school reten-
tion/leaving and socio-demographic outcomes with
relevant earlier waves of  data collection: waves 2 (early
year 10), 4 (early year 11) and 6 (early year 12). Logistic
regression was used to identify predictors of  early school-
leaving using robust standard errors to allow for cluster-
ing and the lack of  independence between successive year
outcomes in the same individual (Carlin et al. 1999).
Thus a model was ﬁtted to the data so that the odds of
leaving school during each school year (10, 11, 12) were
modeled as a function of  cannabis use measured in the
corresponding wave (2, 4, 6) conducted earlier that year
and a range of  prospectively assessed risk factors. Inter-
actions were assessed using Wald tests.
Associations between early school-leaving and social
outcome measures were assessed using logistic regres-
sion adjusted for age and sex. Odds ratios and percentages
are presented with 95% conﬁdence intervals.
RESULTS
Weekly cannabis use and early school-leaving
Overall, young people were more likely to leave school
early if  they attended a rural school (37% non-completers
versus 25% completers, P = 0.002), their parents were
divorced or separated (27% versus 18%, P = 0.014) and
their parents had not completed secondary school (59%
versus 33%, P < 0.001). There was no difference in the
gender ratio between early school-leavers and school
completers. School-leavers in year 10 were older on aver-
age than school completers at wave 2 (15.7 years versus
15.4 years, P < 0.001), school leavers in year 11 were
Cannabis use and high school completion 689
© 2003 Society for the Study of  Addiction to Alcohol and Other Drugs Addiction, 98, 685–692
possibly slightly older at wave 4 (16.5 years versus
16.3 years, P = 0.09) but school-leavers in year 12 were
the same average age as school completers at wave 6
(both 17.4 years, P = 0.53).
Young people who used cannabis weekly were more
likely to leave school than their peers: in years 10 and 11
rates of  school-leaving were 2–5 times higher among
weekly cannabis users than among other cohort mem-
bers (Table 1). Interestingly, the association between
weekly cannabis use and early school-leaving appeared
strongest at younger ages and diminished progressively
with increasing age: in year 10 weekly cannabis users
were 5.8 times more likely to leave school, in year 11 they
were 3.2 times more likely to leave school and by year 12
they were 2.0 times more likely to leave school.
While these results suggest an association between
weekly cannabis use and early school-leaving, this asso-
ciation may not have been causal but may have arisen
from the effects of  confounding factors that were associ-
ated with increased risks of  both weekly cannabis use and
of  early school-leaving. We ﬁrst assessed the univariate
association between early school-leaving and a range of
prospectively measured covariates, both time-varying
and ﬁxed. In order to assess the independent predictive
effect of  cannabis use we examined this in a multivariate
model including these possible confounders. Given the
apparent decreasing effects of  weekly cannabis use on
risks of  early school-leaving with school year of  observa-
tion, discussed above, the interaction between weekly
cannabis use and school year was assessed. There was
evidence supporting this interaction in the multivariate
model (c2(2) = 6.0, P = 0.049).
The results of  these analyses are summarized in
Table 2 and indicate that, even after controlling for anti-
social behavior, psychiatric morbidity, other substance
use, parental education and socio-demographic charac-
teristics, young people who reported cannabis use were at
increased risks of  early school-leaving. Weekly cannabis
use in year 10 was independently associated with a 5.6-
fold increase in the odds of  early school-leaving while by
year 12 there was no evidence of  an association [odds
ratio (OR) 1.1].
DISCUSSION
This study indicates that regular cannabis use is associ-
ated with an increased risk of  early school-leaving. Fur-
thermore, after adjustment for a wide range of  assessed
prospectively covariates, young people who used can-
nabis remained at signiﬁcantly elevated risks of  early
school-leaving. The association between cannabis use
Table 1 Weekly cannabis use and risks of early school-leaving by
school year.
School year
Weekly
cannabis use n
Early school-leaving
% 95% CI
Year 10 Yes 46 15 6–29
No 1396 3 2–4
Year 11 Yes 77 9 4–18
No 1306 3 2–4
Year12 Yes 66 8 3–17
No 1245 4 3–6
Explanatory factor
Univariate Multivariate 
OR 95% CI OR 95% CI
Weekly cannabis use by school year of survey
Weekly cannabis use in year 10 6.8 2.8–16 5.6 2.0–15
Weekly cannabis use in year 11 3.2 1.4–7.3 2.2 0.91–6.0
Weekly cannabis use in year 12 1.8 0.69–4.6 1.1 0.40–2.90
Female 0.86 0.62–1.2 0.80 0.56–1.1
Metropolitan area 0.58 0.41–0.81 0.62 0.43–0.87
Parental divorce or separation 1.9 1.3–2.7 1.5 1.0–2.2
Highest parental education
Incomplete secondary schooling 1 1
Secondary school/technical certiﬁcate 0.45 0.31–0.66 0.43 0.29–0.63
Tertiary 0.21 0.13–0.35 0.22 0.13–0.35
Not known 2.9 1.0–8.4 2. 5 0.93–6.9
Alcohol three or more times in week before survey 1.9 1.0–3.7 1.3 0.59–2.9
Average 5+ units per drinking day 1.7 1.1–2.5 1.0 0.63–1.6
Daily smoking in week before survey 3.2 2.2–4.6 2.5 1.6–3.8
Antisocial behavior 1.3 0.69–2.5 0.88 0.42–1.8
Psychiatric morbidity 0.80 0.52–1.2 0.63 0.39–1.0
Table 2 Univariate and multivariate pre-
dictive associations between weekly can-
nabis use, other explanatory factors and
early school-leaving based on 4136 possible
transitions to early school-leaving.
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and early school-leaving appeared to vary by age, with
cannabis use at younger age being associated more
strongly with risk of  early school-leaving. These results
conﬁrm the results of  a number of  previous studies
(Newcomb & Bentler 1988; Fergusson et al. 1996;
Fergusson & Horwood 1997; Brook et al. 1999; Tanner
et al. 1999) and lead to the tentative conclusion that early
cannabis use may inﬂuence risks of  reduced educational
attainment. There are a number of  potential reasons why
this association remained, as follows.
Uncontrolled confounding
One possibility is that the observed association between
cannabis use and later educational attainment is non-
causal but arises from the effects of  confounding factors
that were not included in the analysis. It is possible to
hypothesize a number of  factors not included in these or
previous analyses, such as neighbourhood (Ensminger,
Lamkin & Jacobson 1996) and genetic effects (Plomin &
Craig 1997), which may, potentially, explain the relation-
ship. Additionally, it may be that the process of  disengage-
ment from education preceded, and may even have
encouraged, the onset of  weekly cannabis use. Nonethe-
less, the prospective design and the large number of  the-
oretically relevant covariates that were available in the
current study and the convergence between these and
previous results provide reassurance that the association
is not spurious.
An amotivational syndrome
It has been proposed that chronic cannabis use leads to
an amotivational syndrome (McGlothlin & West 1968;
Smith 1968; Kolansky & Moore 1971; Tennant &
Groesbeck 1972; Millman & Sbriglio 1982; Brill & Nahas
1984), but this has not been supported by ﬁeld studies
conducted in societies where heavy cannabis use is wide-
spread (Carter, Coggins & Doughty 1980; Rubin &
Comitas 1975) or by laboratory studies (Mendelson,
Rossi & Meyer 1974; Edwards 1976). Furthermore this
syndrome, if  it exists, is extremely rare (Halikas et al.
1982) and has been reported only in those with a chronic
history of  prolonged, heavy cannabis use. As the partici-
pants in the current study were not old enough to have
developed such a history of  use, it is highly improbable
that the observed association between cannabis use and
early school-leaving could be attributed to such a
syndrome.
Cognitive impairments
A second possible explanation is that cannabis use
causes cognitive impairments, which in turn impair
school performance and increase the likelihood of  leav-
ing school early. However, in a review of  this issue,
Solowij (1999) concluded that, although long-term can-
nabis use produced subtle and selective impairment of
cognitive functioning, such use did not produce gross
cognitive deﬁcits.
Precocious transitions into adult roles
Another hypothesis is that early cannabis use is associ-
ated with the precocious transition to adult roles, includ-
ing early school-leaving. Fergusson & Horwood (1997)
have argued that much of  the apparent inﬂuence of  early
cannabis use on subsequent outcomes can be attributed
to the social setting in which adolescent cannabis use
occurs typically, namely, within a group of  delinquent
and substance using peers.
This hypothesis may also help to explain why alcohol
use was not independently associated with increased
risks of  early school-leaving after adjustment for the
effects of  background family, social and individual fac-
tors. Speciﬁcally, alcohol use is legal, more socially
approved and also more prevalent within Australian soci-
ety and it may be that alcohol use among adolescents is
not associated with the adoption of  anticonventional
norms and attitudes. This result is consistent with ﬁnd-
ings that a strong relationship between alcohol use and
academic problems in college could be explained largely
by deviance, other drug use and background variables
(Wood et al. 1997).
We found that the association between weekly can-
nabis use and school-leaving diminished with age, with
no evidence of  an effect of  weekly cannabis use upon edu-
cational attainment once participants had reached the
ﬁnal year of  high school. This ﬁnding is consistent with
previous literature indicating that it is early onset sub-
stance use that is associated with a range of  other prob-
lems such as later problematic substance use (Fergusson
& Horwood 1997; Grant & Dawson 1997, 1998; Brook
et al. 1999), risky sexual behaviour (Brook et al. 1999;
Newcomb & Bentler 1988) and criminal activity (Brook
et al. 1999) and research indicating that the effects of
cannabis use diminish with age (Fergusson, Horwood &
Swain-Campbell 2002; Solowij & Grenyer 2002). It also
lends support to the hypothesis that the mechanism
through which early cannabis use acts to disrupt educa-
tion is through both the social context of  cannabis use,
and the precocious adoption of  adult roles. Previous
research has suggested that when there is a high preva-
lence of  cannabis use and it can be considered normative,
it is no longer associated with factors such as psycholog-
ical distress (Shedler & Block 1990). The present study
suggests that as cannabis use becomes more prevalent
with increasing age, it is also no longer associated with
Cannabis use and high school completion 691
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outcomes suggesting the adoption of  an anticonventional
life-style such as leaving school early.
Potential limitations
Several potential limitations of  the current study need to
be acknowledged. First, all data were based on self-report
and there was no external validation of  these self-report
measures. Nonetheless, given that leaving school is a
‘milestone’ event that can be recalled easily and about
which there appears to be little motivation to deny, we are
conﬁdent that our self-report measures of  outcome are
both reliable and valid. Similarly, there is a considerable
research literature indicating that individuals’ self-
reports of  substance use are both reliable and valid. Our
strategy of  assessing cannabis use only at each second
wave may have obscured some transitions to and from
weekly cannabis use. Nonetheless, levels of  cannabis and
other drug use are often stable and it could be argued
that, if  anything, our strategy may have diminished the
observed associations between cannabis use and early
school-leaving. In addition, as it might be expected that
both early school-leaving and weekly cannabis use would
be higher among those lost to follow-up, our assessment
of  early school-leaving in wave 7 may have acted to reduce
the observed association between cannabis use and later
school-leaving. Similarly, our selection of  a relatively
crude—yet highly important—outcome may potentially
have obscured more subtle effects of  cannabis use on edu-
cational performance. Given these potential limitations,
our ﬁnding of  a signiﬁcant association between cannabis
use and early school-leaving is, if  anything, even more
striking.
SUMMARY AND CONCLUSIONS
Regular early cannabis use (at 15 years) was associated
with increased rates of  early school-leaving, even after
accounting for a range of  factors that might have
explained the relationship such as family background,
mental health and other substance use. The most plausi-
ble hypothesis to account for this ﬁnding is that early can-
nabis use is associated with the adoption of  an
anticonventional life-style, of  which early school-leaving
is one indicator. Given the enduring consequences of  an
arrested education, strategies and interventions need to
be developed to prolong cannabis users’ engagement
with the education system.
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CHAPTER 5 Consequences of adolescent cannabis use: 
other substance use 
5.1 Chapter outline 
In this chapter, §5.2 presents an introduction to five papers focusing on substance use 
outcomes associated with adolescent cannabis. §5.3 describes an paper examining 
the possibility that cannabis use by non-smokers increased the risk of subsequent 
cigarette smoking uptake and nicotine dependence measured at 24 years. The focus 
of §5.4 is a discussion of our paper addressing outcomes for both occasional and 
regular adolescent cannabis users with respect to psychosocial, mental health and 
substance use outcomes at the same age. This paper forms a corollary to the final 
paper discussed in Chapter 3, Paper 5: (Swift et al. 2009), which examined cannabis 
use outcomes in young adulthood associated with moderation of cannabis use in 
adolescence. A recently published paper is presented in §5.5 in which risks 
associated with cannabis use for both problematic licit and other illicit substance use 
in young adulthood at 29 years are assessed. In §5.6, a paper examining the 
predictors and consequences of adolescent amphetamine use is discussed. The 
dominant role of cannabis use in the prediction of amphetamine initiation in 
adolescence illustrates the importance of this in relation to illicit substance use in 
general. Finally, these papers are summarised in §5.7. 
5.2 Introduction 
The tendency for cannabis users to also use other substances has long been a 
concern. It was important to assess the extent to which this occurred in cannabis 
users in the VAHCS, by looking at alcohol and cigarette use on the one hand and 
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other illicit substances on the other. We were in a good position to examine the 
interplay between cannabis use and other substance use as young people progressed 
through adolescence to young adulthood. We measured both licit substance use and 
amphetamine use throughout the cohort study, augmented by assessment of cocaine 
and ecstasy use in the young adult phase. We also enquired about other illicit 
substances, for example, narcotic and sedative use, but we found that these were too 
rare to permit sensible estimation. 
An paper discussed earlier in this thesis presented a brief summary of adverse 
outcomes of problematic cannabis and alcohol use (Paper 3 in Chapter 3: (Patton, 
GC et al. 2007), foreshadowing a more detailed examination of some of the 
consequences in the papers included in this chapter, including psychosocial outcomes 
such as educational attainment, welfare dependence, anxiety and depression and 
personality disorder. These were the focus of attention as they are intrinsically 
associated with substance use in general. 
As had become usual practice in this series of analyses focusing on cannabis, we 
used multiple imputation to correct for possible bias arising from missing waves of 
observation. I prepared each dataset for imputation and with imputation then 
conducted by a statistician, under the supervision of Professor John Carlin.  
5.3 Cannabis use and smoking initiation 
Paper 7. Reverse Gateways? Frequent cannabis use as a predictor of tobacco 
initiation and nicotine dependence. Patton G.C., Coffey C. Carlin J.B., Sawyer S., 
Lynskey M. Addiction, 100; 1518-25, 2005 
Journal impact factor 4.3 (source: Journal Citation Reports, 4/03/2013) 
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116 citations, as 4/03/2013 (source: Google Scholar). 
The association between cigarette smoking and cannabis use is well documented and 
we demonstrated this in the papers discussed in Chapter 4. Kandel’s Gateway Theory 
hypothesises that adolescents move progressively through use of the licit substances, 
alcohol and tobacco, to cannabis and then on to other illicit substances (Kandel 1975; 
Kandel et al. 1986), but does not consider possible reciprocal influences. Cigarette 
smoking constitutes the highest risk for preventable death in high income countries 
(WHO 2004) and there are plausible biological pathways by which cannabis smoking 
may increase the risk for lung cancer, although this has still not been definitively 
demonstrated (Tashkin 2010). We therefore considered it important to understand the 
impact of cannabis use on cigarette smoking from the perspective of the acquired 
burden of disease, a question that, to our knowledge, had not been previously 
addressed in quantitative studies. 
We examined the risk associated with adolescent cannabis use for later nicotine 
dependence in young adulthood. This could possibly indicate individual addiction 
vulnerability as a consequence of exposure to cannabis during pubertal development 
(Schneider 2008), or perhaps be due to the social milieu in which participants 
matured. We also assessed the reciprocal hypotheses: that adolescent cannabis use 
increased the likelihood of subsequent cigarette smoking initiation and that young 
adult cannabis use was associated with tobacco quitting. 
5.3.1 My contribution 
This paper was led by Professor George Patton. I assisted with the conceptualisation 
of the research question, with the analysis, with the paper preparation and finally 
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with the response to the reviewers’ comments. The declaration of my contribution, 
estimated as 30%, is in Appendix 2. 
5.3.2 Analysis and results 
The paper reports on data from Wave 1 to Wave 8, at 24 years. We used summary 
measures of cannabis use and cigarette smoking in the adolescent phase as the 
exposures of interest, along with other possible adolescent confounders or mediators. 
Our major findings were firstly, that regular (weekly+) cannabis use in non-smoking 
adolescents placed them at substantially elevated risk of subsequent smoking 
initiation in young adulthood, showing that the first stage of the Gateway Theory, 
licit substance use to cannabis use, could be reciprocal. Secondly, non-dependent 
smokers at 20 years (Wave 7) were more likely to progress to nicotine dependence at 
24 years (Wave 8) if they were daily cannabis users. Comparison with the transition 
to alcohol dependence in non-alcohol dependent cannabis users showed a similar but 
weaker effect. There was no evidence of cigarette quitting subsequent to cannabis 
use at 20 years. 
5.3.3 Implications 
A major complexity in interpreting these findings is that, in Australia, cannabis is 
usually smoked (AIHW 2010) and that when smoked it is generally mixed with 
tobacco (mulled), thus priming non-smokers with exposure to tobacco. This may not 
account for the uptake of cigarette smoking which is possibly more likely to be due 
to a variety of triggers such as cigarette smoking by cannabis using peers, diminished 
motivation to resist limiting smoking frequency and biological mechanisms related to 
addiction or addiction proneness (Bava & Tapert 2010). It is possible that the effect 
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of exogenous cannabis on the endocannibinoid system may interact with 
dopaminergic pathways implicated in substance dependence (Schneider 2008), thus 
constituting biological mediation, a process suggested in the context of other illicit 
drugs, but which may also apply to nicotine. Despite equivocal evidence of 
respiratory health consequent to cannabis use, both contemporary with paper 
preparation and since, cannabis use by adolescents at the start of their substance 
using career would seem to be an important mediator of later cigarette use, nicotine 
dependence and, to a lesser extent, alcohol dependence. Thus, there appear to be 
important health sequalae involving licit substance use beyond those directly 
attributable to cannabis, at least in Australia and possibly globally. 
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5.3.4 Paper 7: Reverse Gateways? Frequent cannabis use as a 
predictor of tobacco initiation and nicotine dependence. 
Patton G.C., Coffey C. Carlin J.B., Sawyer S., Lynskey M. Addiction, 100; 1518-25, 
2005 
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ABSTRACT
 
Aims
 
To examine the risk posed by cannabis use in young people for tobacco
use disorders. Speciﬁcally we examined whether cannabis use in non-smokers
predicted later initiation of  tobacco use and whether cannabis use predicted
later nicotine dependence in tobacco users.
 
Design
 
A 10-year eight-wave cohort study.
 
Setting
 
State of  Victoria, Australia.
 
Participants
 
A community sample of  1943 participants initially aged 14–15
years.
 
Measurements
 
Self-report of  tobacco and cannabis use was assessed in the
teens using a computerized interview assessment and in young adulthood with
a CATI assessment. The Fagerström Test for Nicotine Dependence was used to
deﬁne nicotine dependence.
 
Findings
 
For teen non-smokers, at least one report of  weekly cannabis use in
the teens predicted a more than eightfold increase in the odds of  later initiation
of  tobacco use (OR 8.3; 95% CI 1.9–36). For 21-year-old smokers, not yet
nicotine-dependent, daily cannabis use raised the odds of  nicotine dependence
at the age of  24 years more than threefold (OR 3.6, 1.2, 10) after controlling
for possible confounders, including level of  tobacco use and subsyndromal signs
of  nicotine dependence.
 
Conclusions
 
Weekly or more cannabis use during the teens and young adult-
hood is associated with an increased risk of  late initiation of  tobacco use and
progression to nicotine dependence. If  this effect is causal, it may be that a
heightened risk of  nicotine dependence is the most important health conse-
quence of  early frequent cannabis use.
 
KEYWORDS
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disorder.
 
INTRODUCTION
 
Smoking remains the leading preventable cause of  death
in Australia, the United Kingdom, the United States and
other western countries with a rising tide of  tobacco-
related mortality in the developing world (World Health
Organisation 1996; Mokdad 
 
et al
 
. 2004). Despite recent
falls in adult smoking in some developed countries, smok-
ing rates in adolescence and young adulthood have not
yet fallen substantially. Around a quarter to a third of
those who have ever smoked develop an entrenched
pattern of  nicotine dependence, a proportion which may
have increased in recent birth cohorts (Anthony 
 
et al.
 
1998; Breslau 
 
et al.
 
 1993). The incidence of  nicotine
dependence rises sharply in the mid-20s, probably
because progression to more regular daily smoking is
uncommon after the age of  25 years (Breslau 
 
et al
 
. 2001).
The Gateway Theory proposed a strong sequence in
the initiation and progression of  substance use with can-
nabis typically following tobacco and alcohol use and
regular cannabis use in turn preceding the use of  other
illicit drugs (Kandel 
 
et al.
 
 1992; Piomelli 2003). This is a
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common explanation for how cannabis users also come
to be tobacco users (Rigotti 
 
et al.
 
 2000). Longitudinal
studies in US teenagers in the 1970s and 1980s indeed
found that tobacco use preceded and predicted subse-
quent cannabis use. Various explanations for the gateway
sequence in drug use have been proposed (MacCoun
1998; Hall & Lynskey 2005). Much interest has been in
the possible causal role of  earlier substance use where the
pharmacological effects of  one substance may render an
individual more vulnerable to experimentation or addic-
tion to other substances. Alternatively, exposure to social
and peer settings, where other drugs are more readily
available, may explain the progression. Lastly, the person-
ality or other individual characteristics of  early tobacco
users may in turn predispose to experimentation and use
of  other substances as opportunities arise.
There is therefore a possibility that patterns of  pro-
gression might change over time with changing avail-
ability and social disapproval of  different kinds of
substance use (Donovan & Jessor 1983; Robins 1995).
Indeed, much has changed in cannabis use in the past
20 years. A majority of  young people in the developed
world have experimented with cannabis and the propor-
tion of  daily users has approached one in 10 in some com-
munity studies (Gledhill-Hoyt 
 
et al
 
. 2000; Coffey 
 
et al
 
.
2002; Johnson 
 
et al.
 
 2003). Over the same time social
sanctions against tobacco use have progressed, with less
favourable attitudes to adolescents smoking cigarettes.
In this changing context of  earlier and more frequent
cannabis use and declines in tobacco use, it is timely to
consider the possibility of  a more reciprocal relationship
between tobacco and cannabis use. In adults, cannabis
use as little as monthly has been shown to predict con-
tinuing tobacco use (Ford 
 
et al.
 
 2002)
 
.
 
 In a qualitative
study of  teen smokers in Scotland, tobacco smoking was
reported as a consequence of  cannabis use, with contin-
ued cannabis use described as a barrier to quitting
tobacco smoking (Amos 
 
et al
 
. 2004). However, the extent
to which cannabis use might now pose a risk for tobacco
use and nicotine dependence has not been widely consid-
ered (Humﬂeet & Haas 2004). The Gateway Theory
focused primarily on stages of  initiation and early use,
with little attention to reciprocal inﬂuences or, more
importantly, to escalation in use (Kandel & Faust 1975).
The present paper draws on data from a study of  2000
participants studied on eight occasions from the age of
14–24 years. It addresses the following questions about
the relationship of  cannabis to tobacco use:
 
1
 
Does cannabis use in the teen and young adult years
predict later nicotine dependence?
 
2
 
Does cannabis use in the teen years predict the later
initiation of  tobacco smoking in young adulthood?
 
3
 
Does young adult cannabis use affect the likelihood of
cessation of  tobacco use?
 
METHOD
 
Sample
 
Between August 1992 and March 2003 we conducted an
eight-wave cohort study of  adolescent and young adult
health in the state of  Victoria, Australia. Data collection
protocols were approved by The Royal Children’s Hospi-
tal’s Ethics in Human Research Committee. The cohort
was deﬁned in a two-stage cluster sample in which we
selected two classes at random from each of  44 schools
drawn from a stratiﬁed frame of  government, Catholic and
independent schools (total number of  students 60 905).
School retention rates in Victoria to year 9 (i.e. the per-
centage of  adolescents enrolled in school) in the year of
sampling were 98%. One class from each school entered
the cohort in the latter part of  the ninth school year (wave
1) with the second class 6 months later, early in the 10th
school year (wave 2). Participants were subsequently
reviewed at a further four 6-month intervals during the
teens (waves 3–6) with two follow-up waves in young
adulthood aged 20–21 years (wave 7) and 24–25 years
(wave 8). In waves 1–6, participants self-administered the
questionnaire on laptop computers (Paperny 
 
et al.
 
 1990)
with telephone follow-up of  those absent from school. The
seventh and eighth waves of  data collection were under-
taken with computer assisted telephone interviews.
From a total sample of  2032 students, 1943 (95.6%)
participated at least once during the ﬁrst six (adolescent)
waves. In wave 7, 1601 young adults (79% of  the initial
sample or 82% of  teenage participants) were interviewed
between April and December 1998. In wave 8, 1520
(75% of  the initial sample, 78% of  teenage participants)
were interviewed between April 2002 and June 2003.
Response rates are shown in Fig. 1. Reasons for non-
completion at follow-up in young adulthood were refusal
(W7 
 
n
 
 
 
=
 
 152, W8 
 
n
 
 
 
=
 
 269), loss of  contact (W7 
 
n
 
 
 
=
 
 192,
W8 
 
n
 
 
 
=
 
 152) and death (W7 
 
n
 
 
 
=
 
 2, W8 
 
n
 
 
 
=
 
 7). Character-
istics of  non-completers were examined in a logistic
regression model. Males were over-represented [odds
ratio (OR) 1.9, 95% conﬁdence interval (CI) 1.5–2.4], as
were those with a background of  parental divorce or
separation (OR 1.8, 1.4–2.5), and those who were daily
smokers at study inception (OR 2.1, 1.5–2.9). Neither
teenage cannabis use nor depression/anxiety were asso-
ciated independently with loss to follow-up. The mean
age (SD) at wave 1 was 14.5 (0.5), at wave 7 was 20.7
(0.5) and at wave 8 was 24.1 (0.6) years.
 
Measures
 
Tobacco consumption
 
Tobacco  consumption  was  detailed  at  each  wave  using
a 7-day retrospective diary. To reduce unnecessary
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questions, never smokers and self-deﬁned ex-smokers
who had not smoked a cigarette in the past month did not
complete the diary. Smoking was categorized on the basis
of  frequency. Reported smoking on 6 or 7 days of  the past
week was classiﬁed as current daily smoking. Reported
smoking of  a cigarette in the past month was categorized
as any current smoking. Self-deﬁned ex-smokers who
reported not having smoked in the month before the sur-
vey were classed as ex-smokers. Those who reported hav-
ing ceased smoking in the 4 weeks before the survey were
categorized as current smokers. Daily smokers were sub-
categorized into those who on average smoked up to 10 or
more than 10 cigarettes per day. Nicotine dependence
was measured at waves 7 and 8 with the Fagerström Test
for Nicotine Dependence (FTND). Nicotine dependence
was deﬁned at a cut-off  point of  3/4 corresponding to a
cut-off  point of  6/7 on the Fagerström Tolerance Ques-
tionnaire (Fagerstrom 
 
et al.
 
 1991). Subsyndromal nico-
tine dependence was deﬁned as scoring between 1 and 3
on the FTND.
 
Cannabis use
 
Cannabis use was assessed using self-reported frequency
of  use in the previous 6 months in waves 1–6 and in the
previous 12 months at wave 7. This allowed classiﬁcation
as follows: never used; less than weekly use; at least
weekly use; and daily use (deﬁned as using on 5 or more
days per week).
A number of  potential confounders of  a prospective
association between cannabis use and tobacco were also
assessed. These included the following.
 
Alcohol use and dependence
 
Alcohol use and dependence was assessed using self-
reported frequency of  use and with a 7-day retrospective
diary for those reporting recent drinking. Those drinking
on 3 or more days in the previous week were classiﬁed as
frequent drinkers and those drinking on average more
than ﬁve standard units at each drinking occasion were
classiﬁed as high dose drinkers. Alcohol dependence
[
 
Diagnostic and Statistical Manual
 
 version IV (DSM-IV)]
was assessed using the Composite International Diag-
nostic Interview 2.1, 12-month version (CIDI) (WHO
1997).
 
Depression and anxiety
 
Depression and anxiety were assessed at each wave using
the computerized revised Clinical Interview Schedule
(CIS-R) (Mann 
 
et al
 
. 1983). The total scores on the CIS-R
were dichotomized at a cut-off  point of  11/12 to delineate
a mixed depression–anxiety state at a lower threshold
than syndromes of  major depression and anxiety disorder
but where clinical intervention would be appropriate
(Harrington 
 
et al
 
. 1991; Lewis 
 
et al
 
. 1992).
 
Antisocial behaviour
 
Antisocial behaviour was assessed in waves 1–6 using
items from the Self-Reported Early Delinquency Scale
covering property damage, interpersonal violence and
theft (Mofﬁtt & Silva 1988).
 
Physical inactivity
 
Physical inactivity was deﬁned in waves 1–6 as self-
reported engagement in sport on less than a weekly
frequency, and in waves 7 and 8 as less than weekly
engagement in physical activity to make you sweat or
breathe heavily.
 
Analysis
 
Data collection was undertaken at a developmental point
when young people are difﬁcult to trace because of  high
mobility. Although the response was high and attrition
 
Figure 1
 
Sampling and ascertainment in the Victorian Adolescent Health Cohort, 1992–2003
phase
survey wave 1 wave 2
year 1992 1993
mean age 14.9 yr 15.5 yr
sample n 898 1727
wave 3
1994
15.9 yr
1697
wave 4
1994
16.4 yr
1628
wave 5
1994
16.8 yr
1575
wave 6
1995
17.4 yr
1530
wave 7
1998
20.7 yr
1601
wave 8
2001/03
24.1 yr
1520
design
     
ascertainment       96% (1943) of sample participated at least once in waves 1–6
2 entry points 
Young adultAdolescent
 Total intended sample = 1037(w1) + 995 (w2) = 2032
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low, 36% of  respondents missed at least one wave of  data
collection in the adolescent phase (waves 1–6), leading to
a potential bias in summary measures of  exposure to can-
nabis and mental health problems calculated from these
data. To address this, we used the method of  multiple
imputation (Rubin 1987), with ﬁve complete data sets
created by imputation under a multivariate normal
model that incorporated all the outcome variables of
interest measured at all waves of  data collection, along
with the ﬁxed covariates of  sex, age, rural/urban resi-
dence and parental education (available on all partici-
pants) (Schafer 1997). Measures were constructed by
classifying participants according to whether they fell
into categories of  interest at least once during waves 1–6
(adolescence) and, separately, in waves 7 and 8 (young
adulthood). Data analysis was undertaken using STATA
8 (Stata Corp 2001). Univariate and multivariate logistic
regression analyses were used to model associations, and
Wald tests and related conﬁdence intervals were used to
assess statistical signiﬁcance and precision.
 
RESULTS
 
Table 1 shows the estimated prevalence of  smoking at
waves 7 and 8. Seventy-one  per cent of  the cohort had
experimented with tobacco by the age of  24 years with
the rate of  ever having smoked tobacco being similar in
males and females (OR 0.85, CI 0.7, 1.1). One in ﬁve of
the sample were ex-tobacco smokers at both young adult
waves, with similar rates in males and females. Just under
half  the sample smoked in young adulthood and one in
eight fulﬁlled the criteria for nicotine dependence.
Around two-thirds (
 
n
 
 
 
=
 
 162) of  the nicotine-
dependent smokers at wave 7 or 8 (
 
n
 
 
 
=
 
 245) had reported
daily tobacco smoking on at least one occasion as
teenagers. Sixty-two (25%) of  the nicotine-dependent
smokers at wave 8 had reported smoking at less than
daily frequency as teenagers, while a smaller number
(9%) had not smoked tobacco
 
.
 
Table 2 shows the association between teenage can-
nabis use and later young adult tobacco use and nicotine
dependence. In those who had not smoked tobacco
throughout the teens, weekly cannabis use in at least one
wave predicted more than eightfold higher odds of  being
classiﬁed as a new smoker in waves 7 or 8. This associa-
tion persisted after adjustment for a range of  potential
confounders in the multivariate model. No signiﬁcant
association was apparent for those already identiﬁed as
smokers during the teens.
Just over 2% of  those who had not used tobacco dur-
ing their teens were nicotine-dependent at wave 8. A
trend was evident in this group for cannabis use weekly at
one or more of  the teen waves to predict later nicotine
dependence but the conﬁdence intervals for the associa-
tion were broad. Of  the group who had been less than
daily tobacco users in their teens, 9% were nicotine-
dependent at follow-up at wave 8. Again, a trend was
apparent for weekly cannabis use to predict later nicotine
dependence but with broad conﬁdence intervals. Twenty-
seven per cent of  the group who had been daily tobacco
smokers in their teens were nicotine-dependent at wave
8. For this group, other teenage variables did not predict
progression to nicotine dependence.
 
Cannabis use and the course of  tobacco use in 
young adulthood
 
Six per cent (
 
n
 
 
 
=
 
 116) of  the non-nicotine-dependent
participants at wave 7 (
 
n
 
 
 
=
 
 1803) became nicotine-
dependent by wave 8. Table 3 shows the association of
factors at wave 7 (age 21 years) with incident nicotine
dependence at wave 8 (age 24 years). The presence of
subsyndromal nicotine dependence symptoms and the
 
Table 1
 
Demographic characteristics (%) of  1943 young adults at wave 8 in the Victorian Adolescent Health Cohort Study catego-
rized by tobacco use.
 
Non-smokers
n
 
 
 
=
 
 
 
588
Ex-smokers
n
 
 
 
=
 
 
 
599
Non-nicotine-
dependent smokers
n
 
 
 
=
 
 
 
571
Nicotine-dependent
smokers
 
 
 
n
 
 
 
=
 
 
 
185
 
Female 54 52 50 49
Non-Australian-born 17 14 10 10
Parental education
Not completed high school 28 32 32 41
Completed high school 38 38 38 32
Completed tertiary 34 30 30 27
Early school leaving
Did not complete year 10 3 8 10 22
Did not complete year 12 6 13 14 18
Completed year 12 91 80 76 60
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level of  smoking at wave 7 were strong independent pre-
dictors of  transition to nicotine dependence. Forty-six per
cent (
 
n
 
 
 
=
 
 821) of  the group (
 
n
 
 
 
=
 
 1803) used cannabis less
than weekly, 6.2% (
 
n
 
 
 
=
 
 112) weekly and 5.8% (
 
n
 
 
 
=
 
 104)
daily. Cannabis use predicted later nicotine dependence
independently of  smoking status, subsyndromal nicotine
dependence and other potential confounders, with the
association reaching an odds ratio of  3.6 (95% CI 1.2, 10)
for daily cannabis use. Adjusted and unadjusted odds
ratios differ because tobacco use, symptoms of  nicotine
dependence and cannabis use are associated at any point
in time.
Twenty-two per cent (
 
n
 
 
 
=
 
 173) of  the 778 current
smokers at wave 7 reported having quit, with no tobacco
use in the previous month before assessment at wave 8.
No clear association was apparent between cannabis use
 
Table 2
 
Comparison of  weekly cannabis use versus no/lower level use as a predictor (odds ratios, 95% conﬁdence intervals) of
tobacco use and nicotine dependence in young adulthood (waves 7 and 8) in 1943 participants.
 
No teen tobacco use
(n
 
 
 
=
 
 
 
818)
Less-than-daily teen tobacco use
(n
 
 
 
=
 
 
 
631)
Daily teen tobacco use
 
 
 
(n
 
 
 
=
 
 
 
494)
 
 
 
Unadjusted Adjusted* Unadjusted Adjusted* Unadjusted Adjusted*
 
Any tobacco use as a young adult
Cannabis use
None (
 
n
 
 
 
=
 
 1273) 1.0 1.0 1.0 1.0 1.0 1.0
 
<
 
 Weekly (
 
n
 
 
 
=
 
 415) 2.2 (1.1,4.2) 2.1 (1.1, 4.4) 2.0 (1.2, 3.2) 1.8 (1.0, 3.1) 1.5 (0.5, 4.6) 1.8 (0.6, 5.3)
 
≥ 
 
Weekly (
 
n
 
 
 
=
 
 255) 8.4 (1.9, 37) 8.3 (1.9, 36) 1.8 (0.8, 4.0) 1.5 (0.6, 3.7) 1.8 (0.4, 7.2) 2.3 (0.6, 9.0)
Nicotine dependence as a young adult
Cannabis use
None (
 
n
 
 
 
=
 
 1273) 1.0 1.0 1.0 1.0 1.0 1.0
 
<
 
 Weekly (
 
n
 
 
 
=
 
 415) 3.4 (0.9, 13) 2.5 (0.6, 10) 1.1 (0.5, 2.3) 1.1 (0.5, 2.3) 1.2 (0.7, 2.0) 1.1 (0.6, 1.9)
 
≥ 
 
Weekly (
 
n
 
 
 
=
 
 255) 5.9 (0.6, 58) 4.7 (0.4, 52) 2.3 (0.9, 5.9) 2.0 (0.7, 5.7) 1.3 (0.6, 2.7) 1.0 (0.4, 2.4)
 
*Multivariate logistic regression included the covariates physical inactivity, frequent and high-dose alcohol use as a teen, sex, parental smoking, anti-
social behaviour and high levels of  depression and anxiety.
 
Table 3
 
Prediction of  incident nicotine dependence at wave 8 (24-year-olds), among non-dependent participants at wave 7
(
 
n
 
 
 
=
 
 1804 20-year-olds) and of  quitting at wave 8 among smokers at wave 7 (
 
n
 
 
 
=
 
 781); association estimated as odds ratio (95% CI).
 
Wave 7 variables
Transition to nicotine dependence Transition to quitting
 
 
 
Unadjusted Adjusted* Unadjusted Adjusted*
 
Smoking level
Never (
 
n
 
 
 
=
 
 650) 1.0 1.0 N/A N/A
Ex-smoker (
 
n
 
 
 
=
 
 512) 3.9 (1.1, 15) 2.3 (0.5, 9.5) N/A N/A
Less than daily (
 
n
 
 
 
=
 
 262) 11 (2.6, 38) 2.8 (0.6, 13) 1.0 1.0
Daily (
 
n
 
 
 
=
 
 519) 34 (12, 102) 4.1 (1.0, 17) 0.3 (0.2, 0.4) 0.5 (0.3, 0.8)
Cannabis use
None (
 
n
 
 
 
=
 
 782) 1.0 1.0 1.0 1.0
Monthly (n = 898) 4.7 (2.3, 9.5) 1.7 (0.9, 3.8) 0.7 (0.3, 1.4) 0.8 (0.4, 1.8)
Weekly (n = 133) 8.4 (2.7, 26) 1.6 (0.5, 5.4) 0.7 (0.3, 1.6) 1.0 (0.4, 2.7)
Daily (n = 129) 15 (6.7, 36) 3.6 (1.2, 10) 0.4 (0.2, 1.1) 0.7 (0.3, 1.7)
Smoking friends
None (n = 151) 1.0 1.0 1.0 1.0
Some (n = 1154) 1.8 (0.5, 6.2) 0.8 (0.2, 3.2) 1.5 (0.1, 25) 1.8 (0.1, 43)
Most (n = 639) 4.6 (1.5, 14) 0.7 (0.2, 2.8) 0.8 (0.1, 13) 1.2 (0.1, 24)
Dependence symptoms
None (n = 1412) 1.0 1.0 1.0 1.0
Subsyndromal (n = 392) 19 (11, 31) 7.9 (3.9, 16) 0.3 (0.2, 0.4) 0.4 (0.2, 0.6)
Full (n = 139) N/A N/A 0.2 (0.1, 0.4) 0.3 (0.1, 0.7)
*Multivariable logistic regression included all variables shown in table as well as the covariates sex, frequency and dose of  alcohol consumption, alcohol
dependence symptoms, high levels of  anxiety and depression, peer and parental smoking
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and quitting. The strongest predictor of  failure to quit was
the presence of  symptoms of  nicotine dependence at wave
7.
Cannabis and transition to alcohol dependence in 
young adulthood
In order to ascertain whether the relationship between
cannabis use and tobacco is different to that with alcohol,
a further analysis of  incident alcohol dependence at wave
8 was undertaken. Ten per cent (n = 169) of  the non-
alcohol-dependent participants at wave 7 were classiﬁed
as alcohol-dependent at wave 8. Table 4 shows the asso-
ciation between wave 7 factors with new cases of  alcohol
dependence. Both frequent drinking (3+ days per week)
and DSM-IV alcohol abuse predicted later dependence.
More frequent cannabis use had a modest association
with later alcohol dependence, with a twofold increase in
risk for those using at least weekly.
DISCUSSION
The major study ﬁndings were that weekly or greater
cannabis use during the teenage years predicted initia-
tion of  tobacco use in non-tobacco-smoking adolescents
and that young adult cannabis use predicted a transition
to later nicotine dependence. Indeed, cannabis use was
second only to previous patterns of  tobacco use as a
predictor of  nicotine dependence. For non-dependent
tobacco smokers, daily cannabis use at the age of
21 years predicted a more than threefold increase in the
odds of  nicotine dependence, independent of  current pat-
terns of  tobacco use. This study suggests that the longi-
tudinal relationship between tobacco and cannabis has
become reciprocal in a context of  a high prevalence of
early and frequent cannabis use (Amos et al. 2004; Hum-
ﬂeet & Haas 2004).
In contrast, there was little evidence from these anal-
yses to suggest that cannabis use affected the likelihood of
smoking cessation, at least until this point in young adult
development. This ﬁnding differs from an earlier report
where cannabis use predicted lower rates of  cessation of
tobacco use in cannabis users, a difference that may
reﬂect the older age of  that sample(Ford et al. 2002).
The majority of  the participants were still living in Vic-
toria at the time of  follow-up. Currently, possession of
cannabis remains a criminal offence but enforcement is
less stringent than in some other counties, with ﬁrst-time
offenders being usually diverted into counselling rather
than being prosecuted. The extent to which these ﬁnd-
ings may apply outside Australia depends on the extent to
which similar patterns of  cannabis use are found else-
where. There are a range of  methodological barriers to
making valid cross-national comparisons(Pirkis et al.
2003). These also limit the extent to which it is possible to
judge whether these ﬁndings are likely to apply else-
where. However, it appears that the rate of  cannabis use
among Australian adolescents and adults is roughly
comparable to that in many other western countries such
as the United States, Canada, the United Kingdom and
New Zealand.
A close to representative sample, high participation
rates and frequent measures of  tobacco and cannabis use
during the teens are strengths of  this study. A telephone
interview strategy was used in data collection in the last
two waves and although prevalence estimates may vary
slightly as a result, it is unlikely to have caused a system-
atic bias in patterns of  association found. The use of  mul-
tiple imputation should have minimized measurement
biases arising from missing data. Nevertheless, it remains
possible that we have not fully captured non-responders
who may still differ in their patterns of  substance use with
some effect on the speciﬁcation of  associations. Perhaps
the most signiﬁcant limitation is that we were unable to
distinguish whether cannabis use took place with or
without tobacco. Thus our study focus was the initiation
of  tobacco use independently of  any use of  tobacco mixed
with cannabis. This consideration also limits the scope for
clarifying the mechanisms underlying the prediction of
later tobacco use by cannabis.
A range of  processes might underlie the associations
we found. Confounding by earlier environmental factors
Table 4 Prediction of  incident alcohol dependence at wave 8
(n = 207, 24 years) among non-alcohol-dependent participants
from wave 7 (n = 1602, 20 years); association estimated as odds
ratio (95% conﬁdence interval).
Unadjusted Adjusted*
Wave 7 variables
High dose drinking (n = 752) 1.7 (1.1, 2.8) 1.2 (0.7, 2.1)
Frequent drinking (n = 295) 2.8 (1.8, 4.4) 2.1 (1.3, 3.4)
Alcohol abuse (n = 341) 2.9 (1.8, 4.8) 2.0 (1.1, 3.5)
Cannabis use
None (n = 782) 1.0 1.0
Monthly (n = 898) 1.8 (1.1, 2.9) 1.3 (0.7, 2.2)
Weekly (n = 133) 3.6 (2.0, 6.7) 2.1 (1.0, 4.4)
Daily (n = 129) 3.7 (1.9, 7.2) 2.0 (1.0, 4.3)
Smoking level
None (n = 650) 1.0 1.0
Ex-smoking (n = 512) 1.3 (0.8, 2.1) 1.1 (0.6, 1.8)
Less than daily smoking 
(n = 262)
2.1 (0.9, 5.0) 1.3 (0.5, 3.2)
Daily smoking (n = 519) 2.3 (1.5, 3.5) 1.2 (0.7, 2.1)
High depression/anxiety 
(n = 315)
2.3 (1.5, 3.3) 1.9 (1.3, 2.9)
*Multivariable logistic regression included all variables shown in table as
well as the covariates sex, peer and parental smoking.
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or genetic background cannot be excluded. However, we
controlled for obvious confounders in terms of  tobacco
use by teenage friends and family and this made little dif-
ference to the associations found.
Tobacco is mixed commonly with cannabis in large
part to ensure it burns smoothly. Thus, cannabis use may
indirectly bring exposure to tobacco, which in turn trig-
gers the use of  tobacco, independently of  cannabis. The
strong association of  teen cannabis use in non-smokers
with later smoking is consistent with this possibility but it
would be difﬁcult to see this mechanism alone as sufﬁ-
cient to explain the strength of  prediction of  nicotine
dependence in current non-dependent tobacco smokers.
Given that most cannabis users are also smokers there is
a second possibility, that cannabis use introduces an indi-
vidual to a peer group where attitudes to smoking are
more favourable, thus increasing risks for both initiation
and heavier use. However, controlling for peer use in the
analysis of  transition to nicotine dependence did not elim-
inate the association with cannabis use, suggesting this is
not in itself  a sufﬁcient explanation. A third possibility is
that the diminished motivation associated with frequent
cannabis use may reduce attempts to cease smoking and
may therefore allow more rapid progression to nicotine
dependence (Hall & Solowij 1998; Humﬂeet & Haas
2004). In this study, however, cannabis use at 21 years
did not independently predict a lesser likelihood of  quit-
ting, suggesting that at least in young adulthood the
inﬂuence of  cannabis is greater on progression in tobacco
use than on cessation.
Biological mechanisms may also account for the asso-
ciation. Cannabis affects mesolimbic dopaminergic func-
tion, increasing the efﬂux of  dopamine in the nucleus
accumbens via its action on CB1 receptors (Tanda et al.
Chiara 1997; Piomelli 2003). Such an action may prime
the dopamine system for dependence on nicotine and
other drugs. An alternative explanation might be that
cannabis withdrawal heightens stress responses that
leads in turn to greater use of  a range of  other substances
(Ashton 2002; de Fonseca, Carrera & Navarro 1997).
The clearest association in this study, between daily can-
nabis use and subsequent nicotine dependence, is consis-
tent with this suggestion. The weaker but still statistically
signiﬁcant association between frequent cannabis use
and later alcohol dependence would also be consistent
with this hypothesis.
Cannabis has rarely been at the forefront of  drug
policy. A lack of  consensus around the health effects of
cannabis has been one factor(Strang et al. 2000). The
Gateway Theory further shifted the focus of  intervention
to tobacco and alcohol use, while the more conspicuous
morbidities associated with opiate and psychostimulant
use have made these drugs the main focus of  treatment
services.
A ﬁnding that frequent cannabis use predicts pro-
gression to nicotine dependence and, to a lesser extent,
alcohol dependence adds to the evidence on its health
consequences in frequent users (Arsenault et al. 2002;
Patton et al. 2002). As cannabis use occurs earlier and
more frequently in many western countries, so too are
these effects likely to grow in importance. Given the bur-
den of  disease associated with tobacco use, an increased
risk of  tobacco dependence may well prove the most
important health consequence of  frequent early cannabis
use.
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5.4 Outcomes of occasional cannabis use in adolescence 
Paper 8. Outcomes of occasional cannabis use in adolescence: 10 year follow-up 
study in Victoria, Australia. Degenhardt L, Coffey C, Carlin JB, Swift W, Moore E, 
Patton GC. British J Psychiatry 196, 290-295, 2010 
Journal impact factor 6.6 (source: Journal Citation Reports, 4/03/2013) 
20 citations, as at 4/03/2013 (source: Google Scholar). 
The nexus between regular cannabis use and licit and other illicit substance use is 
worthy of detailed examination, but the consequences of less than regular use in 
adolescence remains an important and largely untapped area of enquiry. Following 
the paper (Swift et al. 2009) (discussed in Chapter 3, Paper 5) in which we examined 
later cannabis use in adolescent users who modified their use, we were interested to 
know whether adolescents whose maximum frequency of use was occasional (i.e., at 
a relatively low level of drug exposure) were at greater risk of adverse outcomes in 
young adulthood than non-users. This question had not been addressed previously 
and was important in view of the common view that occasional adolescent use is not 
harmful, and also to inform harm minimisation intervention strategies. Although this 
paper was written focusing on occasional users, we also examined outcomes for 
adolescents reporting maximum regular (weekly/daily) use in adolescence, being the 
second of our papers to do so, following that reporting the divergent pathways of 
problematic alcohol and cannabis use discussed in Chapter 3 (Patton, GC et al. 
2007). 
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5.4.1 My contribution 
 The lead author was Professor Louisa Degenhardt from the National Drug and 
Alcohol Centre at the University of New South Wales. I assisted with the 
conceptualisation of the question. I was responsible for the analysis and methods and 
I contributed to the introduction, results and discussion and the response to the 
reviewers’ comments. The declaration of my contribution, estimated as 40%, is in 
Appendix 2. 
5.4.2 Analysis and results 
The current paper included data from Waves 1 to 8, that is, to 24 years, but was 
restricted to those who completed the Wave 8 survey, as this was treated as the 
outcome wave. The exposure of interest was the maximum reported frequency of 
cannabis use between Wave 1 and Wave 6, combined with reported use at Wave 7 
(20 years). We examined the association between this exposure and psychosocial and 
substance use outcomes at Wave 8. Firstly, we illustrated the distribution of these 
outcomes stratified initially by adolescent use, and then by cannabis use at 20 years, 
which appeared to be strongly influential on the outcomes. 
Omitting the Wave 7 observations, we assessed associations between adolescent 
cannabis use and each outcome, progressively adjusting for sex, background factors 
(Australian birth, rural school, parental education) and putative adolescent 
confounders (high risk alcohol use, antisocial behaviour and symptoms of 
anxiety/depression), and, finally, adolescent cigarette smoking. This allowed us to 
determine the relevance of possible confounders, especially cigarette smoking, which 
may be an antecedent and also follow cannabis use. Tobacco use attenuated the 
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relationship between adolescent cannabis use and subsequent educational 
qualifications, suggesting that cigarette smoking may drive poor school completion 
(Lynskey et al. 2003) (in Chapter 5). As there is no clear biological mechanism 
involving nicotine in compromised schooling, we suggest that poor educational 
achievement is likely to be a social phenomenon, due to the influence of like-minded 
smoking peers and family dynamics, rather than a biological one directly attributable 
to the impact of cigarette smoke on the developing brain. 
In this analysis there was little evidence of heightened risk for depression/anxiety 
symptoms for either level of adolescent cannabis use. Welfare dependence was more 
likely to occur in regular adolescent users, but this was confounded by other 
adolescent measures of substance use and anxiety/depression. However, occasional 
adolescent cannabis users, like regular users, were more likely to be using cannabis, 
be cannabis dependent and have reported other illicit substance use at 24 years than 
adolescents who did not use cannabis. The risk profile of the occasional users on 
these outcomes was mid-way between that of non- and weekly+ adolescent users. 
5.4.3 Implications 
Although occasional cannabis use in adolescence endowed some risk, especially if 
use escalated at around 20 years, it was of lesser magnitude than regular use. It is 
noteworthy that 80% of occasional users in adolescence remained as occasional users 
at 20 years. However, the risk of escalation from occasional use in adolescence 
constitutes a conceptual problem in the development of both universal intervention 
and targeted interventions, where this cannot be assumed to be benign. It seems that 
aiming for reduction in cannabis use is not sufficient. 
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5.4.4 Paper 8: Outcomes of occasional cannabis use in adolescence: 10 
year follow-up study in Victoria, Australia 
Degenhardt L, Coffey C, Carlin JB, Swift W, Moore E, Patton GC. British J 
Psychiatry 196, 290-295, 2010 
 
  
Cannabis use in adolescence has been linked to suboptimal adjust-
ment in young adulthood, typically for those who begin or pro-
gress to heavy use.1,2 Although common in many countries,3
most adolescents use cannabis infrequently and it remains unclear
whether they are also at risk of negative outcomes. Little prospec-
tive research has examined the later life circumstances of adoles-
cent cannabis users who do not progress to heavier use. In one
small study of children (n=85) raised in California during the
1970s, children who experimented with cannabis were reportedly
better adjusted psychologically than those who abstained until 18
years.4 This finding was not replicated in a more recent Califor-
nian study which reported that adolescent abstainers had better
peer, family and school engagement and less ‘deviant behaviour’
at 23 years than experimenters.5 In this paper we report data from
a 10-year population-based cohort study, focusing on: (a) associa-
tions between occasional cannabis use during adolescence and
psychosocial and drug use outcomes in young adulthood (20–24
years); and (b) modification of these associations according to
the trajectory of cannabis use between adolescence and age 20
years, and according to other potential risk factors. We focused
in particular on the effect of adjustment for cigarette smoking
in adolescence, because of its strong association with cannabis use.
Method
Sample
We conducted an eight-wave cohort study, 1992–2003, examining
health among young people in Victoria, Australia. Data collection
was approved by The Royal Children’s Hospital’s Ethics in Human
Research Committee. The cohort was a representative sample of
Victorian mid-secondary school adolescents in 1992, defined in
a two-stage cluster sample, with two classes selected at random
from a state-wide sample of 44 schools, one class entering the
study in year nine, at 13–14 years of age (wave 1) and the second
6 months later (wave 2). Participants were interviewed at four
6-month intervals during the teens (waves 3–6) with two
follow-ups in young adulthood: 20–21 years (wave 7) and 24–25
years (wave 8). In waves 1–6, participants self-administered the
questionnaire on laptop computers with telephone follow-up of
those absent from school. Waves 7 and 8 were undertaken using
computer-assisted telephone interviews.6
From a total sample of 2032 students, 1943 (96%) participated
at least once during the adolescent phase (Fig. 1). In wave 8
(April 2001 to April 2003), 1520 were interviewed. Reasons for
non-completion at wave 8 were refusal (n= 269), loss of contact
(n=150) and death (n= 4). In this sample, participation from
waves 1 to 6 was: 6 waves, n=543; 5 waves, n= 617; 4 waves,
n= 192; 3 waves, n=56; 2 waves, n= 43; 1 wave, n=69.
Measures
Background measures
These included school location, place of birth, parental education
and employment status.
Adolescent cannabis use (waves 1–6)
Past 6-month use was categorised as ‘none’, ‘less than weekly’ (oc-
casional) and ‘weekly–daily’ (weekly+). Individuals were classified
according to maximum frequency in waves 1–6 (maximum ado-
lescent use). Frequency of use was assessed without specifying
method or dose.
Other adolescent measures
Tobacco smoking was recorded using a 7-day retrospective diary
and maximum smoking frequency (waves 1–6). Occasional
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Outcomes of occasional cannabis use in
adolescence: 10-year follow-up study in Victoria,
Australia
Louisa Degenhardt, Carolyn Coffey, John B. Carlin, Wendy Swift, Elya Moore and George C. Patton
Background
Regular adolescent cannabis use predicts a range of later
drug use and psychosocial problems. Little is known about
whether occasional cannabis use carries similar risks.
Aims
To examine associations between occasional cannabis use
during adolescence and psychosocial and drug use
outcomes in young adulthood; and modification of these
associations according to the trajectory of cannabis use
between adolescence and age 20 years, and other potential
risk factors.
Method
A 10-year eight-wave cohort study of a representative
sample of 1943 secondary school students followed from
14.9 years to 24 years.
Results
Occasional adolescent cannabis users who continued
occasional use into early adulthood had higher risks of later
alcohol and tobacco dependence and illicit drug use, as well
as being less likely to complete a post-secondary
qualification than non-users. Those using cannabis at least
weekly either during adolescence or at age 20 were at
highest risk of drug use problems in young adulthood.
Adjustment for smoking in adolescence reduced the
association with later educational achievement, but
associations with drug use problems remained.
Conclusions
Occasional adolescent cannabis use predicts later drug use
and educational problems. Partial mediation by tobacco use
raises a possibility that differential peer affiliation may play a
role.
Declaration of interest
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smoking included any smoking within the past month; daily
smoking including smoking 6–7 days of the past week.
Long-term high alcohol risk was assessed using a retrospective
1-week diary which provided estimates of alcohol consumed.
Participants drinking more than 280 g in the previous week were
classified as risky drinkers, according to 2007 draft Australian
guidelines.7
Symptoms of depression and anxiety were assessed at each
wave using the computerised revised Clinical Interview Schedule
(CIS-R). Participants with scores 4118–11 in any wave were
classified as symptomatic.
Young adulthood cannabis use (waves 7 and 8)
Maximum past-year cannabis use was categorised into: 55 times
(none);45 times but less than weekly (occasional); and weekly or
more (weekly+).
Other outcomes at 24 years (wave 8)
Post-school qualifications and current receipt of government
benefits were identified in the final wave. Symptoms of
depression and anxiety were assessed with the General Health
Questionnaire (GHQ–12),12 and were dichotomised at a score
42, a threshold believed to delineate a mixed depression–anxiety
state at a lower level than syndromes of major depression and
anxiety disorder but where clinical intervention would be
appropriate.9,10
Those who had smoked cigarettes within the past month were
also identified in wave 8. Nicotine dependence was measured
using the Fagerstrom Test for Nicotine Dependence (FTND) and
was defined as a score of 4 or more, corresponding to a cut-point
of 7 or more on the Fagerstrom Tolerance Questionnaire.13
Alcohol dependence (DSM–IV) in the past year was assessed using
the Composite International Diagnostic Interview 2.1 (CIDI).14
DSM–IV cannabis dependence among past-year weekly+ users
was also assessed using the CIDI. Other illicit drug use included
amfetamine, ecstasy and cocaine.
Analysis
We graphed the gender-adjusted prevalence of young adult
outcomes according to adolescent cannabis use, stratified by
cannabis use frequency at 20 years. Gender-adjusted proportions
were obtained using predicted values from logistic regression
models. Associations between categories of adolescent cannabis
use and outcomes at 24 years were assessed using odds ratios.
Wald tests and confidence intervals (CI) were used to assess
statistical significance and precision.
Around 22% of the original Victorian Adolescent Health Cohort
Survey participants were not interviewed for wave 8 data, and a
minority provided data at all waves. Consequently, the results of
‘complete-case’ analyses based on only those with complete data
at all waves could potentially be biased. Analyses were therefore
performed using the method of multiple imputation15 to allow
for missing data on outcomes and predictor variables. This
method has advantages over simpler imputation methods such
as mean substitution and last observation carried forward, both
in its potential to reduce bias and in the appropriate accounting
for variance due to uncertainty about the true unobserved values.
Under the multiple imputation method, several copies of the
data-set are created using a modelling process that imputes a value
for each missing item, and final analyses are obtained by
combining the results obtained by applying standard complete-
data methods to each of the imputed data-sets. Imputed values
are randomly drawn using a modelling process that allows for
uncertainty in the model parameters, and includes predictive
information from related variables that may or may not have
missing values themselves. In this study, a multivariate normal
model was used to impute the missing data to create five different
complete data-sets used for the analyses of this paper.
Variables measuring alcohol and drug use, and variables
known to be associated with alcohol and drug use, from all eight
waves were included in the imputation model, along with key
sociodemographic covariates (gender, age, rural/urban residence
and parental education). This was done with the stand-alone
software package NORM for Windows, applying adaptive
rounding post-imputation for binary measures.16
Data analysis used Stata 10.0 for Windows with multiple
imputation analysis performed using special-purpose Stata
commands.17 Parameters were estimated by averaging across the
imputed data-sets with Wald-type confidence intervals obtained
under multiple imputation using Rubin’s combination rules.15
Results
A third of the cohort (34%; 95% CI 32–37) had used cannabis in
the past 6 months in at least one adolescent wave: 331 users (64%,
95% CI 59–68) reported only occasional use and 190 (36%, 95%
CI 32–41) reported weekly+ use. In the first adult wave (20 years,
wave 7), 60% reported using cannabis, of whom 77% (n= 702)
used occasionally and 23% (n=208) used weekly+. At 24 years
(wave 8), 33% (n= 508) used cannabis, of whom 63% (n=318)
reported occasional use and 37% (n=190) reported weekly+ use.
Association between adolescent cannabis use,
background factors and adolescent measures
Adolescent cannabis use was less common in females and in
participants born outside Australia (Table 1). Weekly+ users were
less likely to have parents with low education, and were more
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Adolescent Young adult
Wave
Year
Sample, n
Mean age, years
3
1993
1697
15.9
4
1994
1628
16.4
5
1994
1575
16.8
6
1995
1530
17.4
7
1998
1601
20.7
8
2001–03
1520
24.1
2
1993
1727
15.5
1
1992
898
14.9
Design
Ascertainment
Two entry points
Total intended sample = 1037 (wave 1) + 995 (wave 2) = 2032
96% (n= 1943) of sample participated at least once in waves 1–6
5 5
7 7
Fig. 1 Sampling and ascertainment in the Victorian Adolescent Health Cohort, 1992–2003.
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likely to have attended a metropolitan school, than non-users.
Depression/anxiety symptoms, alcohol use and cigarette smoking
were more likely among both occasional and weekly+ cannabis
users compared with non-users.
Adolescent cigarette smoking was strongly associated with
cannabis use. Eight in ten (81%) adolescent cannabis users also
reported cigarette smoking, and 59% of smokers reported cannabis
use. There was no evidence of effect modification by gender (each
interaction Wald chi-squared P40.1).
Young adult outcomes according to level and trajectory
of adolescent cannabis use at 20 years
We classified individuals according to their cannabis use trajectory
between the adolescent phase and 20 years: 42% of non-users in
adolescence had initiated cannabis use by 20 years, typically
occasional use (90%). Of the 331 adolescent occasional users, 28
(8%) abstained at 20 years, 236 (71%) persisted with that level
of use, and 67 (20%) escalated to weekly+ use.
Figure 2 displays prevalence estimates of outcomes at age 24
years according to adolescent-onset cannabis use, and frequency
of cannabis use at age 20 years, adjusted for gender. For the
psychosocial outcomes (post-school qualifications, receipt of
welfare, and depression/anxiety), persistent weekly users (those
using weekly in adolescence and adulthood) had worse outcomes
compared with those who never used, but there was considerable
overlap in the confidence intervals around estimates for other
categories of users. There was possibly a trend to greater risk of
not having post-school qualifications with increasing adolescent
cannabis use, which we explore in more detail below.
In contrast, patterns in the estimates and confidence intervals
for substance use outcomes could be distinguished more clearly,
particularly with illicit drugs, where there was a tendency for risk
to increase if cannabis use at 20 years was higher. For example,
adolescent occasional cannabis users who progressed to weekly+
use at 20 years were more likely to meet criteria for cannabis
dependence and use other illicit drugs at 24 years than occasional
cannabis users who did not escalate their use.
Young adult outcomes according to level of adolescent cannabis
use
Adolescent cannabis users were less likely than non-users to have
gained post-school qualifications by 24 years (Table 2). This asso-
ciation remained after adjustment for background factors and
adolescent alcohol use and depressive symptoms, but further
adjustment for adolescent cigarette smoking substantially reduced
the association (Table 2). Similarly, the association between
weekly+ cannabis use and government welfare at 24 years was
reduced after additional adjustment for adolescent smoking.
Both alcohol and nicotine dependence at 24 years occurred
more often among adolescent cannabis users, with occasional
users intermediate in risk level between non-users and weekly+
users. However, adjustment for adolescent cigarette use accounted
almost entirely for these associations.
All drug use outcomes at 24 years were more common among
adolescent cannabis users than non-users, even after adjustment.
Occasional adolescent cannabis users were at a risk that was inter-
mediate between the non-users and the more frequent users.
Discussion
Different levels and trajectories of adolescent cannabis use were
associated with different risks for drug use in young adulthood.
Those who were, or became, heavier users were at greatest risk,
whereas those who maintained a stable, occasional pattern of
use – the most populous group of adolescent-onset cannabis users
– were at less marked, but still elevated, risk of drug use problems
at age 24 years. Occasional users in adolescence who persisted with
occasional use were at higher risk for drug use and drug use
292
Table 1 Association of adolescent cannabis use with background factors and other adolescent measures in 1520 cohort participants
Maximum adolescent cannabis use (waves 1–6)
None (n=999) Occasional use (n=331) Weekly+ use (n=190)
Measure na n (%)b n (%) ORc (95% CI) n (%) ORc (95% CI)
Background factors
Gender
Female
Male
Australian birth
Yes
No
Parental education
Parent completed high school
Low parental education
School
Rural
Melbourne metropolitan
824
696
1339
181
1035
485
398
1122
582 (71)
417 (60)
857 (64)
143 (79)
674 (65)
325 (67)
263 (66)
736 (66)
162 (20)
169 (24)
303 (23)
28 (15)
225 (22)
106 (22)
90 (33)
241 (21)
1
1.5 (1.1–1.9)
1
0.55 (0.35–0.89)
1
0.98 (0.74–1.3)
1
0.96 (0.69–1.3)
80 (10)
110 (16)
180 (13)
10 (6)
136 (13)
54 (11)
45 (11)
145 (13)
1
1.9 (1.4–2.7)
1
0.35 (0.17–0.69)
1
0.82 (0.57–1.18)
1
1.2 (0.80–1.7)
Adolescent measures (waves 1–6)
Depression/anxiety symptoms
No
Yes
High-risk alcohol use
No
Yes
Cigarette smoking
No
Yes
789
731
1373
147
805
715
570 (72)
430 (59)
960 (70)
40 (27)
709 (88)
290 (41)
153 (19)
178 (24)
288 (21)
42 (29)
81 (10)
250 (35)
1
1.5 (1.2–2.1)
1
3.6 (1.9–6.8)
1 (1)
7.5 (5.6–10)
67 (8)
123 (17)
125 (9)
65 (44)
16 (2)
174 (24)
1
2.4 (1.7–3.5)
1
13 (7.5–22)
1
27 (15–49)
a. Frequencies and percentages obtained by averaging across the imputed data-sets.
b. Percentage of exposure category in cannabis use category.
c. Odds ratios (OR) from univariate logistic regression models with reference category ‘no adolescent cannabis use’.
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Post-school qualifications
Government welfare
Depression/anxiety
Alcohol dependence
Nicotine dependence
Any cannabis use
Cannabis dependence
Other illicit drugs
0.90 –
0.80 –
0.70 –
0.60 –
0.50 –
0.40 –
0.40 –
0.30 –
0.20 –
0.10 –
0.00 –
0.40 –
0.30 –
0.20 –
0.10 –
0.30 –
0.20 –
0.10 –
0.00 –
0.30 –
0.20 –
0.10 –
0.00 –
0.90 –
0.60 –
0.30 –
0.00 –
0.40 –
0.30 –
0.20 –
0.10 –
0.00 –
0.60 –
0.40 –
0.20 –
0.00 –
Cannabis use at 20 years None Occasional Weekly+
(n = 579) (n = 376) (n = 44)
Cannabis use in adolescence None
None Occasional Weekly+ Any level
(n = 28) (n = 236) (n = 67) (n = 190)
G
e
n
d
e
r-
ad
ju
st
e
d
p
re
va
le
n
ce
-
-
Occasional Weekly+
—a
—a
—a
Fig. 2 Gender-adjusted prevalence of each outcome at age 24 years according to level of cannabis use during adolescence, and then
by level of cannabis use at age 20 years. The diameter of the circle reflects the precision of the estimate (essentially the size of the
subgroup); the vertical lines represent the 95% confidence interval around the estimate.
a. Cell frequencies were too small to allow for sensible estimation of proportion and standard errors.
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problems than non-users and those who only began occasional use
after adolescence.
Occasional adolescent cannabis use was associated with lower
educational attainment, but this association was substantially
attenuated after adjustment for adolescent tobacco use. It seems
unlikely that tobacco smoking directly affects educational
attainment but this finding does raise a possibility that the social
milieu linked to both tobacco smoking and cannabis use may
contribute to such outcomes.18 A recent study suggested that peer
and parental influences that are linked to smoking during
adolescence also predict poor school grades and thus smokers
were more likely to have poorer academic outcomes.19
Adolescent cannabis use has become normative in many
countries. In some, it may be linked to social competence,
popularity and exploration of new experiences; in others, it may
reflect low family connection, low school commitment and
affiliation with a similarly disengaged peer group. Conversely,
abstention may be the result of social reservedness.4,5,20 Continued
occasional cannabis use was not related to later depression/
anxiety. In contrast, early and continued occasional cannabis use
did predispose to later drug use.
This study was consistent with well-conducted, population-
based cohort study findings that the timing of cannabis use onset
may also be important.21,22 Importantly, the current study found
that even if early-onset cannabis use began and remained as
occasional use, nonetheless, risks for drug use and drug use
problems remained elevated. By studying the varying trajectories
of use, this study has suggested that although a clear
dose–response relationship exists between cannabis use and other
outcomes, whereby regular users were most likely to have adverse
outcomes during young adulthood, occasional adolescent-onset
cannabis use that persists into young adulthood is clearly related
to increased risks of some adverse outcomes, particularly drug
use. The link between early-onset cannabis use and subsequent
drug involvement – the so-called ‘gateway effect’ – has been the
subject of much debate.23–25 Disagreement remains about the
reasons why such associations persist, but researchers have
proposed biochemical explanations that suggest that early-onset
drug use might affect the maturing adolescent brain such that
the user becomes more sensitive to (or disposed towards) other
drug effects.26 Others suggest that learning and socially mediated
processes are more important, whereby young users simply ‘learn’
to incorporate drug use into their lives and/or that use is accom-
panied by entry into social circles that are characterised by multi-
ple types of drug use.23–25 Our findings regarding occasional use
might be considered to be more consistent with psychosocial
rather than biochemical mediation for the association, given the
relatively infrequent exposure to the drug itself.26
Strengths and limitations
The main strengths of this study are its population-based sample
and the frequent detailed measures of drug use and psychosocial
outcomes over a 10-year period. One limitation is that non-response
in longitudinal studies is associated with drug use; however,
we had relatively high participation rates and used multiple
imputation to attempt to minimise non-response biases. All data
were based on self-report which was not externally validated, but
this has been accepted as an appropriate way in which to gain
information about population behaviours.27,28 There were also
no negative consequences for admitting to drug use.28
Some cannabis use may not have been ‘captured’ within
assessment windows in the adolescent waves owing to the 6-month
timeframes. This is probably minimal because of the very high
levels of cannabis use that were nonetheless documented, and
the similarity in levels compared with other young people assessed
in Australia around the same timeframe.29 Wave 8 cannabis
dependence may have been underestimated since only weekly+
users were assessed. However, comparison with Australian survey
data found this was unlikely to occur.30 Finally, the small size of
some groups limited the precision of some comparisons.
Implications
Occasional adolescent cannabis use was associated with higher
levels of drug use in young adulthood compared with non-users.
The confounding effect of tobacco use for a number of outcomes
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Table 2 Association of cannabis use in adolescence with psychosocial outcomes and substance use at 24 years in 1520 cohort
participants, adjusted progressively for: gender; gender, background factors, adolescent depression and alcohol use; and gender,
background factors, adolescent depression, alcohol use and cigarette smoking
Outcome at 24 years (wave 8)
Psychosocial outcomes Licit substance use Illicit substance use
Maximum level of
adolescent cannabis
use (waves 1–6)
Post-school
qualificationsa
(n=1130)
Government
welfare
(n=120)
Depression/
anxiety (GHQ
42) (n=321)
Alcohol
dependence
(n=187)
Nicotine
dependence
(n=147)
Any
cannabis use
(n=508)
Cannabis
dependence
(n=111)
Other
substances
(n=236)
No use (n=999)
n (%)b
OR
786 (79)
1
67 (7)
1
204 (20)
1
187 (9)
1
55 (5)
1
216 (22)
1
15 (1)
1
108 (11)
1
Occasional use (n=331)
n (%)
Model 1,c OR (95% CI)
Model 2,d OR (95% CI)
Model 3,e OR (95% CI)
230 (70)
0.63 (0.47–0.83)
0.69 (0.51–0.91)
0.98 (0.71–1.3)
26 (8)
1.2 (0.73–2.1)
1.2 (0.68–2.0)
0.97 (0.55–1.7)
75 (23)
1.2 (0.88–1.7)
1.2 (0.81–1.6)
0.94 (0.65–1.4)
50 (15)
1.6 (1.1–2.4)
1.5 (1.0–2.3)
1.3 (0.82–2.0)
50 (15)
3.1 (2.0–4.8)
2.8 (1.7–4.4)
1.3 (0.79–2.1)
154 (46)
3.0 (2.3–4.0)
2.9 (2.2–3.9)
2.2 (1.6–3.0)
33 (10)
7.1 (3.5–14)
6.4 (3.2–13)
4.0 (1.9–8.4)
92 (28)
3.1 (2.1–4.4)
2.9 (2.1–4.2)
2.4 (1.6–3.6)
Weekly+ use (n=190)
n (%)
Model 1,c OR (95% CI)
Model 2,d OR (95% CI)
Model 3,e OR (95% CI)
113 (60)
0.41 (0.29–0.58)
0.50 (0.34–0.73)
0.84 (0.55–1.3)
27 (14)
2.4 (1.3–4.3)
2.1 (0.97–4.4)
1.6 (0.68–3.7)
42 (22)
1.3 (0.85–1.9)
1.2 (0.77–1.8)
0.88 (0.55–1.4)
43 (23)
2.6 (1.7–4.0)
2.2 (1.3–3.6)
1.7 (0.95–2.9)
42 (22)
5.0 (3.2–7.7)
3.9 (2.4–6.4)
1.3 (0.77–2.3)
139 (73)
9.3 (6.3–14)
8.6 (5.7–13)
5.6 (3.5–9.0)
55 (29)
25 (13–47)
21 (11–41)
10 (4.7–22)
114 (60)
12 (8.1–17)
11 (7.2–16)
7.8 (4.9–12)
GHQ, General Health Questionnaire.
a. Frequencies and percentages obtained by averaging across the imputed data-sets.
b. Percentage of group with each adolescent level of cannabis use with each young adult outcome.
c. Model 1: odds ratios (OR) from multivariable logistic regression models, adjusted for gender.
d. Model 2: as for Model 1, with further adjustment for non-Australian birth and in adolescence (waves 1–6): any symptoms of depression and anxiety and any high-risk alcohol use.
e. Model 3: as for Model 2, with further adjustment for maximum level of cigarette smoking in adolescence.
Occasional cannabis use in adolescence
suggests possible mediating effects of underlying risk-taking
behaviours in increasing risk for some adverse psychosocial
outcomes. Exaggerated messages about severe harms of occasional
cannabis use would be unfounded and at odds with the experience
of this group. Yet interventions to reduce escalation of both
cannabis and other drug use among occasional users do seem
warranted. Given that occasional users are unlikely to present to
specialised services, this message might be best delivered through
screening in primary care or community-level health education.31
Louisa Degenhardt, PhD, National Drug and Alcohol Research Centre, University
of New South Wales, Sydney, New South Wales; Carolyn Coffey, MSc, PhD, Centre
for Adolescent Health, Murdoch Children’s Research Institute, Melbourne, Victoria;
John B. Carlin, PhD, Clinical Epidemiology & Biostatistics Unit, Murdoch Children’s
Research Institute, and University of Melbourne Department of Paediatrics,
Melbourne, Victoria; Wendy Swift, PhD, National Drug and Alcohol Research Centre,
University of New South Wales, Sydney, New South Wales; Elya Moore, PhD,
Department of Microbiology and Infectious Diseases, Royal Women’s Hospital,
Melbourne, Victoria; George C. Patton, PhD, Centre for Adolescent Health, and
Clinical Epidemiology & Biostatistics Unit, Murdoch Children’s Research Institute,
Melbourne, Victoria, and University of Melbourne Department of Paediatrics,
Melbourne, Victoria, Australia
Correspondence: Louisa Degenhardt, National Drug and Alcohol
Research Centre, University of New South Wales, 2052, NSW, Australia.
Email: l.degenhardt@unsw.edu.au
First received 7 Nov 2008, final revision 3 Aug 2009, accepted 21 Dec 2009
Funding
Funding has been provided by the Australian National Health and Medical Research Council
and the Australian Government Department of Health and Ageing. The funding body had
no role in the design, analysis or interpretation of study findings, nor in the decision to
submit this paper for publication.
References
1 Hall W, Degenhardt L, Lynskey M. The Health and Psychological Effects of
Cannabis Use. NCADA Monograph No. 44. Australian Publishing Service,
2001.
2 Moore T, Zammit S, Lingford-Hughes A, Barnes T, Jones P, Burke M, et al.
Cannabis use and risk of psychotic or affective mental health outcomes: a
systematic review. Lancet 2007; 370: 319–28.
3 Hall W, Degenhardt L. Prevalence and correlates of cannabis use in
developed and developing countries (invited review). Curr Opin Psychiatry
2007; 20: 393–7.
4 Shedler J, Block J. Adolescent drug use and psychological health:
a longitudinal inquiry. Am Psychol 1990; 45: 612–30.
5 Tucker J, Ellickson PL, Collins RL, Klein D. Are drug experimenters better than
abstainers? A longitudinal study of adolescent marijuana use. J Adolesc
Health 2006; 39: 488–94.
6 Paperny D, Aono J, Lehman R, Hammar S, Risser JC. Computer-assisted
detection and intervention in adolescent high-risk health behaviours.
J Paediatrics 1990; 116: 456–62.
7 National Health and Medical Research Council. Australian Guidelines to
Reduce Health Risks from Drinking Alcohol. Australian Government
Publishing Service, 2009.
8 Coffey C, Carlin JB, Lynskey M, Li N, Patton GC. Adolescent precursors of
cannabis dependence: findings from the Victorian Adolescent Health Cohort
Study. Br J Psychiatry 2003; 182: 330–6.
9 Lewis G, Williams P. Clinical judgement and the standardized interview in
psychiatry. Psychol Med 1989; 19: 971–9.
10 Lewis G, Pelosi A, Araya R, Dunn G. Measuring psychiatric disorder in the
community: a standardized assessment for use by lay interviewers. Psychol
Med 1992; 22: 465–86.
11 Harrington R, Fudge H, Rutter M, Pickles A, Hill J. Adult outcomes of
childhood and adolescent depression: II. Links with antisocial disorders.
J Am Acad Child Adolesc Psychiatry 1991; 30: 434–9.
12 Goldberg D. The Detection of Psychiatric Illness by Questionnaire. Oxford
University Press, 1972.
13 Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its
assessment. Ear Nose Throat J 1991; 69: 763–6.
14 World Health Organization. Composite International Diagnostic Interview (CIDI
core) Version 2.1 (12-month version). WHO, 1997.
15 Schafer JL. Analysis of Incomplete Multivariate Data. Chapman and Hall,
1997.
16 Bernaards CA, Belin TR, Schafer JL. Robustness of a multivariate normal
approximation for imputation of incomplete binary data. Stat Med 2007; 26:
1368–82.
17 Carlin JB, Galati JC, Royston P. A new framework for managing and analysing
multiply imputed data in Stata. Stata J 2008; 8: 49–67.
18 Mathers M, Toumbourou J, Catalano R, Williams JB, Patton G. Consequences
of youth tobacco use. A review of prospective behavioural studies. Addiction
2006; 101: 948–58.
19 Tucker J, Martinez JP, Ellickson PL, Edelen M. Temporal associations of
cigarette smoking with social influences, academic performance and
delinquency: a four wave longitudinal study from ages 13 to 23. Psychol
Addict Behav 2008; 22: 1–11.
20 Suris J, Akre C, Berchtold A, Jeannin A, Michaud P-A. Some go without a
cigarette. Arch Pediatr Adolesc Med 2007; 161: 1042–7.
21 Brook JS, Balka EB, Whiteman M. The risks for late adolescence of early
adolescent marijuana use. Am J Public Health 1999; 89: 1549–54.
22 Kandel DB, Yamaguchi K, Chen K. Stages of progression in drug involvement
from adolescence to adulthood: further evidence for the gateway theory.
J Stud Alc 1992; 53: 447–57.
23 Hall W. Dissecting the causal anatomy of the link between cannabis and
other illicit drugs. Addiction 2006; 101: 472–3.
24 Fergusson D, Boden J, Horwood LJ. Cannabis use and other illicit drug use:
testing the cannabis gateway hypothesis. Addiction 2006; 101: 556–66.
25 Morral A, McCaffrey D, Paddock S. Reassessing the marijuana gateway
effect. Addiction 2002; 97: 1493–504.
26 Schenk S. Sensitization as a process underlying the progression of drug use
via gateway drugs. In Stages and Pathways of Drug Involvement: Examining
the Gateway Hypothesis (ed D Kandel): 318–36. Cambridge University Press,
2002.
27 Fendrich M, Mackesy-Amiti ME, Johnson TP, Hubbell A, Wislar JS. Tobacco-
reporting validity in an epidemiological drug-use survey. Addict Behav 2005;
30: 175–81.
28 Harrison L. The validity of self-reported drug use in survey research: an
overview and critique of research methods. NIDA Res Monogr 1997; 167:
17–36.
29 Australian Institute of Health and Welfare. National Drug Strategy Household
Survey 2004: Detailed Findings. AIHW, 2005 (http://www.aihw.gov.au/
publications/phe/ndshsdf04/ndshsdf04.pdf).
30 Coffey C, Carlin J, Degenhardt L, Lynskey M, Sanci L, Patton G. Cannabis
dependence in young adults: an Australian population study. Addiction 2002;
97: 187–94.
31 Toumbourou J, Stockwell T, Neighbors C, Marlatt G, Sturge J, Rehm J.
Interventions to reduce harm associated with adolescent substance use.
Lancet 2007; 369: 1391–401.
295
Chapter 5 Other substance use 
 
111 
 
5.5 Progression to other substance use 
Paper 9. Cannabis and progression to other substance use in young adults: Findings 
from a 13-year prospective population-based study. W. Swift, C. Coffey, L. 
Degenhardt, J.B. Carlin, H. Romaniuk, G. C. Patton. J Epidemiol Community Health 
2012;66:e26 Published Online First: 19 July 2011 doi:10.1136/jech.2010.129056 
Journal impact factor 3.2 (source: Journal Citation Reports, 4/03/2013) 
6 citations, as at 4/03/2013 (source: Google Scholar). 
This recently published paper builds conceptually on the first two papers discussed in 
this chapter, in that it examines the Gateway Theory in more detail as it relates to 
both licit and other illicit substance use. We were interested in the interplay between 
cannabis use and each of the substance use outcomes: cigarette smoking, problematic 
alcohol use and any use of amphetamines, cocaine and ecstasy in the past year. This 
paper extends the follow-up period to Wave 9, when participants were about 29 years 
and substance use behaviour was likely to be more entrenched than in earlier waves 
in those who continued using. 
5.5.1 My contribution 
The lead author was Dr. Wendy Swift from the National Drug and Alcohol Centre at 
the University of New South Wales. I contributed substantially to the 
conceptualisation of the question and was responsible for its operationalisation, the 
analysis and methods. I contributed to the introduction, results and discussion and 
with the response to the reviewers’ comments. The declaration of my contribution, 
estimated as 40%, is in Appendix 2. 
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5.5.2 Analysis and results 
Firstly, we illustrated cross-sectional relationships with cigarette smoking, 
problematic alcohol use and any use of amphetamines, cocaine and ecstasy in the 
past year at each young adult wave (Waves 7, 8 and 9) in order to present a 
preliminary picture of the progress of these associations through this developmental 
period. Not only did patterns of cannabis use change during this period from the age 
of peak use at 20 years, largely due to subsequent quitting by occasional users, but 
also the patterns of associated substance use changed on their own account and in 
relation to co-occurring cannabis use frequency. As we would expect from the 
findings of disparate trajectories for problematic alcohol and cannabis use reported in 
Chapter 4, the pattern of associations between cannabis use and risky alcohol use did 
not conform to those found for other substances. For the other substances, peak 
associations tended to be with weekly/daily cannabis use at 20 years and 24 years 
(Waves 7 and 8, the focus of the previous paper), but by 29 years (Wave 9), this 
appeared to be restricted to weekly users. 
We examined the predictive association between the frequency of cannabis use and 
subsequent incident and cessation of each other substance use outcome. Albeit with 
poor precision due to small numbers of incident transitions, we demonstrated that 
daily cannabis use increased the risk for initiation of cigarette smoking, extending the 
findings reported in Paper 7 discussed in this chapter in §5.3 (Patton, GC et al. 2005). 
Weekly and daily cannabis use posed comparable risks for uptake of the other illicit 
substances, but there was no apparent association with initiation of high risk alcohol 
use, as we expected. Predictably, cessation of cigarette smoking and problematic 
alcohol use were more likely in never-cannabis users, and considerably less likely in 
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daily users than in occasional users. While acknowledging our limited ability to 
interpret the associations due to generally poor precision, it seems that those who 
ceased using cannabis were indistinguishable from non-users on most outcomes. 
5.5.3 Implications 
Again, explanations for these observations relate to possible combinations of 
biological and psychosocial liabilities. Animal studies have demonstrated the 
development of cross-tolerance to a range of illicit substances due to the interaction 
between the cannabinoid and dopamine systems affected by cannabis exposure 
during pubertal development (Schneider 2008). This may underlie or contribute to 
the role of peer acceptance of drug use and drug availability, possibly in the context 
of family conflict and other social stressors. Our findings underline the consequences 
of continuing cannabis use well into young adulthood with respect to other substance 
use, but also illustrates that patterns of association between cannabis and the other 
substance use vary across cannabis use frequencies as the cohort ages, and also 
between substances. 
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5.5.4 Paper 9: Cannabis and progression to other substance use in 
young adults: Findings from a 13-year prospective population-
based study. 
W. Swift, C. Coffey, L. Degenhardt, J.B. Carlin, H. Romaniuk, G. C. Patton. J 
Epidemiol Community Health 2012;66:e26 Published Online First: 19 July 2011 
doi:10.1136/jech.2010.129056 
 
  
Cannabis and progression to other substance use in
young adults: ﬁndings from a 13-year prospective
population-based study
Wendy Swift,1 Carolyn Coffey,2 Louisa Degenhardt,1,3 John B Carlin,4,5
Helena Romaniuk,2,4 George C Patton2,4,5
ABSTRACT
Background Adolescent cannabis use predicts the onset
of later illicit drug use. In contrast, little is known about
whether cannabis in young adulthood also predicts
subsequent progression or cessation of licit or illicit drug
use.
Methods 13-year longitudinal cohort study with
recruitment in secondary school students in Victoria,
Australia. There were six waves of adolescent data
collection (mean age 14.9e17.4 years) followed by
three in young adulthood (mean age 20.7, 24.1 and
29.0 years). Discrete-time proportional hazards models
were used to assess predictive associations between
cannabis use frequency (occasional (<weekly), weekly
to less than daily and daily) in 1756 participants in earlier
young adult waves and subsequent cigarette smoking,
high-risk alcohol use and amphetamine, ecstasy and
cocaine use, including incident use (uptake) and
cessation in later young adult waves.
Results Compared with continuing occasional cannabis
use: (1) never use provided the strongest protection from
uptake of all drugs; (2) quitting cannabis lowered rates of
illicit drug use uptake; (3) weekly+cannabis users had
two to three times the rates of illicit drug use uptake,
while daily users had six times the rate of uptake of
cigarette smoking; and (4) never use of cannabis was
associated with higher rates of cessation from licit drug
use, while daily cannabis predicted lower cessation rates
for all drugs except cocaine.
Conclusions This study provides compelling evidence of
the continuing association between cannabis, licit and
other illicit drug use well into young adulthood.
Preventing cannabis use uptake and use escalation
remain crucial health aims given the burden associated
with cigarette, alcohol and illicit drug use.
BACKGROUND
Adolescence brings shifts in lifestyle and social
roles that coincide with experimentation with
cannabis and other drugs. The relationship between
adolescent cannabis use and a variety of adverse
health and life outcomes has been an important
recent research focus. In addition to increasing
the risk of future problematic cannabis use,1e3
educational failure4 and poor social adjustment in
young adulthood,5 6 regular cannabis use has been
found to increase the risk of subsequent use of
other illicit drugs, such as amphetamine and
cocaine.7e10
The ‘gateway ’ theory of drug use posited
a central positioning of cannabis in a sequence of
drug involvement commencing with tobacco and
alcohol use, with cannabis use preceding initiation
into use of other illicit drugs and increasing the
likelihood of their use.11 There remains uncertainty
about whether the association between cannabis
and subsequent illicit drug use reﬂects characteris-
tics of people who use cannabis, the effects of the
drug itself or other uncontrolled confounders in
the available studies.12e15
Cannabis use is believed to peak in early adult-
hood, with a decline from the mid-20s, perhaps due
to new roles and responsibilities.16e18 Few studies
have examined the question of whether cannabis
use may affect the natural history of other illicit
drug use in young adulthooddfor example,
patterns of progression, cessation and relapsedas
well as the initiation of use. This is particularly
relevant in more recent birth cohorts in which there
has been a notable rise in the prevalence of cannabis
use and the use of amphetamines and ecstasy
among young adults, coupled with a decrease in
the age of initiation of drug use.19 20
The effect of cannabis use on the natural history
of alcohol and tobacco use has also received little
attention. This is of substantial public health
importance given the enormous preventable health
burden associated with the latter substances.
Tobacco and alcohol are typically initiated prior to
cannabis use, and the prevalence of their use across
the lifespan is higher. Regular adult cigarette
smoking patterns are commonly established during
adolescence,21 and adolescent tobacco smoking
increases the odds of problematic cannabis use in
young adulthood, even after adjusting for
frequency of adolescent cannabis use.3 There is
a growing body of data suggesting that cannabis
use may predict transitions into, and maintenance
of, tobacco use.22e24 There is some evidence that
adolescents may select into early distinct cannabis
and alcohol use trajectories, but whether cannabis
use affects later uptake and persistence of alcohol
use is uncertain.8 25
In this paper, we extend previous work on the
relationships between cannabis and other drug use
in young adulthood by investigating the:
1. cross-sectional relationships between cannabis
use frequency and cigarette smoking, high-risk
alcohol use and amphetamine, cocaine and
ecstasy use over time; and
2. prospective associations between patterns of
earlier cannabis use and incident use and
cessation of licit and illicit drug use, after
controlling for potential confounding factors.
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METHODS
Sample
Between August 1992 and January 2008, we conducted a nine-
wave cohort study of health in adolescents and young adults in
Victoria, Australia. The cohort was a representative sample of
Victorian mid-secondary school adolescents in 1992, deﬁned in
a two-stage cluster sample. The ﬁrst phase of sampling was by
school and the second by classroom, with two classes selected at
random from a state-wide sample of 44 schools, one class
entering the study in the latter part of the ninth school year
(wave 1) and the second class 6 months later (wave 2). School
retention rates to year 9 in the year of sampling were 98%.
Potential participants absent at the time of surveying in waves 1
and 2 were invited to take part in subsequent waves, but still in
the same year level as other cohort participants. Thus, variation
within wave in the adolescent phase was consistent with the
variation you would ﬁnd in any classroom. Participants were
interviewed at four 6-month intervals during the teens (waves
3e6) with three follow-up waves in young adulthood, aged
20e21 years (wave 7), 24e25 years (wave 8) and 29 years (wave
9). In waves 1e6, participants self-administered the question-
naire on laptop computers with telephone follow-up of those
absent from school. From a total sample of 2032 students, 1943
(95.6%) participated at least once during the ﬁrst six (adolescent)
waves (ﬁgure 1). The seventh to ninth waves were undertaken
using computer-assisted telephone interviews,26 with 1756 (53%
female) participating in at least one of these waves and known
to be alive at the time of the wave 9 survey. Of these, 1282
completed all three young adult waves, 293 completed two and
181 completed one only. Wave 9 interviews were completed by
January 2008, at which time, 15 cohort members were known to
have died, 108 were lost to follow-up and 319 refused to
participate.
Measures
Background measures included sex, school location at study
inception (metropolitan Melbourne or rural), parental education
(not tertiary, tertiary), parental smoking status and parental
divorce/separation during the participant’s adolescence.
Cannabis use: Participants reported their frequency of cannabis
use. We identiﬁed non-use, less than weekly use (‘occasional’),
weekly but less than daily use (‘weekly’) or almost daily use
(‘daily ’). In the prospective analysis of incidence and cessation of
other drugs at waves 8 and 9, cannabis non-users at the previous
waves (7 and 8, respectively) were reclassiﬁed as previous users
(not currently using but reported using in at least one earlier
wave) and non-users.
Cigarette smoking: Participants who reported smoking any
cigarettes in the past month were classiﬁed as cigarette smokers.
Alcohol usewas assessed using a beverage- and quantity-speciﬁc
1-week diary.27 Long-term high-risk alcohol use was calculated
according to Australian guidelines28 from the total alcohol
consumed during the week prior to survey and deﬁned as
exceeding 14 standard drinks (1 standard drink¼10 g alcohol) in
the week prior to survey.
Illicit substance use other than cannabis use was deﬁned as use in
the past year of ecstasy/designer drugs and cocaine at waves 7e9
and amphetamines for waves 2e9.
Incident (new) cigarette smoking and high-risk alcohol use was
identiﬁed at waves 8 and 9 in participants who had not previ-
ously reported this, including in adolescence. Incident cocaine
and ecstasy use was identiﬁed at waves 8 and 9 in participants
who had not reported use at a previous adult wave. Participants
who used amphetamines in adolescence were deemed ineligible
for incident uptake at waves 8 or 9.
Cessation was deﬁned at waves 8 and 9 as a report of not using
cigarettes, amphetamine, cocaine or ecstasy or as drinking
alcohol below the high-risk threshold among those who reported
use in the previous wave.
Analysis
The prevalence of licit and illicit drug use in the adult waves
(7e9) and cross-sectional associations between frequency of
cannabis use and other concurrent drug use were estimated.
Associations between background factors and cigarette smoking,
high-risk alcohol use, cannabis use and any other illicit drug use
at waves 7e9 were assessed using logistic regression models
ﬁtted using generalised estimating equations to allow for
repeated measures within individuals. Discrete-time propor-
tional hazards models, using robust SEs, were used to model
associations between both incidence of other drug use and
cessation of other drug use, and the frequency of cannabis use at
the previous wave. As the young adult survey periods were
longer than those in the adolescent phase, resulting in a larger
spread of ages, we adjusted for age in these analyses (table 1).
While there was little missingness on individual measures for
each survey completed, we used multiple imputation to address
potential bias and loss of information arising from respondents’
missing waves.29 Of the 59 outcome, background and auxiliary
variables included in the multiple imputation model, 4 variables
were completely observed, 12 had <10% missing, 32 had 10% to
<20% missing and 11 had >20% missing. No variable was
missing for >25% of participants. We imputed 20 complete data
sets under a multivariate normal model using adaptive rounding
for binary measures.30 The analysis included only those partic-
ipants who had been seen at least once in adolescence (waves
2e6) and at least once in adulthood (waves 7e9); wave 1 was
omitted as it contained observations from only 46% of the
cohort, and participants with no adult phase observations were
omitted as they contained too little information. Thirty-three
participants had responded to one or more adult waves but were
only seen once in adolescence at wave 1, and we included these
individuals by bringing forward their wave 1 observations to
wave 2. Thus, the analysis data set was deﬁned by participation
in at least one of the young adult waves (waves 7e9) and
known to be alive at the time of the wave 9 survey (n¼1756).
Figure 1 Sampling and ascertainment
in the Victorian Adolescent Health
Cohort, 1992e2008.
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Low prevalence of amphetamine use in waves 2e6 precluded
imputation, so amphetamine use was assumed to be absent in
these waves when not completed. All frequencies and ORs were
obtained by averaging results across the imputed data sets with
inferences under multiple imputation obtained using Rubin’s
rules.29 31 All analysis was undertaken using Stata 11.32
RESULTS
There was a decrease in the prevalence of cigarette smoking from
24 to 29 years, while high-risk alcohol use remained fairly stable
(table 2). A decreased prevalence of any 12-month cannabis use
was largely driven by decreased occasional use, resulting in an
increase in the relative frequency of regular (weekly+) use among
all users: 20 years: 24% (95% CI 22 to 27); 24 years: 36% (95% CI
32 to 40); 29 years: 39% (95% CI 35 to 44). In comparison, the
overall 12-month prevalence of other illicit drug use increased
markedly, albeit from much lower levels. By 29 years, one in ﬁve
participants reported using amphetamine, ecstasy or cocaine in the
past 12 months compared with one in four who used cannabis.
From ages 20e29 years, the prevalence of 12-month cigarette
smoking and high-risk alcohol use was consistently higher
among those reporting at least weekly (although not necessarily
daily) cannabis use (ﬁgure 2). Twelve-month amphetamine,
cocaine or ecstasy use was virtually non-existent among non-
users of cannabis. While use of these drugs was more likely
among more regular cannabis users at 20 and 24 years, by
29 years, the association between cannabis use frequency and
other illicit drug use was less clear, particularly for cocaine.
Table 3 describes the associations between background factors
and cannabis, high-risk alcohol, cigarette and other illicit drug
use in young adulthood. Age, male sex, attending a metropolitan
school and parental tertiary education, divorce/separation and
cigarette smoking were associated with use of at least one
type of substance during the young adult phase (table 3).
We therefore adjusted for these potential confounders in all
models.
Other drug use uptake
Table 1 displays the associations between young adult cannabis
use (ages 20 years_wave 7 and 24 years_wave 8) and rates of
incident uptake and cessation of cigarette smoking, high-risk
alcohol consumption and amphetamine, cocaine and ecstasy use
at the subsequent wave (ages 24 years_wave 8 and 29 years_
wave 9, respectively). Compared with those who reported
Table 1 Cannabis use as a predictor of incident uptake and cessation from licit or illicit drug use at 24 and 28 years (waves 8 and 9) in 1756 cohort
participants, adjusted for possible background confounders
Outcome transition exposure
Cigarettes High-risk alcohol Amphetamine Cocaine Ecstasy
HR* (95% CI) HR (95% CI) HR* (95% CI) HR (95% CI) HR (95% CI)
Incident uptake n¼106y n¼274 n¼212 n¼208 n¼352
Cannabis use in the previous wave
Never user 0.44 (0.25 to 0.76) 0.45 (0.33 to 0.62) 0.23 (0.14 to 0.40) 0.15 (0.08 to 0.28) 0.18 (0.12 to 0.27)
Past userz 0.52 (0.21 to 1.3) 0.72 (0.43 to 1.2) 0.52 (0.31 to 0.88) 0.53 (0.30 to 0.93) 0.37 (0.24 to 0.58)
Occasional 1 1 1 1 1
Weekly 1.4 (0.36 to 5.2) 1.3 (0.74 to 2.4) 2.6 (1.7 to 4.1) 2.3 (1.5 to 3.5) 2.1 (1.5 to 3.0)
Daily 6.1 (2.7 to 13) 1.5 (0.83 to 2.8) 2.9 (1.7 to 4.8) 1.9 (1.2 to 3.2) 2.8 (2.0 to 4.0)
Cessation n¼352 n¼427 n¼173 n¼110 n¼221
Cannabis use in the previous wave
Never user 1.6 (1.1 to 2.3) 1.5 (1.1 to 2.1) 1.2 (0.37 to 3.6) 7.0 (0.42 to 117) 1.4 (0.57 to 3.4)
Past user 1.3 (0.97 to 1.8) 0.94 (0.68 to 1.3) 0.67 (0.35 to 1.3) 1.1 (0.48 to 2.3) 1.5 (0.93 to 2.3)
Occasional 1 1 1 1 1
Weekly 0.90 (0.60 to 1.4) 0.81 (0.56 to 1.2) 0.67 (0.42 to 1.1) 0.75 (0.40 to 1.4) 0.73 (0.49 to 1.1)
Daily 0.59 (0.37 to 0.93) 0.66 (0.42 to 1.0) 0.57 (0.36 to 0.91) 0.79 (0.45 to 1.4) 0.65 (0.42 to 1.0)
*HRs from multivariable discrete-time proportional hazards models, adjusted for sex, age, school location at study inception, parental divorce/separation, parental smoking status and parental
tertiary education, using robust SEs to allow for repeated measures within individuals.
y‘n’ denotes the number of events across both waves 8 and 9.
zReported cannabis use at a wave prior to the at-risk interval for incident transition or cessation, that is, participants who reported using any cannabis in adolescence (waves 2e6) were
identiﬁed, and this information was used to determine whether non-users in wave 7 were actually ‘past users’ (they had used prior to the index wave). Similarly, wave 8 non-users were
deemed ‘past users’ if they reported adolescent use or use in wave 7.
Table 2 Prevalence of drug use in the past 12 months at ages 20 years, 24 years and 29 years in 1756
cohort participants
Substance use in past 12 months
20 years (wave 7) 24 years (wave 8) 29 years (wave 9)
% (95%CI) % (95% CI) % (95% CI)
Any cigarette smoking 40.9 (38.5 to 43.3) 39.6 (37.1 to 42.0) 34.0 (31.6 to 36.3)
High-risk alcohol use 24.5 (22.4 to 26.6) 29.2 (26.9 to 31.4) 26.4 (24.1 to 28.7)
Any cannabis use 58.4 (56.1 to 60.8) 34.1 (31.8 to 36.4) 27.7 (25.4 to 30.0)
Maximum frequency of cannabis use
Occasional 44.1 (41.7 to 46.5) 21.8 (19.7 to 23.9) 16.8 (14.8 to 18.7)
Weekly 7.3 (6.0 to 8.5) 6.5 (5.2 to 7.7) 4.1 (3.1 to 5.2)
Daily 7.1 (5.8 to 8.3) 5.8 (4.7 to 6.9) 6.8 (5.6 to 8.0)
Any of amphetamines, cocaine, ecstasy 11.0 (9.4 to 12.5) 21.2 (19.1 to 23.3) 21.2 (19.1 to 23.4)
Amphetamines 7.7 (6.4 to 9.0) 11.1 (9.5 to 12.7) 12.5 (10.6 to 14.4)
Cocaine 3.0 (2.2 to 3.8) 8.4 (7.0 to 9.7) 8.8 (7.3 to 10.3)
Ecstasy 7.7 (6.4 to 9.0) 18.3 (16.4 to 20.2) 15.8 (14.0 to 17.7)
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occasional cannabis use in the previous wave, never-users were
clearly at reduced risk of incident use of all other drugs. Past (or
‘lapsed’) users had lower rates of incident use of all illicit drugs.
The relatively small proportion of incident transitions (7% of
never smokers) into smoking means these estimates were less
precise. Participants reporting daily cannabis use had started
smoking cigarettes by the next wave at six times the rate of
occasional cannabis users, but there was only weak evidence
that daily cannabis users were at greater risk of incident high-
risk alcohol consumption. In those reporting weekly and daily
cannabis use rates of subsequent incident amphetamine, cocaine
and ecstasy use were consistently about two to three times the
rate of those reporting occasional use.
Cessation of other drug use
Cessation of cigarette smoking and high-risk alcohol use was
somewhat more likely among those who had never used
cannabis compared with those reporting occasional cannabis use
in the previous wave. Conversely, those using cannabis daily
were less likely than occasional users to quit cigarette, high-risk
alcohol, amphetamine or ecstasy use. Additional adjustment for
high-risk alcohol use and cigarette smoking in the previous wave
had a negligible impact on the associations between cannabis
use and incidence and cessation of other illicit drug use.
CONCLUSIONS
The prevalence of cannabis use declined sharply as this cohort
aged, with regular users comprising an increasing proportion of
ongoing users; concomitantly, prevalence of other illicit drug use
increased, consistent with Australian population data.33
Cannabis use appeared intimately connected with the course of
both licit and illicit drug use in these years beyond adolescence.
We conﬁrmed the links between adolescent cannabis use and
subsequent illicit drug use7e10 as well as its ‘reverse gateway ’
effect on smoking uptake.22e24 33 We found that frequent
cannabis use in young adulthood was associated with increased
rates of progression in both cigarette smoking and other illicit
drug use. Never having used cannabis predicted substantially
reduced rates of uptake of all other drugs. So too, quitting
cannabis predicted a reduced uptake of drug use, particularly of
illicit drugs.
Ongoing regular cannabis use (particularly daily use) predicted
the maintenance of other drug use, markedly reducing rates of
cessation of high-risk alcohol use and use of all other drugs
excluding cocaine. This latter may partly reﬂect differing
population patterns of illicit drug use in Australia during this
period, with lower cocaine prevalence rates (5% reporting past
year use) than amphetamine (7%) and ecstasy (11%), and more
sporadic patterns of use, compared with these other drugs.34
Figure 2 Prevalence of substance use at 20 years (wave 7), 24 years (wave 8) and 29 years (wave 9) in 1756 cohort participants, stratiﬁed by
concurrent cannabis use at each wave. Per cents are shown with 95% CIs.
Table 3 Associations between background factors and drug use from 21 to 28 years in 1756 cohort
participants
Background factor N
Cannabis use High-risk alcohol Cigarette smoking
Any of amphetamine,
cocaine, ecstasy
OR* (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Age at wave (years) 0.9 (0.85 to 0.88) 1.01 (1.00 to 1.03) 1 (0.96 to 0.98) 1.08 (1.06 to 1.10)
Sex
Female 931 1 1 1 1
Male 825 1.9 (1.6 to 2.2) 4.3 (3.6 to 5.1) 1.3 (1.1 to 1.6) 2.0 (1.6 to 2.4)
School at study inception
Metropolitan 1299 1 1 1 1
Rural 457 0.9 (0.74 to 1.0) 1.3 (1.1 to 1.5) 0.9 (0.76 to 1.1) 0.7 (0.56 to 0.90)
Parental education
Not tertiary 1183 1 1 1 1
Tertiary 573 1.3 (1.1 to 1.5) 1.2 (1.0 to 1.4) 0.9 (0.72 to 1.0) 1.4 (1.1 to 1.7)
Parental divorce/separation
No 1369 1 1 1 1
Yes 387 1.6 (1.3 to 1.9) 1.2 (0.94 to 1.4) 1.6 (1.3 to 1.9) 1.3 (1.1 to 1.7)
Parental smoking
No 1066 1 1 1 1
Yes 690 1.3 (1.1 to 1.5) 1.1 (0.95 to 1.3) 1.9 (1.6 to 2.3) 1.2 (0.97 to 1.5)
*ORs from univariate logistic regression models, with robust SEs allowing for repeated measures within individuals.
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Despite being protective in the uptake of other drugs, cannabis
quitting had no clear effect on cessation of other drug use.
Given the differential association between cannabis use
frequency and uptake versus cessation of different drug classes,
it is likely that various mechanisms might underpin these
associations. Cannabis affects dopaminergic reward systems
implicated in the rewarding and reinforcing properties of several
drugs, including alcohol, opioids and MDMA (ecstasy).35e38
Recent evidence suggests that both repeated administration of
tetrahydrocannabinol (THC, the main psychoactive cannabi-
noid in cannabis) and cannabis withdrawal may exert long-
lasting functional and structural changes to this system.39e41
Our ﬁndings on increased uptake and persistence of other
substance use in regular cannabis users may also reﬂect
psychosocial processes. Various indices of social marginalisation,
such as poorer educational outcomes, unemployment and
welfare dependence, as well as greater exposure to availability of
drugs and more permissive attitudes towards other drug use that
may be associated with regular cannabis use, might provide
a conducive context and lower the barriers for engaging in other
substance use.14 42 Our data on smoking uptake and cessation
suggest a reciprocal relationship between cannabis use and
cigarette smoking that varies according to age and stage of drug
involvement,43 and which may be changing due to earlier initi-
ation to cannabis use and decreasing approval of cigarette
smoking. In addition to the mechanisms described above, our
data on an increased likelihood of smoking among regular
cannabis users may also reﬂect reduced barriers to smoking due
to shared route of administration.43 44 Given the sparse literature
on the natural history of cannabis and other drug use in young
adulthood, a better understanding of possible mechanisms
underpinning these associations is an important direction for
research.45
Kandel and colleagues’ seminal longitudinal work on cannabis
cessation in adulthood42 found that, among other factors, adult
social role participation, particularly marriage and parenthood,
were important in shortening a cannabis use career. Our ﬁndings
suggest that promoting the transitions out of cannabis use in
young adulthood may also bring beneﬁts in reducing use of other
substances. However, as the likelihood of cessation also depends
on earlier levels of cannabis use, delaying onset and reducing
early escalation in cannabis use will also remain important.
Strengths and limitations
The main strengths of this study include the population-based
sample, the high participation rates and the frequent drug use
and other measures over 13 years. By deﬁnition, we can only
speculate on the possible effects of non-participation at waves
7e9 on outcome patterns compared with those seen in the
participants, but given the relatively high cohort retention (78%
of adolescent participants), we believe that it is unlikely to have
caused major biases in our results. All data were based on self-
report that was not externally validated, but this has been
accepted as an appropriate way in which to gain information
about population behaviours.46e48 As ecstasy and cocaine use
were not measured during adolescence, it is possible that some
cases of illicit drug use incidence were overstated. However,
given the low population prevalence of use of these drugs among
adolescents (1%e4%) and an average age of initiation of at least
20 years,34 it is unlikely this had a notable effect on estimates.
Furthermore, Australian national guidelines used to deﬁne high-
risk alcohol consumption did not distinguish between binge
drinking and long-term harm. As the threshold for harm is 14
standard drinks per week, this should encompass serious binge
drinking. There is also potential for misclassiﬁcation of drinking
status as alcohol consumption was based on diary data collected
for the week prior to survey. Finally, confounding by unmea-
sured genetic or other background factors cannot be excluded,
although controlling for several important contextual factors
made little difference to the estimates.
The generalisability of these data beyond Australia is
supported by a general comparability between rates of cannabis
use among Australian adults and adolescents in other Western
countries such as New Zealand, the USA, Canada and the UK.49
Nevertheless, it is worth considering recent research across 17
countries that revealed a strong inﬂuence of the background
national prevalence of drug use on patterns of drug use initiation
and progression.15
Implications
Ongoing regular cannabis use in young adulthood predicts the
uptake and maintenance of licit and illicit drug use throughout
this period. Whether cannabis use is a marker for other risk
processes remains debatable but promotion of reduced use of
cannabis in young adulthood including cannabis quitting may be
a valuable and potentially cost-effective public health strategy in
reducing the burden of disease associated with licit and illicit
drugs.
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5.6 Cannabis use and the initiation of amphetamine use 
Paper 10. The predictors and consequences of adolescent amphetamine use: findings 
from the Victorian Adolescent Health Cohort Study. Degenhardt, C Coffey, P 
Moran, J B. Carlin and G C. Patton. Addiction 102(7): 1076-84, 2007 
Journal impact factor 4.3 (source: Journal Citation Reports, 4/03/2013) 
27 citations, as at 4/03/2013 (source: Google Scholar). 
This paper was one of two papers focusing on amphetamine use, lad by Professor 
Louisa Degenhardt, from the National Drug and Alcohol Centre at the University of 
New South Wales. The paper was prepared well before the previous paper (Swift et 
al. 2012) (discussed in §5.4), but its findings are relevant here as they extend the 
examination of the relationship between cannabis use and other illicit substance use. 
We were well-placed to assess questions concerning amphetamine use, in that this is 
the most frequently used illicit drug after cannabis, and we had measured its use 
throughout the cohort. Our aim was to examine factors associated with both 
amphetamine use and its initiation in adolescence, similar to the first paper discussed 
in Chapter 3 (Coffey et al. 2000) which focused on the correlates and predictors of 
adolescent cannabis use. 
5.6.1 My contribution 
The lead author was Professor Louisa Degenhardt from the National Drug and 
Alcohol Centre at the University of New South Wales. I contributed substantially to 
the conceptualisation of the question and was responsible for its operationalisation, 
the analysis and methods. I also contributed to the introduction, results and 
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discussion and with the response to the reviewers’ comments. The declaration of my 
contribution, estimated as 40%, is in Appendix 2. 
5.6.2 Analysis and results 
In contrast to the earlier paper, our analytical techniques had advanced with the use 
of multiple imputation to adjust for possible bias arising from missing waves. We 
therefore could use generalised estimating equations and discrete time proportional 
hazards modelling with the adolescent phase data, being the most parsimonious way 
of analysing fairly sparse outcomes, in this case 7% of participants. The association 
between a number of putative explanatory factors and adolescent amphetamine use 
was examined. These included dieting behaviour (amphetamine use was bracketed 
with dieting pills in the question in Waves 1-6), frequent alcohol drinking, cigarette 
smoking, cannabis use, peer cigarette smoking and cannabis use, and antisocial 
behaviour. The outstanding independent cross-sectional association was with 
cannabis use, with a clear dose response with increasing frequency of cannabis use. 
When the same factors were examined prospectively as predictors of incident 
amphetamine use, cannabis use in the prior waves showed a similar independent 
effect, again with clear evidence of a dose response. 
A further question related to psychosocial, mental health and substance use outcomes 
of adolescent amphetamine use in Wave 8. Unadjusted associations between 
adolescent amphetamine use and educational outcomes, mental health measures 
including anxiety/depression symptoms and cluster-B personality disorder, and all 
substance use outcomes were observed, but all associations, with the exception of 
symptoms of depression and anxiety, were largely or completely confounded by 
adolescent cannabis use. 
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5.6.3 Implications 
These findings, of course, conform to the Gateway Theory, though again we were 
unable to identify the reasons why it occurred. It is notable that it was only cannabis 
that was an effective confounder, not cigarette smoking or alcohol use, pointing 
towards the necessary condition of being illicit, invoking availability, peer 
acceptance and possibly biological priming or susceptibility. The explanation for 
confounding or mediating effect of cannabis use is unclear. It could be due to 
priming effects of early cannabis use on the developing neural structure, the 
incorporation of pleasurable drug use into day-to-day lifestyle or attitudes adopted 
from drug-using peers.   
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5.6.4 Paper 10: The predictors and consequences of adolescent 
amphetamine use: findings from the Victorian Adolescent 
Health Cohort Study. 
L Degenhardt, C Coffey, P Moran, J B. Carlin and G C. Patton. Addiction 102(7): 
1076-84, 2007 
 
 
  
The predictors and consequences of adolescent
amphetamine use: ﬁndings from the Victoria
Adolescent Health Cohort Study
Louisa Degenhardt1, Carolyn Coffey2, Paul Moran3, John B. Carlin4 & George C. Patton2
National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia,1 Centre for Adolescent Health, Murdoch
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ABSTRACT
Objectives Previous work has highlighted the adverse consequences of early-onset cannabis use. However, little is
known about the predictors and effects of early-onset amphetamine use. We set out to examine these issues using a
representative cohort of young people followed-up over 11 years in Victoria, Australia. Methods A stratiﬁed, random
sample of 1943 adolescents was recruited from secondary schools across Victoria at age 14–15 years. This cohort was
interviewed on eight occasions until the age of 24–25 years (78% follow-up at that age). Cross-sectional associations
were assessed using logistic regression with allowance for repeated measures. Both proportional hazards models and
logistic regression models were used to assess prospective associations. Results Approximately 7% of the sample had
used amphetamines by the age of 17 years. Amphetamine use by this age was associated with poorer mental health
and other drug use. The incidence of amphetamine use during the teenage years was predicted by heavier drug use and
by mental health problems. By young adulthood (age 24–25 years), adolescent amphetamine users were more likely to
meet criteria for dependence upon a range of drugs, to have greater psychological morbidity and to have some
limitations in educational attainment. Most of these associations were not sustained after adjustment for early-onset
cannabis use. Conclusion Young people in Australia who begin amphetamine use by age 17 years are at increased
risk for a range of mental health, substance use and psychosocial problems in young adulthood. However, these
problems are largely accounted for by their even earlier-onset cannabis use.
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INTRODUCTION
Signiﬁcant shifts have occurred in the patterns of drug
use among young people. Over the past decade, amphet-
amine use among young adults has increased across the
world, and more potent forms of the drug have become
available [1–3]. The psychosocial consequences of this
use are of increasing public health interest, but have not
been studied systematically [4].
Our current understanding derives largely from cross-
sectional studies of amphetamine users [5–7]. Typically
these have taken place with convenience samples or in
treatment or prison settings. Some US studies have
assessed prospectively post-treatment outcomes for
dependent users [7–9]. There has been some examination
of gender differences in patterns of amphetamine use and
associated harm [7–10]. Treatment studies have sug-
gested that the similarities generally outweigh the differ-
ences, although male users may be more involved in
criminal activity and greater polydrug use [7,10],
whereas females may be more likely to be aiming to
control weight [7]. This suggests that there may be a rela-
tionship between amphetamine use and dieting behav-
iour for some users.
The concentration of work in treatment or prison
populations makes it difﬁcult to draw inferences about
amphetamine use in the general population, as most
users will never come into contact with either treatment
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or law enforcement agencies [6,11]. As a result, little is
known about the aetiology and consequences of amphet-
amine use that does not come to the attention of police or
treatment services.
There is now good evidence from well-conducted,
population-based cohort studies in the United States,
New Zealand and Australia that early-onset cannabis use
is associated with increased risks for negative outcomes
across a number of domains, including incomplete edu-
cation [12], other illicit drug use [13,14], risky sexual
behaviour [13,15], involvement in criminal activity [13]
and mental health problems [16–19]. Little is known of
the associations between the early onset of the next most
widely used illicit drug, amphetamine and poor psycho-
social outcomes. Moreover, little is known about the pos-
sible interplay between cannabis and amphetamine use
in the prediction of psychosocial outcomes in young
people.
In this report we examined factors associated with
amphetamine use, and with amphetamine uptake, in a
representative sample of young Australian adolescents,
and the extent to which early-onset amphetamine use
predicted mental health problems, personality pathology,
drug use and indicators of poor social functioning at age
24 years.
METHOD
Sample
Between August 1992 and December 2003 we con-
ducted an eight-wave cohort study of adolescent health
in the state of Victoria, Australia. Protocols were
approved by The Royal Children’s Hospital’s Ethics in
Human Research Committee. The cohort was deﬁned
using a two-stage cluster sampling procedure, in which
we selected two classes at random from each of 44
schools drawn from a stratiﬁed frame of government,
Catholic and independent schools (total number of stu-
dents 60 905) [20]. School retention rates to year 9 in the
year of sampling were 98%. One class from each school
entered the cohort in the latter part of the ninth school
year (wave 1) and the second class 6 months later, early in
the tenth school year (wave 2). Participants were
reviewed subsequently at four 6-month intervals during
the teenage years (waves 3–6), with two follow-up waves
in young adulthood aged 20–21 years (wave 7) and
24–25 years (wave 8).
In waves 1–6, participants self-administered the ques-
tionnaire on laptop computers with telephone follow-up
of those absent from school. Waves 7 and 8 were under-
taken using computer-assisted telephone interviews.
From a total sample of 2032 students, 1943 (96%)
participated at least once during the ﬁrst six waves
(Fig. 1). In wave 8, 1520 (75% of the initial sample, 78%
of teenage participants) were interviewed between April
2001 and April 2003. Reasons for non-completion at
wave 8 were refusal (n = 269), loss of contact (n = 147)
and death (n = 7). We removed the seven individuals who
had died from analysis of the wave 8 data.
Measures waves 1–6
Amphetamine use. Amphetamine use in the last 6 months
from waves 2–6 was assessed from self-reported use of
‘speed/amphetamines/diet pills’.
Frequent alcohol drinkers. Those reporting alcohol con-
sumption on 3 or more days in the previous week were
classiﬁed as frequent drinkers.
Cannabis use. Self-reported frequency of use in the previ-
ous 6 months was classiﬁed as: none, less than weekly,
weekly and daily. Maximal cannabis use between waves 1
and 6 was identiﬁed.
Symptoms of depression and anxiety. These were assessed
at each adolescent wave using the computerized revised
phase
survey wave 1           wave 2           wave 3           wave 4           wave 5           wave 6           wave 7            wave 8
year 1992              1993               1993               1994              1994               1995               1998            2001/03
mean age 14.9 yr            15.5 yr           15.9 yr           16.4 yr           16.8 yr           17.4 yr            20.7 yr            24.1 yr
sample n 898                1727               1697              1628               1575              1530               1601               1520
design
Total intended sample = 1037 (w1) + 995 (w2) = 2032
ascertainment 96% (1943) of sample participated at least once in waves 1-6
2 entry points 
Young adultAdolescent
Figure 1 Sampling across eight data collection points
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Clinical Interview Schedule (CIS-R) with total scores
dichotomized at a cut-off point of 11/12 [21–24].
Tobacco consumption. Any cigarette smoking was deﬁned
as smoking within the past month and daily use as
smoking 6 or 7 days in the week before survey.
Antisocial behaviour. Antisocial behaviour was assessed
using 10 items from the Self Report of Early Delinquency
Scale relating to property damage, interpersonal conﬂict
and theft in the previous 6 months [25]. Antisocial
behaviour was deﬁned as reporting more than one behav-
iour more than once.
Measures wave 8
Educational, occupational and social measures. Having left
school before the ﬁnal possible year (year 12,
17–18 years); gained or gaining post-school qualiﬁca-
tions; current employment and relationship status;
whether living with family of origin.
Personality disorder. Personality disorder was assessed
using the Standardised Assessment of Personality, a
friend–informant semistructured interview [26]. DSM-IV
recognizes three ‘clusters’ of personality disorder: A, B
and C [27]. The cluster B group includes the following
categories: histrionic, narcissistic, antisocial and border-
line personality disorders. Previous research (including a
report from this cohort [26]) has demonstrated the exist-
ence of robust associations between cluster B personality
disorders and substance use disorders, and that associa-
tions between substance use disorders and cluster A or C
personality disorders appear to be confounded by the
presence of comorbid cluster B personality disorder. We
therefore focused solely on the cluster B personality
disorders.
Depression and anxiety. Depression and anxiety were
assessed with the General Health Questionnaire version
12 (GHQ-12) [28], dichotomized at the cut-off point > 2
to delineate a mixed depression–anxiety state at a lower
threshold than syndromes of major depression and
anxiety disorder but where clinical intervention would
still be appropriate [22,23].
Alcohol and cannabis dependence (DSM-IV). Alcohol and
cannabis dependence (DSM-IV) in the past year were
assessed using the Composite International Diagnostic
Interview 2.1, 12-month version (CIDI) [29].
Daily tobacco smoking. Daily tobacco smoking was
assessed in the same manner as in waves 1–6.
Amphetamine, ecstasy and cocaine use. Participants were
classiﬁed as users if they reported using these substances
in the past year.
Analysis
We used multiple imputation to address potential bias
and loss of information arising from respondents missing
waves of data collection [30]. We imputed ﬁve complete
data sets under a multivariate normal model incorporat-
ing all the outcome variables of interest measured at all
waves, along with the ﬁxed covariates of sex, age, rural/
urban residence and parental education (available on all
participants) [31] using ‘adaptive rounding’ for binary
outcomes [32]. We omitted wave 1 amphetamine use
from analysis because its extremely low frequency at this
wave rendered imputation for this measure potentially
unstable. Characteristics of wave eight non-completers
were examined in a logistic regression model. Males were
over-represented [odds ratio (OR) 1.7, 95% conﬁdence
interval (CI) 1.3–2.1], as were those who were smokers at
study inception (OR 1.4, CI 1.1–1.9).
Data analysis was undertaken using STATA 8 [33]
with all estimates of prevalence and odds ratios obtained
by averaging across the ﬁve imputed data sets and infer-
ences under multiple imputation using Rubin’s rules
[31]. Cross-sectional associations were assessed using
logistic regression with robust standard errors to allow
for repeated measures within participant. Univariate and
multivariable discrete time proportional hazards models
were used to model associations with incident amphet-
amine use in waves 3–6 [34]. Logistic regression analysis
was used to model associations between any amphet-
amine use in waves 2–6 and outcomes measured in wave
8. Wald tests and related conﬁdence intervals were used
to assess statistical signiﬁcance and precision. Effect
modiﬁcation by sex was assessed at the 0.1 level of
signiﬁcance.
RESULTS
By 17–18 years, 143 cohort participants had used
amphetamines (Table 1). Boys were more likely than girls
to initiate amphetamine use in the ﬁrst three waves (by
16 years), but there were no sex differences in either inci-
dent or prevalent use by age 17 years.
Table 2 shows that adolescent amphetamine use
(15–17 years) was associated crudely with a range of
social and behavioural factors, but only parental
smoking, concurrent cannabis use and symptoms of
depression and anxiety showed clear independent asso-
ciations with use. Increasing frequency of cannabis use
was associated with increasing likelihood of amphet-
amine use, with daily cannabis users at highest risk of
1078 Louisa Degenhardt et al.
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amphetamine use. Participants reporting symptoms of
anxiety and depression were at over twice the risk of con-
current amphetamine use.
No ﬁrst-order interactions with sex were identiﬁed,
with the exception of parental smoking (multivariate
Wald P = 0.09). As there was no obvious mechanism for
this effect, we considered it open to over-interpretation so
did not include it in Table 2 or later adjusted models.
Small numbers of male dieters precluded sensible
assessment of sex-speciﬁc associations and the estimates
in Table 2 are driven predominantly by the female partici-
pants. Examining females separately, there was a some-
what stronger univariate association with severe dieting
and amphetamine use in females (moderate dieting: OR
1.2: 0.68–2.2, P = 0.50; severe dieting: OR 2.4: 1.2–4.9,
P = 0.02), which was weakened slightly when adjusted
for the other factors in Table 2 (moderate dieting OR 1.0:
0.59–1.8, P = 0.89; severe dieting OR 1.9: 0.75–4.7,
P = 0.18).
Table 3 shows that, similar to prevalent use, a cluster
of indicators of wellbeing and drug use measured in the
previous wave increased the likelihood of incident transi-
tion to amphetamine use. The only independent predic-
tors of incident amphetamine use were cannabis use and
peer cannabis use. Occasional cannabis users were at
more than twice the risk and weekly daily users had six to
seven times the risk of initiating amphetamine use, com-
pared with non-users of cannabis. Participants reporting
some peer cannabis use showed an almost three times
elevated risk and those with most peers using were at an
almost ﬁve times elevated risk of initiating amphetamine
use. There was no evidence of a sex difference or effect
modiﬁcation by sex. Severe dieting in females did not
predict initiation of amphetamine use (univariate hazard
ratio [HR] 1.1: 0.25–4.5, P = 0.95).
Table 4 shows that early-onset amphetamine users
had higher rates of a number of indicators of disadvan-
tage in young adulthood, including incomplete schooling,
no post-school qualiﬁcations and cluster B personality
disorder and high rates of drug use and dependence.These
rates were clearly inﬂated relative to adolescents who had
not begun amphetamine use by 17 years, even after
adjustment for possible background confounders. There
was no evidence of effect modiﬁcation by sex.
Most of these relationships were weakened substan-
tially after adjusting for maximal adolescent cannabis
use, with the exception of symptoms of anxiety and
depression. The fact that relationships with other drug
use and mental health were explained largely by adjust-
ment for cannabis use in adolescent-onset amphetamine
users suggests a strong confounding effect. Further addi-
tion to the models of adolescent maximal cigarette
smoking and exposure to frequent drinking made no sub-
stantive difference to the estimated associations in
Table 4.
The univariate and multivariable analyses in
Tables 2–4 were repeated restricting the data set to par-
ticipants who completed each survey from waves 1–8.
There were minor differences in the results but no sub-
stantive changes in estimates.
DISCUSSION
This study examined the predictors of adolescent-onset
amphetamine use among a population cohort of young
people and their psychosocial and health outcomes in
young adulthood. Around 7% of the cohort reported that
they had used amphetamines recently (in the past 6
months) between the ages of 12 and 17 years. These ado-
lescents were more likely to have had parents who had
separated or divorced and, in females, to have a parent
who smoked regularly. Use was not concentrated among
adolescents living in metropolitan areas or among those
who came from less educated families.
Table 1 Prevalence and incidence (n) of adolescent amphetamine use by wave and gender in 1431 ever users in waves 2–6 in 1943
cohort participants.
Wave
Frequency1 of amphetamine use (w1-6) Association with female sex
Total (n = 1943) Males (n = 943) Females (n = 1000) Prevalent Incident
Prevalent Incident Prevalent Incident Prevalent Incident OR2 (95% CI) P OR2 (95% CI) P
2 43 – 33 – 10 – 0.28 (0.13–0.57) < 0.001 –
3 36 20 28 20 9 0 0.29 (0.11–0.75) 0.012 –3
4 36 17 20 8 16 9 0.76 (0.37–1.6) 0.46 1.1 (0.90–4.2) 0.28
5 61 34 28 11 33 23 1.1 (0.63–2.0) 0.68 2.0 (0.19–5.8) 0.69
6 61 28 26 11 35 17 1.3 (0.76–2.3) 0.33 1.4 (0.45–3.3) 0.59
1Frequencies obtained by averaging across the ﬁve imputed datasets.
2Odds ratios from univariate logistic regression models.
3Could not be assessed.
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Early-onset amphetamine users were more likely than
non-users to report regular alcohol use, regular tobacco
use and cannabis use during the same period that they
had used amphetamines. They were more likely to report
that their peers were tobacco and cannabis users. Depres-
sion, anxiety, antisocial behaviour and (in girls) severe
dieting were associated with amphetamine use.
In young adulthood, rates of drug dependence and
drug use were all much higher among adolescent-onset
amphetamine users, as were rates of mental health prob-
lems. There was some indication that early-onset
amphetamine users had more limited educational attain-
ment than non-users. However, multivariable analyses
showed that most of these associations did not persist
after adjustment for adolescence cannabis use.
The main strengths of this study include the represen-
tative nature of the sample, the high participation rates
and the frequent measures of drug use and psychosocial
outcomes over a 10-year period. Non-response in longi-
tudinal studies tends to be associated with substance use,
but our use of multiple imputation should have mini-
mized such biases. None the less, there are some potential
limitations that need to be acknowledged.
First, all data were based on self-report. There was no
external validation of these self-report measures, but
other research indicates that individuals’ self-reports of
substance use in surveys of this type are reliable and
valid. It is accepted that epidemiological surveys are
important for the information they provide about the cor-
relates and possible causal mechanisms between drug use
Table 2 Cross-sectional associations of adolescent amphetamine use and psychosocial context (waves 2–6) in 1943 cohort
participants.
Concurrent adolescent measure
Amphetamine use in adolescence
Univariate Multivariable
OR1 (95% CI) P OR2 (95% CI) P
Background factors (ﬁxed)
Female sex 0.72 (0.47–1.1) 0.12 0.72 (0.43–1.2) 0.20
Non-Australian birth 0.90 (0.51–1.6) 0.72 –3
Metropolitan school 1.6 (0.91–2.7) 0.10 –3
Parent regular smoker 2.1 (1.4–3.3) 0.001 1.6 (1.1–2.4) 0.03
Parental divorce/separation 2.3 (1.5–3.6) < 0.001 0.94 (0.60–1.5) 0.79
Parental education incomplete secondary school 1 –3
complete school/certiﬁcate/diploma 0.94 (0.56–1.6) 0.82
tertiary qualiﬁed 0.93 (0.57–1.5) 0.78
Behaviour and substance use measures (time-varying)
Depression & anxiety (CIS > 11) 3.6 (2.5–5.0) < 0.001 2.4 (1.7–3.4) 0.00
Dieting behaviour none 1 1
moderate 1.1 (0.70–1.6) 0.74 1.2 (0.77–1.9) 0.42
severe 1.8 (0.86–4.0) 0.12 1.8 (0.74–4.2) 0.20
Frequent alcohol drinking 6.2 (4.0–8.9) < 0.001 1.6 (0.97–2.5) 0.07
Smoking none 1 1
< daily 4.3 (2.7–6.9) < 0.001 1.1 (0.59–1.9) 0.81
daily 8.9 (5.9–13) < 0.001 1.2 (0.68–2.0) 0.61
Cannabis use none 1 1
< weekly 8.9 (5.7–14) < 0.001 4.6 (2.2–10) < 0.001
weekly 28 (17–48) < 0.001 10 (4.3–25) < 0.001
daily 79 (44–140) < 0.001 27 (11–68) < 0.001
Peer cigarette smoking none 1 1
some 2.1 (0.5–9.2) 0.26 1.2 (0.58–2.6) 0.59
most 11 (3.6–35) < 0.001 2.1 (0.68–6.6) 0.18
Peer cannabis use none 1 1
some 3.5 (2.08–5.8) < 0.001 1.2 (0.58–2.6) 0.59
most 23 (13.1–42) < 0.001 2.1 (0.67–6.5) 0.19
Antisocial behaviour 6.2 (4.1–9.3) < 0.001 1.5 (0.86–2.4) 0.15
1Odds ratios from logistic regression models with allowance for clustering within individuals.
2Odds ratios from logistic regression models including all factors listed as covariates and also adjusted for sex.
3Omitted from multivariate model as there was little evidence that this measure could be a confounder (P > 0.1). CIS: clinical interview schedule.
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and other factor; this has been accepted as an appropriate
way in which to gain information about population
behaviours [35–37]. There were also no negative (or
other) consequences for admitting to drug use [36]. Sec-
ondly, the question regarding amphetamine use included
diet pills in the adolescent phase. However, almost all
those responding positively to this question would have
used illicit amphetamines given the limited availability of
diet pills in Australia, the need for private (i.e. not govern-
ment subsidized) prescriptions and very low rates of pre-
scribing of these drugs in Australia (Maxine Robinson,
Australian Government Department of Health and
Ageing, personal communication, 26 June 2006).
Finally, we did not assess amphetamine dependence at
any wave in the study. This would have been a useful
addition to the work and future studies would do well to
examine the possible link between early-onset amphet-
amine use and the development of dependent use later in
life.
Regardless of the reasons for the associations found
here, adolescent-onset amphetamine use is a strong
marker for adolescent and young adult drug use and
drug dependence. It is also a marker for mental health
problems (depression, anxiety, and cluster B personality
disorders) in young adulthood, and antisocial behaviour
throughout adolescence and young adulthood. As a
result, clinicians working with adolescents who are using
amphetamines should be aware of the cluster of other
drug use and mental health issues that such adolescents
may be dealing with. It remains to be seen whether
comorbid problems among amphetamine users become
more prominent if amphetamine use (both its prevalence
and frequency) continues to increase among young
people.
In this study, the majority of associations between
adolescent amphetamine use and poor adult psychosocial
outcomes were confounded by earlier-onset cannabis use
(but not tobacco or alcohol use). This is consistent with
data from numerous studies suggesting that early-onset
cannabis use is a very strong predictor of the problematic
use of other illegal drugs (the so-called ‘gateway’ model).
The ‘gateway’ effect describes a commonly observed pro-
gression of drug use; it does not explain the reasons for it.
Less agreement exists about the reasons for this associa-
tion [16,38–43], which remains even after adjusting
for numerous observed and unobserved variables [44].
Table 3 Association of incident adolescent amphetamine use with psychosocial predictors measured 6 months earlier.
Time-varying measures in prior wave
Incident amphetamine use in adolescence (n1 = 100)
Univariate Multivariable
HR2 (95% CI) P HR3 (95% CI) P
Depression & anxiety (CIS > 11) 2.3 (1.3–3.8) 0.004 1.6 (0.79–3.4) 0.17
Dieting behaviour none 1 1
moderate 1.2 (0.67–2.3) 0.47 1.3 (0.73–2.4) 0.34
severe 1.2 (0.25–5.6) 0.81 1.0 (0.17–6.0) 0.99
Frequent alcohol drinking 3.3 (1.7–6.6) 0.001 1.1 (0.53–2.2) 0.81
Smoking none 1 1
< daily 2.0 (0.88–4.5) 0.09 0.82 (0.36–1.9) 0.62
daily 5.8 (3.5–9.5) < 0.001 1.5 (0.80–3.0) 0.20
Cannabis use none 1 1
< weekly 5.2 (3.0–9.2) < 0.001 2.7 (1.2–5.9) 0.02
weekly 15 (7.5–29) < 0.001 5.8 (2.6–13) < 0.001
daily 20 (7.7–52) < 0.001 7.2 (2.3–22) 0.001
Peer cigarette smoking none 1 1
some 1.7 (0.60–5.1) 0.30 0.68 (0.19–2.4) 0.54
most 4.7 (1.8–12) 0.003 0.63 (0.16–2.5) 0.50
Peer cannabis use none 1 1
some 3.8 (1.9–7.7) < 0.001 2.7 (1.1–6.8) 0.04
most 15 (7.3–31) < 0.001 4.8 (1.7–13) 0.003
Antisocial behaviour 3.7 (1.9–7.2) < 0.001 1.2 (0.60–2.5) 0.55
1Frequency obtained by averaging across the ﬁve imputed datasets.
2Hazard ratios (HR) from univariate discrete time proportional hazard models.
3Hazard ratios (HR) models including all factors listed as covariates and also adjusted for sex, parental smoking and parental divorce/separation during
adolescence. CIS: clinical interview schedule.
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Proposed causal explanations include (a) biochemical,
where early adolescent cannabis use affects the maturing
adolescent brain in ways that make the individual more
sensitive to other drug effects [45]; (b) learning, in that
the adolescent learns to incorporate (pleasurable) drug
use into their lives [46]; and (c) socially mediated, where
early cannabis use reﬂects entry into a culture and peer
group where illegal drug use occurs, where it is reinforced
by the context and where there are greater opportunities
to use other illegal drugs. No studies examining the
‘gateway’ effect have yet been able, however, to disen-
tangle the potentially important impact of the availability
of cannabis (relative to other illegal drugs) and its effect
upon age of onset of use. The fact that it was cannabis
use—and not adolescent alcohol or tobacco use—
suggests that it is related to the use of an illegal drug at
this young age. It remains to be seen if this is a speciﬁc
pharmacological effect of cannabis.
CONCLUSIONS
This ﬁrst population cohort study of early-onset amphet-
amine use suggested that it typically did not present sub-
stantial additional risk to cannabis use for later adverse
psychosocial outcomes, apart from a suggestion of inde-
pendent association with depression and anxiety. On the
basis of these data, we are unable to establish whether
poor psychosocial outcomes are associated speciﬁcally
with early-onset cannabis use (as opposed to early use of
any illicit drug). Future work should probe further the
reasons for this ﬁnding.
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5.7 Summary 
Four papers were presented which look at different aspects of the interplay between 
cannabis use and other substance use, and, to a lesser extent, social outcomes in 
young adulthood. Adolescents who use cannabis regularly were at high risk, not only 
of developing cannabis dependence, but also escalation to other substance use, 
especially other illicit substance use. They were also at risk of other adverse 
outcomes, including poor educational achievement and welfare dependence. Our 
paper examining the consequence of adolescent amphetamine use (Degenhardt et al. 
2007) brings this into stark focus, where the adverse psychosocial outcomes of 
amphetamine use were all predicated on regular cannabis use in adolescence. We did 
not examine whether there was an extra burden consequent to regular cannabis use 
early in the cohort follow-up, so cannot contribute to the discussion around the 
specific effect of cannabis exposure on the developing brain structure with respect to 
later substance dependence (Schneider 2008), except so far as to say there appeared 
to be a dose relationship. The question remains to determine whether cannabis is 
actually causal in the escalation to other drugs of dependence (Strang, Witton & Hall 
2000) or arises as a result of drug availability or the adoption of peer attitudes. 
The uptake of other illicit substance use by regular adolescent cannabis users has 
been replicated by many other investigators (e.g.,(Fergusson, Horwood & Swain-
Campbell 2002), but we have extended the field by focusing on outcomes for 
adolescents who do not proceed beyond occasional cannabis use. Although the 
majority of these young people do not progress beyond this level of use, they are 
clearly not completely protected from joining their heavier using contemporaries on 
the path to increasing use in young adulthood and consequent poor outcomes, 
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especially in relation to other illicit substance use. This is an important concept for 
practitioners and educators to consider, when faced with adolescents who may be 
using cannabis infrequently. 
The evidence suggests that prevention should aim at cannabis abstinence. As a 
secondary aim, interventions in adults should discourage regular use, as significant 
improvement in associated problems can be achieved without complete abstinence 
(Hall 2010) 
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CHAPTER 6 Consequences of adolescent cannabis use: 
mental health 
6.1 Chapter outline 
In this chapter §6.2 presents an introduction to two papers focusing on the mental 
health consequences of adolescent cannabis. Our paper examining the cross-sectional 
and longitudinal associations between cannabis use and depression/anxiety 
symptoms in Wave 7 at 20 years is described in §6.3. In §6.4, a recently published 
paper is discussed, which examines the association between adolescent cannabis use 
and the diagnostic outcomes of MDE and AD at Wave 9, 29 years. The two papers 
are summarised in §6.5, including a supplementary analysis of the Wave 7 data.  
6.2 Introduction 
A question as to whether cannabis use causes mental health problems was raised in 
the late nineteenth century and culminated in the British Government’s Indian Hemp 
Report (Carlson 1974). It is interesting that from the autobiographical accounts of 
cannabis use in the nineteenth century (1973a) to recent accounts from heavy users in 
rural Australia (Reilly et al. 1998), there are recurrent references to feelings of 
anxiety, paranoia, and depression in both acute intoxication and in chronic users. 
There is growing evidence that both psychosis symptoms and, more rarely, 
schizophrenia can follow initiation into cannabis use (Morgan & Curran 2008; 
Zammit et al. 2002), especially in young people with a genetic liability (Barkus & 
Murray 2010). Because both of these are relatively rare outcomes, it was not 
considered feasible to examine them in the VACHS. The study was designed to look 
at the common mental disorders which had, to date, received far less attention 
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(Crippa et al. 2009). By the time of writing the first of the papers included in this 
chapter, it was reasonably well-documented, though not universally, that substance 
dependence and depression and anxiety co-occurred in both clinical and population 
samples, but these observations were cross-sectional and made primarily in adult 
populations (Degenhardt, Hall & Lynskey 2003a; Rao 2006). Uncertainty remained 
as to the direction of the association in adolescence, that is, whether cannabis use 
preceded these mental health problems, or young people used cannabis to self-
medicate, or whether the association was an expression of other factors common to 
both conditions (e.g.,(Jessor, Chase & Donovan 1980). This question has been 
addressed by two separate New Zealand cohorts originating in childhood (Fergusson 
& Horwood 1997; Fergusson, Horwood & Swain-Campbell 2002; McGee et al. 
2000). Although they confirm an association, their findings were inconclusive as to 
direction and causality, other than observing that early cannabis users were 
vulnerable to a later poor mental health and social outcomes. 
The VAHCS was able to address questions about the temporal relationship between 
cannabis use and mental health, as it encompassed the developmental period when 
there is often onset and progression in cannabis use and when common mental health 
problems are often first manifest. By examining the early history of these disorders 
in VAHCS, it is theoretically possible for us to identify pre-morbid markers for 
illness, in contrast to studies commencing in adulthood when the temporal course of 
disorders is unclear and confounding, due to the consequences of these illnesses, may 
make interpretation difficult (Rao 2006). We assessed symptoms of depression and 
anxiety throughout VAHCS, using the CIS-R (described in Chapter 2) in the 
adolescent phase and in the first of the young adult waves, Wave 7. The CIS-R, at the 
cutoff of 11/12, is an indicator of emotional distress at which medical intervention 
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would be appropriate (Lewis et al. 1992). Then in Waves 8 and 9, we applied the 
much shorter 12-item GHQ (see Chapter 2), also measuring mixed symptoms of 
anxiety and depression (Goldberg 1988), augmented in Wave 9 with CIDI diagnostic 
instruments for major depressive episode (MDE) and anxiety disorder (AD) in the 
past year (see Chapter 2). 
6.3 Cannabis use and mental health at 20 years 
Paper 11. Cannabis and mental health in young people: cohort study. Patton G.P., 
Coffey C., Carlin J.B., Degenhardt L., Lynskey M.L., Hall W. BMJ 2002; 325 
(7374): 1199-212 
Journal impact factor 14.1 (source: Journal Citation Reports, 4/03/2013) 
489 citations as at 4/03/2013 (source Google Scholar) 
In this paper we focused on Wave 7, when the cohort participants were 20 years and 
were at the at the peak age for cannabis use. We were interested in assessing cross-
sectional associations between cannabis use and anxiety and depression symptoms at 
this age. We then examined predictive associations between adolescent cannabis use 
and later symptoms of anxiety and depression at 20 years and, as a corollary, whether 
there was evidence for the reverse hypothesis, that symptoms of anxiety and 
depression in adolescence predicted cannabis use at 20 years. 
6.3.1 My contribution 
The lead author was Professor George Patton. My role in the preparation of this 
paper was to prepare the dataset for imputation, to conduct the analysis and prepare 
the tables, to contribute to the writing of the introduction, methods, results and 
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discussion, and to assist with the response to reviewers’ comments. The declaration 
of my contribution, estimated as 30%, is in Appendix 2. 
6.3.2 Analysis and results 
We found strong, cross-sectional association at 20 years between anxiety/depression 
symptoms (CIS-R>11) and daily cannabis use in females, independent of other 
concurrent substance use and possible confounders, including parental divorce or 
separation and any anxiety/depression symptoms in adolescence. In contrast, we 
found no evidence of an equivalent association in males. Reflecting this sex 
difference, regular (weekly or more frequent) adolescent cannabis use was predictive 
of anxiety/depression symptoms in females, after adjustment for possible 
confounders and mediators. The risk appeared to increase with increasing frequency 
of use, suggesting a dose response to drug exposure in adolescence. That we only 
observed the association in females may be due to their greater susceptibility to 
depression and anxiety. Testing the converse hypothesis, there was no evidence that 
teenage anxiety/depression symptoms independently predicted regular cannabis use 
in young adulthood1. 
Implications 
                                                 
1 For the sake of clarity, it is worth mentioning a minor typographical error in 
Tables 3 and 4 (but not the text) where the most frequent cannabis use category is 
shown as “>weekly” when it should have been shown as “≥weekly”. 
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The finding of a robust association between daily cannabis use and symptoms of 
anxiety and depression in females constituted an important contribution to the then 
current evidence base. There are consequences of illicit substance use such as 
compromised life chances and social disadvantage which may give rise to 
psychosocial distress and common mental disorder. There is also a possibility of a 
biological mechanism involving drug exposure at a critical stage of development of 
the central nervous system CB1 receptors, now known to be involved in dopamine 
transmission, and closely involved not only with the cannabinoid effect on mood and 
cognition (Schneider 2008), but also with the experience of anxiety and depression 
(Rao 2006). We suggested that the predominance of these symptoms in females was 
a reflection of the higher prevalence of anxiety and depression in females generally. 
In addition, it is also possible that because non-conforming behaviour such as 
antisocial behaviour and illicit substance use is less common in teenage females then 
males, as illustrated in the first paper in Chapter 1 (Coffey et al. 2000), these 
behaviours identify a more extreme risk group than the equivalent group of males 
that therefore is more susceptible to psychosocial stress. However, this does not 
account for the absence of effects in males. 
Since our paper was published, similar findings have been reported in a large birth 
cohort the Mater University Study of Pregnancy, described in Chapter 2 
(Hayatbakhsh et al. 2007). They reported an association between early-onset frequent 
cannabis use and anxiety and depression at 21 years (measured using the Achenbach 
Young Adult Behaviour Checklist), independent of putative confounders, including 
family background measures and licit substance use, externalising behaviour and, 
importantly, symptoms of anxiety and depression at 14 years (measured using the 
age-equivalent Achenbach Youth Self-Report). There was no apparent investigation 
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of effect modification by gender. Cannabis use at 14 years was measured 
retrospectively at 21 years, and so was possibly subject to recall bias, but none-the-
less, this study offers tentative confirmation of our findings. 
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6.3.3 Paper 11: Cannabis and mental health in young people: cohort 
study. 
Patton G.P., Coffey C., Carlin J.B., Degenhardt L., Lynskey M.L., Hall W. BMJ 
2002; 325 (7374): 1199-212 
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Cannabis use and mental health in young people:
cohort study
George C Patton, Carolyn Coffey, John B Carlin, Louisa Degenhardt, Michael Lynskey, Wayne Hall
Abstract
Objective To determine whether cannabis use in
adolescence predisposes to higher rates of depression
and anxiety in young adulthood.
Design Seven wave cohort study over six years.
Setting 44 schools in the Australian state of Victoria.
Participants A statewide secondary school sample of
1601 students aged 14-15 followed for seven years.
Main outcome measure Interview measure of
depression and anxiety (revised clinical interview
schedule) at wave 7.
Results Some 60% of participants had used cannabis
by the age of 20; 7% were daily users at that point.
Daily use in young women was associated with an
over fivefold increase in the odds of reporting a state
of depression and anxiety after adjustment for
intercurrent use of other substances (odds ratio 5.6,
95% confidence interval 2.6 to 12). Weekly or more
frequent cannabis use in teenagers predicted an
approximately twofold increase in risk for later
depression and anxiety (1.9, 1.1 to 3.3) after
adjustment for potential baseline confounders. In
contrast, depression and anxiety in teenagers
predicted neither later weekly nor daily cannabis use.
Conclusions Frequent cannabis use in teenage girls
predicts later depression and anxiety, with daily users
carrying the highest risk. Given recent increasing
levels of cannabis use, measures to reduce frequent
and heavy recreational use seem warranted.
Introduction
After increases in cannabis use during the early 1990s,
a majority of young people in the United Kingdom,
United States, New Zealand, and Australia now use
cannabis recreationally.1 2 Despite the high prevalence
of cannabis use, uncertainty persists about its physical
and psychological consequences.3
Among the most prominent concerns have been
putative links between use of cannabis and mental dis-
orders. A large intake of cannabis seems able to trigger
acute psychotic episodes and may worsen outcomes in
established psychosis.4 5 Associations with non-
psychotic disorders have received less attention. Yet
evidence for an association between cannabis use and
depression and anxiety has grown.6 Chronic daily users
report high levels of anxiety, depression, fatigue, and
their motivation is low.7 In one recent survey of young
adults, over a third reported symptoms of anxiety that
were associated with cannabis use; young women
reported these more commonly.8 Cross sectional asso-
ciations between cannabis use and depression and
anxiety have now been reported in surveys in both
adolescents and adults,9 10 although not all studies have
found an association in male participants.11
Questions remain about the level of association
between cannabis use and depression and anxiety and
about the mechanism underpinning the link. Pre-
existing symptoms might raise the likelihood of canna-
bis use through a mechanism of self medication.12
Alternatively, cannabis use may be more likely in
people with a background of social adversity or
particular characteristics—factors that might also raise
risks for mental disorders. Cannabis may also carry a
direct risk for depression and anxiety.
We examined the risks for later depression and
anxiety associated with cannabis use in teenagers. Spe-
cifically, the study addressed three questions. Firstly,
does cannabis use in adolescents predict the develop-
ment of symptoms of depression and anxiety in young
adults? Secondly, do symptoms of depression and
anxiety in adolescence predict cannabis use in young
adults? Thirdly, is any relation explained by factors
such as family background or intercurrent use of other
substances?
Methods
Sample
Between August 1992 and December 1998 we
conducted a seven wave cohort study of adolescent
health in the Australian state of Victoria. The cohort
was defined in a two stage cluster sample, in which we
selected two classes at random from each of 44 schools
drawn from a stratified frame of government run,
Catholic, and independent schools (total number of
students 60 905). School retention rates to year nine in
the year of sampling were 98%. One class from each
school entered the cohort in the latter part of the ninth
school year (wave 1) and the second class six months
later, early in the 10th school year (wave 2). Participants
were subsequently reviewed at six month intervals for
the next two years (waves 3 to 6), with a final follow up
(wave 7) at the age of 20-21, three years after the final
school year in Victoria. In waves 1 to 6, participants self
administered the questionnaire on laptop computers,13
and those absent from school were followed up by tele-
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phone. The seventh wave of data collection used com-
puter assisted telephone interviews. All stages of the
study were approved by the ethics committee of the
Royal Children’s Hospital.
From a total sample of 2032 students, 1947 (95.8%)
participated at least once during the first six
(adolescent) waves. In wave 7, 1601 young adults (79%
of the initial sample or 82% of teenage participants)
were interviewed between April and December 1998.
Response rates are shown in figure 1. Reasons for non-
completion at follow up were refusal (n=152), loss of
contact (n=192), and death (n=2). We examined
characteristics of non-completers in a logistic
regression model. Male participants were over-
represented (odds ratio 1.9, 95% confidence interval
1.5 to 2.4), as were parental divorce or separation (1.8,
1.4 to 2.5), and daily tobacco smoking at study
inception (2.1, 1.5 to 2.9). Neither teenage depression
and anxiety nor cannabis use were independently
associated with loss to follow up. The mean age at wave
1 was 14.5 (SD 0.5) years; at wave 7 it was 20.7 (0.5)
years. Of the 1601 participants in wave 7, 1130 (71%)
still lived at home, 429 (27%) lived with others, and 42
(3%) lived alone. A total of 1345 (82%) had completed
the final year of school; 1355 (85%) had started
post-school study.
Measures
We used the computerised revised clinical interview
schedule (CIS-R) to assess depression and anxiety at
each wave.14 The schedule provides data on the
frequency, severity, persistence, and intrusiveness of 14
common psychiatric symptoms and has been widely
used in population based surveys.15 A total score of 12
or greater was taken to define a mixed state of depres-
sion and anxiety at a lower threshold than syndromes
of major depression and anxiety disorder but one
where clinical intervention would still be appropriate.16
We assessed cannabis use on the basis of self
reported frequency of use in the previous six months in
waves 1 to 6 and in the previous 12 months in wave 7.
This allowed classification as never used, less than weekly
use, at least weekly use, and daily use (defined as using on
five or more days per week), and initiation after wave 6.
We assessed use of alcohol, tobacco, and other illicit
drugs (including ecstasy, heroin, amphetamines, LSD,
and steroids) on the basis of self reported frequency of
use and with retrospective diaries over seven days for
participants reporting recent drinking or smoking.
Participants drinking on three or more days in the pre-
vious week were classified as frequent drinkers.
We assessed antisocial behaviour in waves 1 to 6 by
using items from the self reported early delinquency
scale that covered property damage, interpersonal vio-
lence, and theft.17
Analysis
We collected data at a developmental point when
young people are difficult to trace because of high
mobility. Although the response rate was high and
attrition low, 70% of respondents missed at least one
wave of data collection, which led to potential bias in
summary measures of exposure to cannabis and
mental health problems calculated from the six waves
of data collection among adolescents. To circumvent
this, we used multiple imputation with five complete
datasets created by imputation under the multivariate
mixed effects model of Schafer and Yucel, incorporat-
ing the covariates sex, age, rural or urban residence,
and parental education (available for all partici-
pants).18 19 These covariates were strongly associated
with missingness, and the model incorporated a
random effects structure to accommodate correlation
within participants over time.We constructed principal
measures by classifying participants according to
whether they fell into categories of interest at least
once during wave 1 to 6 (adolescence) and, separately,
in wave 7 (young adulthood). Data analysis was
performed with Stata 7. We modelled associations by
univariate and multivariate logistic regression analyses
and used Wald tests and related confidence intervals to
assess statistical significance and precision.
Results
Altogether 71 male participants (9.7%, 95% confidence
interval 7.5% to 12%) and 188 (22%, 19% to 25%) of
female participants reported depression and anxiety as
young adults (odds ratio 2.6, 1.9 to 3.5). Sixty six per
cent (484/731) of male participants and 52%
(448/859) of female participants reported using
cannabis at some time (11 participants did not respond
to this question), with three quarters starting use when
they were teenagers. Twenty per cent (146; 17% to
22%) of male participants and 8% (69; 6% to 10%) of
female participants were using cannabis at least weekly,
with 10% (73; 8% to 12%) of young men and 4% (37;
3% to 6%) of young women using it daily.
Cannabis and depression in young adults
The prevalence of depression and anxiety increased
with higher extents of cannabis use, but this pattern
was clearest in female participants (table 1). We used
logistic regression to analyse the level of association
between depression and anxiety and cannabis use in
young adults (table 2) after adjustment for concurrent
substance use. We found a significant interaction
between sex and daily cannabis use. In the adjusted
model, young women who used cannabis daily had an
over fivefold increase in the odds of depression and
anxiety found in non-users.
Cannabis in adolescence and depression in young
adults
We used logistic regression to examine the prediction
of depression and anxiety in young adults by cannabis
use in adolescence. In the univariate analysis a dose
response was evident: daily use in female teenagers
1st sample
(n=1037)
Wave 1
(n=898;
87%)
late 1992
2nd sample
(n=995)
Total intended sample (n=2032)
Total achieved sample (n=1947; 96%)
Wave 2
(n=1728;
85%)
early 1993
Wave 3
(n=1699;
84%)
late 1993
Wave 4
(n=1629;
80%)
early 1994
Wave 5
(n=1576;
78%)
late 1994
Wave 6
(n=1530;
75%)
early 1995
Wave 7
(n=1601;
79%)
1998
Young
adult
survey
Adolescent phase
Fig 1 Participation rates of 2032 secondary school students in the Victorian adolescent health
cohort study. The percentages in waves 2-7 are the proportions of the total intended sample
for which complete data were collected
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predicted fourfold higher odds of later depression and
anxiety (odds ratio 4.2, 1.6 to 11), weekly use a twofold
elevation (2.3, 1.3 to 4.2). In the multivariate model we
collapsed the top categories of cannabis use (table 3).
The interaction between sex and weekly or more
frequent use was significant. An almost twofold
increase in risk for weekly or more frequent users who
were female persisted after adjustment for potential
confounders.
Depression in adolescence and cannabis in young
adults
We considered whether depression and anxiety in ado-
lescence predicted later cannabis use in young
adulthood in two further logistic regression models,
examining the predictions of weekly and daily use
(table 4). After adjustment for adolescent cannabis use
and other potential confounders, adolescent depres-
sion and anxiety predicted neither weekly nor daily
use.
Discussion
Around 60% of the statewide secondary school sample
had used cannabis recreationally by young adulthood;
most participants first experimented while at second-
ary school. By young adulthood 7% were daily users
and in young women this level of use was associated
with over five times the odds of depression and anxiety
found in non-users. In young women, weekly use as
teenagers predicted a twofold increase in later depres-
sion and anxiety and daily use a fourfold increase. In
contrast, depression in teenagers did not predict
higher cannabis use.
Strengths
Earlier cohort studies had a limited capacity to
address the key questions of this study. One study
reported a prospective relation between cannabis use
and later depression but started well after the risk
period of onset for both.20 Two important studies in
adolescence examined either monthly cannabis use or
use in the preceding year—doses that in the light of
this study are unlikely to be associated with mental
health problems.21 22
Our close to representative sample, high rates of
participation, and frequent measures during partici-
pants’ teenage years are strengths of this study. A tele-
phone interview strategy was used in data collection in
the last wave, and, although prevalence estimates may
vary slightly as a result, it is unlikely to have caused a
systematic bias in patterns of association. The use of
multiple imputation minimised measurement biases
arising frommissing data during the teenage years, but
we did not attempt to adjust for differential
participation of young adults. Even though depression
and anxiety in teenagers and cannabis use did not pre-
dict dropout from the study, the difference in
non-responders on other factors (for example, sex or
family structure) may have had some bearing on the
specification of associations.
What the results might mean
Possible explanations for the high degree of depres-
sion and anxiety found in young women who used
cannabis often include underlying characteristics that
predispose to both anxiety and depression, self
medication of pre-existing depressive symptoms, and
an adverse effect of cannabis on mental health.21 The
association with cannabis use persisted after adjust-
ment for concurrent use of alcohol, tobacco, and other
illicit substances as well as indices of family
disadvantage—findings consistent with a more direct
relation. We considered self medication with cannabis
Table 1 Prevalence of depression and anxiety according to cannabis use by sex in 1590 young adults in wave 7 (n=1601) of the
Victorian adolescent health cohort study
Frequency of cannabis use in
previous 12 months
Men Women
No % (95% CI) Odds ratio* (95% CI) No % (95% CI) Odds ratio* (95% CI)
None to <5 times ever 523 9 (6 to 11) (1) 744 19 (17 to 22) (1)
5 times ever to less than weekly 62 10 (2 to 17) 1.1 (0.46 to 2.8) 46 17 (6 to 29) 0.87 (0.40 to 1.9)
1 to 4 times per week 73 12 (5 to 20) 1.5 (0.70 to 3.2) 32 31 (14 to 48) 1.9 (0.87 to 4.1)
Daily 73 15 (7 to 23) 1.9 (0.93 to 3.8) 37 68 (52 to 83) 8.6 (4.2 to 18)
*Obtained from univariate logistic regression models.
11 (7 female) participants in wave 7 did not answer the questions about cannabis use.
*Obtained from univariate logistic regression models.
Table 2 Association between cannabis use in the previous 12 months and depression
and anxiety in 1590 young adults in wave 7 (n=1601) of the Victorian adolescent health
study, derived from a multivariate logistic model
Cannabis use No Adjusted odds ratio (95% CI)
None to <5 times in previous 12 months 1267 1
5 times ever to <weekly 108 0.80 (0.44 to 1.5)
1-4 times/week 105 1.1 (0.60 to 2.0)
Daily*:
Men 73 1.1 (0.55 to 2.6)
Women 37 5.6 (2.6 to 12)
Female sex in the absence of daily cannabis use 822 2.5 (1.8 to 3.4)
Odds ratios are adjusted for parental separation, parental education, current smoking, frequency of drinking,
and use of other illicit drugs.
11 (7 female) participants did not answer the questions about cannabis use in wave 7.
*Wald test for interaction between daily cannabis use and sex: P=0.003.
Table 3 Association of cannabis use in teenagers with later depression and anxiety in
1601 young adults in wave 7 of the Victorian adolescent health cohort study
Measures in waves 1-6 No*
Unadjusted odds ratio
(95% CI)
Adjusted odds ratio
(95% CI)†
Depression and anxiety (at least one wave) 744 6 (4.3 to 8.4) 5.1 (3.6 to 7.3)
Maximal cannabis use
None 1083 1 1
<Weekly 332 1.5 (1.1 to 2.1) 1.4 (94 to 2.0)
>Weekly‡:
Male teenagers 108 0.62 (0.24 to 1.6) 0.47 (0.17 to 1.3)
Female teenagers 78 2.6 (1.6 to 4.3) 1.9 (1.1 to 3.3)
Female sex in the absence of >weekly
cannabis use
788 2.3 (1.6 to 3.1) 1.6 (1.1 to 2.3)
*Numbers for adolescent cannabis use and depression and anxiety were estimated from five imputed
datasets.
†Odds ratios by the highest frequency of cannabis use in teenagers (waves 1 to 6), obtained by using a
multivariate logistic model, adjusted for teenagers’ depression and anxiety, alcohol use, antisocial behaviour,
parental separation, and parental education.
‡Wald test for interaction between more frequent than weekly cannabis use and sex: unadjusted P<0.001,
adjusted P=0.011.
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but found no prospective relation between depression
and anxiety in adolescence and later frequent cannabis
use, consistent with an earlier report.22
The persistence of associations in the multivariate
models and the evidence for a prospective dose-
response relation are consistent with a view that
frequent use of cannabis in young people increases the
risks of later depression and anxiety. Psychosocial
mechanisms—for example, the adoption of a counter-
cultural lifestyle—possibly underlie the association.
Social consequences of frequent use include edu-
cational failure, dropout, unemployment, and crime—
all factors that may lead to higher rates of mental
disorders. Because risks seem confined largely to daily
users, however, the question about a direct pharmaco-
logical effect remains. Cannabinoid receptors (CB1)
are found widely in the central nervous system, with a
distribution that is consistent with effects on a wide
range of brain functions including memory, emotion,
cognition, and movement.23
Cannabis use in young people remains a controver-
sial area, and absence of good data has handicapped the
development of rational public health policies.3 These
findings contribute to evidence that frequent cannabis
use may have a deleterious effect on mental health
beyond a risk for psychotic symptoms. Strategies to
reduce frequent use of cannabis might reduce the level
of mental disorders in young people.
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Table 4 Association of cannabis use in teenagers (waves 1-6) with later depression and
anxiety in 1590 young adults in wave 7 (n=1601) of the Victorian adolescent health
cohort study
Measures in waves 1 to 6 No*
Odds ratio (95% CI)†
>Weekly use Daily use
Depression and anxiety: at least one wave 739 1.2 (0.86 to 1.8) 1.3 (0.80 to 2.2)
Maximal cannabis use:
None 1074 1 1
<Weekly 330 3.7 (2.4 to 5.6) 3.1 (1.7 to 5.7)
>Weekly 185 15 (9.2 to 23) 15 (8.2 to 27)
Female sex 859 0.38 (0.26 to 0.54) 0.5 (0.29 to 0.77)
11 (7 female) participants in wave 7 did not answer the questions about cannabis use.
*Numbers for adolescent cannabis use and depression and anxiety estimated from five imputed datasets.
†Odds ratios obtained by using multivariate logistic models, adjusted for teenagers’ cannabis use, drinking
frequency, parental separation, and parental education.
What is already known on this topic
Frequent recreational use of cannabis has been
linked to high rates of depression and anxiety in
cross sectional surveys and studies of long term
users
Why cannabis users have higher rates of
depression and anxiety is uncertain
Previous longitudinal studies of cannabis use in
youth have not analysed associations with frequent
cannabis use
What this study adds
A strong association between daily use of cannabis
and depression and anxiety in young women
persists after adjustment for intercurrent use of
other substances
Frequent cannabis use in teenage girls predicts
later higher rates of depression and anxiety
Depression and anxiety in teenagers do not
predict later cannabis use; self medication is
therefore unlikely to be the reason for the
association
Endpiece
Surgical innovation
It is infinitely better to transplant a heart than to
bury it so it can be devoured by worms.
Christiaan Barnard (1922-2001), who performed
the first human heart transplant in 1967
Submitted by Max Edwards,
surgical trainee, London
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6.4 Cannabis use and common mental disorders at 29 years 
Paper 12. The persistence of the association between adolescent cannabis use and 
common mental disorders into young adulthood. L. Degenhardt, C. Coffey, H. 
Romaniuk, W. Swift, J. B. Carlin, W. D. Hall, G. C. Patton. Addiction DOI: 
10.1111/j.1360-0443.2012.04015.x 2012 
Journal impact factor 4.3 (source: Journal Citation Reports, 4/03/2013) 
3 citations as at 4/03/2013 (source Google Scholar).  
Since publishing the first paper described in this chapter, there had been an increased 
attention to the question of the temporal association between cannabis use and 
anxiety as well as depression in adolescence, but, as yet, with no apparent consensus 
(Crippa et al. 2009). In order to elucidate possible causality and direction of reported 
associations between cannabis abuse and depression (Degenhardt, Hall & Lynskey 
2003a) and anxiety (Crippa et al. 2009), there was a need for longitudinal follow-up 
from adolescence into adulthood. Prompted by the emerging understanding of 
extraneous cannabis on developing brain structure in adolescence, we were 
specifically interested to know whether the putative effect of early regular cannabis 
use on later mental health we described in the previous paper persisted further into 
young adulthood after cannabis use had declined as the cohort matured. With 
repeated measures in young adulthood to 29 years, as well as the intense coverage in 
the adolescent period, the VAHCS was in a prime position to assess this question 
over the 15 years of follow-up. 
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6.4.1 My contribution 
The lead author was Professor Louisa Degenhardt from the National Drug and 
Alcohol Research Centre. My role in the preparation of this paper was to prepare the 
data for imputation, conduct the analysis and prepare the tables and methods, to 
contribute to refining the question and writing the introduction, results and 
discussion, and finally to the response to the reviewers’ comments. We used multiple 
imputation to deal with missing waves of data, specifically performed for this 
analysis by Dr. Helen Romaniuk, under the supervision of Professor John Carlin. The 
declaration of my contribution, estimated as 40%, is in Appendix 2. 
6.4.2 Analysis and results 
We assessed the influence of both concurrent and earlier cannabis use on MDE and 
AD measured in Wave 9 when the cohort was around 29 years. In order to allow for 
possible confounding by background and time-varying factors, associations were 
progressively adjusted for putative confounders, including sex, rural school location 
at study inception, parental education, parental divorce/separation during 
adolescence, then other concurrent licit and illicit substance use and, lastly, 
depression/anxiety symptoms in adolescence. We found, in agreement with other 
investigators, that daily cannabis use and cannabis dependence were concurrently 
and independently associated with AD at Wave 9 when participants had a mean age 
of 29 years (Crippa et al. 2009; Degenhardt, Hall & Lynskey 2003a; Rao 2006). We 
also identified an association between MDE and cannabis dependence (but not with 
regular cannabis use), and though largely independent of putative confounders, it was 
marginally mediated by anxiety/depression symptoms in adolescence. However, this 
in itself could have resulted from early onset cannabis use. Unlike the earlier analysis 
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when the cohort was aged 20 years, there was no effect modification by sex in any of 
these analyses. 
Regular adolescent cannabis use independently predicted AD at Wave 9. Although 
Wave 7 cannabis use and dependence did not appear to be predictive, both daily use 
and dependence at Wave 8 independently predicted AD at Wave 9, with no evidence 
of effect modification by sex. When we stratified concurrent cannabis use by the 
frequency of adolescent use, we demonstrated that adolescents who had reported 
regular cannabis use (weekly+) were more likely to be identified with AD at Wave 9 
than non- or occasional-users, whether or not they had discontinued daily use by 
Wave 9, even after adjustment for possible confounders. Again, there was no 
evidence of effect modification by sex. 
There was little prospective association with MDE at Waves 7, 8 and 9, with no 
marked effects due to regular cannabis use in adolescence, or cannabis dependence in 
Waves 7 and 8. Furthermore, there was no evidence of an association between the 
stratified measure of cannabis use and MDE equivalent to that with AD. 
6.4.3 Implications 
Probably the most important observation that we made was that AD was clearly 
associated most strongly with daily concurrent cannabis use when this had escalated 
from regular use in adolescence, and it also appeared that the effects of regular use in 
adolescence had a persisting effect on the later development of AD, even when the 
intensity of use was subsequently moderated. These findings were independent of 
possible confounders, including concurrent licit and illicit substance use, but most 
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notably adolescent symptoms of anxiety and depression, thus making it unlikely that 
the mechanism was self-medication. 
There were a number of possible explanations for the association between both daily 
and dependent cannabis use and AD. The distress and stress resulting from poor life 
choices and outcomes consequent to long term regular cannabis use that we have 
illustrated in Chapters 4, 5 and 6 might affect the risks for mental disorders. These, 
broadly, include a susceptibility to poor educational outcomes, other substance abuse 
and dependence, reduced ability to sustain or enter relationships and welfare 
dependency (Degenhardt, Louisa et al. 2010; Lynskey & Hall 2000; Patton, GC et al. 
2007). In addition, parental divorce or separation was associated with many 
outcomes including substance use and anxiety/depression symptoms, indicating the 
importance of family dysfunction in the natural history of these outcomes. It is 
therefore possible that both frequent cannabis use and anxiety disorder may have 
common causes, including biological, social and environmental stressors (Crippa et 
al. 2009; Rao 2006). A suggested mechanism that may account for the cross-
sectional associations we observed is that the response to psychosocial stress could 
be mediated by elevated nocturnal cortisol secretion resulting from effects on the 
limbic-hypothalamic-pituitary-adrenal (LHPA) system, implicated in both substance 
dependence and anxiety symptoms (Rao 2006). 
The hypothesis of common causes for both substance abuse and anxiety due to stress 
does not account for the persistence of AD in those individuals who moderated their 
cannabis use. This observation supports the emerging hypothesis that exposure of the 
central nervous system to exogenous cannabinoids during pubertal development 
could increase the risk of later mental health problems in those young people with a 
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genetic liability (Schneider 2008). It is reasonable to speculate that the coincidence 
of psycho-social stress precipitating and/or consequent to frequent cannabis use in 
adolescents during the period of developmentally related biological vulnerability to 
exogenous cannabis, could jointly increase the risk of developing later anxiety 
disorder in vulnerable young people. 
We did not investigate a possibility that the participants who reported their maximum 
use in the past year or who were identified with cannabis dependence could have 
been experiencing anxiety as a consequence of withdrawal (Crippa et al. 2009). As 
withdrawal symptoms last for a relatively brief period, this was unlikely to be an 
influential component of the reported symptoms (Budney et al. 2003). 
We identified only a weak association between MDE and concurrent cannabis 
dependence, but not daily cannabis use, at 29 years. This association with cannabis 
dependence was attenuated by inclusion of putative confounders in the model, 
perhaps indicating that it was mediated by factors other than cannabis use. In Chapter 
3, I discussed Paper 4 (Swift et al. 2008), the paper that identified an escalating 
trajectory of cannabis use from around 14 years to dependence at 28 years. However, 
we found no evidence that MDE at 29 years was similarly influenced by earlier 
exposure to cannabis use, which indicates that the cross-sectional association we 
observed at 29 years was of contemporary origin. The association between the two 
outcomes at this age could possibly arise from a response to psychosocial stressors 
consequent to substance dependence, similar to that suggested for AD (Rao 2006). 
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6.4.4 Paper 12: The persistence of the association between adolescent 
cannabis use and common mental disorders into young 
adulthood. 
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Louisa Degenhardt1,2, Carolyn Coffey3, Helena Romaniuk3,4, Wendy Swift1, John B. Carlin4,
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ABSTRACT
Aims Debate continues about whether the association between cannabis use in adolescence and common mental
disorders is causal. Most reports have focused on associations in adolescence, with few studies extending into adult-
hood. We examine the association from adolescence until the age of 29 years in a representative prospective cohort
of young Australians. Design Nine-wave, 15-year representative longitudinal cohort study, with six waves of data
collection in adolescence (mean age 14.9–17.4 years) and three in young adulthood (mean age 20.7, 24.1 and 29.1
years). Participants Participants were a cohort of 1943 recruited in secondary school and surveyed at each wave
when possible from mid-teen age to their late 20s. Setting Victoria, Australia. Measurements Psychiatric morbidity
was assessed with the Revised Clinical Interview Schedule (CIS-R) at each adolescent wave, and as Composite Inter-
national Diagnostic Interview (CIDI)-deﬁned ICD-10 major depressive episode and anxiety disorder at 29 years. Fre-
quency of cannabis use was measured in the past 6 months in adolescence. Cannabis use frequency in the last year and
DSM-IV cannabis dependence were assessed at 29 years. Cross-sectional and prospective associations of these out-
comes with cannabis use and dependence were estimated as odds ratios (OR), using multivariable logistic regression
models, with the outcomes of interest, major depressive episode (MDE) and anxiety disorder (AD) at 29 years.
Findings There were no consistent associations between adolescent cannabis use and depression at age 29 years.
Daily cannabis use was associated with anxiety disorder at 29 years [adjusted OR 2.5, 95% conﬁdence interval
(CI):< 1.2–5.2], as was cannabis dependence (adjusted OR 2.2, 95% CI: 1.1–4.4). Among weekly+ adolescent cannabis
users, those who continued to use cannabis use daily at 29 years remained at signiﬁcantly increased odds of anxiety
disorder (adjusted OR 3.2, 95% CI: 1.1–9.2). Conclusions Regular (particularly daily) adolescent cannabis use is
associated consistently with anxiety, but not depressive disorder, in adolescence and late young adulthood, even among
regular users who then cease using the drug. It is possible that early cannabis exposure causes enduring mental health
risks in the general cannabis-using adolescent population.
Keywords Anxiety, cannabis, cohort, depression, epidemiology, psychiatry.
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INTRODUCTION
The extent and nature of the association between canna-
bis use and the more common mental health problems,
namely anxiety and depression, has attracted much
recent attention [1–7]. An earlier review [8] concluded
that there was an association particularly among
early-onset regular cannabis users, but that further
prospective population-based studies were needed to
carefully evaluate the strength of associations; consider
potential mechanisms underlying these associations; and
extend the age range of follow-up because most studies
RESEARCH REPORT
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measured only adolescent mental health outcomes. Some
[3,5,7], but not all, of the recent work [2] has reported
positive associations between cannabis use in adoles-
cence and depressive symptoms or episodes in very early
adulthood. Very few have extended follow-up to later
ages [4]. Some suggest that there may be stronger positive
associations between cannabis use and depression in
females [3,9] and in early adulthood [5,6].
The links between cannabis use and anxiety disorders
are less clear [10]. Cross-sectional studies have often
found elevated rates of anxiety disorders among cannabis
users, but these associations have not always persisted
after controlling for confounding variables [10]. Prospec-
tive studies have reported similarly inconsistent ﬁndings
[11], with some ﬁnding an association that persisted
after control for confounders [5] and others have not
[4,12].
There are good reasons to assess potential conse-
quences of adolescent cannabis use into adulthood.
It is possible that adolescent cannabis use may have
longer-term effects on brain neurotransmitter systems
[13], which may cause psychotic symptoms [14] and
perhaps depressive and anxiety symptoms [13,15,
16]. Adolescence is also an important time for the
achievement of many developmental milestones: edu-
cational, personal, social and occupational. The use of
cannabis and other drugs may adversely affect function-
ing across these domains in ways that impair later
mental health.
In this study, we extend an earlier examination of the
association between adolescent cannabis use and mental
health at the age of 21–22 years [9] in a representative
cohort of young Australians until the age of 29 years. We
addressed the following questions:
1 Is cannabis use in adolescence associated with depres-
sion or anxiety disorders at 29 years?
2 To what extent can any such associations be
accounted for by potential confounding variables?
3 What impact does the pattern of cannabis use between
adolescence and young adulthood have on the risk of
depression and anxiety disorders at 29 years?
METHODS
Sample
Between August 1992 and January 2008 we conducted a
nine-wave cohort study of health in adolescents and
young adults resident in the state of Victoria, Australia.
Data collection protocols were approved by The Royal
Children’s Hospital’s Ethics in Human Research Commit-
tee. The cohort was designed to be representative of the
Victorian population of mid-secondary-school adoles-
cents in 1992. It was deﬁned by two-stage cluster sam-
pling, with two classes selected at random in each of a
state-wide sample of 44 schools, which were selected at
random using a state-wide stratiﬁed frame of govern-
ment, Catholic and independent private schools, with
probability of selection proportional to the number of
students. One class entered the study in the latter part of
the ninth school year (wave 1) and the second class 6
months later (wave 2). School retention rates to year 9 in
the year of sampling were 98%. Participants were subse-
quently reviewed at a further four 6-month intervals
during the teens (waves–6) with three follow-up waves in
young adulthood aged 20–21 years (wave 7), 24–25
years (wave 8) and 28–29 years (wave 9). In waves 1–6,
participants self-administered the questionnaire on
laptop computers, with telephone follow-up of those
absent from school. Waves 7–9 were undertaken using
computer-assisted telephone interviews [17].
From a total sample of 2032 students, 1943 (95.6%)
participated at least once during the ﬁrst six (adole-
scent) waves (Fig. 1). Waves 7–9 were undertaken using
computer-assisted telephone interviews [17], with 1756
(53% female) participating in at least one of these waves
and known to be alive at the time of the wave 9 survey. Of
these, 1282 completed all three young adult waves, 293
completed two and 181 completed one only. Wave 9 inter-
views were completed by January 2008, at which time 15
cohort members were known to have died, 108 were lost
to follow-up and 319 refused to participate. In wave 9,
1501 participants were interviewed between May 2006
and January 2008, 1407 of whom completed the full
phase
survey wave 1 wave 2 wave 3 wave 4 wave 5 wave 6 wave 7 wave 8 wave 9
year 1992 1993 1993 1994 1994 1995 1998 2001/3 2006/8
mean age 14.9 yr 15.5 yr 15.9 yr 16.4 yr 16.8 yr 17.4 yr 20.7 yr 24.1 yr 29.0 yr
sample n 898 1727 1697 1628 1575 1530 1601 1520 1388
design
     Total intended sample = 1037( w1) + 995 (w2) = 2032
ascertainment      96% (1943) of sample parcipated at least once in waves 1-6
2 entry points 
Young adultAdolescent
Figure 1 Sampling and ascertainment in the Victorian Adolescent Health Cohort, 1992–2008
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(1383) or part (24) interview schedule and 94 completed
a reduced hard-copy subset of the questions, without the
Composite International Diagnostic Interview (CIDI). The
strategy of administering a hard-copy subset of questions
was pursued with people who would otherwise not have
been surveyed.
Analysis measures
Adolescent symptoms of depression and anxiety were
assessed at each adolescent wave using the revised
Clinical Interview Schedule (CIS-R). The CIS-R is a
branched psychiatric interview designed to assess symp-
toms of depression and anxiety in non-clinical popula-
tions [18,19]. Its 14 subscales delineate the frequency,
severity, persistence and intrusiveness of common symp-
toms and their addition result in a possible total of 55
points. The total scores on the CIS-R were dichotomized
so that scores greater than 11 delineated a mixed
depression–anxiety state. This was at a lower threshold
than syndromes of major depression and anxiety disor-
der, but at a level where clinical intervention would be
considered appropriate [19–21]. Adolescent exposure
was assessed by identifying participants who had scored
at this level in any adolescent wave (waves 2–6)—this
was termed ‘clinically signiﬁcant anxiety/depression’.
Major depressive episode (MDE) was deﬁned according
to ICD-10 [22] and was measured at 29 years using
the Composite International Diagnostic Interview
(CIDI)–Auto.
Anxiety disorder (AD) was deﬁned according to ICD-10
and was measured at 29 years using the CIDI–Short Form
[23]. Participants were classiﬁed with anxiety disorder if
they were diagnosed with any of: generalized anxiety dis-
order; social phobia disorder; agoraphobia; or panic dis-
order. Speciﬁc phobic disorders were not measured.
Adolescent cannabis use (to wave 6) was assessed using
self-reported frequency of use in the previous 6 months,
categorized as: never, less than weekly (occasional),
weekly and daily. We classiﬁed participants according to
their maximum frequency of use during the adolescent
phase: non-users, occasional users and weekly+ users
(weekly or daily).
Young adult cannabis use. Participants in the young adult
phase (waves 7–9) were asked to report their maximum
cannabis use in the past year. At each wave, we identiﬁed
participants who were non-users, using cannabis less
than weekly (occasional), weekly or more often (daily).
Young adult cannabis dependence
We administered the computerized CIDI (2.1, 12-month
version) at all young adult waves to generate the
DSM-IV criteria for a diagnosis of cannabis dependence
in participants reporting at least weekly cannabis use in
the past 12 months. We applied this ﬁlter to minimize
responder fatigue because we considered that a diagno-
sis of cannabis dependence required regular cannabis
use, given the DSM-IV description of substance depend-
ence as occurring with a ‘pattern of repeated (sub-
stance) self-administration’ [24]. People with three or
more criteria were considered to have DSM-IV cannabis
dependence.
Cannabis use from adolescence to young adulthood. We con-
structed a variable to describe the continuity of cannabis
use from adolescence to wave 9. Maximum adolescent
cannabis use was reduced to the dichotomous variable
none/occasional and weekly/daily and then stratiﬁed
by wave 9 cannabis use measured on three levels:
none, occasional/weekly and daily, resulting in a six-level
variable.
Background measures included: the participant’s
sex; neither parent having completed secondary
education (yes/no); school location at study inception
(non-metropolitan/metropolitan location); and parental
divorce/separation by wave 6 (yes/no).
Other substance use. Alcohol consumption in each wave
was calculated from a retrospective alcohol diary
(beverage- and quantity-speciﬁc) in which participants
reported alcohol use in the previous week. High-risk
alcohol use was deﬁned as 15 or more standard drinks
(one standard drink = 10 g alcohol) in the previous week.
For each of the young adult waves we identiﬁed any illicit
drug use as any reported use of ecstasy, cocaine or
amphetamines in the past year.
Auxiliary variables
Additional measures believed to be associated with
incomplete participation (missing data) were included in
an imputation model as auxiliary variables (see Analysis
section). These included further background details of
the subject’s age; level of education (completed second-
ary education/did not complete); nationality (Australian/
non-Australian born); parental smoking status (yes/no);
tobacco use (non-smoker, occasional, daily) at each
wave and symptoms of depression and anxiety (yes/no)
at waves 7, 8 and 9 (CIS-R at wave 7 and the General
Health Questionnaire (GHQ-12) [25] at waves 8 and 9).
In wave 9 the participant’s maximum qualiﬁcation
achieved (secondary education, vocational qualiﬁca-
tion, degree) and a selection of dichotomous variables
with yes/no responses: ever had a baby; currently
partnered/married; receiving government welfare; in
paid employment.
Adolescent cannabis use and mental health 3
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Analysis
The outcomes of interest in each analysis were MDE and
AD measured at wave 9. Cross-sectional and prospective
associations of these outcomes with cannabis use and
dependence were estimated as odds ratios (OR) [with 95%
conﬁdence intervals (CI)], using multivariable logistic
regression models. All models were (a) adjusted for back-
ground factors, then (b) for these plus alcohol use and,
for waves 7–9, other illicit drug use measured concur-
rently with the cannabis exposure, and ﬁnally (c) for all
the above plus any adolescent symptoms of anxiety/
depression. The increasing levels of cannabis use were
entered into the logistic regression models as dummy
variables with ‘no use’ as the baseline category. The Wald
test was used to assess the joint null hypothesis of no
cannabis effects. Potential modiﬁcation of cannabis use
and dependence effects by sex were also assessed in each
model using a Wald test for interaction, with P < 0.1 as a
threshold for inclusion in the model.
Data collection was undertaken at a developmental
point when young people are difﬁcult to trace because of
high mobility. There was very low missingness on indi-
vidual measures, but including individuals who missed
waves creates bias in summary measures calculated from
these data. To address this, we used the method of multi-
ple imputation [26]. We imputed 20 complete data sets,
separately for males and females, under a multivariate
normal model in STATA version 11 [27], incorporating
all analysis and auxiliary variables. CIS anxiety and
depression scores (waves 2–7) and units of alcohol
(waves 7–9) were imputed after Box–Cox transforma-
tions. Cannabis use, smoking, wave 9 illicit drug use and
level of education variables were log-transformed before
imputation. Depression and anxiety measures at waves
8 and 9, risky drinking at waves 2–6, illicit drug use at
waves 7 and 8, cannabis dependence and dichotomous
background measures were imputed as binary variables.
Maximum level of parental education and age were
imputed as normal variables. After imputation, trans-
formed variables were converted back to their original
scale and all were categorized for analysis, with adaptive
rounding used for binary measures [28].
Wave 1 was omitted, as it contained observations
from only 46% of the cohort, and 182 participants
with no adult-phase observations were omitted as they
contained too little information. Forty-one participants
had responded at one or more adult waves but had only
a single adolescent observation in wave 1. When using
summarized adolescent measures, we considered it was a
reasonable strategy to include these individuals by bring-
ing forward their wave 1 observations to wave 2. Thus the
imputation analysis data set was deﬁned by adult phase
(waves 7–9) participation (n = 1761, 53% female).
Although there was little missingness on individual
measures for each survey completed, we used multiple
imputation to address potential bias and loss of informa-
tion arising from respondents’ missing waves [26]. Of
the 59 outcome, background and auxiliary variables
included in the multiple imputation model, four variables
were completely observed in the imputation analysis data
set, 12 had <10% missing, 32 had 10–<20% missing and
11 had more than 20% missing. No variable was missing
for more than 25% of participants. After imputation, a
further ﬁve participants who had died by wave 9 were
excluded from the analysis (n = 1756).
All frequencies and odds ratios were obtained by aver-
aging results across 20 imputed data sets with inferences
under multiple imputation obtained using Rubin’s rules
[26]. Data analysis was undertaken using STATA version
11 [27].
RESULTS
The analysis data set consisted of 1756 participants,
of whom 931 (53%) were female, 457 (26%) and were
attending a school outside the Melbourne metropolitan
area at study inception; for 579 (33%) neither parents
had completed their education, and 387 (22%) had
parents who were divorced or separated by the comple-
tions of the participant’s schooling, or equivalent age.
At 29 years, there was little association between fre-
quency of concurrent cannabis use and the occurrence
of MDE in all adjusted models (Table 1). There was
some evidence that cannabis dependence approximately
doubled the odds of MDE compared with no cannabis use,
after adjusting for background factors and concurrent
alcohol use. There was no evidence of effect modiﬁcation
by sex in any of the models (all interactions P > 0.5).
Cannabis use and dependence were associated con-
currently with an elevated risk of AD. After adjusting for
background factors, we found the following pattern of
risk associated with cannabis use: daily cannabis users
were at 2.3 times the odds (95% CI: 1.1–4.5) of meeting
criteria for AD compared to non-users, while weekly
users and occasional users were similarly at risk. Those
who were cannabis-dependent were at 2.5 times elevated
odds (1.3–4.8) compared to those who were not depend-
ent. These effects remained after controlling for other
concurrent drug use and adolescent anxiety/depression.
Table 2 shows the levels of cannabis use in adoles-
cence and at waves 7 and 8, as well as the results of
analyses examining potential predictive associations
between cannabis use and dependence during earlier
waves and MDE and AD at age 29 years (Table 2). There
was little convincing evidence of an association between
MDE at age 29 years and earlier cannabis use. In con-
trast to MDE, there was some evidence of a predictive
4 Louisa Degenhardt et al.
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association between AD and weekly+ cannabis use
during adolescence (which reduced after adjustment for
adolescent anxiety/depression). There was an association
between daily cannabis use and also cannabis depend-
ence at age 24 (the prior wave), compared with no can-
nabis use at the same age, and AD at age 29 years. There
was no evidence of effect modiﬁcation by sex in any pre-
dictive model for either outcome (all interaction P-values
>0.17).
Table 3 shows the association between cannabis use
patterns across adolescence and young adulthood with
MDE and AD at age 29. Compared to the lowest risk cate-
gory (none or<weekly cannabis use in adolescence and no
concurrent use) there was little evidence of increased risk
for MDE at 29 years for those who discontinued adoles-
cent use or whose use continued into young adulthood.
There was also some weak indication of an elevated risk
in both categories that included young adult daily users,
which is consistent with the results shown in Table 1.
Similarly, consistent with Table 1, the two groups with
concurrent daily cannabis use clearly had a higher risk of
AD at 29 years than those in the lowest risk category.
Weekly+ adolescent uses who did not report cannabis use
at 29 years still had an approximately twofold elevated
risk for AD, compared with the lowest risk category. This
association was marginally signiﬁcant after adjustment
for psychiatric morbidity during the teens. There was
no evidence of effect modiﬁcation by sex (interaction
P-value = 0.96 for both models).
DISCUSSION
We have described patterns of cannabis use and their
changing associations—both cross-sectional and
longitudinal—with mental health problems during
almost 15 years of follow-up of this cohort. There was no
strong evidence of an association between adolescent
cannabis use and MDE at age 29, with or without adjust-
ment for potential confounders. Heavier adolescent
cannabis use was associated more consistently with a
roughly twofold higher risk of anxiety disorder at 29
years, particularly if cannabis use continued at 29 years.
It seemed clearest that early regular cannabis use in
adolescence increased risk of anxiety disorder at age
29 years, with slightly higher risks if regular use also
occurred at 29 years. A similar level of risk was found at
29 years for people who had not used cannabis regularly
(weekly+) in adolescence but who used cannabis at age
29 years. There also appeared to be an increased risk of
anxiety disorders at age 29 among adolescent cannabis
users, even if they ceased using cannabis in adulthood.
Multiple potential confounders were considered, and
the associations for anxiety disorders remained. It is still
possible that other confounding variables may explain
the observed associations. It is possible, for example, that
continued and/or escalating cannabis use is a marker for
other life-course features that are also associated with an
increased risk of anxiety, such as impaired social role
transitions and unemployment [29].
Our ﬁndings suggest that the association that has
been reported between cannabis use and anxiety in
other studies in young adults may arise because the
same factors that predispose people to use cannabis
also increase their risks for common mental disorders
[30–32]. These common factors might include biological,
personality, social and environmental factors, or a com-
bination of these factors. This is a plausible hypothesis
because social disadvantage is more common among
people who are problematic substance users [33] and
who meet criteria for common mental disorders [34–36].
There are also higher rates of separation and divorce, and
lower rates of being married or in a de-facto relationship
among people with mental and substance use disorders
[34–37]. Other factors that have been associated with
both cannabis use disorders and common mental dis-
orders include parental psychiatric illness and family
dysfunction [38–41].
It is also possible that the association between
cannabis use and anxiety disorders may be causal that
was biologically or socially mediated in some way. For
example, recent reviews have suggested that there may be
speciﬁc points during the life-span—in particular, during
adolescence (puberty)—when changes in endocannabi-
noid activity (caused by D9-tetrahydrocannabinol) might
have more long-lasting effects on brain functions and
behaviour that persist into adulthood [13,14,16].
One possible mechanism could be through changes in
hypothalamic–pituitary–adrenal (HPA) axis function:
cannabinoid agonists have biphasic effects upon HPA axis
activity in animal studies [42]. Furthermore, young
people with lower HPA activity (as measured by cortisol
levels at waking) were found in one study to have earlier-
onset cannabis use, leading the authors to suggest that
lower HPA activity may increase sensation seeking to
increase stimulation [43]. It could also be that regular
cannabis use during adolescence and in young adulthood
is one marker of developmental trajectories (including
educational and social) that place young people at greater
risk of mental health problems. These possibilities would
be consistent with the increasing evidence that the asso-
ciations observed between cannabis use and both anxiety
and depression are strongest when cannabis use begins
during adolescence.
Limitations
The cross-sectional association between cannabis
use and depression/anxiety symptoms in adolescence
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weakened during adulthood, with cross-sectional asso-
ciations observed at some assessment periods and not
others. In part, this may have reﬂected the slightly differ-
ent assessment approaches used in some waves of assess-
ment, where scales were used that assessed symptoms of
both.
Our capacity to see consistent associations with
depression may be affected by the limited precision of
estimates of the associations, as cannabis prevalence
decreased sharply across young adulthood. The overall
trend was for cannabis use to decrease over young adult-
hood, whereas the pattern of use associated most clearly
with anxiety disorders was either the maintenance or
increasingly frequent use of cannabis in young adult-
hood. Furthermore, there is the possibility that unmeas-
ured confounders may have explained the associations
observed here. Future research needs to consider this
possibility in other cohorts across similar ages to examine
whether this occurs in other groups. Pooling of cohorts
might improve capacity to examine these associations
across age periods when cannabis use becomes less
prevalent.
CONCLUSIONS
Regular use of cannabis in adolescence was not associ-
ated consistently with depressive disorders in late young
adulthood (age 29 years) but was associated more
consistently with anxiety disorders, even after statistical
adjustment for potential confounders. A suggestive trend
for higher rates of anxiety disorders later in adulthood in
heavier teen users who ceased use in young adulthood
raises the possibility that early cannabis use produces
an enduring increase in the risks of mental disorders.
Further work is required to replicate this ﬁnding and
clarify whether there is a causal relationship between
early heavy cannabis use and anxiety disorders, or
whether this association is better explained by residual
confounding by social context or temperament.
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6.5 Summary. 
These two papers have made an important contribution to the evidence around 
regular cannabis use being causally linked with common mental disorders. The 
relevance of the first paper is illustrated by the large number of citations. We 
anticipate a similar reception for the second paper, as it delineates a connection 
between frequent cannabis use in adolescence and AD in adulthood, not previously 
reported. Regular cannabis use in the adolescent phase implied that use generally 
commenced early in follow-up: looking at complete case data, 61/66 (92%) of 
maximal daily users and 131/157 (83%) of maximal weekly users in adolescence had 
first reported use by Wave 3, that is, by 15 years. Thus, combining the findings from 
the two papers, we can say that they support the hypothesis that early uptake 
culminating in regular cannabis use in adolescence constitutes an identifiable risk for 
emotional distress in women by 20 years and in AD for both young women and men 
by 29 years, independent of background factors, other substance use and adolescent 
symptoms of anxiety/depression. 
In order to clarify the connection between the two sets of findings reported in these 
papers, I examined the associations at Wave 7 between daily cannabis use and 
symptoms of anxiety/depression (Table 6.1), using the same models as shown in the 
first paper. I applied a coding scheme to identify symptoms within the CIS-R 
instrument, developed by Professor George Patton but not yet published (paper in 
preparation). The estimates can be interpreted only cautiously, because of the 
relatively small frequency of daily cannabis users, resulting in imprecision. In males, 
the related symptoms of worry and anxiety predominated though the association, 
with anxiety symptoms attenuated by adjustment for background and previous 
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adolescent factors, including any anxiety/depression symptoms. Clearly, these 
symptoms were not sufficient to generate an excess in the total score on the CIS-R 
above the cut-point in more daily users than non-daily users/non-users, but they 
indicated a higher frequency of these two component symptoms of anxiety disorder 
compared with non-and <daily-users. In females, all symptoms, except possibly 
depressive symptoms and sleep problems, were endorsed more frequently in daily 
cannabis users than non-and <daily-users. These observations would tend towards 
the interpretation that the association observed at Wave 7 in females, and to a lesser 
degree in males, were consistent with the later identification of AD. 
Table 6.1 Adolescent symptoms severity measured by daily cannabis use at 20 years (Wave 
7) in 1575 participants with complete data on all measures. 
 
1 "N" denotes frequency of the symptom and "%" denotes the percent of these who report daily cannabis use  
2 Odds ratios from univariable logistic models  
3 Odds ratios from multivariable multinomial logistic models adjusted for sex, parental divorce and education and adolescent 
factors: any antisocial behaviour, high risk drinking and symptoms of anxiety/depression (CIS-R>11) 
 
An association between heavy cannabis use and depression that has been frequently 
reported in community based studies may, in some instances, be a reflection of an 
association with mixed anxiety and depression, depending on the measures used 
(Degenhardt, Hall & Lynskey 2003a). As illustrated in Table 1, such measures can 
mask a tendency towards one of these outcomes, so papers reporting DSM diagnoses 
of major depression or anxiety give a more precise account. Other publications 
N1 (%) OR2 OR3 N1 (%) OR2 OR3
Poor concentration 7 (0) - - 19 (4) 3.2 (2.1 - 21) 6.5 (1.9 - 23)
Worry 74 (15) 2.6 (1.4 - 4.9) 2.7 (1.4 - 5.4) 148 (11) 4.1 (2.1 - 8.2) 3.4 (1.6 - 7.2)
Anxiety 34 (8) 3.0 (1.3 - 6.8) 2.3 (0.89 - 5.8) 66 (9) 2.5 (1.0 - 6.3) 1.6 (0.61 - 4.3)
Depressive symptoms 29 (10) 1.0 (0.30 - 3.5) 0.61 (0.14 - 2.7) 60 (5) 2.2 (0.83 - 6.0) 1.9 (0.67 - 5.6)
Depressive ideas 32 (9) 0.92 (0.27 - 3.1) 0.95 (0.26 - 3.4) 58 (7) 3.6 (1.5 - 8.7) 2.9 (1.1 - 7.5)
Fatigue 94 (12) 1.2 (0.61 - 2.4) 1.1 (0.52 - 2.2) 206 (8) 3.0 (1.5 - 5.8) 2.5 (1.2 - 5.1)
Irritablity 27 (19) 2.1 (0.77 - 5.7) 1.7 (0.51 - 5.4) 56 (18) 6.4 (2.9 - 14) 4.8 (2.0 - 11)
Obsessive & compulsive symptoms 47 (7) 1.6 (0.70 - 3.8) 1.4 (0.54 - 3.6) 99 (10) 3.1 (1.5 - 6.7) 2.4 (1.0 - 5.4)
Sleep problems 44 (5) 0.41 (0.10 - 1.7) 0.23 (0.03 - 1.7) 83 (8) 2.3 (0.99 - 5.5) 1.7 (0.67 - 4.1)
Somatic symptoms 22 (18) 2.0 (0.67 - 6.2) 2.2 (0.66 - 7.2) 73 (17) 5.3 (2.5 - 11) 4.1 (1.8 - 9.3)
Males (N=724) Females (N=851)
Daily cannabis use
(95% CI) (95% CI) (95% CI)
Univariate Adjusted
(95% CI)
Symptoms reported at wave 7
Univariate Adjusted
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reporting co-morbidity between depression and substance dependence in adults tend 
not to distinguish cannabis from other illicit substances, or do not allow for other 
illicit substance use. In a recently published paper by the Cannabis Cohort Research 
Consortium, in which an integrative analysis of four Australasian cohorts, including 
VAHCS, showed a modest but robust association between increasing rates of 
cannabis use and depressive symptoms in adolescence, this association was age-
dependent, reducing as the cohorts aged, so that it was negligible by 30 years 
(Horwood et al. 2012). Anxiety disorder was not examined in this analysis, and it is 
hoped that this will be a focus in the future, as our findings from the VAHCS need 
replication. 
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CHAPTER 7 Summary and discussion 
7.1 Chapter outline 
Chapter 7 commences with a summary of the findings from the 12 papers included in 
this thesis relating to the natural history of cannabis use and those concerning the 
consequences in educational achievement, illicit substance use and mental health 
(§7.2). A critical appraisal of the strengths and limitations of the VAHCS are given 
in §7.3, in order to interpret the findings about the natural history and consequences 
of cannabis use discussed in §7.4. Possible biological mechanisms for the 
consequences of regular cannabis use and comorbidities are discussed in §7.6. The 
translation of finding into practice in terms of public education, social policy and 
preventative intervention are presented in §7.7. In §7.8, implications for future 
research are discussed and several important questions are identified in general and 
with reference to the forthcoming survey, when the cohort participants are in their 
mid-30s. 
7.2 Summary of findings from the VAHCS 
7.2.1 Natural history 
In the papers included in Chapter 3, we described the natural history of cannabis use 
from 14 years, at or near the youngest age when cannabis use commenced, through 
to 29 years, a point at which dependence was clearly evident in some participants. 
Sixty percent of VAHCS participants reported using cannabis at least once during 
follow up from Wave 1 to 9, with half of these commencing whilst of school-age (by 
Wave 6), and a further 40% by the time they were 20 years (Wave 7). Peak 
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prevalence of use was at 20 years, with almost three of five participants reporting 
use. Both initiation and prevalence of use declined substantially thereafter, largely 
due to a reduction in the proportion of occasional users from 77% at Wave 7, to 62% 
and 66% in Waves 8 and 9. By 29 years, most had ceased, only 17% of those 
surveyed reporting cannabis use. 
DSM-IV-defined cannabis dependence was measured in each of the three young 
adult waves. Eleven percent of those who were surveyed in young adulthood were 
diagnosed with dependence at least once. Twenty seven percent of all adolescent 
users were later diagnosed with dependence. Stratifying by maximum frequency of 
adolescent use, 44% of weekly- and 52% daily-users in adolescence were later 
diagnosed with dependence. 
The frequency of adolescent cannabis use varied within individuals over time. An 
investigation of the outcomes for occasional users, and regular users who moderated 
their use in adolescence showed that these young people were less at risk of later 
problematic cannabis use than consistent regular users, but nonetheless were still at 
substantially elevated risk compared with non-users in adolescence (Swift et al. 
2009). While most adolescent use was sporadic and of limited duration, it was 
apparent that teenage occasional users were not free of later escalation. About 20% 
of occasional users in adolescence subsequently escalated their use sometime after 
the age at which they completed the Wave 6 survey. Those who commenced use in 
adolescence, but abstained by Wave 6, were much less likely to escalate their use in 
young adulthood. 
These data clearly lend themselves to the examination of predictors of initiation, 
continuation, escalation and remission, within the limitations of the available 
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measures. Antisocial behaviour, cigarette smoking, frequent and high-dose alcohol 
drinking, as well as peer cannabis use and the degree of school level involvement in 
regular cannabis use, all independently increased the likelihood of commencing 
cannabis use in adolescence, with symptoms of anxiety and depression also 
implicated (Coffey et al. 2000). In two papers we examined the predictors of later 
DSM-IV-defined dependence at 20 years and again at 24 years (Coffey et al. 2003; 
Swift et al. 2008), shown consistently to be more common in males. The salience of 
regular use in adolescence as a predictor of later problematic use was underlined in 
both papers, with use before 16 years carrying most of the burden of risk for 
dependence at 24 years. Male sex, parental divorce, along with antisocial behaviour 
and persistent cigarette smoking in adolescence were shown to be associated with 
escalation of use. 
The finding that symptoms of anxiety and depression predicted initiation of cannabis 
use in adolescence (Coffey et al. 2000) raised the possibility that self-medication was 
influential in cannabis use initiation. As the cohort matured and our understanding 
evolved, we identified a minor but consistent predictive influence of mental health in 
the maintenance and escalation of use in adolescence, and consistent cross-sectional 
association (Coffey et al. 2003; Degenhardt, Louisa et al. 2010; Patton, GC et al. 
2002). We observed that symptoms of anxiety and depression were associated with 
escalation of use to dependence at 24 years in adolescents already using cannabis. 
The disparate trajectories of problematic alcohol and cannabis use was identified and 
examined in detail (Patton, GC et al. 2007). In general, but not universally, when 
young people were on a track to substance abuse, they appeared to select one or the 
other, possibly as a result of availability and peer acceptability (Patton, GC et al. 
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2007), with more extreme consequences of social and illicit substance use in the 
cannabis group than in the alcohol abuse group, at least at 24 years. 
7.2.2 Consequences of adolescent cannabis use  
A cascade of problematic outcomes was more likely in young people using cannabis 
regularly in adolescence than in those who commenced later, or used less frequently. 
Frequent cannabis use in Year 10 was associated with reduced rates of high school 
completion (Lynskey et al. 2003), but this effect weakened as the cohort matured 
towards the end of secondary schooling, presumably as other considerations became 
influential in the decision to leave school early. Consistent with this, we 
subsequently demonstrated that adolescents using regularly were less likely to obtain 
a post-school qualification than their non-using peers (Degenhardt, Louisa et al. 
2010). This later finding was replicated subsequently in the Australasian context by 
the Cannabis Cohort Research Consortium using pooled data from several 
Australasian studies (Horwood et al. 2010) including the VAHCS. 
Apart from later dependence (Coffey et al. 2003), using cannabis weekly or more 
often in adolescence increased the likelihood of other problematic illicit substance 
use and compromised social outcomes (Patton, GC et al. 2007). Frequent adolescent 
cannabis use was also associated with both subsequent initiation of cigarette smoking 
and nicotine dependence, thus increasing the risks for smoking-related health effects 
in later years, beyond those attributable to smoking cannabis mixed with tobacco 
(Patton, GC et al. 2005; Swift et al. 2008). Regular cannabis use in adolescence was 
the primary risk factor for amphetamine use initiation (Degenhardt et al. 2007) and 
we showed that the poor outcomes in young adulthood associated with amphetamine 
use were confounded by early regular cannabis use. Consistent with this, we also 
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demonstrated that early frequent cannabis use predicted increased rates of cocaine 
and ecstasy use in young adulthood (Swift et al. 2008; Swift et al. 2012). 
We investigated the possibility of later mental health problems in adolescents who 
had reported using cannabis daily in any wave during the adolescent phase. Young 
women using daily in adolescence or at 20 years were shown to be more likely to 
report anxiety and depression symptoms at 20 years, than non-users (Patton, GC et 
al. 2002). Anxiety symptoms predominated and there was some evidence that young 
men also were reporting anxiety symptoms at that age, but below the threshold for 
identification (unpublished finding). We observed that symptoms of anxiety and 
depression were associated with escalation of use to dependence at 24 years in 
adolescents already using cannabis, perhaps a consequence of established cannabis 
exposure (Swift et al. 2008). Later, daily adolescent cannabis users were 
demonstrably at increased risk of developing anxiety disorder by 29 years, whether 
or not they had abstained in the meantime (Degenhardt et al. 2012). 
Occasional users in adolescence were not immune to compromised outcomes in 
young adulthood, as use at this level still constituted a risk for later escalation to 
daily use and dependence, though not as frequently as the higher risk group of 
regular adolescent users (Degenhardt, Louisa et al. 2010). Similarly, those who 
moderated their use during adolescence reduced their risk of later poor outcomes, but 
the risk remained to some extent (Swift et al. 2009), except in those who abstained in 
adolescence, consistent with the related association with cannabis dependence. 
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7.3 Methodological considerations 
7.3.1 Generalisability 
There are four questions to consider regarding generalisiblity of our findings. Firstly, 
was our achieved sample representative of the Victorian population at the time of 
sampling? Can we generalise our findings to the Australian population of high 
school-aged children at the time of sampling? Are our findings likely to be relevant 
to future generations of cannabis users within Australia? Finally, are they 
generalisable to other high income countries? 
7.3.1.1 Victoria 
The cohort was designed as a representative sample of the Victorian population of 
mid-secondary school students in 1992. The sampling methodology has been 
described in detail in Chapter 2, §2.3.2. School retention rate in Victoria in the year 
of sampling, 1992, was 98% and we ascertained 96% of our intended sample. 
Weights calculated to correct for chance sampling variation within the school 
type/region strata ranged from 0.6 to 1.2 with a mean of 1.1. Thus, with the 
exception of a small subgroup of very early school leavers, possibly with extreme 
behaviours and different experiences, we can say that our sample was representative 
of almost all the Victorian population at the time of sampling. In common with all 
longitudinal studies, there was some attrition as the cohort matured. Possible 
selective attrition of high risk participants and strategies to address this are discussed 
in §7.3.2. 
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7.3.1.2 Australia 
Legislation regarding cannabis possession differs between jurisdictions and may 
have some influence on generalisibility to the Australian population, although there 
is no evidence that this has influence on the prevalence of cannabis use (Williams 
2004). Other influences may have arisen from variation in the ethnic composition of 
each state, where particular ethnic groups, may be more prone to problematic 
substance use, for example, Indigenous Australians who have known higher rates of 
cannabis use (AIHW 2010). Examination of the variation in Victorian prevalence 
estimates at the time of sampling may indicate our ability to generalise beyond that 
state, as confounding, if it is a major consideration, should be evident. 
State data focusing on cannabis use obtained by the National Drug Strategy (NDS) 
Surveys in 1985, 1991, 1993 and 1995 were published as part of the NDS 
monograph series (Makkai & McAllister 1997). Figure 7.3.1.2 shows point estimates 
of cannabis use in the past 12 months in four jurisdictions: Australian Capital 
Territory (ACT), South Australia (SA), New South Wales (NSW) and Victoria (Vic). 
This shows consistent estimates for NSW and Victoria, with the other States 
converging in 1995.  
The monograph reported pooled estimates over four surveys from 1985 to 1995 
stratified by age group, shown in Table 7.2.1.2. The authors warn that the small 
sample size of teenagers in the Northern Territory data resulted in imprecise 
estimates and that these do not appear different from Western Australia, which in 
turn, is similar to South Australia and the ACT. Thus, it seems that the authors are 
not prepared to declare a substantive difference in the estimates of the prevalence of 
one year cannabis use between States. 
Chapter 7 Summary and discussion 
 
144 
 
Figure 7.3.1.2 Used cannabis in the past 12 months in four jurisdictions 
 
Source: NDS 1988, 1991, 1993, 1995 data. Australian Institute of Health and Welfare, Canberra 
Thirty-one percent of VAHCS participants reported cannabis use in the adolescent 
phase from 14 to 18 years, but as this is a cumulative measure of use every six 
months and not comparable to the estimates shown in Table 7.3.1.2. Therefore, in so 
far as the VAHCS is representative of the Victorian population, it appears reasonable 
to suggest that we can generalise our findings to the Australian population, but not 
necessarily to subgroups with different patterns of cannabis use, such as Indigenous 
Australians and school non-attendees. 
Table 7.3.1.2 Used cannabis in the past 12 months: pooled data 1985-95 
 
 
Source: NDS 1985, 1988, 1991, 1993, 1995 pooled data file. Australian Institute of Health and Welfare, Canberra 
14-19 
years
20-39 
years
40+ 
years (n)
New South Wales 17 16 2 (2805)
Victoria 20 17 1 (2692)
Queensland 18 14 1 (2258)
South Australia 23 18 2 (2168)
Western Australia 26 23 3 (2052)
Tasmania 24 14 1 (1244)
Australian Capital Territory 28 21 2 (1164)
Norther Territory 30 30 10 (855)
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7.3.1.3 Future users  
Can we generalise to future generations of cannabis users within Australia? The 
prevalence of recent use of cannabis in Australia at 14 years and over was estimated 
to be 13.1% in 1995, decreasing to 9.1% in 2007 but apparently increasing again 
with the most recent estimate at 10.3% in 2010 (according to the authors, a 
statistically significant increase) (AIHW 2010). The drop in prevalence from 1993 to 
2007 was accompanied by a corresponding increase in the age of initiation 
(Roxburgh et al. 2010), but current observations are not available. Thus, the VAHCS 
may have ascertained a sample with a larger proportion of adolescent cannabis users 
than would be possible were the study conducted now. This is an advantage as far as 
our analysis is concerned, as it endows increased power to examine questions of 
interest. However, the adverse outcomes that we report, such as educational 
attainment, may currently be less affected overall by these lower levels of adolescent 
cannabis use than in the 1992 cohort. 
7.3.1.4 Other high income countries 
Patterns of substance use escalation have been shown to be susceptible to the 
national background prevalence of each substance (Degenhardt, L.  et al. 2010). For 
example, in countries with low prevalence of cannabis use, the transition to other 
illicit substance use occurs independently of previous exposure to cannabis. The 
prevalence of cannabis use in Australia appears to be reasonably consistent with 
countries such as New Zealand, the United States, Canada, and Western Europe 
(Copeland & Swift 2009; Murray et al. 2007) and generalisation of our findings 
concerning outcomes of adolescent cannabis use to these high income countries is 
probably justified, with the proviso that the extent of possible confounding by 
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variation in legislation between jurisdictions is unknown. It is noteworthy that the 
highest prevalence of cannabis use globally is in these countries. 
Comparing cannabis uptake in the VAHCS with the Christchurch Health and 
Development (CHD) study, 31% of VAHCS and 27% of CHD participants initiated 
cannabis use before 18 years and at 20/21 years 59% and 47% respectively were 
active users (Fergusson, Horwood & Swain-Campbell 2002). These estimates are 
close enough to feel that the studies are comparable and meta-analysis, including 
data from the two studies in publications generated by the Cannabis Cohort Research 
Consortium, have presented consistent findings including adjustment for study 
specific covariates (Horwood et al. 2012; Horwood et al. 2010). 
Cannabis use was measured at 13 and 15 years in the Health Behaviour in School-
Aged Children (HBSC), consisting of periodic cross-national, cross-sectional surveys 
in a large number of European countries. Point prevalence for onset cannabis use by 
15 years from the 2001-2 surveys was 17%, 22%, 18%, 15%, 4% and 14% for 
Belgium, Czech Republic, France, Ireland, Greece and Poland respectively, showing 
a considerable variation (Kokkevi, Nic Gabhainn & Spyropoulou 2006). In the 
VAHCS, in 1993, 19% (CI 17-21%) had initiated cannabis use before 16 years, 
comparable with these estimates for Belgium and France. Taking into account 
possible cofounding by country-level factors such as specific cannabis legislation, 
socio-economic factors, availability and attitude to drugs, it appears that our findings 
will have relevance for cannabis use in some other high income countries. 
I reported in Chapter 3 that 27% of adolescent cannabis users in the VAHCS were 
later identified with dependence, a considerably elevated figure compared with the 
generally cited figure of 10% (Anthony 2006; Hall, Johnston, Donnelly 1999). This 
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is most likely explained by important methodological differences and possibly 
selection bias due to low response rates. The figure of 10% was based on cross-
sectional National Household Survey (NHS) data and is the proportion of active 
users who were identified with DSM-defined dependence. This is not comparable 
with the VAHCS ascertainment of both adolescent users and young adult dependence 
over multiple waves, and illustrates the lack of comparability between cross-sectional 
surveys and prospective cohort studies, as well as the effect of selection bias, in 
which heavy drug users may have been under-represented in the NHS. Thus, our 
estimates are likely to be relevant to other high income settings in which there is a 
high prevalence of cannabis use by young people. 
7.3.2 Study design and analysis  
The novel contribution that the VAHCS has been able to make due to its design and 
conduct were discussed in Chapter 2, §2.7.2, and included the population-based 
sample, the high participation rates, the large sample size, the frequency of survey 
waves during adolescence, the way in which we measured cannabis use and the 
consistency of these measures and those of other substance use throughout the 
cohort. 
As I mentioned in §7.2.1, the representativeness of the sample at inception of the 
cohort was excellent, as it occurred at an age when school retention was 98%, and 
96% of the intended sample were interviewed at least once during adolescence. This 
does not exclude the possibility that a small sub-group of heavy cannabis users was 
not captured in the study, perhaps in those who were invited but did not participate, 
or in the 2% not included in the Year 9 school population. Attrition was minimised 
by allowing participants to miss waves but to be still included subsequently. Missing 
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data within waves were rare, due to the computer based interviewing, and did not 
constitute a problem. Of the 1943 ever adolescent participants, and taking into 
account the staggered entry between Waves 1 and 2, 1248 (62%) completed all 
possible adolescent waves, and by Wave 9, 78% of the living adolescent participants 
were interviewed. 
Unlike any other cohort study examining adolescent exposures, the six-monthly 
surveys during adolescence enabled us to identify transitions in cannabis use and 
other measures such as licit substance use, antisocial behaviour and symptoms of 
anxiety and depression. They also allowed us to assess exposure measures of 
duration of use and maximum use during adolescence when examining questions 
relating to young adult outcomes. 
The study design was complicated by the staged entry into the cohort over two 
waves. In addition, in common with all longitudinal studies, sample attrition and 
missing waves of data after study entry constituted a considerable challenge in 
deciding how best to ensure that bias due missing data was minimised. In order to 
assess potential bias we identified the baseline characteristics of low completers, 
defined as participating in only one or two of six adolescent waves. Low completers 
were more likely to be male, born outside Australia, with divorced or separated 
parents, and to report smoking cigarettes at study entry (Coffey et al. 2003; Patton, 
GC et al. 1998a). Completers and non-completers were similar on other factors: 
urban/rural school location, parental smoking and education, and symptoms of 
anxiety and depression at baseline (Patton, GC et al. 1998b). Early smoking and 
parental divorce/separation were of particular concern as a source of selection bias, 
as both of these predict cannabis uptake and continuation. It was therefore possible 
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that we had lost contact with participants involved in extreme behaviours, resulting 
in differential under-ascertainment of cannabis and other illicit substance users in the 
course of the cohort study,  
We employed different methods to deal with this possible response bias. Early in the 
cohort analysis we used weighting by factors associated with missingness 
e.g.,(Patton, GC et al. 1998a). In the first paper in the series presented in this thesis 
we did not weight, under the assumption that, at the subject-specific level, this was 
unnecessary, as within-id relationships were represented by those individuals 
retained in the study and were similar in those who were absent. We acknowledged 
this assumption, stating that we could only speculate on the possible effects of non-
participation on exposure and outcome patterns compared with those seen in the 
participants. 
As the cohort matured and our questions evolved, we wanted to summarise 
adolescent exposures over a number of adolescent waves, and so the issue of missing 
waves became more acute. When using complete case data, we were essentially 
imputing missed waves to zero occurrence, and were therefore likely to be under-
estimating the frequency and duration of summarised exposures. Our interest in 
multiple imputation was largely stimulated by this problem, and the first time we 
employed this technique to generate response probabilities was in the second paper 
in this thesis (Coffey et al. 2000). We were fortunate to be in a position to implement 
multiple imputation ahead of others in the field, due to the support of Professor John 
Carlin and his team in the Clinical Epidemiology and Biostatistics Unit (CEBU) in 
MCRI. Subsequently, this method has become mainstream, but the continued support 
of CEBU statisticians has ensured best practice in this complex area. As I described 
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in some detail in Chapter 2, §2.5.1, multiple imputation allowed us to make the least-
biased estimation of missing data and summary measure. However, the method of 
imputation required that data were missing at random and deviations from this 
assumption may have left residual bias, though the inclusion of auxiliary variables in 
the imputation models should have ameliorated this effect. It became our practice to 
do a sensitivity analysis using complete case and wave data for each model 
employing imputed data, though this inevitably also was prone to further selection 
bias, as it only contained data from the most compliant participants. 
7.3.3 Measurement issues 
7.3.3.1 Cannabis use 
The comparability of measures throughout the study within a developmental 
framework allowed for monitoring of behaviour as the cohort matured, including 
longitudinal comparisons between measures in the adolescent and young adult 
phases. Specifically, the measurement of frequency of cannabis use throughout the 
cohort allowed us to identify changes in status, in a way that is clearer than is 
possible when the question refers to the “number of time in the past 
month/year/ever”, or as retrospective life-histories, as is the practice in many other 
studies. 
Frequency of use is only one aspect of cannabis consumption. We did not attempt to 
measure the dose of cannabis consumed as recently recommended by some (Temple, 
Brown & Hine 2011). A primary consideration in the design of the study was that it 
had scope to investigate a broad range of adolescent risk behaviours and mental 
health problems and so had limited scope to investigate a single behaviour, such as 
cannabis use, in exhaustive detail. In Chapter 1, §1.4, I discussed the many factors 
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that determine the dose of THC received by the consumer, including the method and 
technique of delivery, the part of the plant consumed, and plant potency, which may 
depend on the cultivation method and region. In order to improve the accuracy of our 
measure, we would have had to ask about the type of cannabis use (e.g., resin or 
plant) and how it was taken (e.g., smoked or consumed), whether participants mixed 
their smoked cannabis with tobacco (mulling) and also how many times a day they 
used it. As smoking is the most common method of delivery (AIHW 2010), we could 
have based our enquiry substantially on this method, but we would still need to know 
which part of the plant was used, whether it was grown hydroponically, and whether 
the participant inhaled, and for how long. If users titrate their consumption to 
correspond with fluctuations in potency, thus ameliorating potency variations (Korf, 
Benschop & Wouters 2007; McLaren et al. 2008), some of the detail may be 
redundant, but accurate measurement would remain a vague science, with specificity 
obtainable only by direct assay, clearly not feasible in a large population study. For 
this reason, although still prone to measurement error and reporting variability, self-
reported frequency of use has been accepted as an appropriate way in which to gain 
information about population behaviours (Darke 1998; Fendrich et al. 2005). In the 
VAHCS, this measure had face validity, supported by the way in which it ‘behaved’ 
in our analyses, where occasional, weekly and daily use carried distinctively different 
risks for various outcomes, and often displayed a “dose effect” with risk increasing 
with increasing frequency of use. 
An important and consistent finding that we reported is the augmented risk for 
adverse outcomes if regular cannabis use commenced in adolescence, with earlier 
use conferring greater risk than later use. However, it is possible that reporting bias 
may have affected our findings, as survey participants have been shown to 
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increasingly under-report as they age, which could possibly have resulted in under-
estimation of these effects (Fendrich et al. 2005). Our interviewers reported that 
occasionally an adult participant would hesitate before declaring that they had never 
used cannabis (or other substance), possibly because they wanted to avoid the 
detailed dependence assessment that they knew would follow. I employed data 
cleaning to minimise this effect by identifying “non-users” at, say Wave 8 or 9, who 
had previously reported significant use or dependence, and setting their response to 
missing prior to imputation. 
We used DSM-IV to diagnose dependence in each of the young adult waves. This 
has been shown to have excellent concordance with that obtained from the ICD-10 
classification system (ߢ ൌ ͲǤͻሻ (Swift, Hall & Teesson 2001). However, Temple and 
associates have criticised the measurement of dependence used in both DSM and 
ICD systems as people can be categorised with dependence when they use 
infrequently (Temple, Brown & Hine 2011). This situation was minimised in 
VAHCS by applying the instrument only to participants reporting at least weekly 
use, which we justified on the basis of the DSM requirement for “pattern of repeated 
(substance) self-administration” (Composite International Diagnostic Interview 
(CIDI) Core Version 2.1, 12 month version 1997) before a diagnosis of dependence 
can be considered. Even so, it is possible in VAHCS to obtain a diagnosis when 
reporting use of only once or twice a week, and this occurred in 17%, 28% and 29% 
of these users in Waves 7, 8 and 9 respectively. I acknowledge that the diagnosis 
may sometimes be over-specified and perhaps the diagnostic threshold should be 
higher than weekly use. However, if we reported dependence conditional on, for 
example, daily use, comparison with other studies then becomes invalid, and we 
would also be relying on there being no under-reporting of frequency of use. Temple 
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also pointed out that a diagnosis of dependence is obtained by endorsing three of the 
seven criteria in DSM-IV (three of six in ICD-10), with no actual assessment of harm 
generally interpreted as implicit in the diagnosis. Clearly, the diagnosis obtained 
from these instruments is sometimes flawed, or, perhaps, incorrectly labelled, but in 
the absence of anything better, we must interpret our findings within these 
limitations. 
7.3.3.2 Other measures 
Unlike birth cohorts, we had no measures of early childhood. The VAHCS was 
specifically designed to investigate continuities and consequences of risk behaviours 
and mental health problems occurring in adolescence, and did not invoke any 
hypotheses depending on early childhood constructs. This could be considered a 
disadvantage, but all studies necessarily have their limitations, and the VAHCS 
focused in detail on adolescence with frequent measurement points not undertaken 
by any other cohort study to my knowledge. We have limited direct measurement of 
genetic material which we have not, as yet, included as confounders or mediators in 
epidemiological questions such as those included in this dissertation. 
The measurement of background factors, outcomes and putative risk factors were 
important features of the study. We had access to only a limited number of 
background factors, as we were largely dependent on participant report for such 
measures as parental divorce, education, substance use and so on. 
The same criticism of the measurement of cannabis use detailed above would have 
also applied to other substance use, with under-reporting in young adulthood due to 
social desirability likely playing a part (Johnson & Fendrich 2005), again possibly 
leading to under-estimation of effect sizes. The VAHCS was unusual in that it 
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measured amphetamine use throughout the cohort from inception, allowing insight 
into early transitions into other illicit substance use beyond cannabis use. 
7.4 Discussion of findings 
In a recent series focusing on global adolescent health, Sawyer and colleagues 
described the various influences that may impact successful and healthy transition 
from childhood to adulthood (Sawyer et al. 2012). Preconceptual and perinatal 
influences are followed by factors affecting early childhood before puberty by which 
time social role transitions commence leading towards attainment of adulthood. 
From the social perspective, adolescence is a time of huge social change, with 
successful negotiation dependent on personality and ability, as well as early 
influences that may impinge on this, such as chaotic parenting and childhood 
adversity, and a multitude of environmental risk and protective factors in the family, 
peers, school and community. From the physiological perspective, puberty is a 
developmental phase driven by radically different biological and hormonal processes 
in girls and boys that affect behaviour and emotional development in fundamentally 
different ways (Sawyer et al. 2012). In addition, asynchronous neural development of 
the control and reward systems during pubertal development may contribute to the 
propensity for some young people to engage in risky behaviour with enhanced 
sensitivity to incentives, resulting in poor decisions determined by a need for 
immediate gratification, thus making participation in risky behaviours such as 
cannabis use more likely (Bava & Tapert 2010). 
In the VAHCS, we did not assess perinatal and early childhood influences or 
temperament that may impinge on risk-taking behaviour in adolescence, so these are 
outside our frame of reference. These influences may be the source of important 
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confounding in each of our analyses, which we can consider but cannot resolve. We 
did account for possible confounding in the domain of social determinants of health 
(such as non-Australian birth, parental education, urban/rural school location) and 
risk factors (such as parental separation/divorce and peer substance use) and other 
deviant and health-risk behaviours, which may function as confounders or mediators, 
as well as symptoms of anxiety and depression. Thus, it is important to consider our 
findings not only in light of what we measured, but also of what we might have 
missed. 
7.4.1 Life history of cannabis use 
The influential view that adolescent cannabis users generally mature out of use by 
the late 20s has been promulgated by Kandel and colleagues since the 1980s (Kandel 
& Logan 1984). Using life histories of drug use reported by a population cohort of 
secondary school students in New York, they observed that initiation into cannabis 
use was generally completed by 20 years and thereafter declined rapidly, along with 
alcohol use but not cigarette smoking. Conversely, in the VAHCS we found that 
cannabis use appeared to have stabilised from 24 to 29 years, with about quarter of 
participants reporting cannabis use in the past year and 30% of these users reporting 
daily use at 29 years (Chapter 1, Table 2.7.3), and 28% of them diagnosed with 
dependence, definitively not conforming to Kandel’s hypothesis. 
Kandel’s (1984) view of the natural progression of cannabis use has been challenged 
using data from the Monitoring The Future project in the U.S.A, in which nearly 
13% of 35 year-old men and 7% of 35 year old women reported using cannabis 
within the past 30 days (Merline et al. 2004). Assuming adult roles such as attaining 
qualifications, employment, marriage, and parenthood were reported to be protective 
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against continued cannabis use, consistent with other reports. (e.g., Staff et al. 2010), 
and accounted for the decline in use from late adolescence. We cannot test this 
hypothesis in the VAHCS until we analyse the data when the cohort is 35 years, but 
in the meantime it is interesting to speculate about the reasons for the difference 
between the trajectory observed by Kandel and the one we observed twenty years 
later. Methodological differences between the studies may have accounted for the 
difference at least to some extent. Importantly, Kandel relied on retrospective life 
history known to be subject to recall bias, whilst we measured cannabis use 
prospectively. Also, selective attrition may have resulted in selection bias in 
Kandel’s achieved sample with systematic loss of entrenched drug users, including 
blacks and Hispanics, although the VAHCS is likely to have experienced a similar 
effect but perhaps to a lesser extent (Kandel et al. 1986). If we accept Kandel’s 
observed trajectory as valid when it was proposed, then we may be observing a 
temporal effect due to the current higher prevalence of use in young people 
compared with the early 1980s in the predominantly white U.S. sample, resulting in, 
or perhaps resulting from, a shift in social mores reducing the social imperative to 
quit, and a more obvious proportion of hard core users. The role of social transitions 
in young adulthood as a conduit to abstention may now be a less potent harbinger of 
change, or, indeed, occur at a later stage in our sample than in Kandel’s. In summary, 
the trajectory of cannabis use into adulthood appears now to be less uniform and 
optimistic than Kandel proposed. 
7.4.2 Initiation and escalation in use 
We demonstrated early in the cohort study that perceived use by peers and a school 
environment in which regular cannabis use was reported more frequently in Year 10 
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provided an milieu in which initiation and continued use were more likely to occur, 
consistent with previous findings (Hawkins, Catalano & Miller 1992), and was also 
associated with escalation to daily use in boys (not girls). Although this did not 
measure the prevailing attitude to drug use, it does indicate that cannabis was more 
likely to be available and we can infer from this that within an individual’s frame of 
reference, it may have been acceptable behaviour, at least as perceived by those 
considering commencing use. It suggests, too, that these young people, especially 
boys, were conforming to what they perceived as “cool” behaviour, possibly along 
with other social deviant behaviours such as smoking cigarettes, drinking alcohol and 
antisocial behaviour, also risks we identified for initiating use. Parental 
divorce/separation, an indicator of parental disharmony, was an influential risk 
factor, but it is possible that unmeasured confounding may have occurred due to pre- 
and peri-natal factors and early childhood disadvantage and other parental factors, 
such as substance abuse or criminality. However, it seems that teenagers from more 
disturbed families, who were exposed to an environment where it was easy to 
conform with class-mates and friends displaying health risk behaviours, were more 
prone to initiating and continuing cannabis use and, in the case of boys, escalating 
use. 
A component of the explanation for cannabis escalation may be the pharmacological 
effect of the drug itself. Disinhibition as a consequence of frequent cannabis use 
possibly enhances the cycle of wanting and using, which becomes self-perpetuating, 
providing supply is maintained. Although initiation of cannabis use is likely a 
response to availability and acceptability, precipitated by temperament, parental, 
childhood and environmental factors, continuation towards heavy and dependent use 
would appear to also involve inherited vulnerability (Kendler et al. 2008). The sex 
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divergence in risk factors for escalation of use in adolescence, in which the males 
continued their previous risk pattern but the females demonstrated more general 
deviant behaviour without the reliance on peer use, was perhaps an indication that 
different mechanisms were involved, characterised by unusually extreme behaviour 
in these girls, although unmeasured confounding due especially to early childhood 
adversity may have contributed to this observation. 
Throughout our analyses we have observed a greater propensity for males than 
females, both to initiate cannabis use and also, once commenced, to escalate its use. 
Explanations for this sex discrepancy may also lie within the domain of discrepant 
neurodevelopmental processes and susceptibility between males and females, with 
puberty lasting longer in males, extending the period of vulnerability (Schneider 
2008; Viveros et al. 2012). The disparate hormonal and biological mechanisms of 
puberty also make males more responsive to their peers and vulnerable to risk-taking 
(Bava & Tapert 2010). Thus, the sex-related disparity in cannabis-related initiation 
and escalation may be, at least partially, biologically driven. 
7.4.3 Social outcomes and other illicit substance use  
We observed that a number of compromised outcomes, including incomplete 
education, unemployment, welfare dependency and other illicit substance use in 
young adulthood, were associated with frequent cannabis use commonly initiated in 
adolescence (Degenhardt, Louisa et al. 2010; Lynskey et al. 2003). We established 
that substance use early in the cohort predicted non-completion of later surveys, so 
our results may have been attenuated due to selective attrition. We are, of necessity, 
assuming that the associations we observed in those surveyed were similar in 
individuals not surveyed, but this may not be the case. 
Chapter 7 Summary and discussion 
 
159 
 
Of particular importance to the finding regarding poor education and employment 
outcomes in young adulthood is the possibility that this may be confounded by early 
personality and childhood factors, for example, intellectual capacity or dysfunctional 
family life, unmeasured in our cohort. We observed that incomplete high schooling, 
an important mediator, was particularly likely if adolescents were using cannabis 
daily before Year 11, but not subsequently. It is feasible that disengagement with 
school, accompanied by a history of failure, may have occurred before initiation and 
escalation of cannabis use, or even may have contributed to it causally, due to 
association between like-minded peers, who commenced cannabis use in a concerted 
effort not to conform to adult expectations. Those young people at risk of initiating 
cannabis use also reported other risky behaviours such as frequent or high dose 
alcohol use, cigarette smoking and antisocial behaviour, corresponding to the cluster 
of behaviours described by Jessor (Jessor 1976) as “transition proneness”, and 
implying deviance from expected norms. This characterises those very early daily 
users as being at high risk of failure in the transitions to adulthood, not exclusively as 
a result of their cannabis use. An over-arching contributory explanation may be that 
deviant behaviours, including cannabis use, are more common in families with low 
socio-economic status (SES) where a tradition of continued schooling is also less 
common (Rogeberg 2013), so confounding by SES is entirely plausible. 
When we examined the association between adolescent exposures and young adult 
social and substance use outcomes, with the exception of alcohol-related outcomes, 
we consistently identified adolescent cannabis use as a predictor independent of other 
adolescent health-risk behaviours, licit and other illicit substance use, antisocial 
behaviour, symptoms of anxiety and depression, and confounding by background 
factors including parental education, parental divorce and rural school location at 
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study inception (e.g., (Degenhardt et al. 2012). Furthermore, a “dose” response was 
apparent: the more frequent the use of cannabis in adolescence, the more likely was 
each adverse outcome, an observation that lends weight to a causal mechanism. We 
conclude that regular cannabis use in adolescence is an important risk factor for later 
adverse social and substance use outcomes, with the proviso that we were unable to 
assess confounding by peri-natal influences or early childhood adversity and 
temperament. On this last point, it is interesting, though not definitive, to consider 
the integrated data analysis by the Cannabis Cohort Research Consortium examining 
the association between adolescent cannabis use and educational outcomes. The 
pooling of the VAHCS analysis adjusted for available confounders with those from 
two other cohorts (Christchurch Health and Development Study and the Mater 
Hospital and University of Queensland Study of Pregnancy), adjusted for a broad 
range of confounders including scholastic measures, early childhood and pre-
adolescent behaviour and family SES, showed that the negative relationship between 
adolescent cannabis use and higher education was consistent across the three cohorts. 
7.4.1 Mental health outcomes 
In our examination of common mental health problems and cannabis use throughout 
the cohort, we could not account for possible confounding by family SES, childhood 
adjustment and family functioning beyond adjusting for parental education and 
parental divorce and separation, e.g., as illustrated in (Fergusson & Horwood 1997). 
The same proviso for social and substance use outcomes also applies to observations 
regarding mental health outcomes – that there was possibly systematic loss to follow-
up in young people involved with extreme substance use and possibly with severe 
mental health issues. 
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The association between social disadvantage and cannabis use initiation and 
escalation could be attributed to confounding due low family SES, when both of 
these more commonly occur than in families with higher SES. There is also the 
possibility of mediation by other illicit substance use, which again is associated with 
low SES, is commonly used in conjunction with cannabis, and often leads to poor 
mental health. Thus, the emotional distress that we observed in young adulthood 
could be a direct consequence of social disadvantage and independent of cannabis 
use. However, the association we identified between earlier daily cannabis use and, 
particularly, anxiety disorder at 29 years were independent of parental divorce and 
education and rural location as well as other illicit substance use, and anxiety and 
depression in adolescence (Degenhardt et al. 2012). Possible confounding due to 
shared risk factors of early childhood disadvantage and behavioural problems cannot 
be discounted, but again, in the integrated analysis conducted by the CCRC, 
examination of cross-sectional associations between depression and cannabis use 
showed that our results were in accord with those from the three other cohorts, which 
were adjusted for confounding due to extensive childhood and SES factors (Horwood 
et al. 2012). 
We need to interpret the associations we observed between common mental disorder 
and cannabis use throughout follow-up in the context of the pressures in these young 
peoples’ lives. Over a period of time, educational and employment failure with 
enhanced welfare dependency are likely to have contributed to diminished self-
concept and a sense of poor life satisfaction (Swain et al. 2012), in turn leading to 
emotional distress, identified in the VAHCS as symptoms of anxiety and depression. 
A further stressor may also have been the process itself of obtaining cannabis and the 
illegal activities that may be consequent to this need (Rao 2006), frequently in 
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concert with other illicit substance use, which would possibly not only contribute to 
poor life choices, but also to the practical need to obtain supply. We observed a 
marked likelihood of anxiety symptoms in females at 20 years who were using or 
had used cannabis daily in adolescence, young people already noted to be at excess 
risk of poor outcomes due to their unusual proclivity for antisocial behaviour and 
substance use. The demonstrable link between daily cannabis use in the teens and 
anxiety disorder at 29 years in both males and females, could therefore be partially 
mediated by accumulated stress. 
7.5 Possible biological mechanisms for adverse mental health 
and substance use outcomes 
Although social factors are undoubtedly important in the development of mental 
health problems, the possibility of contributory biological explanations of our 
observed associations are obtaining increasing currency, as our understanding of the 
endogenous cannabinoid and dopaminergic systems emerge (Rao 2006). However, 
the manner in which environmental insult by cannabis interrupts neurogenesis, 
neuronal differentiation and other neurobiological maturation process in adolescence 
has still to be fully understood (Rubino, Zamberletti & Parolaro 2012). Nonetheless, 
the link between cannabis abuse and symptoms of anxiety and depression in 
adolescence is consistent with that between the effect of exogenous cannabis on both 
the central cannabinoid system and the dopaminergic system. In the only currently 
available detailed review of the literature addressing neurobiological mechanisms 
underlying substance abuse and depression comorbidity in adolescence, Rao argued 
for a link between the serotonergic system underlying depression and anxiety and the 
response to drug withdrawal (Rao 2006). Specifically, Rao postulated that the 
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immaturity of the neuro-biological systems in adolescence may lead to greater 
vulnerability to co-occurrence of substance use and common mental health disorders. 
The association between psycho-social stress, depression/anxiety and substance 
abuse may be mediated by the limbic-hypothalamic-pituitary-adrenal (LHPA) 
system. Furthermore, the LHPA system may be involved in acute intoxication and 
withdrawal, via alteration of the anxiolytic mediator involved in the stress-substance 
interactions. 
Susceptibility to adverse influence by exogenous cannabis is intriguing, but we are 
unable to contribute to this expanding field beyond adding our consistent 
observations of the disadvantages suffered by those young people who commenced 
regular cannabis use in their apparently susceptible peri-pubertal stage of 
development. A recent publication reporting findings from a population based study 
of about 1000 people in New Zealand is consistent with this effect in relation to 
neuropsychological decline in young people who reported regular use before 18 
years in a New Zealand cohort (Meier et al. 2012), echoing our finding of a tendency 
to anxiety disorder by the late 20s in daily users in adolescence, independent of later 
abstinence (Degenhardt et al. 2012). However, the possibility that the observed 
decline in IQ in the New Zealand cohort may be partially or entirely confounded by 
low SES has not been discounted (Rogeberg 2013). 
7.5.1 Special case: cannabis and cigarettes 
It is interesting that adolescent cigarette smoking was implicated both in the 
initiation of cannabis use in adolescence (Coffey et al. 2000) and as a mediator of 
adverse outcomes in young adulthood (Degenhardt, Louisa et al. 2010), as well as an 
adverse outcome of adolescent cannabis use in its own right (Patton, GC et al. 2005; 
Chapter 7 Summary and discussion 
 
164 
 
Swift et al. 2012). The possibility that confounding could produce such temporal 
intertwining of these health-risk behaviours whilst they remain independent of each 
other must be considered. Again, both tobacco and cannabis use are characteristically 
more likely in families with low SES and so may result from this influence, rather 
than from any specific inter-dependence. Furthermore, they can share common 
antecedents determined by adverse peri-natal and early childhood influences 
(Creemers et al. 2009). Conversely, these inter-relationships may be indicative of 
both the social aspect of smoking cannabis and cigarettes and desensitisation to the 
route of administration, perhaps demonstrating early concurrent dependent 
behaviour. Unmeasured mediation due to the common practice of smoking both on 
the same occasion, specifically mulling (mixing cannabis leaves with tobacco leaves) 
and chasing (following cannabis smoking with cigarettes) (Agrawal, Budney & 
Lynskey 2012), may also have contributed to our observed associations. It is possible 
that the suggested biological interaction, as yet confirmed only in the animal model, 
between the effect of exogenous cannabis on the central cannabinoid system and on 
the dopaminergic system implicated in other illicit substance abuse (Rao 2006; 
Schneider 2008), may also apply to the synergistic effect we observed between 
cigarette smoking/nicotine dependence and cannabis use/dependence. 
7.5.2 Disrupted transition to adult roles: the amotivational syndrome? 
In Chapter 1, §1.5.4.1, I discussed a diagnosis that was mooted in the 1970s in 
chronic cannabis users, the “amotivational syndrome”. It was defined as “an 
impaired desire to engage in normal social activities and situations due to external 
factors such as relationships, substance or events” and included reduced energy and 
attentiveness, apathy, reduced motivation, passivity, and reduced concentration and 
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desire to work (McGlothlin & West 1968). It was a speculative suggestion rather 
than a clearly defined diagnosis and was supported by very little solid evidence, with 
the possibility of substantial confounding due to sampling bias (Hall, Johnston, 
Donnelly 1999). There was also a view that the diagnosis arose as a comment on the 
disaffected youth who were using it, rather than a specific drug effect (Manderson 
1993). Whether this syndrome was reversible was not considered. 
In view of consistent observations from our study and others that regular cannabis 
use in adolescence may lead to compromised educational and employment outcomes 
compared with non-users, and that its use is often accompanied by common mental 
health disorders, and other illicit substance use, the concept requires re-evaluation, 
especially with regard to enduring effects in those who have ceased using. If such a 
disorder is identifiable, for it to be useful, examination is needed as to whether and to 
what extent it is reversible by abstinence, rather than merely description relevant to 
current users. 
There are a few possible explanations for the confluence of these outcomes in 
problematic cannabis-using adolescents as they mature. As suggested earlier, there is 
the possibility of confounding by SES, early childhood adversity and individual 
personality traits, with cannabis use as a consequence of these, but not necessarily 
with a direct causal relationship to these adverse outcomes. Another, possibly 
related, mechanism in which this could occur reflects the highly social nature of 
cannabis smoking, at least initially, illustrating the inter-dependence of socially 
deviant young people with strong peer affiliations who may pursue an adverse 
trajectory in concert, with persisting disengagement from adult roles and 
expectations. Despite peer approval, the constant failure that this trajectory implies, 
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with challenged self-image, alongside the laborious and sometimes illegal task of 
obtaining and using illicit substance(s), could adversely affect mental health. 
Conversely, cumulative mental health problems arising for reasons other than 
cannabis use could result in functional impairment and the inability to fulfil these 
roles, with cannabis consumption occurring as self-medication. 
The common trajectory shared by teens who were regular cannabis users may indeed 
have many explanations, but the imperative for successful intervention is to identify 
a common thread amenable to intervention and that may substantially account for 
these observations. The compelling reason to look to cannabis use itself, is the 
consistency with which cannabis is implicated in these outcomes after adjustment for 
possible confounding, and the correlation between increased exposure and increased 
susceptibility. That is, we consistently observed that the more frequent and extended 
the adolescent cannabis use, the more likely was the adverse outcome in young 
adulthood. 
In a recent review of acute and long term effects of cannabis use on executive 
functioning in humans, Crean and associates identified induced deficits still 
detectable after three or more weeks of abstinence (Crean, Crane & Mason 2011). 
The focus of the report was to assess barriers to effective treatment for dependent 
users aiming for abstinence. The authors reported that subtle and enduring changes in 
decision-making and risk-taking abilities due to heavy and chronic cannabis use, and 
sometimes occasional use, may not resolve with abstinence, especially when regular 
use started in adolescence when the executive functions had not yet matured. In 
addition, verbal fluency, impaired while using at this level, did not always resolve. 
The deficits specifically identified included “the ability to plan, organise, solve 
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problems, remember, make decisions, and control emotions and behaviour”. In so far 
as the amotivational syndrome applied to current or recently abstinent users, these 
findings clearly support the concept. 
The aspect that is particularly relevant to understanding long term harm that regular 
cannabis use in adolescence may endow, and to inform intervention, is whether these 
deficits eventually resolve after abstinence of months or years, or whether the 
neurological changes they imply are irreversible. Most markedly, our finding of a 
propensity to anxiety disorder at 29 years in adolescent daily users, even in those 
participants who had ceased using at this level, supports the concept of irreversible 
neurotoxicity. In addition, the recent publication arising from the Dunedin cohort 
study in New Zealand of a demonstrable neuropsychological decline at 38 years was 
identified in adolescents who had used cannabis daily (Meier et al. 2012). As in our 
study, this was identified despite later abstinence. Both findings require replication, 
but are possibly explained broadly by peri-pubertal susceptibility to perturbations in 
the development of the endo-cannabinoid system by exogenous cannabis, identified 
and replicated in the animal model (Schneider 2008). 
Cannabis use during puberty in humans has repeatedly been shown to carry far 
greater long term risk for adverse outcomes than later initiation. Although prone to 
definitional variations, different studies have shown structural and functional brain 
differences between early (before 17 years) and later initiators. Magnetic resonance 
imaging and positron emission tomography studies in humans have shown that early 
onset users had a higher proportion of grey matter (primarily associated with 
processing and cognition), a lower proportion of brain white matter (links the grey 
matter and actively affects how the brain learns) and higher cerebral blood flow, 
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compared with late onset users, reflecting the observation that early onset users 
display poorer cognitive performance than later initiators (Schneider 2008). Animal 
studies have confirmed increased susceptibility to cannabinoids during pubertal 
development under controlled situations, mimicking the observations in humans. 
Prolonged behavioural disturbance in adult male rats has been shown to follow 
chronic consumption of cannabinoids during pubertal development. Specifically, 
object recognition memory was shown to be affected in both males and female rats 
after prolonged exposure to THC during puberty. Some animal studies have 
produced equivocal results but these did not restrict cannabis exposure to the specific 
age at which pubertal development in rats has been identified (Schneider 2008). 
Thus, both physiological andsocial and behavioural observational studies provide 
justification for considering that prolonged exposure to cannabis during pubertal 
development carries heightened risk for neuro-cognitive impairment. The 
“amotivational syndrome” may indeed be a viable and useful concept, but, given its 
bad press earlier, perhaps by another name. 
7.6 Translation of findings to public health  
The underlying justification for conducting studies such as the VAHCS is that the 
findings will advance general understanding, ultimately influence public health and 
clinical practice and improve the common good. Specific focus on adolescence, 
leading to better understanding of the origin of behaviour problems and the 
implications for later adulthood is essential to this process. There are a number of 
aspects of our cannabis-based research that have practical value, beyond the not 
insignificant contribution to the world literature. 
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By the end of the twentieth century the risks for cannabis initiation and some of the 
consequences of long term use were understood in the broad sense, but whether 
cannabis was a drug of dependence was still hotly debated, and the evidence 
regarding pubertal exposure to regular use was unknown. Although the prevalence of 
cannabis use by young people was documented, rigorous evidence about initiation of 
use, its natural history as early users matured and the harms that may result 
especially from early initiation into regular use was crucially needed to inform public 
policy. The polarised and emotional public and political debate about the wisdom of 
punitive cannabis legislation was often conducted with little reference to the 
evidence then available (Hall, Johnston, Donnelly 1999). 
The findings of the VAHCS cannabis research were especially relevant to the 
development of policy, as they had immediacy and described Australian youth. The 
study has advanced the evidence base in three important ways. Firstly, we showed 
that, although cannabis use reduced after the early 20s, there was still substantial 
continuation into the late 20s and possibly beyond. Attrition in use after the early 20s 
was largely in the group of experimental (occasional) users, resulting in the more 
entrenched users being at elevated and not inconsiderable risk of cannabis 
dependence as their duration of exposure to the drug extended. Secondly, we 
demonstrated that teenage users, including occasional users, are at notable risk of 
moving onto other illicit substances and that heavy users are at risk of developing 
later common mental health problems, in addition to the well-documented, though 
rarer, risk of psychosis and schizophrenia. Thirdly, we quantified the tendency for 
early cannabis users to have compromised educational achievement, so that 
prevention and early identification of children at risk is an educational imperative. 
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Furthermore, we demonstrated that poor life choices and delayed transitions into 
adult roles can follow early uptake. 
The paradigm that cigarettes and alcohol use lead to cannabis initiation, long 
espoused by the highly regarded Gateway Theory (Kandel 1975), has stood 
unchallenged until recently. In contravention of this cause and effect model, our 
observation that cannabis use posed a significant risk for cigarette smoking initiation 
and nicotine dependence showed that cannabis use has the potential for harmful, long 
term physical health consequences, outside the unproven but likely respiratory 
effects of long term exposure to cannabis smoke. In addition, there is possible harm 
resulting from uncontrolled use of insecticides and other chemicals by back yard 
growers. Thus, the prevention of early cannabis use also belongs squarely in the 
public health domain with smoking prevention. The recent introduction of plain 
packaging for cigarettes, which follows consumption tax increases remains to be 
evaluated, but these strategies are unavailable in the domain of cannabis use 
prevention without a radical change in the legislation. Our findings, therefore, have 
implications for law enforcement policies, regulation of use and the timing and 
emphasis of clinical and legal responses. 
7.6.1 Health and social policy 
Focusing on the imperative to address the adverse consequences of early, regular 
cannabis use gives a constructive lead into public health and legislative discussion. It 
is a self-evident that some people will continue to use cannabis, as they have since 
time immemorial, despite any legislative and public health disincentives that may be 
instigated, and possibly without harmful consequences in those who use only 
occasionally. However, we have shown that occasional cannabis users in adolescence 
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sometimes escalate their use to dependence by early adulthood. Initiation after 
adolescence carries much reduced likelihood of dependence, other illicit substance 
use, mental health problems, and compromised educational outcomes, so devising a 
system whereby teenagers are actively discouraged from initiating use, for example, 
until they reach voting age, would have considerable public health merit. This harm 
minimisation approach lowers the bar from attempting to induce total abstinence, 
clearly an unattainable target. 
Importation of cannabis is illegal in Australia, with federal border control reporting 
recent annual detections to be the highest on record, primarily originating in the 
Netherlands (ACC 2012), where substantial advances in production techniques have 
occurred (Decorte 2010). Cultivation with intent to traffic and trafficking are 
punishable by law in all Australian jurisdictions. Cannabis possession remains illegal 
nationally, but penalties vary among Australian states, with de jur decriminalisation 
for small quantities in four jurisdictions: South Australia, Western Australia, the 
Australian Capital Territory and the Northern Territory. Decriminalisation involves 
prohibition with civil penalties in the form of fines, comparable with traffic 
infringement fines, for possession of a small amount of cannabis and equipment for 
personal use (Lenton 2004), without intent to sell. The remaining states, Victoria, 
New South Wales, Queensland and Tasmania, have varying diversion options for 
drug offenders, depending on the age of the offender, severity of the offence, history 
of criminal involvement and previous treatment compliance and success. Diversion 
can take the form of ignoring the offence, informal or formal caution, health and/or 
education intervention, and conferencing. It can be a condition of bail, or delayed 
sentence and can include coercive treatment (Spooner, Hall & Mattick 2001). Thus, 
in practice, diversion functions as de facto decriminalisation. There are many 
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advantages of both systems, primarily the avoidance of onerous and traumatic 
consequences of imprisonment and a criminal record in people who may be 
otherwise law-abiding, as well as providing opportunities for treatment and education 
with diversion. Conversely, expiation sometimes results in net-widening, as 
offenders who have agreed to a reduced penalty may then, due to non-compliance, be 
subject to legal sanctions that may have not occurred at all, or would have been less 
severe had they accepted the usual criminal justice process initially. Australia-wide 
comparison of cannabis use according to criminal status and dollar cost shows no 
difference in the prevalence of use in those under 25 years or in their frequency of 
use with decriminalisation, but does demonstrate a responsiveness to price (Williams 
2004). This introduces the concept of market control. 
Population prevalence estimates of recent (past year) use in Australians 14 years and 
older fluctuate, but the 2010 estimate of 10.3% (AIHW 2010) is an increase of 13% 
on the 2007 estimate, though well below the peak in 2001, when the estimated recent 
use was 12.1%. There is also an apparent increase in the proportion of recent users 
across all age groups since 2007. This may be a trend towards increasing use, or may 
just reflect sample variation. The 2013 estimates will be of great interest. It is clear, 
though, that current legal sanctions have not yet reduced uptake substantially or 
limited the duration of use, and it may be that the capacity of legal control to 
contribute to this issue is at its maximum. The adverse consequences of attempted 
repression then come to the fore for consideration. Specifically, net widening is an 
undesirable consequence, and serving a sentence and obtaining a criminal record for 
a notional crime can be a destructive experience from many perspectives, for 
example, limitation to future employment prospects, the trauma associated with the 
experience of incarceration, the placing of individuals into an environment where 
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they are exposed to organised crime. This would be better avoided if reasonable to do 
so. 
It is tempting to advocate change in legislation to allow possession for both personal 
use and commercial marketing, so that supply of recreational cannabis to under 18 
year-olds could be notionally controlled by tight legislation as for cigarettes. 
Australia, in accordance with the WHO Framework Convention on Tobacco Control, 
bans sales to minors, smoking in work and public places, advertising, restricts 
display and packaging and, in addition, applies a heavy sales tax. One of many 
impediments to invoking the same restriction for cannabis use and sales is the ease 
with which cannabis is grown, thus likely to result in impotent legislation. In his 
review of the effects of cannabis cultivation policies in the Netherlands, Decorte 
suggests that a policy of tolerance rather than repression on small scale growers 
would result in the latter becoming the bulk of the production industry and would 
result in separation of this group from the large scale international crime syndicates, 
enabling improvements in quality and control at the point of sale (Decorte 2010). He 
maintains that the illegal status of possession and small scale production is a major 
impediment to effective public health initiatives. 
In general, the reluctance of politicians to take a stand on changes in the legislation 
was demonstrated clearly by the failure of the attempt at decriminalisation of 
cannabis possession in Victoria in the 1990s, though at that time, the health 
imperative was not as well supported. Despite this inertia, legislation allowing 
decriminalisation in Western Australian occurred in an environment of support by 
politicians, the general public, law enforcement, cannabis users and, most 
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importantly, evidence, illustrating that it is possible to do this given sufficient will 
(Lenton 2004). 
If the type and severity of legal sanction is to be selected on the theoretical basis of 
reducing the prevalence of cannabis use by young people, rather than dealing with 
issues arising from a repressive policy, we need to take note of the experience of 
other jurisdictions. A comparison of cannabis use between countries with vastly 
disparate legislation, from Sweden with a highly restrictive policy, to the Netherlands 
where cannabis can be purchased in designated outlets, shows that consumption is 
not necessarily linked to the strictness of legislation (Murray et al. 2007). Inevitably, 
unless politicians have the heart and can carry the general public towards a more 
effective legislative structure, the least-worse solution is to provide clear evidence-
based information easily accessible by the lay public designed to dispel myths, 
inform about potential harms and encourage responsible use (Murray et al. 2007). 
Specifically, we need more active engagement with both parents and teens in a teen-
acceptable fashion (Hall 2010). 
7.6.2 Provision of information and social marketing. 
The national response to the public concerns generated, at least partly, by evidence 
from our cannabis findings, was the formation of the National Cannabis Prevention 
and Information Centre (NCPIC) in 2010, auspiced by the Department of Health and 
Ageing. The NCPIC missions is to “reduce the use of cannabis in Australia by 
preventing uptake and providing the community with evidence-based information 
and interventions.” The website provides information, a helpline, bulletins on the 
latest research findings and the initiative offers free training on motivational and 
brief interventions, project development concerned with intervention delivery, course 
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materials, community activities to increase awareness of harms and targeted 
information for Indigenous Australians. This is clearly a great step forward, but it 
seems to be largely targeting providers and it is possible that it is only “preaching to 
the converted”, with the likely result that it misses those young people with already 
entrenched use and early adolescents who may go down that track. Specifically, 
engagement with entrenched users who may not be interested in moderating their use 
is a huge public health challenge, as it is with persistent cigarette smokers. 
7.6.3 Community education 
The traditional approach supporting prohibition as the best, and perhaps only, means 
of drug control are clearly impotent, but conservative public and political opinion 
demanding a punitive cure prevails. At the other extreme, cannabis use is promoted 
as being fun, harmless and cool by those groups with an interest in ignoring adverse 
outcomes. With the proliferation of evidence-based information, education is now 
essential. 
7.6.3.1 Mainstream media 
The recent legalisation of cannabis use by some United States jurisdictions, along 
with increasing publicity surrounding possible harms of cannabis use, and possible 
lack of harm in the case of ecstasy, has prompted increasing media attention on this 
topic. Recent publication by a leading newspaper in Australia of editorial support of 
public debate around policies to minimise the harm resulting from substance abuse 
within an evidence-based environment, is an interesting development. To quote the 
editorial:  
“The Age will continue arguing for reform and publishing clear, sober, 
evidence-based information to help foster debate and change” (Short 2012). 
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The editorial was published in conjunction with an opinion piece promoting the idea 
that “drug use be considered a health issue rather than a criminal one”. The current 
de facto policy of diversion in Victoria was lauded, but the inhibiting fear of possible 
public backlash for politicians supporting a change in policy, illustrates the need for 
comprehensive and convincing community education. It is encouraging that this 
newspaper, at least, is calling for evidence-based decision making. 
7.6.3.2 Web-based media 
Perusal of many internet websites using the search terms ‘cannabis’ or ‘marijuana’ 
illustrates the strength of the lobby supporting cannabis use and the strident denial 
that it may harm some users. A similar search for tobacco smoking does not reveal a 
similar flurry of denial, with the possible exception of promotional sites for snus, a 
moist derivative of snuff placed under the lip. To date it is apparent that the existence 
of cannabis dependence, and consequent abuse of other illicit substances has been 
largely ignored by the general public. Similarly, the increasing evidence that 
cannabis-affected driving contributes substantially to motor vehicle accidents and to 
fatal accidents (Asbridge, Hayden & Cartwright 2012; Hall 2010) is not addressed by 
the recreational cannabis lobby, and also ignored by activists urging legislative 
reform to permit medicinal use. In contrast, the association between cannabis use and 
psychosis and schizophrenia has been well publicised and has apparently caught the 
imagination of the general public and, judging by blogs and social media, of at least 
some users. The paper reporting a substantial drop in IQ in adolescent regular users 
(Meier et al. 2012), immediately following the recent publication of our anxiety 
disorder paper (Degenhardt et al. 2012) appeared to attract considerable social media 
attention. There were 90,000 hits on the National Drug and Alcohol Research Centre 
internet site in the first three days after the media release for this paper, perhaps 
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pointing to emerging public interest in the possibility that early cannabis use may 
compromise current or later welfare. However, there is now an ever-present hurdle to 
community education using digital media, due to the hijacking of online information 
and search engines by competing pro-cannabis groups. 
7.6.4 Public health intervention 
Public health interventions should attempt to prevent cannabis uptake or, at least to 
delay commencement beyond adolescence. The challenge in designing such an 
intervention is that it must reach young people who are possibly disengaged from 
mainstream activities, involved in antisocial behaviour, associating with drug-using 
friends, and the progeny of a chaotic and/or unsupportive home environment, as 
illustrated in the first paper (Coffey et al. 2000). Clearly cannabis use is just one of a 
number of potentially harmful behaviours in this multi-faceted risk profile that need 
to be addressed in a prevention framework by early adolescence, in order to delay or 
prevent initiation. It is therefore clearly not constructive to design community-based 
interventions for late primary and early secondary school children which specifically 
target cannabis use in isolation (Catalano et al. 2012). 
7.6.5 The Gatehouse Project 
A cogent example is the Gatehouse project, a school-based intervention which was 
informed by VAHCS data and used the survey design and school based data 
collection methodology to evaluate its effectiveness in a randomised controlled study 
design. The Gatehouse Project was led Professor George Patton at the Centre for 
Adolescent Health and was developed in collaboration with teachers within the 
Centre and in the target schools. I was Project Manager of the instrument 
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development and data collection in the pilot study and the first year of 
implementation, and I developed the initial process evaluation in collaboration with 
study teachers. 
The Gatehouse Project was a two-year school-based intervention which used the 
school curriculum to build social, problem-solving and coping skills in the 
individual, to promote inclusion at the school- and classroom-levels and build 
community-school links (Catalano et al. 2012; Patton, G et al. 2003). The project 
aimed to increase emotional well-being and, specifically, to reduce substance use 
initiation, known to be associated with well-being. This was successfully 
demonstrated at follow-up with fewer students in the target schools reporting regular 
cigarette smoking and, in those who were non-smokers at baseline, less initiation of 
cannabis use, compared with the control schools (Bond et al. 2004). This finding is 
an interesting reflection on the Guttman model used in the design of the Gateway 
Theory whereby reduction of one risk factor theoretically should have a flow-on 
effect on the next outcome in the model. This would appear to have been a functional 
paradigm, at least to some extent. The study also illustrated the advantage of a 
general approach to increasing resilience and addressing risk factors rather than 
specifically targeting a single behaviour. 
7.7 Translation of findings to clinical practice 
General medical practitioners (GPs) play an important role in identifying young 
people experiencing distress from out-of-control cannabis use or at risk of cannabis-
related harm and offering timely intervention. A key contribution of VAHCS 
research has been to demonstrate the dependence syndrome in young adults, 
particularly in those who commenced using cannabis in adolescence. Findings from 
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the VAHCS have contributed to the National Training Guidelines for Physicians in 
Adolescent Health and have influenced developments in primary care. Screening for 
cannabis use in adolescents is now commonly part of routine practice due to training 
of adolescent physicians and GPs. 
In a recent report on the epidemiology of cannabis-related harm in Australia, found 
that, despite the drop in the prevalence of use by teenagers between 2003 and 2007, 
young frequent users were reporting using larger quantities when compared with 
older users (Roxburgh et al. 2010). Young people who are already experiencing 
marked distress due to difficulty with control over use need to have effective 
treatment options available to them (Hall 2010). In our examination of outcomes 
associated with occasional use in adolescence and for those who moderated their use 
by 17 years (Wave 6), it is clear that abstinence is the best outcome to achieve in a 
clinical setting as occasional use continued to carry risk of relapse and escalation. 
Demands for treatment services for dependence are increasing (Roxburgh et al. 
2010), especially in people with comorbid mental health problems (Danovitch & 
Gorelick 2012), but there is a paucity of treatment options, which currently largely 
rely on cognitive behaviour therapy (CBT), motivational enhancement therapy and 
CBT with contingency management, all shown to be only modestly successful in 
achieving continued abstinence in adolescents (Hall 2010; Roxburgh et al. 2010). 
Impairment of executive functions in heavy cannabis users, some of which do not 
resolve after an extended period of abstinence, make comprehension and follow-
through of treatment regimes challenging, and continuing disinhibition can lead to 
relapse (Crean, Crane & Mason 2011), with long term abstinence in dependent users 
achieved in fewer than 20% (Danovitch & Gorelick 2012). Withdrawal, now that it is 
recognised, has been shown in about half of people receiving treatment. Although 
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not medically serious, it can affect compliance and it has been suggested that it 
should be a major focus of treatment (Danovitch & Gorelick 2012). Targeted chemo-
therapy is not yet available but evaluation of the effectiveness of different 
pharmacotherapies involving agonist substitution, antagonist and modulation of other 
neurotransmitters is currently underway. Other treatment options exist such as the 12 
step program, but rigorous evaluation is lacking (Hall 2010). 
Failure to negotiate adult role transitions by heavy persisting cannabis users could 
indicate the need for intervention in older users who are concerned about their use. 
Once intervention has commenced, successful negotiation of problematic transitions 
could become desirable endpoints of treatment, rather than just the achievement of 
abstinence or moderation, demonstrably difficult to sustain. Invariably, this would 
call for extended treatment plans, possibly including multi-sectoral input including 
housing and employment sectors, but in the context of the risk of relapse, the 
personal and economic benefit could outweigh short term considerations. 
7.8 Implications for future research 
There are two aspects to the implications for future research. Firstly, there are the 
questions that can be addressed using descriptive research designs, including the 
current and future VAHCS. Secondly, there are generic questions, to be informed by 
studies such as those involving public education and prevention, regulation and 
treatment  
7.8.1 Descriptive research 
In terms of the VAHCS, our findings are important, but require replication. It is of 
interest to know whether they are valid in a cohort commencing in a subsequent 
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generation, where the background prevalence of cannabis use and age of initiation 
may have changed, along with legislative and socio-economic factors, including the 
acceptability of drug use. There is also uncertainty about cannabis use in sub-groups 
who were not accessed, such as out-of-school youth who may be consistently truant, 
in detention or in special education facilities not included in the VAHCS sampling 
frame. 
7.8.1.1 Natural history 
A number of questions arise from the papers and their discussions presented in this 
thesis. We have studied the natural history of cannabis use only until the late 20s 
when continued problematic and dependent use was still fairly common, with one in 
four participants reporting some use, 8% reporting daily use and 4% identified with 
cannabis dependence. Cannabis use was clearly not time-limited to the extent that 
previous studies predicted (Kandel & Logan 1984) and there is to date little 
understanding of the long term natural history beyond the age of expected “maturing 
out”. Observation of cannabis use into middle-age and beyond is needed to gauge the 
full extent of the natural history of cannabis use. An examination of any treatment 
regimens undertaken and their effectiveness is an essential component of this history. 
7.8.1.2 Social, substance use and mental health consequences  
We have reported a number of adverse outcomes associated with teenage cannabis 
use in the areas of other illicit substance use, common mental health problems and 
delayed or failed adult transitions, including persisting mental health problems 
despite abstention. These observations led to several questions about continuity of 
disability and disadvantage. Firstly, the sequence of events around cannabis 
use/abstention and achievement of adult transitions should be explored in concert and 
separately. Secondly, by examining these factors in both continuing and currently 
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abstinent users in the long term will enable further understanding of persistent 
disadvantage, if any, in adolescent users who subsequently abstain. Other factors 
such as mental health problems, other illicit substance use, problematic alcohol use 
and cigarette smoking will continue to be important outcomes, within the context of 
life events and other confounding. 
7.8.1.3 Biological explanations 
There are emerging questions about genetic liability for pre-disposing factors for 
problematic cannabis abuse identified in many studies. These possibly include a 
tendency to risk–taking, including experimentation with substance use in 
adolescence, escalation of substance use to dependent substance use, multi-substance 
abuse and co-occurring mental health problems. Microbiological pursuit of 
explanations for these liabilities is constructive only if it moves beyond these 
academic questions to an understanding of gene-environment interactions. The 
working paradigm should be that “environmental pathogens cause disorder, and … 
genes influence susceptibility to disorder” (Caspi & Moffitt 2006), allowing 
environmental causes and heterogeneity in responses to those causes. Identifying the 
reasons why environmental stimuli will be devastating for some people but not 
others will lead towards an understanding of susceptibility to substance dependence 
and mental illness, hopefully ultimately enabling control or prevention of these 
outcomes. Specifically, longitudinal observational studies designed to address 
questions relevant to understanding the vulnerability of some adolescents to adverse 
consequences from cannabis use need to be very large to deal with low frequency 
risk alleles at relevant loci (typically 1-5%) and multiple environmental exposures, 
whilst allowing the identification of a sufficiently large pool of carefully defined 
phenotypes or sub-phenotypes (Caspi & Moffitt 2006). 
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7.8.1.4 The VAHCS into established adulthood and middle age 
Some these questions will be addressed with the next wave of data collection, when 
the cohort participants are in their mid-30s. Subsequent waves beyond this age will 
continue to elucidate the life course of teenage cannabis users. Immediately relevant 
questions are outlined. 
7.8.1.4.1  Natural history  
What is the prevalence of cannabis dependence and regular use in the 
mid-30s? What are the patterns of use from adolescence through to the 
mid-30s? 
Reporting the natural history of cannabis use to the mid-30s will be a valuable 
extension of the findings to 24 years, presented in the third paper in this series (Swift 
et al. 2008). Understanding the trajectories and the importance and timing of 
moderation of use is important to describe as the background to more detailed 
examination of cannabis use to this age. This paper will be followed by successive 
detailed investigations on related topics. 
7.8.1.4.2  Social consequences 
(a) Does problematic cannabis use influence social transitions by mid-
30s? What are the psycho-social and substance usage confounders or 
modifiers of associations between transitions in cannabis use and social 
transitions? 
(b) Do social transitions predict changes in cannabis use status by mid-
30s? What are the psycho-social and substance usage confounders or 
modifiers of associations between social transitions and transitions in 
cannabis use? 
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These are complementary questions, and encompass related concepts. In Wave 10, 
when participants are in their mid-30s, we expect that many will have made 
transitions into adult roles, such as stable relationships, regular employment, 
parenthood, and financial independence and we anticipate that these transitions will 
impact on their substance-using careers and vice versa. Whether these transitions 
occur or do not occur can be investigated, along with other putative influences. 
Necessarily, these will include mental health measures and other substance use such 
as cigarette smoking, problematic alcohol use and other illicit substance use. 
Transitions in cannabis use will be identified including (a) remission from 
dependence, (b) abstinence from any use, (c) abstinence from problematic use (d) 
transition to dependent use. Composite role transition variables in adulthood will be 
defined following a literature search on this topic. 
How do psycho-social outcomes at 35 years for problematic cannabis 
users in their 20s compare with those for problematic alcohol users and 
those who abused both cannabis and alcohol in their 20s? How do social 
transitions influence subsequent substance use? 
This question is a sequel to our earlier paper in which we identified participants with 
problematic substance use were generally adopting either alcohol or cannabis as their 
substance of choice (Patton, GC et al. 2007). We showed that outcomes at 24 years 
for adolescents with problematic alcohol use were less severe than those using 
cannabis at problematic levels. So we will be interested to know whether this 
difference is sustained to the mid-30s or whether there is any reversal of this trend. 
This will also involve the identification of social transitions and will examine the 
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effect of each exposure on these outcomes. Again, the importance of each social 
transition in effecting transitions in substance use will be assessed. 
7.8.1.4.3 Mental health consequences 
Is regular cannabis use associated with individual anxiety symptoms 
throughout adolescence into young adulthood? Are these associations 
mediated by the direct stressful consequences of cannabis use in terms of 
school dropout, unemployment, welfare dependence, early parenthood?  
These questions form a sequel to the final paper in the series I presented in this thesis 
(Degenhardt et al. 2012). The association between cannabis use and anxiety 
symptoms needs to be examined in more detail, following the identification of a 
persisting effect at 29 years in adolescent daily cannabis users. In the discussion in 
Chapter 6, I identified a profile corresponding to elevated anxiety symptoms in Wave 
7 at 20 years, and this type of analysis could be extended to encompass the whole 
adolescent phase. Understanding whether these associations, when identifiable, are 
mediated by the consequences of cannabis use is an important question in the context 
of the suggestion by Rao (Rao 2006), who reported a possible link in the underlying 
biology of depression and anxiety and drug dependence, possibly involving the CNS 
response to stress, which we may be able to support or refute empirically. 
7.8.1.4.4 Cannabis and nicotine dependence  
How do the rates of later adolescent cannabis dependence in cannabis 
users compare with those of nicotine dependence in adolescent cigarette 
smokers? What is the inter-relationship between nicotine and cannabis 
dependence and how does this relate to anxiety and depression? What is 
the influence of personality disorder on this association? 
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Investigation of the relative rates of later dependence in adolescent cigarette smokers 
and cannabis users and the inter-relationships between them would add to the 
evidence linking these substances and consequent health burden, again examining 
data collected in the next wave at 35 years. By this age, many people will have 
moved away from dependent use of both substances, but we expect that there will be 
a core of persistent heavy users of either or both. Symptoms of depression and 
anxiety have already been linked to cigarette smoking (Patton, GC et al. 1998b), as 
has cannabis use (Degenhardt et al. 2012; Patton, GC et al. 2002) and Cluster-B 
personality disorder has been linked to substance use (Moran et al. 2006) in VAHCS. 
Again, it is important to provide empirical evidence to support or refute the 
biological explanations of the inter-relationship between substance dependence and 
psychological distress (Rao 2006). This would provide further evidence that could be 
used to inform public education and policy, given the ongoing health consequences 
of cigarette and cannabis smoking (Agrawal, Budney & Lynskey 2012). 
7.8.1.4.5 Genetic risk 
Can we identify genes associated with initiation and progression to daily 
cannabis use in adolescence, co-occurrence of cannabis dependence and 
major depression and anxiety disorders? What is the extent of overlap in 
genetic profiles of these disorders?  
In the VAHCS to date we have collected genetic samples using mouth swabs in 
Wave 8 from 963 participants (50% of ever participants) and have the opportunity to 
examine variants in genes directly involved in the cannabinoid CNS system. We 
probably do not have sufficient power to identify novel genes but we already have a 
track record in publishing findings supporting (or not) variants within candidate 
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genes underlying neurobiology systems known to be implicated in mental disorder 
and substance use problems (e.g., (Olsson, C et al. 2004; Olsson, CA et al. 2011). We 
also have the opportunity to improve power for genetic association studies by 
contributing VAHCS data into the Cannabis Cohort Research Consortium (CCRC), 
provided phenotype definition is valid and robust. The CCRC has enabled data 
pooling across four large population-based cohort studies, so far providing a sample 
of around 6,000 with limited existing genetic information on candidate genes 
involved in serotoneric and dopaminergic neurotransmission. Importantly, these two 
cohorts have genome-wide data which opens the possibility of whole genome scans 
for new variants associated with cannabis use that may or may not sit within known 
cannabinoid pathways. Findings from this investigation will make an important 
contribution to the genetic discussion. 
7.8.1.4.6 A new cohort study 
(a) Can the finding from the VAHCS be replicated in a new cohort study 
of adolescents conducted a generation later?  
(b) What is the natural history and consequences of cannabis use in out-
of-school subgroups not surveyed in VAHCS? 
(c) Can useful gene-environment interactions be identified? 
To answer these questions, a new cohort would need to be formed using the same 
sampling methodology as the VAHCS, but also including over-sampling of specific 
subgroups, including those absent from school at study inception, persistent truants, 
ethnic minorities attending small ethnic schools unlikely to be selected, those 
excluded from school for disciplinary reasons, those in custody and those in special 
education facilities not included in the VAHCS sampling frame. Consideration 
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should be given to extending the project interstate. There would be an advantage in 
continuing to use the same or, failing that, related measures (e.g., DSM-V for 
substance dependence) but these may be augmented by additional measures where 
further clarity would be obtained. These would be included at the cost of either 
increasing respondent burden, or at the expense of other measures which would need 
to be omitted, so would require careful consideration. Another component of the 
study would be an interview with the parents of participants at study inception and 
periodically afterwards in order to remedy the relatively poor ascertainment of 
parental factors in the VAHCS and to gain insight into putative childhood 
confounders and mediators which were unmeasured previously. 
Whether collection of genetic samples would be feasible depends on the anticipated 
sample size. Large samples are required to endow sufficient power to examine 
genetic-environment interactions and, although a fascinating and important project, 
without this facility it probably would not be a good use of resources. Pooling 
observational data and genetic material with other studies would be extremely 
desirable, but in order to do this, phenotype definition must be consistent between 
studies, a tall order when dealing with other project teams with different agendas. 
7.8.1 Education, regulation and treatment 
The findings lead to further questions around policies to regulate cannabis use, as 
well as the scope for prevention and treatment. Tobacco consumption and exposure 
are now accepted globally as having long-term health, social, environmental and 
economic consequences, resulting in widely applied restrictions on the consumption 
and distribution of cigarettes throughout WHO member countries. The tobacco 
control movement has been built on incontrovertible evidence on the consequences 
Chapter 7 Summary and discussion 
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of tobacco use over a prolonged period. Until now our state of understanding of 
cannabis use and its consequences have been less clear and less convincing. Public 
education in in the harms associated with cannabis use will be an important facet of 
prevention.   Other strategies that may be important include the development of more 
preventive legislation and the scope for raising the price of cannabis. Given its ease 
of cultivation the latter may prove difficult.  
Although deregulation and diversion as they are practised in Australia coincided with 
a reduction from 1998 to 2007, cannabis use may now be on the rise again (ACC 
2012). As both systems constitute deregulation to a certain degree, the possibility of 
further deregulation could be considered. Further curtailment of legal penalties for 
possession and small-scale production could take place while retaining penalties for 
commercial production and dealing.  So too, improved education of the general 
public and providers might lead to better recognition, and timely and effective 
treatment. Removing sanctions on possession and production, or at least lifting the 
threshold for prosecution, has the potential to reduce the damaging consequences of 
obtaining a criminal record. Future initiatives should be carefully designed to allow 
the highest possible level of evaluation.   
 
190 
 
REFERENCES 
ACC 2012, Illicit Drug Data Report 2007-08 Australian Crime Commission, 
Canberra. 
 
Agrawal, A, Budney, AJ & Lynskey, MT 2012, 'The co-occurring use and misuse of 
cannabis and tobacco: a review', Addiction, vol. 107, no. 7, pp. 1221-33. 
 
AIHW 2010, 2010 National Drug Strategy Household Survey report, PHE 145, 
Australian Institute of Health and Welfare, Canberra. 
 
AllPsych, retrieved 11/11/2011, <http://allpsych.com/about.html>. 
 
Ames, F 1958, 'A clinical and metabolic study of acute intoxication with Cannabis 
sativa and its role in the model psychoses', J Ment Sci, vol. 104, no. 437, pp. 972-99. 
 
Andreasson, S, Allebeck, P, Engstrom, A & Rydberg, U 1987, 'Cannabis and 
schizophrenia. A longitudinal study of Swedish conscripts', Lancet, vol. 2, no. 8574, 
pp. 1483-6. 
 
Anthony, JC 2006, 'The epiemiology of cannabis dependence', in RAaS Roffman, 
R.S. (ed.), Cannabis dependence: its nature, consequences and treatment, 
Cambridge University Press, Cambridge, UK, pp. 58-105. 
 
Asbridge, M, Hayden, JA & Cartwright, JL 2012, 'Acute cannabis consumption and 
motor vehicle collision risk: systematic review of observational studies and meta-
analysis', BMJ, vol. 344, p. e536. 
 
Australian alcohol guidelines for low-risk drinking: draft for public consultation,  
2007, National Health and Medical Research Council (NHMRC). 
 
Australian alcohol guidelines: health risks and benefits,  2001, National Health and 
Medical Research Council (NHMRC). 
 
Barkus, E & Murray, RM 2010, 'Substance use in adolescence and psychosis: 
clarifying the relationship', Annu Rev Clin Psychol, vol. 6, pp. 365-89. 
 
Bava, S & Tapert, SF 2010, 'Adolescent brain development and the risk for alcohol 
and other drug problems', Neuropsychol Rev, vol. 20, no. 4, pp. 398-413. 
 191 
 
 
Bernaards, CA, Belin, TR & Schafer, JL 2007, 'Robustness of a multivariate normal 
approximation for imputation of incomplete binary data', Stat Med, vol. 26, no. 6, pp. 
1368-82. 
 
Bond, L, Thomas, L, Coffey, C, Glover, S, Butler, H, Carlin, JB & Patton, G 2004, 
'Long-term impact of the gatehouse project on cannabis use of 16-year-olds in 
Australia', Journal of School Health, vol. 74, no. 1, pp. 23-9. 
 
Bromberg, W 1933, 'Marijuana intoxicationn: A clinical study of cannabis sativa 
intoxication', Am J Psychiatry, vol. 91, no. 2, pp. 303-30. 
 
Budney, AJ & Hughes, JR 2006, 'The cannabis withdrawal syndrome', Current 
Opinion in Psychiatry, vol. 19, no. 3, pp. 233-8. 
 
Budney, AJ, Moore, BA, Vandrey, RG & Hughes, JR 2003, 'The time course and 
significance of cannabis withdrawal', J Abnorm Psychol, vol. 112, no. 3, pp. 393-
402. 
 
Carlin, JB, Galati, JC & Royston, PA 2008, 'A new framework for managing and 
analysing imputed data in Stata', Stata Journal, vol. 8, pp. 49-67. 
 
Carlin, JB, Wolfe, R, Coffey, C & Patton, GC 1999, 'Analysis of binary outcomes in 
longitudinal studies using weighted estimating equations and discrete-time survival 
methods: prevalence and incidence of smoking in an adolescent cohort', Stat Med, 
vol. 18, no. 19, pp. 2655-79. 
 
Carlson, ET 1974, 'Cannabis indica in 19th-century psychiatry', Am J Psychiatry, vol. 
131, no. 9, pp. 1004-7. 
 
Cascini, F, Aiello, C & Di Tanna, G 2012, 'Increasing delta-9-tetrahydrocannabinol 
(Delta-9-THC) content in herbal cannabis over time: systematic review and meta-
analysis', Curr Drug Abuse Rev, vol. 5, no. 1, pp. 32-40. 
 
Caspi, A & Moffitt, TE 2006, 'Gene-environment interactions in psychiatry: joining 
forces with neuroscience', Nat Rev Neurosci, vol. 7, no. 7, pp. 583-90. 
 
Castle, D & Murray, R (eds) 2004, Marijuana and madness, Cambridge University 
Press, Cambridge, United Kingdom. 
 
 192 
 
Catalano, RF, Fagan, AA, Gavin, LE, Greenberg, MT, Irwin, CE, Jr., Ross, DA & 
Shek, DT 2012, 'Worldwide application of prevention science in adolescent health', 
Lancet, vol. 379, no. 9826, pp. 1653-64. 
 
Chen, K & Kandel, DB 1995, 'The natural history of drug use from adolescence to 
the mid-thirties in a general population sample', Am J Public Health, vol. 85, no. 1, 
pp. 41-7. 
 
Christensen, R, Kristensen, PK, Bartels, EM, Bliddal, H & Astrup, A 2007, 'Efficacy 
and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials', 
Lancet, vol. 370, no. 9600, pp. 1706-13. 
 
Coffey, C, Carlin, JB, Lynskey, M, Li, N & Patton, GC 2003, 'Adolescent precursors 
of cannabis dependence: findings from the Victorian Adolescent Health Cohort 
Study', British Journal of Psychiatry, vol. 182, pp. 330-6. 
 
Coffey, C, Lynskey, M, Wolfe, R & Patton, GC 2000, 'Initiation and progression of 
cannabis use in a population-based Australian adolescent longitudinal study', 
Addiction, vol. 95, no. 11, pp. 1679-90. 
 
Composite International Diagnostic Interview (CIDI) Core Version 2.1, 12 month 
version 1997, World Health Organization. 
 
Copeland, J & Swift, W 2009, 'Cannabis use disorder: epidemiology and 
management', Int Rev Psychiatry, vol. 21, no. 2, pp. 96-103. 
 
Crean, RD, Crane, NA & Mason, BJ 2011, 'An evidence based review of acute and 
long-term effects of cannabis use on executive cognitive functions', J Addict Med, 
vol. 5, no. 1, pp. 1-8. 
 
Creemers, HE, Korhonen, T, Kaprio, J, Vollebergh, WA, Ormel, J, Verhulst, FC & 
Huizink, AC 2009, 'The role of temperament in the relationship between early onset 
of tobacco and cannabis use: the TRAILS study', Drug Alcohol Depend, vol. 104, no. 
1-2, pp. 113-8. 
 
Crippa, JA, Zuardi, AW, Martin-Santos, R, Bhattacharyya, S, Atakan, Z, McGuire, P 
& Fusar-Poli, P 2009, 'Cannabis and anxiety: a critical review of the evidence', Hum 
Psychopharmacol, vol. 24, no. 7, pp. 515-23. 
 
Danovitch, I & Gorelick, DA 2012, 'State of the art treatments for cannabis 
dependence', Psychiatric Clinics of North America, vol. 35, no. 2, pp. 309-26. 
 193 
 
 
Darke, S 1998, 'Self-report among injecting drug users: a review', Drug Alcohol 
Depend, vol. 51, no. 3, pp. 253-63; discussion 67-8. 
 
De Quincey, T 1856, Confessions of an English Opium-Eater, James Hogg. 
 
Decorte, T 2010, 'The case for small-scale domestic cannabis cultivation', Int J Drug 
Policy, vol. 21, no. 4, pp. 271-5. 
 
Degenhardt, L, Coffey, C, Carlin, JB, Swift, W, Moore, E & Patton, GC 2010, 
'Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in 
Victoria, Australia', British Journal of Psychiatry, vol. 196, no. 4, pp. 290-5. 
 
Degenhardt, L, Coffey, C, Moran, P, Carlin, JB & Patton, GC 2007, 'The predictors 
and consequences of adolescent amphetamine use: findings from the Victoria 
Adolescent Health Cohort Study', Addiction, vol. 102, no. 7, pp. 1076-84. 
 
Degenhardt, L, Coffey, C, Romaniuk, H, Swift, W, Carlin, JB, Hall, WD & Patton, 
GC 2012, 'The persistence of the association between adolescent cannabis use and 
common mental disorders into young adulthood', Addiction. 
 
Degenhardt, L, Dierker, L, Chiu, WT, Medina-Mora, ME, Neumark, Y, Sampson, N, 
Alonso, J, Angermeyer, M, Anthony, JC, Bruffaerts, R, de Girolamo, G, de Graaf, R, 
Gureje, O, Karam, AN, Kostyuchenko, S, Lee, S, Lepine, JP, Levinson, D, 
Nakamura, Y, Posada-Villa, J, Stein, D, Wells, JE & Kessler, RC 2010, 'Evaluating 
the drug use "gateway" theory using cross-national data: consistency and 
associations of the order of initiation of drug use among participants in the WHO 
World Mental Health Surveys', Drug Alcohol Depend, vol. 108, no. 1-2, pp. 84-97. 
 
Degenhardt, L & Hall, W 2012, 'Extent of illicit drug use and dependence, and their 
contribution to the global burden of disease', Lancet, vol. 379, no. 9810, pp. 55-70. 
 
Degenhardt, L, Hall, W & Lynskey, M 2003a, 'Exploring the association between 
cannabis use and depression', Addiction, vol. 98, no. 11, pp. 1493-504. 
 
Degenhardt, L, Hall, W & Lynskey, M 2003b, 'Testing hypotheses about the 
relationship between cannabis use and psychosis', Drug and Alcohol Dependence, 
vol. 71, no. 1, pp. 37-48. 
 
 194 
 
DeWit, DJ, Hance, J, Offord, DR & Ogborne, A 2000, 'The influence of early and 
frequent use of marijuana on the risk of desistance and of progression to marijuana-
related harm', Prev Med, vol. 31, no. 5, pp. 455-64. 
 
Di Forti, M, Iyegbe, C, Sallis, H, Kolliakou, A, Falcone, MA, Paparelli, A, Sirianni, 
M, La Cascia, C, Stilo, SA, Marques, TR, Handley, R, Mondelli, V, Dazzan, P, 
Pariante, C, David, AS, Morgan, C, Powell, J & Murray, RM 2012, 'Confirmation 
that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis 
Users', Biol Psychiatry, vol. 72, no. 10, pp. 811-6. 
 
DiNardo, J & Lemieux, T 2001, 'Alcohol, marijuana, and American youth: the 
unintended consequences of government regulation', J Health Econ, vol. 20, no. 6, 
pp. 991-1010. 
 
Edwards, G, Arif, A & Hodgson, R 1981, 'Nomenclature and classification of drug- 
and alcohol-related problems: a WHO memorandum', Bulletin of the World Health 
Organsisation, vol. 59, no. 2, pp. 225-42. 
 
Edwards, G & Gross, MM 1976, 'Alcohol dependence: provisional description of a 
clinical syndrome', Br Med J, vol. 1, no. 6017, pp. 1058-61. 
 
Ellickson, PL, Martino, SC & Collins, RL 2004, 'Marijuana use from adolescence to 
young adulthood: multiple developmental trajectories and their associated outcomes', 
Health Psychol, vol. 23, no. 3, pp. 299-307. 
 
Fendrich, M, Mackesy-Amiti, ME, Johnson, TP, Hubbell, A & Wislar, JS 2005, 
'Tobacco-reporting validity in an epidemiological drug-use survey', Addict Behav, 
vol. 30, no. 1, pp. 175-81. 
 
Fergusson, DM & Horwood, LJ 1997, 'Early onset cannabis use and psychosocial 
adjustment in young adults', Addiction, vol. 92, no. 3, pp. 279-96. 
 
Fergusson, DM, Horwood, LJ & Beautrais, AL 2003, 'Cannabis and educational 
achievement', Addiction, vol. 98, no. 12, pp. 1681-92. 
 
Fergusson, DM, Horwood, LJ & Swain-Campbell, N 2002, 'Cannabis use and 
psychosocial adjustment in adolescence and young adulthood', Addiction, vol. 97, no. 
9, pp. 1123-35. 
 
Fergusson, DM, Lynskey, MT & Horwood, LJ 1996, 'The short-term consequences 
of early onset cannabis use', J Abnorm Child Psychol, vol. 24, no. 4, pp. 499-512. 
 195 
 
 
Goldberg, D, Williams, P,A. 1988, User's Guide to the General Health 
Questionnaire, NFER-NELSON. 
 
Hall, W 1999, 'Assessing the health effects of cannabis', in H Kalant, Corrigall, 
W.A., Hall, W., Smart, R. (ed.), The Health effects of cannabis, Centre for Addiction 
and Mental Health, Toronto, Canada, pp. 3-17. 
 
Hall, W, Fischer, B. 2010, 'Harm reduction policies for cannabis', in T Rhodes, 
Hedrich, D. (ed.), Harm reduction: evidence, impacts and challenges, Publications 
Office of the European Union, Luxemborg, pp. 235-52. 
 
Hall, W, Johnston, L., Donnelly N. 1999, 'Epidemiology of cannabis use and its 
consequences', in H Kalant, Corrigall, W.A., Hall, W., Smart, R. (ed.), The health 
effects of cannabis, 1st edn, Center for Addictiona nd Mental Health, Canada, pp. 19-
68. 
 
Hawkins, JD, Catalano, RF & Miller, JY 1992, 'Risk and protective factors for 
alcohol and other drug problems in adolescence and early adulthood: implications for 
substance abuse prevention', Psychol Bull, vol. 112, no. 1, pp. 64-105. 
 
Hayatbakhsh, MR, Najman, JM, Jamrozik, K, Mamun, AA, Alati, R & Bor, W 2007, 
'Cannabis and anxiety and depression in young adults: a large prospective study', J 
Am Acad Child Adolesc Psychiatry, vol. 46, no. 3, pp. 408-17. 
 
Heatherton, TF, Kozlowski, LT, Frecker, RC & Fagerstrom, KO 1991, 'The 
Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance 
Questionnaire', Br J Addict, vol. 86, no. 9, pp. 1119-27. 
 
Horwood, LJ, Fergusson, DM, Coffey, C, Patton, GC, Tait, R, Smart, D, Letcher, P, 
Silins, E & Hutchinson, DM 2012, 'Cannabis and depression: An integrative data 
analysis of four Australasian cohorts', Drug Alcohol Depend. 
 
Horwood, LJ, Fergusson, DM, Hayatbakhsh, MR, Najman, JM, Coffey, C, Patton, 
GC, Silins, E & Hutchinson, DM 2010, 'Cannabis use and educational achievement: 
findings from three Australasian cohort studies', Drug Alcohol Depend, vol. 110, no. 
3, pp. 247-53. 
 
Jessor, R 'Problem-Behaviour Theory - A Brief Overview', retrieved 25/05/2012, 
<http://www.colorado.edu/ibs/jessor/pb_theory.html>. 
 
 196 
 
Jessor, R 1976, 'Predicting time of onset of marijuana use: a developmental study of 
high school youth', J Consult Clin Psychol, vol. 44, no. 1, pp. 125-34. 
 
Jessor, R, Chase, JA & Donovan, JE 1980, 'Psychosocial correlates of marijuana use 
and problem drinking in a national sample of adolescents', Am J Public Health, vol. 
70, no. 6, pp. 604-13. 
 
Johnson, T & Fendrich, M 2005, 'Modeling sources of self-report bias in a survey of 
drug use epidemiology', Ann Epidemiol, vol. 15, no. 5, pp. 381-9. 
 
Jouanjus, E, Leymarie, F, Tubery, M & Lapeyre-Mestre, M 2011, 'Cannabis-related 
hospitalizations: unexpected serious events identified through hospital databases', Br 
J Clin Pharmacol, vol. 71, no. 5, pp. 758-65. 
 
Kandel, D 1975, 'Stages in adolescent involvement in drug use', Science, vol. 190, 
no. 4217, pp. 912-4. 
 
Kandel, DB 1984, 'Marijuana users in young adulthood', Arch Gen Psychiatry, vol. 
41, no. 2, pp. 200-9. 
 
Kandel, DB & Chen, K 2000, 'Types of marijuana users by longitudinal course', J 
Stud Alcohol, vol. 61, no. 3, pp. 367-78. 
 
Kandel, DB, Davies, M, Karus, D & Yamaguchi, K 1986, 'The consequences in 
young adulthood of adolescent drug involvement. An overview', Arch Gen 
Psychiatry, vol. 43, no. 8, pp. 746-54. 
 
Kandel, DB & Logan, JA 1984, 'Patterns of drug use from adolescence to young 
adulthood: I. Periods of risk for initiation, continued use, and discontinuation', Am J 
Public Health, vol. 74, no. 7, pp. 660-6. 
 
Kendler, KS & Prescott, CA 1998, 'Cannabis use, abuse, and dependence in a 
population-based sample of female twins', Am J Psychiatry, vol. 155, no. 8, pp. 
1016-22. 
 
Kendler, KS, Schmitt, E, Aggen, SH & Prescott, CA 2008, 'Genetic and 
environmental influences on alcohol, caffeine, cannabis, and nicotine use from early 
adolescence to middle adulthood', Arch Gen Psychiatry, vol. 65, no. 6, pp. 674-82. 
 
Kessler, RC, Andrews, G, Mroczek, D, Ustun, B & Wittchen, H-U 2006, 'The World 
Health Organization Composite International Diagnostic Interview short-form (CIDI-
 197 
 
SF)', International Journal of Methods in Psychiatric Research, vol. 7, no. 4, pp. 
171-85. 
 
Kokkevi, A, Nic Gabhainn, S & Spyropoulou, M 2006, 'Early initiation of cannabis 
use: a cross-national European perspective', J Adolesc Health, vol. 39, no. 5, pp. 712-
9. 
 
Korf, DJ, Benschop, A & Wouters, M 2007, 'Differential responses to cannabis 
potency: a typology of users based on self-reported consumption behaviour', Int J 
Drug Policy, vol. 18, no. 3, pp. 168-76. 
 
Lenton, S 2004, 'Pot, politics and the press--reflections on cannabis law reform in 
Western Australia', Drug Alcohol Rev, vol. 23, no. 2, pp. 223-33. 
 
Lewis, G, Pelosi, AJ, Araya, R & Dunn, G 1992, 'Measuring psychiatric disorder in 
the community: a standardized assessment for use by lay interviewers', Psychol Med, 
vol. 22, no. 2, pp. 465-86. 
 
Lewis, G, Pelosi, AJ, Glover, E, Wilkinson, G, Stansfeld, SA, Williams, P & 
Shepherd, M 1988, 'The development of a computerized assessment for minor 
psychiatric disorder', Psychol Med, vol. 18, no. 3, pp. 737-45. 
 
Livingston, M, Laslett, AM & Dietze, P 2008, 'Individual and community correlates 
of young people's high-risk drinking in Victoria, Australia', Drug Alcohol Depend, 
vol. 98, no. 3, pp. 241-8. 
 
Lynskey, M & Hall, W 2000, 'The effects of adolescent cannabis use on educational 
attainment: a review', Addiction, vol. 95, no. 11, pp. 1621-30. 
 
Lynskey, MT, Coffey, C, Degenhardt, L, Carlin, JB & Patton, G 2003, 'A 
longitudinal study of the effects of adolescent cannabis use on high school 
completion', Addiction, vol. 98, no. 5, pp. 685-92. 
 
Makkai, T & McAllister, I 1997, Marijuana in Australia: patterns and attitudes, 
Commonwealth of Australia, Canberra. 
 
Maldonado, R, Berrendero, F, Ozaita, A & Robledo, P 2011, 'Neurochemical basis of 
cannabis addiction', Neuroscience, vol. 181, pp. 1-17. 
 
Manderson, D 1993, From Mr Sin to Mr Big, Oxford University Press, South 
Melbourne, Australia. 
 198 
 
 
Maric, NP & Svrakic, DM 2012, 'Why schizophrenia genetics needs epigenetics: a 
review', Psychiatr Danub, vol. 24, no. 1, pp. 2-18. 
 
McGee, R, Williams, S, Poulton, R & Moffitt, T 2000, 'A longitudinal study of 
cannabis use and mental health from adolescence to early adulthood', Addiction, vol. 
95, no. 4, pp. 491-503. 
 
McGlothlin, WH & West, LJ 1968, 'The marihuana problem: an overview', Am J 
Psychiatry, vol. 125, no. 3, pp. 126-34. 
 
McLaren, J, Swift, W, Dillon, P & Allsop, S 2008, 'Cannabis potency and 
contamination: a review of the literature', Addiction, vol. 103, no. 7, pp. 1100-9. 
 
Meier, MH, Caspi, A, Ambler, A, Harrington, H, Houts, R, Keefe, RS, McDonald, 
K, Ward, A, Poulton, R & Moffitt, TE 2012, 'Persistent cannabis users show 
neuropsychological decline from childhood to midlife', Proc Natl Acad Sci U S A. 
 
Merline, AC, O'Malley, PM, Schulenberg, JE, Bachman, JG & Johnston, LD 2004, 
'Substance use among adults 35 years of age: prevalence, adulthood predictors, and 
impact of adolescent substance use', Am J Public Health, vol. 94, no. 1, pp. 96-102. 
 
Mikuriya, TH 1973a, in TH Mikuriya (ed.), Marijuana: Medcal Papers 1839-1972, 
Symposium Publishing, Nevada City. 
 
Mikuriya, TH (ed.) 1973b, Marijuana: Medical Papers 1839-1972, Symposium 
Publishing, Nevada City. 
 
Mikuriya, TH 2007, Physical, Mental, and Moral Effects of Marijuana: The Indian 
Hemp Drugs Commission Report, retrieved 11/11/2011, 
<http://www.druglibrary.org/schaffer/library/effects.htm >. 
 
Moffitt, TE & Silva, PA 1988, 'Self-reported delinquency, neuropsychological 
deficit, and history of attention deficit disorder', J Abnorm Child Psychol, vol. 16, no. 
5, pp. 553-69. 
 
Moran, P, Coffey, C, Mann, A, Carlin, JB & Patton, GC 2006, 'Personality and 
substance use disorders in young adults', Br J Psychiatry, vol. 188, pp. 374-9. 
 
Morgan, CJ & Curran, HV 2008, 'Effects of cannabidiol on schizophrenia-like 
symptoms in people who use cannabis', Br J Psychiatry, vol. 192, no. 4, pp. 306-7. 
 199 
 
 
Murray, RM, Morrison, PD, Henquet, C & Di Forti, M 2007, 'Cannabis, the mind 
and society: the hash realities', Nat Rev Neurosci, vol. 8, no. 11, pp. 885-95. 
 
Musto, DF 1972, 'The Marihuana Tax Act of 1937', Arch Gen Psychiatry, vol. 26, 
no. 2, pp. 101-8. 
 
Olsson, C, Anney, R, Forrest, S, Patton, G, Coffey, C, Cameron, T, Hassett, A & 
Williamson, R 2004, 'Association between dependent smoking and a polymorphism 
in the tyrosine hydroxylase gene in a prospective population-based study of 
adolescent health', Behav Genet, vol. 34, no. 1, pp. 85-91. 
 
Olsson, CA, Moyzis, RK, Williamson, E, Ellis, JE, Parkinson-Bates, M, Patton, GC, 
Dwyer, T, Romaniuk, H & Moore, EE 2011, 'Gene-environment interaction in 
problematic substance use: interaction between DRD4 and insecure attachments', 
Addict Biol. 
 
Patton, G, Bond, L, Butler, H & Glover, S 2003, 'Changing schools, changing 
health? Design and implementation of the Gatehouse Project', J Adolesc Health, vol. 
33, no. 4, pp. 231-9. 
 
Patton, GC, Carlin, JB, Coffey, C, Wolfe, R, Hibbert, M & Bowes, G 1998a, 'The 
course of early smoking: a population-based cohort study over three years', 
Addiction, vol. 93, no. 8, pp. 1251-60. 
 
Patton, GC, Carlin, JB, Coffey, C, Wolfe, R, Hibbert, M & Bowes, G 1998b, 
'Depression, anxiety, and smoking initiation: a prospective study over 3 years', Am J 
Public Health, vol. 88, no. 10, pp. 1518-22. 
 
Patton, GC, Coffey, C, Carlin, JB, Degenhardt, L, Lynskey, M & Hall, W 2002, 
'Cannabis use and mental health in young people: cohort study', BMJ, vol. 325, no. 
7374, pp. 1195-8. 
 
Patton, GC, Coffey, C, Carlin, JB, Sawyer, SM & Lynskey, M 2005, 'Reverse 
gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine 
dependence', Addiction, vol. 100, no. 10, pp. 1518-25. 
 
Patton, GC, Coffey, C, Lynskey, MT, Reid, S, Hemphill, S, Carlin, JB & Hall, W 
2007, 'Trajectories of adolescent alcohol and cannabis use into young adulthood', 
Addiction, vol. 102, no. 4, pp. 607-15. 
 
 200 
 
Pennington, D 1999, An overview of drug use and drug policy in Australia, Museum 
VIctoria. 
 
Pilgrim, JA, Mellers, JD, Boothby, HA & Mann, AH 1993, 'Inter-rater and temporal 
reliability of the Standardized Assessment of Personality and the influence of 
informant characteristics', Psychol Med, vol. 23, no. 3, pp. 779-86. 
 
Rao, U 2006, 'Links between depression and substance abuse in adolescents: 
neurobiological mechanisms', Am J Prev Med, vol. 31, no. 6 Suppl 1, pp. S161-74. 
 
Reilly, D, Didcott, P, Swift, W & Hall, W 1998, 'Long-term cannabis use: 
characteristics of users in an Australian rural area', Addiction, vol. 93, no. 6, pp. 837-
46. 
 
Robins, LN 1995, 'The natural history of substance use as a guide to setting drug 
policy', Am J Public Health, vol. 85, no. 1, pp. 12-3. 
 
Robson, P 1997, 'Cannabis', Arch Dis Child, vol. 77, no. 2, pp. 164-6. 
 
Rogeberg, O 2013, 'Correlations between cannabis use and IQ change in the Dunedin 
cohort are consistent with confounding from socioeconomic status', Proc Natl Acad 
Sci U S A. 
 
Roxburgh, A, Hall, WD, Degenhardt, L, McLaren, J, Black, E, Copeland, J & 
Mattick, RP 2010, 'The epidemiology of cannabis use and cannabis-related harm in 
Australia 1993-2007', Addiction, vol. 105, no. 6, pp. 1071-9. 
 
Rubin, DB 1987, Multiple Imputation for Nonresponse in Surveys, Wiley, New 
York. 
 
Rubino, T, Zamberletti, E & Parolaro, D 2012, 'Adolescent exposure to cannabis as a 
risk factor for psychiatric disorders', Journal of Psychopharmacology, vol. 26, no. 1, 
pp. 177-88. 
 
Saha, S, Chant, D, Welham, J & McGrath, J 2005, 'A systematic review of the 
prevalence of schizophrenia', PLoS Med, vol. 2, no. 5, p. e141. 
 
Sawyer, SM, Afifi, RA, Bearinger, LH, Blakemore, SJ, Dick, B, Ezeh, AC & Patton, 
GC 2012, 'Adolescence: a foundation for future health', Lancet, vol. 379, no. 9826, 
pp. 1630-40. 
 201 
 
 
Schafer, JL 1997, Analysis of Incomplete Multivariate Data. , Chapman & Hall 
London. 
 
Schneider, M 2008, 'Puberty as a highly vulnerable developmental period for the 
consequences of cannabis exposure', Addiction Biology, vol. 13, no. 2, pp. 253-63. 
 
Semple, DM, McIntosh, AM & Lawrie, SM 2005, 'Cannabis as a risk factor for 
psychosis: systematic review', J Psychopharmacol, vol. 19, no. 2, pp. 187-94. 
 
Shedler, J & Block, J 1990, 'Adolescent Drug use and Psychological Health: A 
longitudinal Inquiry', American Psychologist, vol. 45, no. 5, pp. 612-30. 
 
Short, M 2012, Rethinking our attitude to drugs, The Age, copyright Fairfax Media, 
retrieved 10/12/2012 2012, <http://www.theage.com.au/national/rethinking-our-
attitude-to-drugs-20121209-2b3dn.html>. 
 
Solowij, N & Grenyer, BF 2002, 'Are the adverse consequences of cannabis use age-
dependent?', Addiction, vol. 97, no. 9, pp. 1083-6. 
 
Spooner, C, Hall, W & Mattick, RP 2001, 'An overview of diversion strategies for 
Australian drug-related offenders', Drug and Alcohol Review, vol. 20, pp. 281-94. 
 
Staff, J, Schulenberg, JE, Maslowsky, J, Bachman, JG, O'Malley, PM, Maggs, JL & 
Johnston, LD 2010, 'Substance use changes and social role transitions: proximal 
developmental effects on ongoing trajectories from late adolescence through early 
adulthood', Dev Psychopathol, vol. 22, no. 4, pp. 917-32. 
 
StataCorp,  2011, College Station, TX: StataCorp LP. 
 
Strang, J, Witton, J & Hall, W 2000, 'Improving the quality of the cannabis debate: 
defining the different domains', BMJ, vol. 320, no. 7227, pp. 108-10. 
 
Swain, NR, Gibb, SJ, Horwood, LJ & Fergusson, DM 2012, 'Alcohol and cannabis 
abuse/dependence symptoms and life satisfaction in young adulthood', Drug Alcohol 
Rev, vol. 31, no. 3, pp. 327-33. 
 
Swift, W, Coffey, C, Carlin, JB, Degenhardt, L, Calabria, B & Patton, GC 2009, 'Are 
adolescents who moderate their cannabis use at lower risk of later regular and 
dependent cannabis use?', Addiction, vol. 104, no. 5, pp. 806-14. 
 202 
 
 
Swift, W, Coffey, C, Carlin, JB, Degenhardt, L & Patton, GC 2008, 'Adolescent 
cannabis users at 24 years: trajectories to regular weekly use and dependence in 
young adulthood', Addiction, vol. 103, no. 8, pp. 1361-70. 
 
Swift, W, Coffey, C, Degenhardt, L, Carlin, JB, Romaniuk, H & Patton, GC 2012, 
'Cannabis and progression to other substance use in young adults: findings from a 
13-year prospective population-based study', J Epidemiol Community Health, vol. 
66, no. 7, p. e26. 
 
Swift, W, Hall, W & Teesson, M 2001, 'Characteristics of DSM-IV and ICD-10 
cannabis dependence among Australian adults: results from the National Survey of 
Mental Health and Wellbeing', Drug Alcohol Depend, vol. 63, no. 2, pp. 147-53. 
 
Tashkin, DP 2010, 'Does cannabis use predispose to chronic airflow obstruction?', 
Eur Respir J, vol. 35, no. 1, pp. 3-5. 
 
Temple, EC, Brown, RF & Hine, DW 2011, 'The 'grass ceiling': limitations in the 
literature hinder our understanding of cannabis use and its consequences', Addiction, 
vol. 106, no. 2, pp. 238-44. 
 
Topol, EJ, Bousser, MG, Fox, KA, Creager, MA, Despres, JP, Easton, JD, Hamm, 
CW, Montalescot, G, Steg, PG, Pearson, TA, Cohen, E, Gaudin, C, Job, B, Murphy, 
JH & Bhatt, DL 2010, 'Rimonabant for prevention of cardiovascular events 
(CRESCENDO): a randomised, multicentre, placebo-controlled trial', Lancet, vol. 
376, no. 9740, pp. 517-23. 
 
Townsend, L, Flisher, AJ & King, G 2007, 'A systematic review of the relationship 
between high school dropout and substance use', Clin Child Fam Psychol Rev, vol. 
10, no. 4, pp. 295-317. 
 
UNDOC 2010, World Drug Report, United Nations, Vienna. 
 
van Os, J, Rutten, BP & Poulton, R 2008, 'Gene-environment interactions in 
schizophrenia: review of epidemiological findings and future directions', Schizophr 
Bull, vol. 34, no. 6, pp. 1066-82. 
 
Viveros, MP, Llorente, R, Suarez, J, Llorente-Berzal, A, Lopez-Gallardo, M & de 
Fonseca, FR 2012, 'The endocannabinoid system in critical neurodevelopmental 
periods: sex differences and neuropsychiatric implications', Journal of 
Psychopharmacology, vol. 26, no. 1, pp. 164-76. 
 203 
 
 
Wang, J, Yuan, W & Li, MD 2011, 'Genes and pathways co-associated with the 
exposure to multiple drugs of abuse, including alcohol, 
amphetamine/methamphetamine, cocaine, marijuana, morphine, and/or nicotine: a 
review of proteomics analyses', Mol Neurobiol, vol. 44, no. 3, pp. 269-86. 
 
WHO, World Health Organization, retrieved 11/11/2011, 
<http://www.who.int/substance_abuse/terminology/definition1/en/>. 
 
WHO 2004, Global Health Risks World Health Organisation, retrieved 30/06/2012, 
<http://www.who.int/healthinfo/global_burden_disease/risk_factors/en/index.html>. 
 
Williams, J 2004, 'The effects of price and policy on marijuana use: what can be 
learned from the Australian experience?', Health Econ, vol. 13, no. 2, pp. 123-37. 
 
Yamaguchi, K & Kandel, DB 1984, 'Patterns of drug use from adolescence to young 
adulthood: II. Sequences of progression', Am J Public Health, vol. 74, no. 7, pp. 668-
72. 
 
Zammit, S, Allebeck, P, Andreasson, S, Lundberg, I & Lewis, G 2002, 'Self reported 
cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: 
historical cohort study', BMJ, vol. 325, no. 7374, p. 1199. 
 
 
 204 
 
APPENDIX 1. Publications and grants arising from the VAHCS 
Peer reviewed papers sorted by primary focus 
Cannabis 
1. *Coffey C. Lynskey M. Wolfe R. Patton GC. Initiation and progression of 
cannabis use in a population-based Australian adolescent longitudinal study. 
Addiction. 95(11):1679-90, 2000  
2. *Patton GC, Coffey C, Posterino M, Carlin JB, Wolfe R. Adolescent 
depressive disorder: a population based study of ICD-10 symptoms. Aust. NZ 
J Psychiatry; 34 (5): 741-747, 2000. 
3. Coffey C, Carlin JB, Degenhardt L, Lynskey M, Sanci L, Patton G. Cannabis 
dependence in young adults: an Australian population study. Addiction 97(2) 
187-164,2002. 
4. Degenhardt L, Lynskey M, Coffey C, Patton G. “Diagnostic orphans” among 
young adult cannabis users: persons who report dependence symptoms but do 
not meet diagnostic criteria. Drug and Alcohol Dependence 67 (2): 205-212, 
2002. 
5. *Coffey C, Carlin JB, Lynskey ML, Li N, Patton GC. Adolescent precursors 
of cannabis dependence: findings from the Victorian Adolescent Health 
Cohort Study. British Journal of Psychiatry 182: 330-336, 2003 
6. *Lynskey M,Coffey C, Carlin JB, Patton GC. A longitudinal study of the 
effects of adolescent cannabis use on high school completion Addiction. 98 
(5): 685-692, 2003. 
 205 
 
7. Coffey C., Carlin J.B., Lynskey M.L., Degenhardt L., Patton G.C. Cannabis 
dependence in young adults: findings from the Victorian Adolescent Health 
Cohort Study. Journal Salud Ciencia 
http://www.siicsalud.com/dato/buscador/04126001.htm 2003 
8. *Patton GC., Coffey C., Carlin JB., Degenhardt L., Lynskey M., Hall W. 
Cannabis use and mental health in young people: cohort study. BMJ. 
325(7374):1195-8, 2002  
9. *Patton G.C., Coffey C. Carlin J.B., Sawyer S., Lynskey M. Reverse 
Gateways? Frequent cannabis use as a predictor of tobacco initiation and 
nicotine dependence. Addiction. 100; 1518-25, 2005 
10. *Patton G.C., Coffey C., Lynskey M.T., Reid S., Hemphill S., Carlin JB., 
Hall W. Trajectories of adolescent alcohol and cannabis use into young 
adulthood. Addiction. 102(4):607-15, 2007. 
11. Degenhardt L., Coffey C., Moran P., Patton G.C., Carlin J B., Swift W. Are 
diagnostic orphans at risk of developing cannabis abuse or dependence? Four 
year follow up of young adult cannabis users not meeting diagnostic criteria. 
Drug and Alcohol Dependence. 92: 86-90, 2008. 
12. *Swift W., Coffey C., Carlin J.B., Degenhardt L., Patton G.C. Adolescent 
cannabis users at 24 years: trajectories to more than weekly use and 
dependence in young adulthood. Addiction. 103(8): 1361-70, 2008. 
13. *Swift W., Coffey C, Carlin J.B, Degenhardt L, Calabria B, Patton G.C. Are 
adolescents who moderate their cannabis use at lower risk of later regular and 
dependent cannabis use? Addiction 104(5): 806-14, 2009 
 206 
 
14. Degenhardt L., Coffey C., Carlin J.B., Swift W., Moore E., Patton G.C. How 
risky is occasional cannabis use in adolescence? British J Psychiatry 196, 
290-295, 2010 
15. Horwood L.J., Fergusson D.J., Hayatbakhsh M.R., Najman J.M., Coffey C., 
Patton G.C., Silins E. Hutchinson D.M.. Cannabis use and educational 
achievement: findings from three Ausralasian cohort studies. Drug Alcohol 
Depend.110(3):247-53, 2010. 
16. *Swift W., Coffey C., Degenhardt L., Carlin J.B., Romaniuk H., Patton G.C. 
Cannabis and progression to other substance use in young adults: Findings 
from a 13-year prospective population-based study. J Epidemiol Community 
Health (2011). Doi: 10.1136/jech.2010.129056 
17. * Degenhardt L., Coffey C., Romaniuk H., Swift W., Carlin J. B., Hall W. D., 
Patton G. C. The persistence of the association between adolescent cannabis 
use and common mental disorders into young adulthood. Addiction DOI: 
10.1111/j.1360-0443.2012.04015.x 2012. Published online July 2012. 
Amphetamine use 
18. *Degenhardt L., Coffey C., Moran P., Carlin J. B., Patton G.C. The predictors 
and consequences of adolescent amphetamine use: findings from the 
Victorian Adolescent Health Cohort Study. Addiction. 102(7): 1076-84, 2007. 
19. Degenhardt L., Coffey C., Moran P., Carlin J.B., Patton G.C. Who are the 
new amphetamine users? A ten year prospective study of young Australian. 
Addiction. 102:1269-79, 2007. 
 207 
 
Cigarette smoking 
20. Patton GC, Carlin JB, Coffey C, Wolfe R,, Hibbert ME, Bowes G. The 
course of early smoking: a population based study over three years. Addiction 
93(8); 1251-60,1998. 
21. Patton GC, Carlin JB, Coffey C, Wolfe R, Hibbert ME,, Bowes G. 
Depression, anxiety and the initiation of smoking: a three year prospective 
cohort study. American Journal of Public Health 88(10):1518-22,1998. 
22. Patton G.C., Coffey C., Carlin J.B., Sawyer S.M., Wakefield M., Teen 
smokers reach their mid twenties. Journal of Adolescent Health. 39(2):214-
20, 2006. 
Alcohol  
23. Bonomo Y, Coffey C, Wolfe R, Lynskey M, Bowes G, Patton GC. Adverse 
outcomes of alcohol use in adolescents. Addiction; 96 (10): 1485-1496, 2001  
24. Bonomo Y, Bowes G., Coffey C., Carlin J.B., Patton G.C. Teenage drinking 
and the onset of alcohol dependence: a cohort study over seven years. 
Addiction. 99:1520-28, 2004. 
25. Moore E., Coffey C., Carlin J.B., Alati R., Patton G.C. Assessing alcohol 
guidelines in teenagers: results from a 10-year prospective study. ANZ J 
Public Health. 33 (2), 2009. 
Self harm  
26. Patton, G.C., Harris R, Carlin, J., Hibbert M., Coffey C., Schwarz M., Bowes 
G. Adolescent Suicidal behaviours: a population based study of risk. 
Psychological Medicine (27) :715-24,1997. 
 208 
 
27. Moran P., Coffey C., H. Romanuik, C Olsson, R Borschmann, J. C. Carlin, 
G.C. Patton. The natural history of self-harm from adolescence to young 
adulthood: a population-based cohort study. Lancet, November 2011, 
Published online November 17, 2011 DOI:10.1016/S0140-6736(11)61141-0 
Eating disorders and obesity 
28. Patton GC, Selzer R, Coffey C, Carlin JB, Wolfe R. The onset of adolescent 
eating disorders: a population based cohort study over three years. British 
Medical Journal 318(7186): 765-8, 1999 
29. Patton G.C., Coffey C, Sawyer S.M. The outcome of adolescent eating 
disorders: findings from the Victorian Adolescent Health Cohort Study. 
European Journal of Child and Adolescent Psychiatry. Jan;12 Suppl 1:I25-
I29, 2003 
30. Watson MJ. Coffey C. Carlin JB. Sawyer SM. Paton GC. Dietary restraint 
behaviour in adolescence and weight status in young adulthood. Asia Pacific 
Journal of Clinical Nutrition. 12 Suppl:S11, 2003. 
31. Sanci L., Coffey C., Olsson C., Reid S., Patton G.C. Childhood Sexual Abuse 
and Adolescent Eating Disorders: findings from the Victorian Adolescent 
Health Cohort Study. Archives Paediatrics and Adolescent Medicine. 
162(3):261-7, 2008. 
32. Patton G.C., Coffey C., Carlin J.B., Sanci L. Prognosis of adolescent partial 
syndromes of eating disorder. British Journal of Psychiatry 103(8):294-9, 
2008. 
33. Patton G.C., Coffey C., Carlin J.B., Sawyer S.M., Williams J., Olsson C.A., 
Wake M., Overweight and Obesity between Adolescence and Young 
 209 
 
Adulthood: a ten-year prospective cohort study. J Adolescent Health. 48(3), 
275-80, 2011 
Mental health 
34. Patton GC, Coffey C, Posterino M, Carlin JB, Wolfe R. Parental 
‘affectionless control’ in adolescent depressive disorder. Social Psychiatry 
and Psychiatric Epidemiology 36 (10): 475-480, 2001 
35. Patton GC. Coffey C. Posterino M. Carlin JB. Bowes G. Life events and early 
onset depression: cause or consequence?. Psychological Medicine. 
33(7):1203-10, 2003. 
36. Patton G.C., Coffey C., Carlin JB., Olsson C.A. Prematurity at birth 
adolescent depressive disorder? British J Psychiatry. 184: 446-447, 2004. 
37. Moran P., Coffey C., Mann A., Carlin JB., Patton GC. Dimensional 
characteristics of DSM-IV personality disorders in a large epidemiological 
sample. Acta Psychiatrica Scandinavica. 113(3):233-6, 2006. 
38. Moran P., Coffey C., Mann A., Carlin J.B., Patton G.C. Personality and 
substance use disorders in young adults. British Journal of Psychiatry. 
188:374-9, 2006. 
39. Moran P., Coffey C., Chanen A., Mann A., Carlin J.B., Patton G.C.. 
Childhood sexual abuse and abnormal personality: an epidemiological study. 
Psychological Medicine. 41(06),1311-18, 2010. 
Methods 
40. Patton GC, Coffey C, Posterino M, Carlin JB, Wolfe R. A computerised 
screening instrument for adolescent depression: population-based validation 
 210 
 
and application to a two phase case control study. Social Psychiatry and 
Psychiatric Epidemiology 34 ((3): 166-72,1999 
41. Carlin JB, Wolfe R, Coffey C, Patton GC. Analysis of binary outcomes in 
longitudinal studies using weighted estimating equations and discrete-time 
survival methods: prevalence and incidence of smoking in an adolescent 
cohort. Statistics in MedIcine; 18(19): 2655 –99, 1999 
42. Carlin J.B., Li N, Greenwood P., Coffey C. Tools for analysing multiple 
imputed data sets. Stata Journal;3(3):1-20, 2003. 
Genetics 
43. Olsson C. Anney R. Forrest S. Patton G. Coffey C. Cameron T. Hassett A. 
Williamson R. Association between dependent smoking and a polymorphism 
in the tyrosine hydroxylase gene in a prospective population-based study of 
adolescent health. Behavior Genetics. 34(1):85-91, 2004. 
Book chapter  
Degenhardt L., Hall W., Lynskey M.,, Coffey C., Patton G.C. The association 
between cannabis use and depression: a review of the evidence. Marijuana and 
madness. 2nd Edition. Ed Castle D and Murray R, Cambridge UP, UK, 2011. 
VAHCS-focused research grants as investigator 
Title Funding source Period Amount 
Research grants as a chief investigator       
Adolescent health risk behaviours and psychopathology: continuities 
into adulthood NHMRC 1998 $72,159 
Victorian Adolescent Health Cohort Study Equipment Grant RCH Research Institute 1999 $40,000 
Building an epidemiological framework for the prevention of illicit 
drug abuse 
NHMRC Strategic Research 
Grant 2000/01 $77,658 
Psychosocial disorder of youth: a population-based prospective study 
into young adulthood NHMRC 2001/03 $445,000 
 211 
 
Determinants of adolescent and adult body mass index in the Victorian 
Adolescent Health Cohort Study. MCRI 2003 $50,000 
Depression and cardiovascular risk in young adults: the Victorian 
Adolescent Cohort Study: protocol development  MCRI 2004 $50,000 
Depression and cardiovascular risk in young adults: the Victorian 
Adolescent Cohort Study  NHMRC 2005/07 $526,000 
Research grants as an associate investigator       
Investigation of the genetic and social factors determining addictive 
behaviour RCHRI 1999 $37,569 
Scoping study for an Australia Longitudinal, prospective adolescent 
cohort Study 
NHMRC Strategic Research 
Grant  2000 $110,118 
Investigating the relationship between cannabis and other drug use, 
mental health, early-life factors and life-course outcomes: integrative 
analyses of data from four Australasian cohort studies 
NHMRC Project Grant 2012/13 $283,272 
Research grants as consultant       
Mental disorders and the social transitions of adulthood: a 20 year 
follow-up of the Victorian Adolescent Cohort Study NHMRC Project Grant 2011/13   
 
In addition, I am currently (March, 2013) included as an Associate Investigator in 
two VAHCS-related project submitted to the NHMRC for consideration of funding.  
 
 212 
 
APPENDIX 2. Candidate and co-author declarations for each 
paper included in the thesis. 
 
The following declarations provide evidence of my participation in the development 
of the papers included in the thesis. My percentage contribution was estimated in 
consultation with the signatories who were the last author for Papers 1 and 2 and the 
first author for Papers 3 to 12. Papers are referred to as “articles” in each declaration.   












 
